MSX-2, calcitriol and the control of differentiation in adult human bone-derived cells by Brown, Julie Michelle
        
University of Bath
PHD








Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 22. May. 2019
MSX-2, CALCITRIOL AND THE CONTROL OF DIFFERENTIATION IN ADULT
HUMAN BONE-DERIVED CELLS
submitted by Julie Michelle Brown 
for the degree of PhD 
of the University o f Bath 
1998
COPYRIGHT
Attention is drawn to the fact that the copyright of this thesis rests with its author. This copy 
of the thesis has been supplied on condition that anyone who consults it is understood to 
recognise that its copyright rests with its author and that no quotation from the thesis and no 
information derived from it may be published without the prior written concent of the author.
This thesis may be made available for consultation within the University Library and may be 
photocopied or lent to other libraries for the purposes of consultation.
UMI Number: U601B79
All rights reserved
INFORMATION TO ALL USERS  
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com plete manuscript 
and there are missing pages, th ese  will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U601379
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346

Abstract
In the developing organism, interactions between bone morphogenetic proteins 
(BMPs), homeodomain-containing proteins (including MSX) and fibroblastic growth 
factors_ stimulate and maintain the outgrowth of the limb. As endochondral and 
intramembranous ossification progress, members o f the transforming growth factor-beta 
superfamily, including BMPs, induce expression of MSX genes prior to induction of 
osteogenic markers. The coincident expression o f MSX and BMP genes by cells at bone 
forming sites, for example in craniofacial structures, and at remodelling kites in the adult, 
make them excellent candidates for study in an attempt to understand the regulation of the 
differentiation o f osteoblastic cells. In this project, in adult human boife-derived cells, 
consistent regulation of MSX-2 by BMPs was shown.
The pleiotropic steroid hormone metabolite, calcitriol, has a fundamental role in 
the control o f bone remodelling in the adult. The mechanisms whereby it regulates the 
cascade o f gene expression in the differentiation o f osteoblasts therefore are o f great 
interest. In the following investigations, stimulation of the expression o f osteoblast- 
related genes was seen to be consistent. Its direct regulation of osteocalcin gene 
expression was confirmed, but the control by calcitriol o f mRNA expression of BMP-2, 
BMP-4 and MSX-2 was seen to involve indirect mechanisms.
The presence of osteogenic factors in bone, such as transforming growth factor- 
beta, BMPs and calcitriol, and their association with the mineralised extracellular matrix 
strongly suggest a role in the expression o f osteoblast-related genes, alone or in 
combination with other factors. Regulation o f osteoblast-related gene expression in 
osteosarcoma-derived cells and in osteoblastic cells by osteogenic agents was seen to be 
complex and modulated by other factors, including cell density and cell-matrix interaction. 
Evidence suggests that the effects of these agents are cell maturation-specific and differ 
depen ding.upon the derivation of the cells.
In summary, the regulation of osteoblast-related gene expression in adult human 
osteoblastic cells depends on cell density, maturation state and derivation, and upon the 
dose o f agent(s) used. As in morphogenesis and development, in these adult human 
osteosarcoma- and bone-derived cells, MSX-2-expression was seen to be consistently 
regulated by BMP-2 and -4, and by calcitriol. Calcitriol and the synthetic glucocorticoid 
dexamethasone were seen to respectively enhance the maturation and differentiation of 
osteoblastic cells, and to alter their pattern o f gene expression in a cell maturation stage- 
specific manner.
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Chapter 1
IN T R O D U C T IO N
11.1 THE ANATOMY OF BONE
The skeleton has three main roles in the organism: it acts as a support and site 
for muscle attachment, it protects vital organs and bone marrow, and it is a reservoir of 
mineral ions, particularly calcium and phosphate. It also maintains blood ion 
concentrations and acts as a reservoir for growth factors and hormones which can be 
liberated as required by bone resorbing cells (osteoclasts). In the adult, resorption is 
coupled to bone formation such that bone is in a constant state o f  flux and is 
continuously removed by osteoclasts, then replaced by bone-forming cells (osteoblasts) 
(see figure 1.1, after Baron, 1990). a
There are two kinds of bone in the skeleton: flat bones such as the skull bones, 
scapula and mandible, and long bones, which include the femur and huifterus. There are 
also two types, o f bone structure: hard cortical bone which is found in the shafts o f the 
long bones surrounding. the marrow cavities and spongy, trabecular or cancellous bone, 
which consists o f a delicate interlacing network, the trabeculae, surrounding cavities 
containing red or fatty marrow. This latter kind of bone is found in the vertebrae, in 
most o f the flat bones and in the ends o f the long bones (Vaughan, 1975).
The main constituent o f bone is the extracellular matrix which is composed 
primarily o f collagen fibres, crystals o f hydroxyapatite and a ground substance made up 
o f proteoglycans and glycoproteins. These latter two compounds are strongly anionic 
and have a high ion-binding capacity: these properties are thought to be important in the 
calcification process and in fixing hydroxyapatite crystals to collagen fibres (Baron, 
1990).
Bone formation occurs in the organism during embryonic development, growth, 
remodelling, fracture repair and when induced experimentally. This complex process is 
dependent upon the proliferation and differentiation o f osteoblast precursors and upon 
the activity o f the fully differentiated osteoblasts, which are primarily responsible for 
the synthesis, organisation and deposition of an extracellular matrix which becomes 
physiologically mineralised during bone formation, modelling and focal turnover 
throughout life. Multipotent stem cells present in the bone marrow stroma can also be 
induced to differentiate into other cell types, including myoblasts and adipocytes (see 
figure 1.2, after Bruder et al, 1994). ,
Osteoblasts synthesize a range o f factors including collagen, alkaline 
phosphatase, bone morphogenetic proteins and osteocalcin (see figure 1.3, after Aubin 
et al, 1993) and are capable o f co-ordinating the temporal and spatial relationships 
between necessary constituents for the calcification o f bone. This calcification process 
is partnered by hydroxyapatite, an efficient adsorber for many different proteins, which 
sequesters components from the circulatory system and prevents escape o f  locally 
synthesized factors.
In vitro systems have been devised to allow the study o f osteoblast function at 
the cellular level. Human osteoblast-like cells can be obtained following outgrowth
2from adult trabecular bone fragments (Beresford et al, 1986) and such cells have been 
found to display characteristics o f osteoblasts including high alkaline phosphatase 
activity, production o f type I collagen and response to factors such as la ,  25- 
dihydroxyvitamin D3 (calcitriol) and bone morphogenetic proteins (BMPs).
1.2 BONE FORMATION 
Endochondral ossification
Bone grows in diameter by apposition of new bone on existing bone surface and 
in length by endochondral ossification (see figure 1.4) (Vaughan, 1975). In embryonic 
and adolescent long bone development, the cartilage template laid down at the sites of 
prospective bone is gradually replaced by bone: initially, metaphyseal growth plate 
cartilage becomes hypertrophic, then the matrix is calcified and resorbed. Marrow- 
derived mesenchymal, stem cells migrate to these resorption sites where they 
differentiate along the osteoblastic pathway and produce bone matrix. N ew  bone 
spicules are orientated on the surface of the resorbing hypertrophic cartilage according 
to vasculature. Then, following the interactions o f resorption, synthesis and mechanical 
forces, the spicules are remodelled into mature weight-bearing bone (Bruder et al, 
1994).
Hypertrophic chondrocytes can transdifferentiate into osteoblast-like cells 
(Roach et al, 1995), characterised by the expression and synthesis o f  alkaline 
phosphatase, osteonectin, osteopontin, bone sialoprotein and type I collagen (Fedarko et 
al, 1992) and responsiveness to hormones and growth factors (Pfeilschifter et al, 1993). 
These and cells derived from the bone marrow deposit type I collagen on the surface of 
eroded cartilage to begin the process of endochondral ossification (Galotto et al, 1994).
Bone repair and regeneration
After breaking a long bone, a group of cells which includes mesenchymal stem 
cells is drawn to the fracture site to form the repair blastema. If the fracture is 
mechanically stable, vasculature and bone formation proceeds; if  the fracture is 
unstable, cartilage is produced, then periosteal bone formation occurs to provide a rigid 
framework, and vascularisation takes place. The cartilage hypertrophies and is replaced 
by marrow, then bone: lack o f vascularisation fosters cartilage formation (Bruder et al,
1994).
Bone substitutes consisting of ceramics, hydroxyapatite and titanium have been 
used to repair bone with varying degrees o f success (Holmes et al, 1987; W olff et al, 
1994; Zambonin and Grano, 1995). The characteristics o f material implanted which 
affect the efficiency o f repair are composition, topography, roughness and surface 
energy of the implant (Schwartz and Boyan, 1994), upon which factors the proliferative 
ability or physiology o f interacting cells may depend (Hunter et al, 1995).
3Mechanical loading
In the adult, mechanical forces regulate bone formation: periosteal bone 
formation is increased following loading of the bone with an external force. In rat tibia, 
this was achieved by an initial increase in cell proliferation as shown by increased 
transcription o f transforming growth factor-beta (TGF-beta), c-fos and insulin-like 
growth factor (IGF-II) with a synchronous decrease in differentiation markers such as 
alkaline phosphatase, osteopontin and osteocalcin (Raabcullen et al, 1994). Similarly, 
mouse calvarial cells mechanically loaded by intermittent hydrostatic compression were 
shown to release increased amounts o f TGF-beta activity into the medium (Klein- 
Nulend et al, 1995). Human osteoblast-like cells express more type I collagen mRNA 
and protein, and increased osteopontin and osteocalcin mRNA levels following  
exposure to intermittent mechanical strain (Harter et al, 1995).
: ■ ' ’’ i
1.3 METABOLIC AND CONGENITAL BONE DISORDERS 
Skeletal dysplasia
The abnormal organisation of cells into tissues and its morphological results is 
known as dysplasia (Darby and Byers, 1994). Genetic skeletal dysplasias are disorders 
of pre- and post-natal skeletal growth which are characterised by some or all o f the 
following phenotypic manifestations: short stature, bodily disproportion, deformity and 
functional abnormality. Included are achondroplasia (ACH), thanatophoric dysplasia 
(TD), and hypochondroplasia (HCH), which are fibroblastic growth factor (FGF)- 
related disorders o f the long bones in which abnormal endochondral ossification is 
observed affecting the normal expansion o f the cartilaginous growth plate o f the long 
bones and base o f the skull. Characteristics o f all three disorders include an enlarged 
skull, spinal abnormalities and shortening o f the limbs.
Mutations in the fibroblastic growth factor receptor (FGFR) 3 gene have been 
associated with all three disorders (Muenke and Schell, 1995): ACH is the most 
common skeletal dysplasia and is caused by an autosomal dominant mutation in the 
FGFR3 gene (Rousseau et al, 1994). In the heterozygote, there are minimal histological 
changes and a very mild phenotype; the homozygous condition usually results in death 
at the pre- or neo-natal stage. Hypochondroplasia has an even milder presentation. TD, 
or “death-bearing” dysplasia, is the most common lethal skeletal dysplasia and is 
inherited in an autosomal dominant fashion. Expression of the disease results in severe 
short-limbed dwarfism, characterised by disorganised endochondral ossification, with a 
lack o f ordered rows o f cartilage cells and chondrocytic hypertrophy. It is thought this is 
as a result o f persistence o f abnormal fetal mesenchyme transformed into severely 
abnormal bone and cartilage (McAlister, 1988). TD is characterised also by flattening of  
the vertebral bodies (platyspondyly).
Dvsostotic syndromes
A syndrome is defined as a pattern o f multiple anomalies thought to be 
pathogenetically related and not derived from a single known or assumed prior anomaly 
or mechanical factor (single sequence) or from disturbances o f a single development 
field (polytopic field defect). Included in this category are dysostoses, which is a group 
o f developmental diseases in which individual bones or regional constellations are 
malformed during organogenesis (Darby and Byers, 1994).
The premature fusion of cranial sutures is known as craniosynostosis and it is a 
characteristic o f over 100 inherited syndromes including craniofacial idysostosis (such 
as Crouzon’s syndrome) and acrocephalosyndactyly (including Apert and Pfeiffer’s 
syndromes). Intramembranous bone formation is adversely affected, but other 
phenotypic features can include fusion o f the digital bones and soft tissue syndactyly. 
All o f these d iseases are characterised by one or more o f  the follow ing: 
craniosynostosis, usually complete closure o f the sutures by age 3 years, and facial, 
hand or feet anomalies, resulting in such clinical features as mitten hand and sock foot 
(Apert syndrome) and broad thumbs and toes (Pfeiffer’s syndrome).
Most o f these disorders are due to a single autosomal dominant mutation: 
craniosynostosis, Boston type, has been linked to a dominant point mutation in the 
MSX-2 gene leading to a substitution o f a histidine for a proline in the homeodomain 
(Jabs et al, 1993). Crouzon, Pfeiffer, Apert and Jackson-Weiss syndromes have point 
mutations in the fibroblastic growth factor receptor 2 (FGFR2) gene (Reatdon et al, 
1994; Richman, 1995), although some Pfeiffer syndrome patients have a mutation in the 
same region o f the FGFR1 gene (Muenke and Schell, 1995). It was demonstrated that in 
patients with Crouzon’s disease the levels o f functional FGF receptor 2 were lower than 
in patients with similar but non-syndromic craniosynostosis (Bresnick and Schendel,
1995). No disorder has so far been linked to mutations in the FGFR4 gene.
Osteoporosis
Disruption o f bone homeostasis can lead to a wide variety o f metabolic bone 
diseases. Bone modelling is restricted to the young skeleton where osteoclastic 
resorption pits are fully refilled by osteoblasts. After development o f the-skeleton, the 
efficiency o f the osteoblasts decreases over time, resulting in a net deficit o f bone in the 
remodelling process and the overall reduction o f trabecular bone in the many thousands 
of remodelling sites all over the skeleton (Teitelbaum, 1990).
Osteopenia was defined recently as a value o f between 1 and 2.5 standard 
deviations below the young adult mean value; a level o f bone mineral density loss 
equivalent to 2.5 standard deviations or greater denotes osteoporosis (World Health 
Organisation definition, 1994, as referred to by Kanis et al, 1996). This disease is the 
most common metabolic bone disorder in the Western world and projections indicate 
that the incidence o f osteoporosis will double in the next 30 years. Currently, at least
33% of white women, who have the lowest peak adult bone mass, will have sustained a 
fracture in the distal forearm (Colles’ fracture) and a vertebral fracture by the age o f 70 
years, and a hip fracture by age 90 years (Kleerekoper and Avioli, 1990). In the United 
States, costs incurred from treatment o f this disease run into 10 billion dollars a year 
(Rosen, 1994); in the U.K., the current figure is greater than 750 million pounds a year 
(National Osteoporosis Society, 1996).
Osteoporosis manifests clinically as fracture with associated pain and deformity,
occurring in the vertebrae with associated height loss and possible spinal deformity such
as thoracic kyphosis (Dowager’s hump). Mortality within three months following hip
replacement due to osteoporotic fracture has been gauged at 20%, with permanent care
required for up to half o f all patients. Factors predisposing to osteotgorosis include 
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genetic elements, lifestyle components (including lack or excess o f weight-bearing
exercise, smoking and early natural menopause), nutritional factors and driig treatment.
The incidence in men. is lower than that in women due to higher peak bone mass and
lower life expectancy (Jackson, 1990) and rare cases have been observed,in juveniles
(Norman, 1990).
Loss o f bone mineral density can also occur as a result o f a separate medical 
disorder: marrow-related disorders (including leukaemias, anaemias, lipidoses and 
lymphomas) and connective tissue disorders (including scurvy, osteogenesis imperfecta 
and homocystinuria) have been implicated in the development o f osteoporosis 
(McKenna, 1990). It has been observed following drug treatments: pharmacological 
doses o f glucocorticoid produces severe disease due to direct suppression of osteoblastic 
bone forming activity and increased parathyroid hormone secretion which stimulates 
osteoclastic bone resorbing activity (Hahn, 1990); treatment with heparin, 
anticonvulsants and methotrexate have also been found to induce bone loss. Immobility 
due to injury, stroke, paralysis, lack of exercise or hypogravitational conditions, such as 
space travel, triggers reduction in bone mass, particularly in weight-bearing bones 
(McKenna, 1990).
1.4 THE OSTEOBLASTIC CELL LINEAGE
Osteoblastic cells arise from multipotential primitive mesenchymal stem cells 
which, following commitment to the osteogenic lineage, differentiate progressively to 
preosteoblasts, mature osteoblasts, and either lining cells or osteocytes (reviewed by 
Aubin et al, 1993).
Bone marrow stromal cells
Progenitor cells are found in bone marrow stroma and can commit to several 
lineages: formation o f muscle, fat, bone and cartilage can be induced from these 
multipotential cells (Grigoriadis et al, 1988). A subpopulation o f bone marrow stromal 
cells loaded into diffusion chambers was shown to form cartilage and bone (Bab et al,
61986): the relatedness o f these two lineages can be demonstrated by their ability to 
transdifferentiate under certain conditions (Roach, 1992; Pfeilschifter et al, 1993).
Human bone marrow contains a heterogeneous subset of bone precursor cells 
within which a subpopulation of proliferating osteoprogenitor cells exists: in vitro, these 
earlier cells produce a colony o f cells which respond to treatment with calcjtriol, bone 
morphogenetic protein-2 (BMP-2) and basic fibroblastic growth factor (FGF-2) (Long 
et al, 1995). The less proliferative precursors form smaller clusters of cells and have 
been found to be unresponsive to treatment with FGF-2 and are presumed to represent a 
more mature precursor (Long et al, 1995). t
Bone marrow precursors are identified by their ability in vitro to produce 
colonies o f fibroblast-like cells derived from individual clonogenic progenitors, termed 
colony forming unit-fibroblastic cells (CFU-F), in single-cell suspensions o f bone 
marrow (Gronthos and Simmons, 1995). The monoclonal antibody Stro-1- binds to the 
cell membrane-expressed, trypsin-resistant Stro-1 antigen on a subpopulation o f  human 
bone marrow stromal cells in which all detectable CFU-F are present (Simmons and 
Torok-Storb, 1991). The involvement o f these CFU-Fs in bone formation were shown 
when suspension o f rat hindlimbs reduced bone growth, numbers of adherent marrow 
stromal cells harvested from the femur and tibia, and total population o f colony forming 
unit-fibroblastic cells (Zhang et al, 1995).
Progression through proliferation and differentiation
There are fewer multipotential mesenchymal stem cells (MSCs) than tri- or 
bipotential cells, indicating that MSCs have a limited proliferative capability and that 
marginally more committed cells can proliferate more readily (Grigoriadis et al, 1990). 
A further expansion in population is noted with committed osteoprogenitors: 
preliminary osteoblast-related gene expression is maintained during proliferation while 
expression o f post-proliferation genes is suppressed, then proliferation is down- 
regulated and induction o f differentiation-specific genes occurs (Stein and Lian, 1993).
Genes implicated in cell growth and biosynthesis o f the extracellular matrix are 
highly expressed during the proliferation period, including c-myc, c-fos, c-jun, histone 
H4, type I collagen, fibronectin and transforming growth factor-beta (TGF-beta); with 
development and maturation of the extracellular matrix, these are gradually suppressed 
and alkaline phosphatase, matrix gla protein, osteonectin and osteocalcin are expressed. 
In the final stage o f mineralisation o f the extracellular matrix, these are also down- 
regulated and bone sialoprotein is expressed (reviewed by Stein and Lian, 1993). In a 
different study, the order o f expression was shown to be slightly different in the later 
stages, but the same idea o f a cascade o f gene expression was observed: expression o f 
osteoblastic markers in rat bone marrow stromal cell cultures was shown to be variable 
from cell to cell but overall the temporal sequence o f transcription was osteopontin, 
bone sialoprotein and alkaline phosphatase, then bone Gla protein, known as
7osteocalcin, the latter o f which coincided with a loss o f marrow stromal cell 
proliferation (Malaval et al, 1994). In osteosarcoma-derived cells, this cascade is 
deregulated such that proliferation continues and depending on the cell line, certain 
differentiation-specific genes such as osteocalcin may be constitutively expressed (Stein 
and Lian, 1993).
The sequence o f gene expression in vivo was examined in sheep femora by in 
situ hybridisation. Spindle-shaped cells were located in the first two weeks in the 
granulation tissue: these expressed al(I)procollagen , alkaline phosphatase and 
osteopontin. As osteogenesis occurred, cuboidal cells expressing alkaline phosphatase, 
osteopontin and bone sialoprotein appeared and the spindle-shaped cells were no longer
observed (Zhou et al, 1994). f
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PreosteoblasticphenotvpC ' ’
Committed osteoblastic precursors, preosteoblasts, are identified by their 
proximity to the osteoblast layer at the bone forming surface. They l^ave similar 
morphological and ultrastructural features to osteoblasts and demonstrate alkaline 
phosphatase activity. Preosteoblasts display limited proliferative capacity (Nijweide et 
al, 1988).
Mature osteoblasts
In vivo, osteoblasts are cuboidal polar basophilic cells which are located directly 
opposed to the bone surface. These mesenchyme-derived cells are difficult to 
distinguish from fibroblasts based solely on morphology but can be separated due to 
their bone matrix production capabilities (Aubin et al, 1993). Osteoblasts are thought to 
have a pivotal role in the remodelling of bone as they lay down extracellular matrix 
which is later mineralised, and they initiate and modulate osteoclastic resorption 
(Nijweide et al, 1988). Osteoblasts also mediate bone resorption stimulator actions for 
such agents as parathyroid hormone, prostaglandin, calcitriol, interleukins 1, 6 and 11 
and tumour necrosis factor alpha (Martin and Ng, 1994).
Aside from acting as a depository for secreted factors and lending strength to 
bone, the extracellular matrix was shown to be extremely important in the 
differentiation o f osteoblasts: type I collagen, the major component o f extracellular 
matrix, accelerates the maturation and differentiation o f osteoblasts, and promotes 
mineralisation o f the matrix (Lynch et al, 1995). Ascorbic acid was shown to be 
necessary for the ordered production o f an extracellular matrix: procollagen  
hydroxylation is increased by ascorbic acid, which enables triple-helical conformation. 
This is secreted faster than non-helical collagen. Increased secretion upregulates 
translation and transcription of procollagen mRNAs, all o f which results in a dramatic 
increase in matrix production. Collagen synthesized in the absence o f ascorbic acid is 
thought to be degraded resulting in little or no extracellular matrix (Franceschi and Iyer,
81992): scurvy can induce osteoporosis as evidenced by dramatic thinning o f cortical 
bone and extreme reduction of trabecular cross-links (McKenna, 1990).
The cascade o f gene expression in the maturation o f osteoblasts can be broadly 
defined as having three stages: in early differentiation, osteoblasts express pro a  1(1) 
collagen, growth hormone receptor, biglycan, bone morphogenetic proteins and retinoic 
acid receptors; middle-stage osteoblasts express alkaline phosphatase, osteonectin, 
osteopontin and matrix gla protein; and late-stage osteoblasts express osteocalcin  
(Martin and Ng, 1994).
Maturation-dependent effects o f steroid hormones on this pattern o f expression 
was demonstrated in vitro: proliferating cells adopt a cuboidal appearance after 
glucocorticoid treatment, whereas continuous treatment with calcitr|pl results in a 
permanent block on differentiation; and, treatment o f  mature vnoclules with  
glucocorticoid-produced Osteoblastic cells much reduced in size, where calcitriol 
stimulated osteocalcin production (Pockwinse et al, 1995). This inhibition o f  
differentiation observed with chronic (more than 48 hours) treatment of osteoblasts with 
calcitriol was shown in another study (Stein and Lian, 1993), whereas acute treatment 
(less than 48 hours’ exposure) accelerated cells through proliferation and differentiation.
Bone lining cells and osteocvtes
It is thought that osteoblasts, once they have ceased their secretory activities, can 
progress to bone lining cells or osteocytes. Bone lining cells are very flattened with a 
spindle-shaped nucleus, but contain few other organelles, consistent with the idea that 
osteoblastic secretory function is down-regulated in these cells (Nijweide et al, 1988). 
They are found on the surface o f bone that is not undergoing remodelling, and are 
linked to other lining cells and osteocytes by gap junctions, allowing communication 
through which they may regulate calcium and phosphate ion fluxes, or control the 
growth o f bone crystals (Aubin et al, 1993).
Towards the end of their secretory period, osteoblasts may become incorporated 
into bone matrix, where they progressively lose organelles and reduce in size, with a 
concomitant decrease in expression o f osteoblastic cell surface markers (Nijweide et al, 
1988). Initial embedment prior to expression of an osteocytic-specific marker results in 
the osteocytic osteoblast, or osteoid osteocyte, phenotype; as the matrix mineralises, 
decrease in size and parathyroid hormone (PTH) binding denotes development o f the 
osteocyte (Rodan et al, 1988). These spider-like cells connect with each other and with 
lining cells via cytoplasmic extrusions (canaliculi), maintaining communication through 
gap junctions (Aubin et al, 1993). They maintain contact with each other, even after 
collagenase treatment to remove matrix, and do not proliferate in culture (Nijweide et 
al, 1988). They may be involved in the detection o f mechanical strain and may signal 
bone formation or resorption accordingly (Rodan et al, 1988).
1.5 GENE EXPRESSION IN OSTEOBLASTIC CELLS
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As previously indicated, the study o f gene expression in osteoblasts suggests a 
cascade with the expression of one gene attenuating as the next is induced. There has 
been some disagreement as to the exact order in which the genes studied are transcribed, 
but this could be due to differences in the systems used or heterogeneity o f  the 
osteoblast population. Generally, it is agreed that type I collagen is expressed prior to 
alkaline phosphatase and osteopontin, then bone sialoprotein and osteocalcin are 
expressed.
Type I collagen is vital for the mediation of a signal cascade fpf expression of a 
mature osteoblastic phenotype and for extracellular matrix mineralisation, as shown by
studies in primary and passaged rat calvarial osteoblasts cultured on films o f collagen as
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compared with those cultured on plastic (Lynch et al, 1995). Osteoblasts isolated from 
elderly donors accumulated more collagen than younger counterparts by inhibition of 
collagen degradation as evidenced by vanishingly low levels o f collagenase (Koshihara 
and Honda, 1994).
A lkaline phosphatase is expressed on the cell surface and hydrolyses 
monophosphate esters at high optimum pH. Its activity increases with maturation o f the 
osteoblastic phenotype, but is absent from the osteocyte, suggesting its use as a marker 
of osteoblast differentiation (reviewed by Aubin et al, 1993).
Osteopontin is an a vp3 integrin-binding phosphoprotein secreted by osteoblastic 
cells. It fosters cell attachment, influences gene expression and modulates intracellular 
calcium ion (Ca2+) levels (Denhardt and Guo, 1993) and has been shown to be 
responsive to calcitriol treatment (Noda et al, 1990). The effect on osteopontin  
expression is mediated in part by a ras-activated enhancer, distinct from previously 
described ras elements, which interacts with several unidentified proteins, one o f which 
is associated with increased metastatic potential o f the cell (Guo et al, 1995).
Bone sialoprotein (BSP) is a major constituent o f mineralised tissue in 
vertebrates and is an acidic phosphorylated glycoprotein: sequences are highly 
conserved between avian and mammalian BSP, although overall homology is less than 
40% (Yang et al, 1995).
Osteocalcin, also known as bone Gla protein (BGP), is a 49 kD protein which 
contains 3 vitamin K-dependent gamma-carboxyglutamate residues. It is secreted by 
osteoblasts and odontoblasts (Bradbeer et al, 1994) and is the most abundant 
noncollagenous protein in adult bone (Mahonen et al, 1990). Gammacarboxylation of 
the protein in MG-63 cells can be modified by calcitriol and retinoic acid (RA) but not 
by 9-cis-retin o ic  acid (9-R A ) (Szulc and D elm as, 1996). Incom pletely  
gammacarboxylated bone Gla protein has been found in human bone samples, possibly 
due to variation in the availability of vitamin K (Caims and Price, 1994).
Osteocalcin mRNA is expressed in chicken osteoblasts and hypertrophic 
chondrocytes, but not in non-hypertrophic chondrocytes, brain, heart, intestine, kidney,
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liver or muscle (Neugebauer et al, 1995). Another study, in rats and humans, 
contradicted this: osteocalcin mRNA was detected by reverse-transcription polymerase 
chain reaction (RT-PCR) in liver, kidney, lung, brain, muscle and bone, although levels 
were 1000-fold higher in bone than in duodenal samples (Fleet and Hock, 1994).
Clues to the function o f osteocalcin were suggested by the work o f Ducy et al 
(1996). Both murine osteocalcin genes (mOGl and mOG2) were deleted and the 
resulting phenotypically normal heterozygotes were mated to produce homozygous 
mutant mice at the expected Mendelian frequencies. These mutant mice expressed no 
osteocalcin and appeared normal at birth, without defects in patterning or bone 
formation. With time, abnormalities in bone remodelling occurred, resulting in increases 
in amounts o f trabecular bone and mineralised bone matrix, thicknes^.and density of 
cortical bone, diaphyseal width, cortical bone width and improved inechanical 
properties, where the failure load of the bone was increased. The number o f osteoclasts 
was augmented, exacerbating bone resorption but this was cancelled out by the marked 
rise in bone formation. This was not accompanied by an increase in osteoblast number, 
suggesting that each osteoblast was laying down more extracellular matrix. From this, it 
was concluded that the normal function o f osteocalcin is to constrain bone formation 
without affecting resorption or mineralisation, and that this negative regulation may be 
mediated by an as-yet-to-be identified receptor. There is however a possible role for 
osteocalcin in the coupling of formation to resorption (Stein and Lian, 1993).
1.6 REGULATION OF TRANSCRIPTION
Initiation o f transcription in most prokaryotic and eukaryotic genes is usually 
mediated by the DNA sequence TAT A A A, known as the TATA box, which is situated 
up to 30bp before the transcription start site. An assembly o f transcription factors (TFs) 
and RNA polymerase II is necessary for initiation of transcription: this forms as a result 
o f the sequential binding of TFIID and TFIIA at the TATA box, then binding o f TFIIB, 
RNA polymerase II, and TFIIE (Zubay, 1983a).
Other transcription factors have been discovered which are necessary for 
augmented levels o f transcription: they can be tissue-specific and temporally regulated, 
and reversibly bind downstream, upstream or in the middle of the gene which they 
regulate. These transcription factors tend to contain at least one of the following protein 
structures: helix-loop-helix motif (Drosophila antennapedia and ultrabithorax homeotic 
proteins); zinc finger motif (glucocorticoid steroid receptor in vertebrates) or leucine 
zipper motif (mammalian c-fos and c-jun growth regulators) (Zubay, 1983b).
Homeobox genes and homeodomain proteins
Homeotic proteins are a group o f helix-loop-helix transcription factors which are 
responsible for the proper development o f an organism by regulating specific temporal 
and spatial patterns o f gene expression: specification o f the positional information along
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the anteroposterior and appendicular axes has been attributed to the homeobox (Hox) 
genes (St-Jacques and McMahon, 1996). Each homeotic protein contains a highly 
conserved 60 amino acid segment known as the homeodomain, encoded by a 180 
nucleotide DNA sequence called the homeobox, present in the 3' exon of the homeotic 
gene. The homeodomain binds to specific DNA sequences, thus regulating gene 
expression (Gehring, 1994).
Homeotic proteins were first described in Drosophila, where they were found to 
regulate the development o f the body plan, being expressed temporally in an order 
which reflects their linear arrangement on the chromosome (reviewed by Gehring, 
1994). Homeotic proteins have since been found to be highly conserved throughout a 
wide variety o f species, including mouse, chicken, frog and human (j^cGinnis et al, 
1984). Cluster conservation is due to several constraints: co-ordinateh regulation o f  
closely located genes in a specific order; presence o f enhancer sequences which 
upregulate the expression of a number of genes simultaneously; and, sharing cis-acting 
elements between adjacent genes (van der Hoeven et al, 1996).
In the em bryogenesis o f the Drosophila, co-ordinate genes, including 
morphogens such as the bone morphogenetic proteins, act first to produce the antero­
posterior and dorso-ventral axes; then segmentation genes, o f the muscle segmentation 
class (msh) amongst others, act to induce segment identity along the body plan; 
regionfilisation genes act to specify within each segment; and finally, cell determination 
genes direct individual cells to their differentiated state. At all these points, various 
homeobox genes act to modify expression o f genes (Gehring, 1994). Expression o f  
hom eobox genes may be differentiation-dependent: differential homeobox gene 
expression was demonstrated in human bone marrow subpopulations which had been 
isolated according to their cell-surface expression of CD34+ (Sauvageau et al, 1994). It 
is also possible that interaction o f homeotic gene products may contribute to 
specification, determination or differentiation (White, 1994).
With so many diverse genes containing helix-loop-helix binding motifs in their 
promoters, it was difficult to understand how specificity o f binding could arise. One 
mechanism could involve changes in complex DNA structure: in bone cells expressing 
osteocalcin, chromatin structure remodelling in the osteocalcin promoter has been 
demonstrated at two sites (-600 to -400 and -170 to -70, see figure 1.5) where 
nucleosomes are unpackaged, making the DNA sequence accessible to transcription 
factors and the vitamin D receptor complex (Montecino et al, 1996). Another possibility 
is that helix-loop-helix-containing proteins may act in partnership with other regulatory 
factors; where subtle differences in binding site sequence may select which Hox protein 
is preferred, or where protein-protein binding may alter the conformation o f the Hox 
protein, changing the protein-DNA binding region such that a different binding site is 
required (reviewed by Mann and Chan, 1996).
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All homeotic genes were named Hox genes until it was shown that they could be 
split into two groups: one which resembled the antennapedia-type complex, and another 
which did not. The second group contains genes which have since been renamed. One 
group o f the non-antennapedia-type is the Drosophila muscle-specific homeobox (Msh) 
class o f homeobox genes, which encode putative helix-loop-helix nuclear transcription 
factors. In Drosophila, a complex pattern o f expression is observed with Msh mRNA  
present throughout embryogenesis and concentrated in late em bryogenesis in 
musculature and the central nervous system (Gehring, 1994). Msh genes are expressed 
across phylogenetic borders: homologues are found in insects, fish, bir<Js and mammals 
(De Robertis, 1994). There are at least three Msh class genes in mammals (Burglin,
1994). *
MSX genes
Following use. o f the Msh gene as a probe, mammalian msh-like homeobox 
genes (Msx) were isolated from a mouse cDNA library and shown to be expressed 
during fetal development (Hill et al, 1989). In murine embryonic development, the 
homeodomain-containing protein Msx-2 is expressed in a range of prospective tissues 
including neural crest cells and their derivatives, such as the branchial and mandibular 
arches, and craniofacial cartilage and membranous bone (Takahashi et al, 1991), 
developing cranial sutures in a region o f bone deposition and resorption (Jabs et al,
1993), the developing mandible and tooth (MacKenzie et al, 1992; Jowett et al, 1993) 
and the apical ectodermal ridge and underlying mesenchyme o f the limb bud (Davidson 
et al, 1991). The expression pattern o f this gene depends on epithelial-mesenchymal 
interaction (Jabs et al, 1993) and the presence o f its transcript in the calvarial bones and 
in adjacent mesenchymal cells has led to the proposition that Msx-2 has a role in the 
differentiation o f osteoprogenitor cells. It is thought that expression o f Msx genes in 
limb development is under the control o f growth factors secreted by the apical 
ectodermal ridge o f the limb bud (De Robertis, 1994). These include fibroblastic growth 
factors (FGFs) and bone morphogenetic proteins (BMPs).
The human homologue, MSX-2, has been found to be expressed in adult human 
osteoblastic cells (Hodgkinson et al, 1993). As noted previously, a dominant mutation in 
the gene encoding the M SX-2 protein (substitution o f a histidine for a proline at 
position 7 o f the homeodomain) has been found to result in some limb deformity and 
cranial abnormality, leading to craniosynostosis, Boston type (Jabs et al, 1993). It is 
possible that this mutation affects DNA binding or protein interaction but these may not 
be completely ablated - some functionality may be retained (Davidson, 1995). This may 
explain the otherwise apparently normal phenotype.
M SX-2 expression is tightly restricted temporally and spatially and is down- 
regulated as development progresses (Takahashi et al, 1996). Although the pattern of 
M SX-2 expression is o f interest, it was not until recently that studies were performed to
gain some understanding of the functions of the Msx-2 gene product. MSX-2 expression 
was observed in cells with relatively high proliferative potentials, including carcinoma 
cells and ras-transformed fibroblasts (Takahashi et al, 1996). This is due to either MSX- 
2 expression in the original tissues from which the tumour arose, induction as a result of 
malignant transformation, or as a causal event in carcinogenesis. MSX-2 overexpression 
in chicken myoblast culture induced transformation whereas following transfection of 
an antisense M SX-2 construct into ras-transformed cells, a low rate o f reversion was 
produced (Takahashi et al, 1996). Antisense disruption o f murine Msx-2 gene resulted 
in pronounced reduction o f craniofacial bone development, severe sofnite and neural 
tube deformities and eye abnormalities (Potts and Sadler, 1997). In a second 
investigation, chick mandibular explants were cultured with a
was shown (Mina et al, 1996). However, Msx-2 expression as induced by BMP-4 in the 
chick hindbrain precedes apoptosis (Graham et al, 1994). These studies taken together 
suggest therefore that Msx-2 may act to prevent differentiation, such as allowing 
proliferation in carcinoma cells and in transformed lines, or to block chondrogenesis, or 
may trigger apoptosis by supplying a contrary signal to the differentiation stimulus 
introduced by BMP-4.
1.7 REGULATION OF OSTEOCALCIN TRANSCRIPTION
As mature osteoblasts are the only extracellular matrix-secreting cells in the 
body to express osteocalcin, the presence o f  osteocalcin mRNA transcripts is taken as 
an endpoint of osteoblastic differentiation in this body o f research. Study o f the control 
of osteocalcin transcription has revealed an astonishingly intricate array o f regulatory 
sequences (see figure 1.5). Elements upstream of the coding sequence, and several 
within it, appear to hold crucial roles in osteocalcin gene expression. Developmental, 
stage-specific, basal and induced expression are all tightly regulated by a range of 
factors, some expressed ubiquitously, others specific to bone-forming cells. Nuclear 
architecture and chromatin structure are also shown to have important roles.
The osteocalcin (OC) box
The OC box is a basal regulatory element which supports tissue-specific and 
temporal transcription o f the osteocalcin gene. This primary proximal promoter 
sequence (-99/-76 in relation to the osteocalcin transcription start site) consists of  
several overlapping regulatory sequences: there are two consensus binding sites for 
activator protein-1 (AP-1), one for MSX homeodomain transcription factors, a CCAAT 
box and a binding site for a uniquely expressed osteocalcin binding protein (OCBP). 
Overlapping the OC box at -102/-97 is a consensus binding sequence for E box-binding 
basic helix-loop-helix transcription factors.





The activator protein-1 (AP-1) family o f ubiquitously expressed proto­
oncogenes, including c-fos and c-jun, affect basal transcriptional activity through the 
binding of a heterodimeric protein complex, such as Fos/Jun, to the consensus sequence 
TG/TAG/CT/CCA/C. There are three AP-1 elements in the rat osteocalcin promoter 
(-467/-460, -98/-92 and -88/-82) (Pike et al, 1993; Stein and Lian, 1993), the most distal 
present immediately 5 ’ to the VDRE, and the second and third within the OC box.
Binding at either of the AP-1 sites in the OC box may interfere with binding at 
the CCA AT box, which lies between the AP-1 sites and is overlapped jpy them. Similar 
interference may occur at the VDRE. Occupancy of the three AP-1 sites by Fos/Jun 
heterodimers occurs during osteoblastic proliferation and suppresses osteocalcin gene
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expression: as^proliferation is down-regulated, AP-1 activity is reduced and osteocalcin 
is expressed (reviewed* by Stein and Lian, 1993). Inhibition o f ostebcalcin gene 
expression in proliferating osteoblasts by A P-i occupancy o f all three sites in the VDRE 
and the OC box simultaneously, suppressing basal and vitamin D-induced expression of  
osteocalcin, has been termed phenotype suppression (Lian et al, 1991).
E boxes
Basic helix-loop-helix transcription factors can bind to the E box, the consensus 
sequence for which is CANNTG. One such sequence (OCE1) overlaps the distal AP-1 
site within the OC box (-102/-97); a second (OCE2) is adjacent to the OSE2 element 
(-149/-144) (Tamura and Noda, 1994; Quarles et al, 1997). Binding at the E boxes has 
been shown to occur during osteoblastic differentiation: one study (Kazhdan et al, 1997) 
suggested binding at OCE1 was incidental, perhaps simply occurring upon release o f  
the site by the AP-1 protein. However, treatment o f fibroblastic cells with bone 
morphogenetic protein-2 (BM P-2) dramatically increased binding at OCE1 and 
osteocalcin expression was induced (Tamura and Noda, 1994), suggesting at least a 
supplementary role for this element in osteocalcin expression.
MSX and OCBP binding sequences
A binding motif for the MSX family o f homeodomain-containing proteins was 
recently found to play a role in the transcriptional control o f the osteocalcin gene. 
Maximal levels o f osteocalcin transcription were shown to be induced with an intact 
MSX consensus binding site, TGATTAAC, at -91/-84 (Hoffmann et al, 1994). 
Treatment with vitamin D increased binding at this sequence. However, this does not 
preclude the possibility that other factors which are not MSX-related may interact with 
this binding site. Indeed, the same group postulated the existence o f a novel OC box 
binding protein (OCBP), specific to osteoblast-like cells, which binds in a sequence- 
specific manner to the OC box and upregulates osteocalcin transcription (Hoffmann et 
al, 1996).
As the OCBP and MSX consensus binding sites overlap, it may be anticipated 
that either a temporal constraint allows both proteins to bind independently at different
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times, or competition for binding may result: Msx-2 was shown to be expressed in 
proliferating ROS 17/ 2.8 cells and reduced in differentiating cells, supporting the 
former prospect (Hoffmann et al, 1994). The discovery that, in ROS 17/ 2.8 cells, 
dexamethasone down-regulates Msx-2 messenger RNA levels (Towler et al, 1994) and 
inhibits osteocalcin expression (Aslam et al, 1995) lends support to the idea that Msx-2 
specifically may be involved in the regulation of osteocalcin transcription.
The 3*.5’-cyclic adenosine-monophosphate (cAMP) response region
The rat osteocalcin gene cAMP response region (ROCRR) at-J21/-92 overlaps 
the OC box, encompassing an AP-1 site and the E box. Present within the ROCRR are 
two steroid hormone receptor binding hexameric half-sites separated 10 nucleotides 
(-114/-92) which bind thyroid hormone receptor complexes (Towler and Rodan, 1995). 
The proximal region o f  the ROCRR (-99/-90) was suggested to be a necessary 
component of an element at -144/-138 which regulates FGF-2-mediated activation o f 
the osteocalcin promoter (Boudreaux and Towler, 1996). This induction o f expression 
by FGF-2 also requires an intact sequence further upstream (-678M 76, which includes 
the vitamin D response element) for maximal activation (Schedlich et al, 1994).
Glucocorticoid response element fGRE)
Glucocorticoids have been shown to down-regulate the expression o f the 
osteoblastic phenotype indirectly, by controlling the expression or activity o f  
osteoblastic growth factors, and directly by suppressing transcription o f osteoblastic 
genes, including osteocalcin (Delany et al, 1994).
Immediately adjacent to the start site of transcription in the osteocalcin gene is 
the glucocorticoid response element (GRE). This consists o f two hexameric half-sites 
separated by four nucleotides (-16/-1). There are two further half-elements: one within 
the OC box (-86/-81) and which overlaps the proximal AP-1 site and the Msx binding 
site, and the other at -697/-683. These elements mediate the dexamethasone-induced 
suppression o f osteocalcin transcription with varying degrees o f effect (Aslam et al,
1995).
The TATA and CCA AT boxes
Contiguous with the GRE is the TATA box (-31/-25). This sequence is 
universally conserved and serves to direct the RNA polymerase II transcriptional 
apparatus to begin transcription approximately 30 nucleotides downstream (Darnell et 
al, 1986).
In vivo transcription usually requires one or two elements between -110 and -40. 
Within the OC box is situated a CCAAT box (-92/-88), an element which has been 
shown to be necessary for the basal transcription of several eukaryotic genes, including 
globins (Darnell et al, 1986). It is possible that this element is inaccessible during
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osteoblastic proliferation due to the occupancy of the AP-1 sites surrounding it, thereby 
preventing transcription.
The vitamin D response element (VDRE)
The vitamin D response element (VDRE) consists o f two hexameric half-sites 
separated by three nucleotides. Its consensus sequence is A/GGGNNA/C AT/CG 
A/GGGNNA/C (Demay et al, 1990). The VDREs in the human and rat osteocalcin 
promoters differ by three nucleotides (underlined) (Pike et al, 1993):
Human GGGTGA acg GGGGCA \
Rat GGGTGA atg AGGACA
Vitamin D-mediated upregulation of osteocalcin transcription is dependent upon ligand
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and receptor pccupancy o f the VDRE (Breen et al, 1994b): binding of; the ligand 
(calcitriol) to the vitamin D receptor (VDR) alters its conformation, sb facilitating 
binding o f an accessory factor, usually the 9 cis-retinoic acid receptor (RXR) (Haussler 
et al, 1995), although the VDR can synergise with itself and several other transcription 
factors (Liu and Freedman, 1994) with varying affinities (Schrader et al, 1994). 
Treatment with 9 cis-retinoic acid reduces binding at the VDRE, probably because RXR 
homodimers are formed instead o f VDR:RXR heterodimers, thus inhibiting vitamin D- 
mediated osteocalcin transcription (Haussler et al, 1995).
The VDR gene is differentially spliced to yield three unique mRNA species 
(Miyamoto et al, 1997). This, and varying conformations o f VDR:RXR heterodimers 
may allow recognition of different VDREs (Staal et al, 1996a). The VDR protein 
consists o f an N-terminal zinc finger DNA binding domain, a hinge section, and a C- 
terminal hormone binding domain, which contains two regions allow ing  
heterodimerisation with an RXR (Haussler et al, 1995). To permit binding o f the 
VDR: RXR to the VDRE and to allow transactivation, the VDR must be phosphorylated 
(Desai et al, 1995).
Competition for binding sites at the VDRE is an important factor in the 
regulation of osteocalcin expression. AP-1 counteracts binding of the VDR complex to 
the AP-1/ VDRE site in the osteocalcin promoter (Jaaskelainen et al, 1994): vitamin D- 
mediated stimulation o f osteocalcin expression is accompanied by weak binding o f the 
AP-1 heterodimer. The ubiquitously expressed YY1 factor antagonises VDR: RXR 
activation o f osteocalcin expression in two ways: YY1 directly competes for binding at 
the VDRE, and YY1 can also bind to TFIIB, thereby inhibiting transcription (Guo et al, 
1997). Calreticulin, a calcium binding protein, inhibits DNA binding and transcriptional 
activity o f a range of steroid nuclear hormone receptors, including VDR, by binding to 
the DNA binding domain o f the receptor (Wheeler et al, 1995). Transcription o f  
calreticulin was shown to decline with osteoblastic differentiation so alleviating 
transcriptional inhibition (St-Amaud et al, 1995).
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Transforming growth factor-beta (TGF-beta) can interfere with the effects of 
vitamin D on osteocalcin transcription by mechanisms other than interference with 
VDRrRXR binding to a VDRE oligonucleotide or than by the serine/threonine pathway 
(Pirskanen et al, 1994). Other studies have shown that increased AP-1 activity was 
observed and reduced VDR:RXR binding to the genomic VDRE was demonstrated 
following TGF-beta treatment (Staal et al, 1996b; Banerjee et al, 1996a). The latter 
investigation showed the necessity of a region at -146/-139, which binds Fra-2, a factor 
hyperphosphorylated by TGF-beta, for mediation o f TGF-beta-induced osteocalcin  
repression at the proximal basal promoter.
Critical for maximal induction o f calcitriol-mediated transactivation o f
osteocalcin expression is an intact sequence immediately downstream « f the VDRE at 
i v
-420/-414, whj.ch is incapable of binding the VDR:RXR complex alone (SnCddon et al,
1997). Also, vitamin D modulates osteocalcin expression by post-trdnscriptional
mechanisms through extension of the half-life o f osteocalcin transcripts (Mosavin and
Mellon, 1996).
Osteocalcin-specific elements (OSEs)
Two cis-acting elements were discovered near to the OC box: both were shown 
to increase the activity o f the osteocalcin promoter in osteoblastic cells only. OSE1 
(-64/-47) bound a factor present in nonmineralising and mineralising osteoblast-like 
cells; OSE2 (-146/-132) was active only in mineralising osteoblasts (Ducy and 
Karsenty, 1995). This latter element was shown to contain a consensus binding site for 
the runt homology domain (Merriman et al, 1995). An osteoblast-specific factor (OSF) 
binds to OSE2 at -135/-130 and was shown to be related to the polyoma enhancer 
binding protein 2 / acute m yeloid leukaem ia/ core binding factor-alpha  
(PEBP2/AML/CBFA) DNA binding protein family, the human homologue o f the 
Drosophila runt family o f transcription factors (Geoffroy et al, 1995; Ducy et al, 1996; 
Zeng et al, 1997). The bone-related OSF (CBFA1 or AML-3) protein transcriptionally 
activates the osteocalcin gene in rat osteoblasts (Banerjee et al, 1996b) but interestingly 
in mice, this activation is abolished by calcitriol, which interferes with the binding o f  
OSF to the OSE2 (Zhang et al, 1997). The mechanism o f ascorbic .acid-induced  
osteocalcin expression was suggested to involve the OSE2 as binding o f CBFA1 to the 
OSE2 was increased by ascorbic acid treatment (Xiao et al, 1997).
In an elegant series of experiments by Ducy et al (1997), gene expression in 
CBFA1 -/- mice was examined. Alkaline phosphatase, osteopontin and osteocalcin  
mRNA levels were extremely low; al(I)collagen expression was abolished. MC3T3-E1 
cells, which model undifferentiated osteoblastic cells, and C3H10T1/2 cells, pluripotent
fibroblasts not committed to the osteoblast lineage, do not express genes characteristic 
of the osteoblast phenotype. They were transfected with a construct containing CBFA1, 
following which expression o f bone sialoprotein, osteocalcin and al(I)co llagen  was
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shown. Antisense CBFA1 introduced to ROS 17/ 2.8 cells, which model mature 
osteoblasts and express genes o f the osteoblast lineage, resulted in abolition o f  
a l(I)co llagen  and osteocalcin expression and dramatic suppression o f osteopontin 
expression. Taken together, these data suggest that CBFA1 is essential for the proper 
differentiation o f cells o f the osteoblastic lineage and that CBFA1 must be 
constitutively expressed in mature osteoblasts.
Other unidentified sequences upstream of the osteocalcin gene were shown to be 
required in osteocalcin transcription, possibly to enable formation o f $  more complex 
nuclear structure (Frenkel et al, 1996). Promoter activity has also been shown to be 
affected in vivo by age and gender, with females exhibiting greater acti^ty than males, 
and by the site at which bone was examined: variation was reducedX upon ex vivo  
culturing o f these cells, leading to the suggestion that a factor not present iii culture and 
changing with age and. gender may be responsible for the differences observed (Frenkel 
et al, 1997).
Silencers
Downstream effects have been noted with several elements within the first exon 
in the osteocalcin gene contributing towards the repression o f transcription until 
developmentally appropriate stages. The region +24/+151 also contains an antisilencer 
(+40/+48) whose effect is swamped by the inhibition engendered through the whole 
region (Frenkel et al, 1994). The +29/+35 sequence is critical for the silencing function: 
repression is mediated by the binding at +17/+36 o f a nuclear factor present in 
proliferating osteoblasts but absent in post-proliferative osteoblasts, expression o f this 
factor being down-regulated upon mineralisation o f the extracellular matrix (Li et al, 
1995).
Protein: DNA binding was observed at an element (TTTCTTT) in the first intron 
which results in suppression of osteocalcin transcription in a range o f osteoblast-like 
cells (Goto et al, 1996).
Nuclear architecture
W hen expressing osteocalcin , ROS 17/ 2.8 ce lls  exhib it D N ase I 
hypersensitivity at two sites in the osteocalcin promoter; -590/-390, which encompasses 
the VDRE, and -170/-70, which includes the ROCRR, OC box and the CBFA1 binding 
sites: non-hypersensitivity is registered in cells which do not express osteocalcin  
(Montecino et al, 1994). Nucleosomal structure also altered to allow expression o f the 
mature osteoblastic phenotype (Montecino et al, 1996).
Contained within the VDRE are two binding sites for nuclear matrix proteins 
(NMPs) at -452/-449 and -441/-435, designated NMP-1 and NMP-2 binding sites 
respectively (Stein and Lian, 1993); NMP-2 also binds at -605/-599. A component of
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NMP-2 was shown to be a member of the runt domain transcription factor family which 
associates increasingly with the nuclear matrix during differentiation (Merriman et al, 
1995; Lindenmuth et al, 1997). This supports the notion o f involvement o f the nuclear 
matrix in the expression o f osteoblast-specific genes.
Thus, the organisation o f gene regulatory elements, subtleties in recognition 
between similar sequences by similar factors, chromatin structure, nucleosom e  
organisation and interactions between genes and nuclear matrix all contribute to the 
increasingly complex array o f mechanisms involved in the transcriptional regulation of 
the osteocalcin gene. i
1.8 FACTORS AFFECTING BONE FORMATION f
v  \
A large, group o f related mediators known as the transforming growth Tactor-beta 
(TGF-P) superfamily consists o f several subfamilies including the bone mdrphogenetic 
proteins (BMPs) (see figure 1.6, after MassagUe et al, 1996). These, and calcitriol, have 
significant effects on bone formation.
TGF-beta and osteogenesis
TGF-beta is a 25,000 Dalton protein composed o f two identical polypeptides 
linked by disulphide bonds. There are multiple TGF-beta isoforms which all share 
similar properties: increased DNA and type I collagen synthesis, the latter as a result of 
increased numbers o f collagen-producing cells (Centrella et al, 1986). TGF-betas are 
secreted to the extracellular matrix as latent high molecular weight com plexes 
consisting o f the amino terminal remnant o f the latency-associated protein and which 
may also include TGF-beta binding protein. They are activated following proteolytic 
cleavage, for example during bone resorption (Keski-Oja et al, 1996).
TGF-beta upregulates the proliferation o f a wide range o f cells including 
fibroblasts, vascular smooth muscle cells, articular chondrocytes (Okragly et al, 1994; 
Postlethwaite et al, 1994) and myogenic cells (Katagiri et al, 1994; Yamaguchi et al, 
1995). Cyclins and cyclin dependent kinases are cell-cycle regulatory factors which are 
expressed during proliferation, but are not restricted to this phase only: in normal rat 
calvarial osteoblasts, several cyclins persist in .confluent cultures, suggesting a role for 
these molecules in osteoblastic differentiation. TGF-beta treatment during proliferation 
extenuates the enhanced expression o f these cyclins. In confluent tumour-derived cells 
(ROS 17/ 2.8), the augmented cyclin levels are not observed postproliferatively, 
consistent with the notion o f ablation o f growth control and differentiation regulatory 
mechanisms (Smith et al, 1995).
The proliferative effects o f TGF-beta are linked to a negative effect on 
differentiation. M yotube formation is blocked following TGF-beta treatment in 
myogenic cells but they are not induced to become osteogenic (Katagiri et al, 1994; 
Yamaguchi, 1995). Osteoblastic cells cultured constantly in the presence o f TGF-beta 1
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are irreversibly impeded from differentiating into mature osteoblasts (Breen et al, 
1994a).
TGF-beta is required for production o f a mature crosslinked collagenous 
extracellular matrix (Feres-Filho et al, 1995) as it stimulates matrix synthesis by 
increasing collagen and hyaluronic acid expression (Postlethwaite et al, 1994). Upon 
secretion to the bone matrix, TGF-beta 1 binds to decorin, a bone matrix proteoglycan, 
and when bound the inhibitory effect o f TGF-beta on cell proliferation is enhanced, 
although decorin alone has no effect. It is thought this synergistic effect is mediated 
through enhanced binding of TGF-beta to its receptors, types I and II #nd betaglycan, 
resulting in increased bioactivity following resorption when TGF-beta and decorin are 
both released from the matrix (Takeuchi et al, 1994). Neutralising antibodies to TGF-
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betas 1, 2 and.3 were applied to extracellular matrix derived from the rat dsteoblastic 
ROB-C26 cell iine. Cells plated onto this extracellular matrix were then found to 
produce no osteoblastic markers of expression, suggesting that TGF-beta secreted into 
the extracellular matrix has an important role in the development o f the osteoblastic 
phenotype (Kirk and Kahn, 1995). Following dexamethasone treatment o f a human 
osteoblastic cell line, SV-HFO, expression o f the tetranectin gene is upregulated and 
mineralisation occurs. TGF-beta treatment suppresses expression o f tetranectin (Iba et 
al, 1995) and alkaline phosphatase in the early phase o f mineralisation, indicating 
phase-dependent effects o f TGF-beta treatment (Iba et al, 1996).
Tissue inhibitor o f metalloproteinases (TIMPs) proteins are localised to the 
extracellular matrix: in the mouse, TIMP-1 and TIMP-3 are inducible by TGF-beta 1 
(Leco et al, 1994). In fibroblasts and osteoblasts, TGF-beta 1 diminishes the expression 
o f matrix metalloproteinases (MMPs) and augments the transcription o f TIMP-1 
(Overall, 1995). Ecto-nucleoside triphosphate pyrophosphatase (ENTP) is a potential 
source o f inorganic phosphate, which may be involved in mineralisation. TGF-betas 1 
and 2 havp been found to induce bone-derived, but not tooth-derived, ENTP activity in 
a dose-dependent manner up to 10 ng/ ml and also to diminish alkaline phosphatase 
(AP) activity over the same dose range. If AP hydrolyses extracellular pyrophosphate in 
bone, then TGF-beta modulation o f the activities o f both these proteins results in an 
increase in extracellular levels of pyrophosphate and may therefore affect mineralisation 
(Oyajobi et al, 1994).
The expression o f an important osteoblastic gap junction protein, connexin-43, 
normally expressed with an increase in cell density, was promoted by treatment with 
TGF-beta but was not influenced by calcitriol. Similar effects were noted in relation to 
gap junctional intercellular communication, suggesting that accretion o f intercellular 
communication between osteoblastic cells by TGF-beta might maintain bone as an 
organised tissue in vivo (Chiba et al, 1994). In a variety of osteoblast-like cells, it was 
observed that bone matrix proteoglycan synthesis was stimulated by TGF-beta 
treatment only in those cell types which expressed types I and II TGF-beta receptors.
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Therefore, changes in the cell-surface TGF-beta receptors may account for the 
variations in response to treatment with TGF-beta and subsequent expression of 
biglycan and decorin (Takeuchi et al, 1995).
TGF-beta has also been found to induce cartilage formation (Noda and 
Camilliere, 1989). TGF-betas 1, 2 and 3 are expressed in cultured chick limb 
mesenchymal cells at the initiation of and during cartilage differentiation (Roark and 
Greer, 1994). TGF-beta-1 fosters smooth muscle differentiation in mouse neural crest 
stem cells (Shah et al, 1996) and chondrogenesis in high density C3H /10T 1 /2  cells
(Denker et al, 1995) and rat calvarial cells, but blocks the formation^of hypertrophic 
chondrocytes (Moses and Serra, 1996). Chick growth plate chondrocytes treated with 
TGF-beta showed increased DNA synthesis after 24 hours and i n c i t e d  alkaline 
phosphatase 'activity. A dose-dependent increase in chondrocyte proliferation was seen 
following treatment witliTGF-beta (Guerne et al, 1994). The expression o f osteonectin 
in chondrocytes is upregulated by TGF-beta at transcriptional and translational levels 
(Nakamura et al, 1996).
Bone is the largest reservoir of TGF-beta in the body. The effects of TGF-beta 
on osteoblastic cells have been extensively reviewed (Centrella et al, 1989; Bonewald 
and Mundy, 1989; Kim and Ballock, 1993). Transforming growth factors p i and p2 
(TGF-betas 1 and 2) are present in large quantities in the bone matrix (Seyedin et al, 
1985) and have been found to stimulate the proliferation, chemotaxis and differentiated 
function o f cells o f the osteoblast lineage (Mundy, 1995) and to stimulate bone 
formation in vivo (Oue et al, 1994).
Genetic effects o f TGF-beta in osteoblastic cells have been examined: TGF-beta 
1 application to the rat preosteoblast cell line UMR 201 induced matrix gla protein 
(MGP) and promoted the steady state levels of osteonectin (ON) and pro-alpha 1 (I) 
collagen mRNA. Osteopontin (OP) expression was reduced (Zhou et al, 1993). 
Treatment of subcultures of fetal rat calvarial osteoblasts With TGF-beta inhibited bone 
nodule formation and the expression of genes associated with osteoblast differentiation 
was diminished: type I collagen, alkaline phosphatase, osteopontin, BM P-2 and 
osteocalcin levels were down-regulated. This suggests that TGF-beta can affect less 
differentiated cells in the osteoblastic lineage (Harris et al, 1994a).
TG F-beta augm ents transcription, ligand binding and parathyroid 
hormone/parathyroid hormone related protein (PTH/PTHrP) receptor signalling in 
ROS 17/ "2.8 cells (McCauley et al, 1994). Also, in MC3T3-E1 cells, TGF-beta was 
shown to inhibit PTH/PTHrP receptor expression and osteocalcin expression  
persistently in less differentiated osteoblasts - similar but not persistent effects were 
noted in more mature cells, leading to the suggestion that TGF-beta inhibits osteoblastic 
maturation in earlier cells (McCauley et al, 1995).
TGF-beta influences the expression o f transcription factors: a novel TGF-beta- 
inducible early gene (TIEG) and putative transcription factor expressed only in
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osteoblasts and skeletal muscle tissue may be important in osteoblast intracellular 
signalling (Subramaniam et al, 1995). In MC3T3-E1 cells, TGF-beta exaggerates the 
expression o f retinoic acid and retinoid X receptors (RAR and RXR respectively): 
RAR-alpha, RAR gamma, RXR alpha genes are transcriptionally activated; RAR beta, 
RXR beta and RXR gamma are not. Transcriptional activation is inhibited by addition 
of antisense c-fos and c-jun, implying a role for AP-1, a transcriptional activation 
complex composed o f Fos and Jun proteins (Chen et al, 1996).
TGF-beta has biphasic effects on osteoblast proliferation and activity which 
appear to be differentiation-dependent. Differences in the quantities o f  type I and II 
receptors on the cell surface between fibroblast bone-derived cells and highly 
differentiated osteosarcoma cultures, respectively reflecting early .‘ftnd late stage
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osteoblast phenotype, point to the regulation of receptor expression as a mechanism for 
this effect (Ceritrella et al, 1995; Moses and Serra, 1996). Type II receptor expression 
was found to decrease relative to that of the type I receptor with increased osteoblastic 
activity.
TGF-beta was seen to regulate the expression o f its own receptors: in MC3T3- 
E1 cells treated with TGF-beta, diminished levels o f TGF-beta receptors were expressed 
on the cell surface. The mechanism was thought to be related to the interaction of  
collagen matrix induced by TGF-beta and a2p  1 integrin expressed on the osteoblast 
surface (Takeuchi et al, 1996). The TGF-beta type-III receptor, betaglycan, is expressed 
prodigiously in osteoblastic cells and is a cell surface heparan/chondroitin sulphate 
proteoglycan. Binding o f TGF-beta to betaglycan is ameliorated by dexamethasone 
(dex) treatment: dex was shown to augment de novo transcription o f betaglycan, but not 
of TGF-beta type II receptor (Nakayama et al, 1994). Cell surface TGF-beta receptors 
have a rapid turnover rate; inhibition of de novo transcription resulted in a slower loss 
of cell surface receptor than protein synthesis inhibition (Centrella et al, 1996).
Intracellular signalling by members o f the TGF-beta superfamily remains to be 
fully elucidated. However, a putative model o f transduction has been put forward 
(Derynck and Zhang, 1996). TGFs signal by binding first to a type II serine/threonine 
kinase receptor which then forms a heteromeric receptor complex by binding to and 
phosphorylating a type I serine/threonine kinase receptor (Dewulf et al, 1995). An 
intracellularly associated Smad (vertebrate hom ologue o f  the mothers against 
decapentaplegic protein first noted in Drosophila and which has homology with the 
human tumour suppressor gene DPC4) is subsequently phosphorylated and dissociates, 
binding to and synergizing with another Smad. This complex is translocated to the 
nucleus where Smads function as transcriptional activators: Mad 3 has been shown to 
act as a mediator linking TGF-beta/ activin receptors to transcriptional regulation 
(Derynck and Zhang, 1996).
Targets o f  this transcriptional activation as mediated by Smads may include 
cyclin-dependent kinase inhibitor p 15 (pl5), expression of which blocks cdk4 and cdk6,
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and leads to cell arrest in G1 (Moses and Serra, 1996; Massague, 1996), and dwarfins, 
which are phosphorylated in a dose- and time-dependent manner following treatment 
with TGF-beta. BMP-2 treatment also resulted in phosphorylation o f one dwarfin, 
suggesting that dwarfins may act as mediators for the TGF-beta superfamily. It was 
postulated that Smads are tumour suppressor genes as growth arrest is blocked in 
tumour cells which are resistant to TGF treatment (Alexandrow and Moses, 1995) and 
transient overexpression of two murine dwarfins, which are downstream o f Smads, 
caused growth arrest (Yingling et al, 1996).
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Bone morphogenetic proteins and bone formation
A morphogen is a protein which induces morphological change depending on its 
concentration (Gehring, 1994). Bone morphogenetic proteins BMP-1 to BMP-7 were 
isolated from bovine bone matrix and their genes cloned from human cD'NA libraries 
(Wozney et al, 1988), and based on their homology, four sub-groups were found: BMP-
I alone bearing little homology to any o f the other BMPs; BMP-2 and BMP-4, the 
human equivalent o f the Drosophila dpp  gene; BMP-3 alone; BMP-5, BM P-6 and 
BMP-7. Six further members of the BMP family have since been cloned and sequenced 
(Dube and Celeste, 1995; Celeste et al, 1995). BMPs are expressed in a wide variety of 
tissue other than bone and are therefore assumed to have a fundamental role in the 
regulation o f the early development o f the embryo. They are thought to be secreted and 
then sequestered in or on the bone matrix (Mundy, 1995).
BMPs stimulate osteoblast differentiation by enhancing the expression o f 
alkaline phosphatase and osteocalcin, and also induce the formation o f mineralised bone 
nodules in vitro under the appropriate culture conditions. They have proven to be useful 
in healing bone defects: craniosynostotic defects were treated with a combination of 
lyophilised cartilage and BMP, which appeared to accelerate the ossifying and 
calcifying, effects o f the lyocartilage (Sailer and Kolb, 1994); and, following treatment 
o f craniotomy defects in rats with rhBMP-2, it was shown that BMP-2 promotes the 
regeneration o f osseous tissue (Marden et al, 1994).
Individual BMPs
BMP-1 is co-purified with other BMPs from active demineralised bone matrix, 
suggesting interaction with these other proteins (Shore et al, 1995). It is not a member 
o f the TGF-beta superfamily but is similar to Drosophila tolloid protein and suggested 
to be a member o f a family of astacin proteases which is involved in pattern formation 
in insect development (Shimell et al, 1991; Takahara et al, 1994). BMP-1 in mammals 
has been identified as procollagen C-proteinase: the carboxy-terminii o f procollagens I,
II and II are cleaved by this protease to produce components o f the extracellular matrix 
(Kessler et al, 1996).
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The other BMPs have osteogenic effects: osteogenin (BMP-3) has been shown 
to have regenerative properties when applied to bone defects created in rats and baboons 
(Marden et al, 1993; Ripamonti et al, 1993b; Stevenson, et al, 1994). A spontaneous 
mutation in the short ear locus of mice was shown to result in the deformation o f bone 
and the development o f soft tissues (Kingsley et al, 1992). King et al (1994) showed  
that this was due to a nonsense mutation in the gene for BMP-5 and that the pattern o f  
expression of this gene spatially resembled that o f forming skeletal elements. An 
implied role for BMP-6 is in the terminal differentiation o f chondrocytes: BM P-6 
expression was transiently increased then down-regulated, following which type II 
collagen was decreased and finally collagen type X was stimulated. Simultaneously, cell 
size progressively increased (Carey and Liu, 1995). tf-
Comparison o f the sequences for murine and human BMP-2 revealed that 
structuring of the gene was very different between the two species although the amino 
acid product is over 90% homologous (Feng et al, 1994). In the same study it was 
shown also that BMP-2 and BMP-4 have great similarity at the genetic level only in the 
last exon and in regions o f the 5' flanking sequence, suggesting conservation o f  
regulatory elements. In the carboxyterminal region, BMP-2 is 75% homologous to the 
Drosophila dpp protein, which is a potent dorsalizing factor in the Drosophila embryo 
(Rusch and Levine, 1996), and can induce endochondral bone formation in the rat 
subcutaneous bone induction model (Sampath et al, 1993).
A clone spanning the entire BMP-4 gene was analysed, showing that two 
transcriptional start sites were present (5' to exons I and II) and that different variants 
could be expressed as a result. No TATA box was indicated within 300bp o f either 
transcriptional start site but two Spl sites were found (Kurihara et al, 1993). Creation of 
null BMP-4 mutants in mice resulted in death of murine embryos at 6.5-9.5 days post- 
coitum (dpc): some do reach the somite stage or beyond but are developmentally 
delayed with many posterior structures truncated or disorganised. These embryos may 
have been partially rescued from the effects o f the BMP-4 mutation by the presence of  
maternally-derived transcripts o f BMP-4 (Winnier et al, 1995). BMP-4 is expressed in 
the presumptive dental epithelium at the inception o f tooth development. This induces 
expression o f BMP-4, and Msx-1 and M sx-2 v(homeodomain-containing_ transcription 
factors) in the mesenchyme in a paracrine manner (Vainio et al, 1993). It is thought that 
this is mediated by the binding to syndecan-1, a cell surface heparan sulphate 
proteoglycan expressed in the dental mesenchyme, of tenascin, a matrix glycoprotein: 
growth factors expressed in the dental epithelium, such as BMP-2 and -4, then bind to 
syndecan-1 and induce the expression o f Msx-1 and Msx-2 in the dental mesenchyme 
(Thesleff et al, 1996). Alkaline phosphatase activity is upregulated in preodontoblasts 
by treatment with BMPs, and expression o f osteocalcin and type I collagen is induced 
by BMP-2 and BMP-4 respectively (Nakashima et al, 1994).
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BMP-7 mRNA is present in the heart, kidney, limb bud, tooth and intestine of  
human fetuses (Helder et al, 1995). BM P-7 or osteogenic protein-1 (OP-1) is 
structurally related to TGF-beta and is 70% homologous to the Drosophila 60A protein 
in the carboxyterminal region - 60A protein induced endochondral bone formation in 
the rat subcutaneous bone induction model (Sampath et al, 1993). Ectopic expression of 
60A in Drosophila embryos lead to defects in adult structures or lethality during 
metamorphosis (Staehling-Hampton et al, 1994).
BMP-7 v/as found to be expressed in the hypertrophic chondrocytes adjacent to 
and at the ends o f the metaphyseal vessels o f the chick (Houston et ai, 1994). BMP-7 
has been found to induce new bone formation subcutaneously in rats when implanted
with a suitable carrier, and can repair defects: treatment o f canine loqg-bone defects
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with BMP-7'resulted in regeneration o f tissue to 67-92% of control levels (Cook et al, 
1994). It is riot a fibroblastic mitogen nor does it stimulate matrix synthesis 
(Postlethwaite et al, 1994). Primary rat calvarial pells treated in vitro with BMP-7 prior 
to confluence became chondroblastic, whereas when treated at a more confluent stage, 
cells o f an osteoblastic phenotype were found. Co-treatment with TGF-beta-1 resulted 
in cancellation o f chondrogenesis (Asahina et al, 1993). BMP-7 reduces proliferation 
and stimulates development o f the osteoblastic phenotype: it was shown to inhibit the 
synthesis o f DNA in ROS 17/ 2.8 cells in a dose-dependent manner (Maliakal et al,
1994) and simultaneously increase the levels o f type I collagen mRNA, and the levels of  
osteocalcin and alkaline phosphatase activity and mRNA. The proliferative and 
differentiative effects o f BMP-7 on human bone cells were shown to be mediated at 
least in part by BMP-specific receptors (Malpe et al, 1994).
BMP-2 and BMP-4 in development
The role o f BMPs in the development of organisms has been studied in a range 
of species, In the developing mouse, BMP-4 mRNA is expressed early and is restricted 
solely to the facial epithelium; BMP-2 is expressed later in the neural crest 
mesenchyme, where Msx-2 transcripts are found, and in the developing mouth (Bennett 
et al, 1995). BMP-2 and BMP-4 transcripts were found in the developing facial 
primordia o f the chick: they were localised .to the epithelium initially, then in the 
mesenchyme, with some overlap in the expression patterns of the genes (Francis-West 
et al, 1994).
BMP-2 and BMP-4 transcripts are stored maternally in the Xenopus egg, and 
BMP-2 is expressed at the gastrulation stage throughout the ectoderm where BMP-4 
transcription is restricted to the ventrolateral marginal zone (Hemmati-Brivanlou and 
Thomsen, 1995). BMP-4 has a specific ventralising function which is conserved in 
insects and mammals: in Xenopus gastrula, BM P-4 is expressed in regions 
complementary to the goosecoid gene (gsc) where gain and loss of function experiments 
performed using antisense RNA injections show that BMP-4 ventralises dorsalised
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mesoderm, as does antisense gsc, and vice versa (Steinbeisser et al, 1995). Ectopic 
ectodermal dpp expression during gastrulation o f the Drosophila embryo resulted in 
respecification of dorsoventral patterning and in cells where 60A was also expressed no 
inhibition of dpp function was shown (Staehling-Hampton et al, 1994). The Drosophila 
short gastrulation gene sog, an antagonist o f dpp, was shown to have similar effects in 
Xenopus embryos as mutated BMP receptors, that is, overexpression of sog resulted in 
dorsalisation o f the embryo, also allowing partial rescue of ventralised embryos. These 
suggest that sog acts in part by opposing BMP-4 signalling (Schmidt et al, 1995). 
Another BMP-4 inhibitor, chicken ovalbumin upstream transcription factor-1 (COUP- 
TF1) was found to bind to response regions in the BMP-4 promoter, abrogating its 
activity (Feng et al, 1995). #:
v'
BMP-2* and BM P-4 may play a part in the specification of the limb/wing bud: 
BM P-2 is expressed in the apical ectodermal ridge (AER) and abblishes limb 
outgrowth, as is FGF-4, a potent instigator of mesenchymal proliferation. It seems likely 
therefore that limb outgrowth is regulated by the ratio between the inhibitory and 
stimulatory signals o f BMP-2 and FGF-4 respectively (Niswander and Martin, 1993). 
BMP-2 expression in anterior cells of the chick limb bud is activated by retinoic acid, 
but BMP-2 does not have any apparent polarising activity. BMP-4 has a similar 
expression pattern in the wing bud. It was observed that Hoxd-13 and BMP-2 
expression appears to be activated simultaneously upon treatment with retinoic acid 
(Francis et al, 1994).
BMP-2 and BMP-4 in bone formation
BMPs have been found to induce endochondral bone formation by causing 
chemotactic events (infiltration of cartilage and bone cell precursors), proliferation and 
differentiation of precursors into chondrocytes, induction o f vascularisation, maturation 
o f chondrocytes and differentiation of cells into osteoblasts (Reddi, 1981). Recombinant 
or endogenous bone morphogenetic proteins induce de novo bone formation when 
adsorbed onto biomaterials, such as a collagen carrier (Aaboe et al, 1995; Kusumoto et 
al, 1995). A gel consisting o f reconstituted basement membrane, laminin or collagen 
without addition of other components was shown to increase bone repair at.fracture sites 
in rats 6- to 12-fold when compared with untreated fractures left to heal without 
intervention (Sweeney et al, 1995).
Ectopic bone formation was induced by BMP treatment of rats: homologues of 
Hox cluster genes and two Msx genes were found to be expressed in the BMP- 
implanted tissue (Iimura et al, 1994b). BMPs 2, 4 and 6 were shown to induce bone 
nodule formation in cultures of rat osteoprogenitor cells, suggesting that these are 
targets for the action o f BMPs in bone induction, with BMP-6 affecting an earlier stage 
progenitor than BMP-2 or -4 (Hughes et al, 1995). BMPs 1, 2 ,4  and 6 were shown to be 
expressed by rat calvarial osteoblasts coincident with expression o f  alkaline
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phosphatase, osteopontin and osteocalcin, and prior to formation o f mineralised bone 
nodules (Harris et al, 1994b). BMP was implanted in mice: type I collagen levels 
increased from day 3 to 7 and on day 17, increased expression correlated with the 
incidence of osteoblasts. Type II collagen mRNA expression was augmented from day 7 
on the appearance o f  chondroblasts, but suppressed by day 17 when degenerative and 
hypertrophic chondrocytes were in attendance. Alkaline phosphatase expression was 
dramatically enhanced from day 7 to day 11, at which point mineral deposition began 
(Sakano et al, 1993). Similarly, rat abdominal muscle was implanted with a diffusion 
chamber containing rabbit BMP. After two weeks, chondrogenesis had occurred outside 
the chamber and after four weeks this was replaced with bone (Ono et al, 1994). 
Activation o f c-fos transcription by BMP-2 and BMP-3 in the late pha^e may mediate
v‘
the transcription o f the genes which mark differentiation o f osteoblasts (Ohta et al, 
1992). ; i
With age, bone marrow stromal cells differentiate along the adipogenic pathway 
(Glowacki, 1995). Upon treatment o f a bone marrow stromal cell line, BMS2, with 
BM P-2, adipogenesis was suppressed and alkaline phosphatase induced at 
concentrations o f BMP-2 in the range 50-500 ng/ ml. It was also found that the cells 
constitutively expressed BMP-4 mRNA which was suppressed following treatment of  
the cells with adipogenic agonists, suggesting that BMPs act as adipogenic antagonists 
(Gimble et al, 1995).
Endochondral ossification is induced by BMP-2 by stimulated proliferation and 
accelerated differentiation o f pre-osteoblastic cells (Ghosh-Choudhury et al, 1996) and 
mesenchymal cells into chondroblasts and osteoblasts, elevating the production of 
cartilage and matrix, and promoting the terminal differentiation of osteoclasts (Rosen et 
al, 1994; Zheng et al, 1994). This accelerated osteogenesis is mediated by TGF-beta 
receptors, the expression of which is altered by BMP-2, therefore modulating the effects 
o f TGF-beta and augmenting the osteoblastic function o f the cells (Centrella et al,
1995). Chick limb mesenchymal cells treated with BMP-2 produced more extracellular 
matrix - this effect was amplified in condensed or differentiated cells (Roark and Greer, 
1994). BMP-2 treatment o f the murine mesenchymal stem cell line C3H10T1/2 caused
dose-dependent differentiation o f these multipotent cells into adipocytes at low  
concentrations, and chondrocytes and osteoblasts at high concentrations: these 
phenotypes remained constant when the agent was removed (Wang et al, 1993). As well 
as precip itating d ifferentiation  o f  m esenchym al ce lls , BM P-2 exhib its  
transdifferentiation abilities with more committed cells: prechondroblasts (Rosen et al, 
1994) and myoblasts (Katagiri et al, 1994) were converted into osteoblastic cells by 
treatment with BMP-2.
These differentiation-stim ulating effects o f  BM P-2 are mediated by 
enhancement o f  osteoblast-specific gene expression. BMP-2 induced expression of  
insulin-like growth factors (Canalis and Gabbitas, 1994) and TGF-beta 1 in osteoblast­
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like cells (Zheng et al, 1994). Importantly, BMP-2 mRNA expression was found to be 
autoregulated (Ghosh-Choudhury et al, 1996). BMP-2 treatment of osteoblastic cells 
results in decreased TGF-beta type II receptor expression, but type I receptor levels 
remained constant so it would appear that the ratio between the receptor types is 
important in the development of a more differentiated phenotype (Centrella et al, 1995).
BM P-4 is expressed by osteoprogenitor cells and not by differentiated  
osteoblasts (Nakase et al, 1994). However, ectopic introduction of BMP-4 resulted in 
bone formation and the sequential expression o f osteonectin, osteopontin and 
osteocalcin, localised respectively to fibroblast-like cells; hypertrophic chondrocytes 
and middle stage osteoblasts; and, middle to late stage osteoblasts and a subset of
osteocytes (Hirota et al, 1994). <*■
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BMP-4,treatment of a rat preosteoblast cell line (UMR 201) resulted in no effect 
on matrix gla protein (MGP) or osteonectin (ON) mRNA expression, an augmentation 
of pro-alphal(I) collagen and a reduction in osteopontin (OP) mRNA levels. Following 
co-treatment with retinoic acid (RA), MGP mRNA expression was enhanced, a further 
increase in pro-alpha 1 (I) collagen levels was observed, although the transcription rate 
o f this gene was unaffected, and the retinoic acid-induced increase in the OP 
transcription rate was not reduced (Zhou et al, 1993).
In their mature forms, BMPs can form dimers, therefore heterodimers may affect 
bone formation by increasing or decreasing the effects o f the homodimers: BMP-2 and 
BMP-7 have been found to be co-localised in the zone o f polarising activity, the 
notochord and in the apical ectodermal ridge o f the developing limb o f the mouse 
(Lyons et al, 1995). This suggests that heterodimers o f these BMPs may play a part in
these tissue interactions. In cultured rat marrow stromal cells (Aono et al, 1995) and
>
insect cells (Hazama et al, 1995), increased induction o f osteogenic properties in 
conditioned medium was seen when more than one BMP was expressed.
Signalling mediated by BMPs involves binding oFthe ligand to heterodimers of  
type I and type II receptors on the cell surface: a functional type I BMP receptor is 
necessary for effective induction o f the mesoderm (Mishina et al, 1995). Under certain 
circumstances, other receptors can bind BMPs, for example in Drosophila, the punt 
gene product binds activin and not BMP-2. However, complexed with a type I receptor, 
BMP-2 is bound (Letsou et al, 1995).
In transfected COS cells, BMP-4 and BMP-7 were shown to bind to certain o f  
the activin receptor-like kinase (ALK) family. It was shown that ALK-3 and -6 are type 
I receptors for BMP-4 and BMP-7 and also that ALK-2 is a type I receptor for BMP-7 
but not BMP-4 (ten Dijke et al, 1994). The mRNA for these receptors have very 
different and restricted patterns of expression in the developing mouse: ALK-3 is found 
ubiquitously except for the liver, whereas ALK-6 is expressed later in development and 
in specific areas only, including the developing cartilage and bone. In the adult mouse, 
ALK-3 mRNA is found ubiquitously and that of ALK-6 is present only in the brain and
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lung (Dewulf et al, 1995). These data indicate a wider role for BMPs in embryogenesis 
compared to that in the adult.
The signalling pathways mediated by BMPs are similar to those triggered by 
TGF-beta. In the intracellular signalling pathway initiated by the Drosophila dpp gene 
product, the functions o f the maternally expressed genes Mad (Mothers against dpp) and 
Medea are indicated to have a temporal effect on the cascades o f expression in the dpp 
pathways (Raftery et al, 1995). Receptor activation phosphorylates Mad-related proteins 
which are then translocated to the nucleus (Ferguson, 1996).
BMPs have been shown to use the mitogen-activated protein Kinase (MAPK) 
signalling pathway: MAPK is phosphorylated by MAPK kinase (MAPKK) which was 
previously activated by MAPKK kinase (MAPKKK). It was demonstrated in mice thatY> \
the activity o f a protein kinase was stimulated upon treatment o f the cell with TGF-beta 
or BMP, and was proposed to have a role in the regulation o f transcription by TGF-beta. 
It was therefore suggested that this protein kinase may be a mediator in the signalling 
pathway o f the TGF-beta superfamily (Yamaguchi et al, 1995).
Calcitriol
The vitamin D endocrine system is pivotal to the regulation o f bone and calcium  
homeostasis. Vitamin D 3, a member o f the steroid hormone superfamily, is formed by 
photoproduction in the skin and metabolised to its active form in the liver and kidney: it 
is hydroxylated at position 25 in the liver and then it is transported to the kidney where 
hydroxy lation o f position l a  or 24R produces la,25-dihydroxy vitamin D3 or 24R,25- 
dihydroxyvitamin D 3 respectively (Tanaka et al, 1977). The most active naturally 
occurring metabolite o f vitamin D3, 1 a,25-dihydroxyvitamin D3 (calcitriol), has 
dramatic effects on the control of plasma calcium and phosphorus levels, and regulates 
the proliferation and differentiation of cells in a range o f tissues including bone. It has 
been suggested that aging and sunscreen use coupled to inadequate dietary vitamin D 
can lead to osteomalacia and foster osteoporosis and that at least 400IU/day vitamin D 
plus at least lOOOIU/day calcium are required to sustain good bone health (Holick,
1996). However, high doses o f calcitriol can produce adverse physiological effects, 
including soft tissue calcification and hypercalcemia (Norman, 1995)^. Calcitriol is 
broken down upon further hydroxylation by 24-hydroxylase, the expression o f which is 
upregulated by calcitriol itself (Nishimura et al, 1994) via interaction with two vitamin 
D response elements (VDREs) located within 263bp o f the start site o f transcription 
(Chen and DeLuca, 1995; Zierold et al, 1995).
Genomic effects o f calcitriol
The effects o f vitamin D are mediated through a specific nuclear receptor, the 
vitamin D receptor (VDR), which is expressed in a wide variety of tissues including the 
pituitary gland, placenta, keratinocytes, colon, breast tissue and prostate gland, as well
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as in the intestine, bone and kidney (Norman, 1995). The VDR binds to DNA in the 
form o f a homodimer or a heterodimer with other members o f the steroid hormone 
receptor subfamily, such as the retinoic acid, retinoid X or thyroid hormone receptors 
(RAR, RXR and THR respectively) (White et al, 1994). The mouse VDR gene was 
cloned and sequenced, revealing high homology with rat and human sequences in the 
DNA and ligand binding regions, with increased variability in the region between the 
two domains (Kamei et al, 1995): autosomal recessive calcitriol-resistant rickets can be 
caused by a mutation in the VDR (Hochberg and Weisman, 1995).
VDR expression was detected in the dental epithelium and mesenchyme o f bud, 
cap and bell stages o f the developing tooth germ, as well as in ameloblasts and 
odontoblasts (Bailleul-Forestier et al, 1996). Expression of COUP-TFs, fnembers of the 
steroid hormone receptor superfamily and negative regulators o f gene transcription (for 
example, o f BMP-4), is. regulated by retinoic acid (Qiu et al, 1996). They can bind to 
response elements o f receptors of the steroid hormone superfamily, including receptors 
for vitamin D, thyroid hormone, retinoic acid and retinoid X. The transcription o f a 
vitamin D-regulated gene, such as osteocalcin, may therefore depend on the ratio of 
COUP-TFs to positive regulators.
Calcitriol affects gene expression dose-dependently in chondrocytes: 10 nM 
calcitriol resulted in increased TGF-beta activity, and lower doses o f calcitriol actively 
inhibited TGF-beta activity (Del Rio-Tsonis and Tsonis, 1994). Messenger RNA levels 
of TGF-betas 1 and 3 were found to be decreased, TGF-beta 2 transcription was raised 
(Farquharson et al, 1996) and N-cadherin expression was shown to decline with 
progression of chondrogenesis (Tsonis et al, 1994).
Pre-treatment o f MG-63 osteoblastic cells with calcitriol transiently abolished 
the inhibitory effects o f TGF-beta on alkaline phosphatase expression. This was shown 
to be due to the downregulatory effects o f calcitriol on TGF-beta type II receptor levels 
(Iimura ef.al, 1994a). MG-63 cells were shown to express‘a variety o f steroid hormone 
receptors, including those for glucocorticoid, retinoic acid and calcitriol. Vitamin D 
receptor (VDR) m RNA expression and stability, and protein expression was 
upregulated by calcitriol treatment; stability o f VDR mRNA was unaffected by 
dexamethasone (dex) and increased by retinoic,acid treatment (Mahonen nnd Maenpaa, 
1994). Calcitriol treatment of the osteoblastic MG-63 cell line augmented expression of 
VDR and osteocalcin mRNA, and o f secreted osteocalcin protein (Mahonen et al, 
1990). Under mechanical strain, increased levels o f bone matrix proteins such as 
osteopontin and osteocalcin are produced without the presence o f an inducing hormone 
such as calcitriol. Treatment with calcitriol resulted in a further augmentation o f the 
levels o f these proteins (Harter et al, 1995). Calcitriol and TGF-beta act synergistically 
to increase type I collagen synthesis and alkaline phosphatase activity, but increased 
osteocalcin synthesis due to calcitriol treatment was ablated by TGF-beta treatment 
(Ingram et al, 1994).
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As well as increasing expression o f the VDR directly, calcitriol augments 
transcription and translation of its receptor indirectly using other signalling pathways. 
Phorbol 12-myristate 13-acetate (PMA) is a potent activator o f the protein kinase C 
(PKC) pathway; treatment with PMA resulted in a time and dose-dependent increase in 
VDR expression in ROS 17/ 2.8 cells. PMA or calcitriol alone stimulated expression of 
VDR at the transcription and translation levels; co-treatment had a synergistic 
augmentation o f VDR mRNA and protein expression which was not accompanied by 
increased affinity o f VDR for calcitriol ligand. This evidence supports a link between 
VDR and PKC signalling pathway (Reinhardt and Horst, 1994). \ H
Non-genomic effects of calcitriol #
V' 1
Calcitriol has been shown to have non-genomic effects in osteoblasts and 
chondrocytes, such as changes in arachidonic acid metabolism, prostaglandin 
production, protein kinase C activity and calcium ion flux. Cells which mineralise their 
matrix, such as chondrocytes, produce matrix vesicles which contain calcification 
enzymes, metalloproteinases and plasminogen activator. Vitamin D metabolites regulate 
the production o f these vesicles, augment the expression o f active and total 
metalloproteinase, and attenuate the expression of plasminogen activator and its activity 
by up to 75% in matrix vesicles isolated from growth zone chondrocyte cultures (Dean 
et al, 1996), facilitating their ability to activate latent TGF-beta (Boyan et al, 1994). It 
was postulated that activation of genomic and non-genomic pathways o f calcitriol may 
be mediated by distinct receptors, as cells lacking the VDR still exhibit calcitriol- 
mediated effects and because the activation o f the rapid non-genomic pathway is
independent o f the long-term effects on target genes (Khoury et al, 1995). Also,
.>
phospholipase C is activated and calcium channels are opened, suggesting that this is 
mediated by a receptor on the membrane (Baran et al, 1994).
Calcitriol induces ce ll-ce ll com m unication Via gap junctions at low  
concentration; at higher levels of calcitriol, communication is suppressed, but this is 
reversed upon removal o f calcitriol from the medium and replacement with trans- 
retinoic acid. Reciprocally, stimulation o f intercellular communication by retinoic acid 
is blocked following removal o f RA from the medium and consecutive treatment with 
calcitriol (Stahl et al, 1994).
Other bone formation stimulators include retinoids, fibroblast growth factors 
(FGFs), prostaglandins, platelet-derived growth factor (PDGF), insulin-like growth 
factors (IGFs), interleukins, thyroid hormone (T3) and parathyroid hormone (PTH) 
(Kang et al, 1995). Table 1.1 summarises the effects o f several o f these agents on gene 
expression in osteoblastic cells; table 1.2 illustrates the overall effects on osteoblastic 
proliferation and/  or differentiation.
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Specific aims of the project
M SX-2 expression is regulated by BMP-4 and BMP-2 and is associated with 
embryonic skeletal morphogenesis and development. There is some evidence to suggest 
that it is expressed in adult bone-derived cells. Therefore, a principal aim of this project 
was to investigate the role of M SX-2 in adult osteogenic differentiation, namely its 
expression and regulation in adult human bone-derived cells by osteogenic factors, 
including calcitriol and bone morphogenetic proteins (Chapter 4).
Osteoblastic cell culture systems are documented to provide models for the 
study of specialisation of osteoblasts, therefore a further aim was to investigate the 
appropriateness o f using MG-63 osteosarcoma cells as a model o f osteoblastic 
differentiation (Chapter 3).
Considered to be of great interest was to gain some understanding o f the 
mechanisms by which calcitriol regulates MSX-2, and the other genes of interest, in 
comparison with the regulation of osteocalcin mRNA expression, which was used as a 
model of calcitriol-induced expression and as a marker of osteoblastic differentiation.
The importance o f cell: cell and cell: matrix interactions with regard to 
osteoblast-related gene expression, and their modulation o f the effects of osteogenic 
agents, were also evaluated.
Finally, to be examined were the effects of calcitriol and o f the synthetic 
glucocorticoid dexamethasone, which is known to increase the incidence o f  
osteoporosis with long-term use, on the differentiation of osteoblastic cells at different 
stages of maturation and on their pattern of gene expression (Chapter 5).
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The bone rem odelling seq u en ce (after Baron, 1990)
o s te o c la s t
l in in g  c e ll
q u ie s c e n t  p h a s e
o s te o c y te
t r a b e c u la r
b o n e I .
f o rm a t io n  p h a s e r e s o r p t iv e  p h a s e
o s te o b la s t
r e v e rs a l  p h a s e  
b o n e  r e s o r p t io n  c o u p le d  to  b o n e  f o rm a tio n
F ig u r e  1.1
T h is  d ia g ra m  i l lu s tr a te s  th e  b o n e  r e m o d e l l in g  s e q u e n c e ,  w h e re  b o n e  is  in i t ia l ly  
in  a  r e s t in g  p h a s e ,  th e n  o s te o c la s t s  a r e  a t t r a c te d  to  th e  s i te  a n d  r e s o r p t io n  
o c c u r s .  O s te o b la s t s  r e p la c e  th e  e x t r a c e l lu la r  m a tr ix ,  w h ic h  th e n  m in e r a l i s e s  
te n  d a y s  la te r .  O s te o b la s t s  b e c o m e  e i th e r  o s te o c y te s  o r  f la t  l in in g  c e lls  to w a r d s  
th e  e n d  o f  th e  s e c r e to r y  p e r io d .
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Diagrammatic representation of events associated with progression from bone marrow 
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This figure is a simplified illustration o f the putative progression o f bone marrow stem 
cells to fully differentiated mature cells o f the specified lineages. With advancing 
differentiation, the proliferative potential of the cell is reduced. However, evidence has 
been shown that diminished switching between phenotypes can occur under the 
appropriate conditions, for example, myoblast to osteoblast phenotype with BMP-2 
treatment (Murray et al, 1993).
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Figure 1.3 Sequential gene expression during osteoblast proliferation and differentiation
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S c h e m a t ic  r e p r e s e n ta t io n  o f  a lo n g  b o n e  d u r in g  d e v e lo p m e n t  a n d  o f  th e  g r o w th  p la te








F ig u re  1.4
D u r in g  e m b r y o n ic  d e v e lo p m e n t ,  c h o n d r o c y te s  in  th e  c e n tr e  o f  th e  c a r t i la g e  
te m p la te  p r o l i f e r a te ,  th e n  m a tu re  a n d  h y p e r tro p h y . T h e  s u r ro u n d in g  m a tr ix  
c a lc i f ie s  a n d  o s te o b la s t s  in v a d e ,  p r e c ip i ta t in g  th e  r e p la c e m e n t  o f  c a r t i la g e  w ith  
b o n e  a n d  b o n e  m a r ro w . T h is  w a v e  o f  r e p la c e m e n t  r a d ia te s  o u tw a rd  w ith  th e  
r e s u l t in g  f o rm a t io n  o f  th e  g ro w th  p la te s  a t th e  m e ta p h y s e s ,  s e p a r a t in g  th e  
c a r t i la g in o u s  e p ip h y s e s  f ro m  th e  b o n y  d ia p h y s is .  O n  th e  r ig h t  is  a n  i l lu s tr a t io n  
o f  a  m a g n if ie d  g r o w th  p la te ,  d e s c r ib in g  th e  p r o g re s s io n  o f  c h o n d r o c y te  





















Figure 1.5 The regulation of osteocalcin transcription 
5' flanking region o f the rat osteocalcin gene
-600 -400 ■170 -70
+1
5 4 3 2 1
1 -33 GAT AT A AA AGGT ATTGC AGAACAGACAAGTCCC -1
The sequence contains a TATA box (underlined) and a glucocorticoid 
response element (boxed, with the hexameric half-sites underlined)V: '
Included within the 28bp sequence located at -74 to -47 is the OSEl element 
(sequence beldw), which is activated also in osteoclastic cells eaily in their 
differentiation
5' CCTCCTGCTTACAT 3'
This region is a primary transcription regulatory sequence. From t121 to -74, 
it has been designated a cAMP response region. It encapsulates the osteocalcin 
box (OC box, -102 to -76, boxed), within which are several consensus binding 
sites: AP-1 (small boxes), Msx (underlined), CAAT box (heavy overline), E box 
(overline) and steroid hormone half-sites (heavy underline).
Also binding here was an osteoblast-specific binding protein (OCBP) 
whose binding sequence overlaps with that o f MSX.
-121 TTGGGTTTGACCTATTGCC CAC/ TGACCCC CA/ TTAGTCC' GGCACCA -74
4 The OSE2 sequence (-146 to -132) binds an osteoblast-specific factor which 
activates osteocalcin gene expression only in mature, mineralising osteoblasts. 
Contained within this region is the consensus binding, sequence for members 
the runt family of core-binding factors. CBFA1, a runt domain-containing 
transcriptional activator, is essential for the normal formation o f bone and binds 
the osteocalcin promoter at the following sequence within the OSE2:
5 'CCAACCACA 3,;
5 Basal transcription is regulated in part at least through a CP-1 binding motif 
located between -200 and -180.
5' TCTGATTGTGT 3'
A vitamin D response element (boxed with the hexameric half-sites underlined), 
two binding sites for nuclear matrix proteins (overlined) and an AP-1 site (heavy 
underline) are located between -465 and -434:
5' GCACT GGGTGAATGAGGACA TTACTGACCGCT 3'
7 Element(s) associated with upregulation o f osteocalcin expression following FGF-2 
treatment are thought to bind in the region between -678 and -476






























20 40 60 80 100
% amino acid homology
Figure 1.6
The transforming growth factor-beta superfamily contains several subfamilies 
which are grouped according to their amino acid sequence homology. Included 
are members whose sequences and functions are highly conserved in different 
species for example Bmp-2 and Bmp-4 (human) and dpp (Drosophila).
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dex 11,40
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TGF-beta 36
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Where agents appear in both columns, their effects are biphasic, depending on the 
maturation stage of the cells when treated and/or upon the dose of the agent used.
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Table 1.2 Agents affecting proliferation/differentiation of osteoblasts
Increased proliferation Increased differentiation
TGF-beta
FGF-2





thyroid hormone 15 
parathyroid hormone6> 18 
prostaglandins 3
B M Ps4’7’34’384 , 7 , 34, 38
calcitriol45-
*  , 
retinoic acicf 43
dexamethasone45
As before, where agents appear in both columns, their effects are biphasic, 
depending on the maturation stage o f the cells when treated and/or upon the dose o f the 
agent used.
1 Araki et al, 1993;2 Centrella et al, 1991; 3Raisz and Fall, 1990; 4reviewed by Hogan,
1994;5Graham et al, 1994; 6Hruska et al, 1993; 7Iwasaki et al, 1994; 8Koli and Keski-
Oja, 1995; 9Petkovich et al, 1984; 10 Chen and Feldman, 1985; ^Chen et al, 1986;
12 Costa et al, 1985; 13Noda et al, 1988; 14 Ohishi et al, 1994; 15Pavlin et al, 1994;
16 Pitaru et al, 1993; I7Nishida et al, 1994; 18Thiebaud et al, 1994; 19 Ozono et al, 1991;
20 reviewed by Young et al, 1993; 21 Barlow and Francis-West, 1997; 22reviewed by
Bonewald and Mundy, 1989;23 Breen et al, 1994 a ; 24 Breen et al, 1994 b; 25Canalis et
al, 1988;26 Ghosh-Choudhury et al, 1996;27Centrella et al, 1989;28 Delany et al, 1994;
29Beresford et al, 1984;30 Farquharson et al, 1996;31 Franceschi and Iyer, 1992;32 Harter
et al, 1995; 33 Hughes et al, 1995; 34Iimura et al, 1994; 35 Hodgkinson et al, 1993;
36reviewed by Kim and Ballock, 1993;37 reviewed by Wozney, 1993; 38Lian and Stein,
1992; 39Mahonen et al, 1990; ^Mahonen and Maenpaa, 1994;41 reviewed by Massague,
1996;42 reviewed by Moses and Serra, 1996; 43Piskanen et al, 1994; ^Pockwinse et al,
1995; 45 reviewed by Stein and Lian, 1993; 46Towler et al, 1994.
Chapter 2 
M ATERIALS AND M ETHODS
41
M ATERIALS
1. Human bone explants
Bone samples were collected from patients undergoing surgery for fracture or 
joint replacement from the Bristol Royal Infirmary, Frenchays Hospital and from the 
University o f Bristol Medical School. These were stored in sterile sealed bags or in 
flasks containing sterile medium at 4°C until use.
2. Human osteosarcoma cells fMG-63i
These were stored in liquid nitrogen in aliquots o f 1 ml, sufficient to seed 2 T75 
flasks. They were obtained from the European Collection o f Animal Cell Cultures 
(ECACC) at passage 107.
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3. Rat osteosarcoma cells (ROS 17/ 2.8i and mouse calvaria-dierived cells
(MC3T3-E1V
These were stored in liquid nitrogen in aliquots o f 1 ml and were supplied by the 
American Tissue Culture Collection (ATCC).
4. Tissue culture reagents
These were generally supplied by Gibco BRL, unless otherwise stated.
5. FACS antibodies
Hybridomas for the monoclonal mouse anti-human antibodies Stro-1 and AP 
(B4-78) were supplied by the Developmental Studies Hybridoma Bank, University of 
Iowa (Stro-1, Simmons and Torok-Strob, 1991; AP, Lanson et al, 1985). These were 
cultured and the supernatants, containing secreted antibody, were collected for use in 
the FACS analysis: the alkaline phosphatase antibody was purified by protein G column 
separation by Dr. Carolyn Jefferiss. IgGt was supplied by Sigma and OB/L was raised
in-house by Dr. Susan Walsh. The goat anti-mouse human adsorbed secondary 
conjugates anti-IgGi R-PE and IgM FITC were supplied by Southern Biotechnology 
Associates Inc. in 1ml quantities.
6. Bacterial strains
The E. coli. strain D H 5a was used for plasmid amplification and was supplied 
by Promega.
7. Bacterial growth media




The phagemid pBluescript was used as a vector for a 2.6 kb MSX-2 insert and 
was supplied as containing the insert by Professor Paul Sharpe, UMDS, London.
251 bp o f the propeptide coding region o f BMP-2 were cloned into the pSP65 
vector and 500 bp o f the propeptide coding region o f BMP-4 were cloned into pSP64, 
and supplied as containing the insert by John Wozney, Genetics Institute, Cambridge, 
Massachusetts.
The vector pAT153 containing the 2.6 kb insert for alkaline-phosphatase was 
supplied to us by Mitchell Weiss at the University of Pennsylvania (Weiss et al, 1986).
The sequence for a 40 base oligonucleotide which binds to the coding region of 
osteocalcin was selected by J. Beresford and made originally at the Nfp.C Molecular 
Haematolbgy Unit, John Radcliffe Hospital, Oxford by J. Lamb. The sequence reads: 5' 
- CCA ACT CGT CAC AGT CCG GAT TGA GCT CAC ACA CCT C C C t -3'
A 1 kb fragment spanning the entire amino acid coding region o f GAPDH was 
cloned into pUC18 (Beresford et al, 1992).
9. Enzymes
Restriction enzymes and DNA modifying enzymes were obtained from New  
England Biolabs Ltd., Promega Ltd., Gibco BRL, Northumbria Biologicals Ltd., 
Boehringer Mannheim or Pharmacia Biotech and were used in accordance with 
manufacturer's instructions.
10. Radioisotopes
32P-labelled radioactive isotopes (dATP and dCTP) were supplied in aqueous 
10 p.Ci/ pi solution by Amersham Life Sciences UK Ltd.
11. General laboratory chemicals
All chemical reagents used in the making of buffers and other compounds were 
obtained from BDH Ltd. or Sigma Ltd. unless otherwise indicated and were o f  




2.1.1 Isolation and culture of cells from explants o f human trabecular bone
Bone fragments were handled in a Class 2 hood only and were cut into smaller 
fragments using sterile instruments. Fragments were kept moist at all times by 
immersing the bone in sterile phosphate buffered saline (PBS). Forceps were used to 
hold the bone explant in place while small pieces o f trabecular bone were cut from it 
using a scalpel or scissors. These pieces were then cut down again into fragments o f 2x 
2x 2 mm or less. These were placed in a 50 ml Falcon tube with 20 nil fresh PBS and 
vortexed vigorously for 15 seconds. The bone chips were allowed to settle and the PBS 
was removed carefully (with a pipette if  a large amount of fat was pre^int), The chips 
were washed in PBS a further 4-5 times or until all contaminating blood cells and 
marrow tissue was removed. The chips were transferred to 75 cm2 tissue culture flasks 
and 15 ml Dulbecco's modified Eagle's medium (DMEM) (see Appendix 1) plus 10% 
fetal calf serum (heat-inactivated FCS, Globepharm) was added. The cultures were 
maintained in an incubator at 37°C in a humidified atmosphere of 95% air: 5% C 0 2 and
were fed at days 7 and 14. After this, the cultures were fed every 3-4 days until near 
confluence (usually 5-6 weeks) when cultures were fed every 2-3 days.
2.1.2 Isolation and culture of cells derived from human marrow
Samples o f bone were handled in sterile conditions as for trabecular explants. 
All connective tissue and periosteum was removed with a scalpel blade to prevent 
contamination o f  the culture with fibroblasts and other cells. The marrow was 
suspended in serum-free DMEM and spun at 400g for 5 minutes in a benchtop 
centrifuge (Beckman centrifuge, model GPR) before the supernatant was removed. The 
cell pellet was resuspended in 25 ml o f DMEM which were then layered onto 20 ml 
Lymphoprep in a 50 ml Falcon tube. This was then centrifuged at 500g for 30 minutes 
with the brake off, so as not to disturb the final cell layers. The mononuclear cells were 
collected by removing the interface to a fresh tube whereupon 10 ml o f DMEM were 
added and the cells spun again at 250g for 10 minutes to wash out the Lymphoprep. 
Cells were resuspended in 15 ml DMEM and passed through a 70 pm cell filter 
(Falcon) to remove clumps. The filter was washed through with DMEM and the wash 
added to the cell suspension.
Viability was examined prior to plating by taking a small sample o f cell 
suspension and adding Trypan blue:
60 pi DMEM 
20 pi cell suspension 
20 pi Trypan blue
(0.5% solution in 0.85% saline, Flow Laboratories Inc.)
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The mix was allowed to stand for 2 minutes, then a small amount was loaded 
into a haemocytometer and counted. Any cells staining blue were counted as non-viable 
and cells remaining white were counted viable. The method for counting was thus: cells 
lying within the boundaries o f the grid were counted. Any that were lying on the 
boundaries to the left vertically or to the top horizontally were also included. Those 
cells lying on the vertical right or bottom horizontal were not included. A count was 
taken until at least 80 viable cells had been counted, then this number was multiplied by 
104 to account for the dimensions of the haemocytometer and again by 5 as this was the 
dilution factor. *
Cells were seeded at 2x 104 cells/ cm2 and left to establish in an incubator for 3 
days. At this point, non-adherent cells were removed by washing twice^in BBS and the 
medium replaced. Cells were fed with fresh medium every 3-4 days thereafter for 2 
weeks at which point the cells were redistributed following collagenase and trypsin 
treatment. Incubation was continued until confluency was reached.
2.1.3 Culture o f human, mouse and rat osteoblast-like cell lines
MG-63, MC3T3-E1 and ROS 17/ 2.8 cells were removed from storage in liquid 
nitrogen and heated rapidly to 37°C by placing them in a waterbath or incubator. An 
aliquot o f 1 ml was split between 2 75 cm2 flasks and 15 ml DMEM plus 10% FCS 
were added (MC3T3-E1 cells were cultured constantly in the presence o f 50 jxM 
ascorbate-2-phosphate). The contents o f the flasks were swirled gently to mix and the 
cells were incubated overnight as above. The following day, the medium was removed 
and fresh culture medium was added so that the high concentration o f dimethyl 
sulphoxide (DMSO) from the storage medium would not affect the cells. Thereafter, the 
cultures were fed every 2-3 days until confluency (10-14 days).
2.1.4 Passaging o f cultured cells
Culture medium was removed from the flask and the cell layer was washed by 
addition o f PBS to an opposite corner and gentle swirling. The supernatant was then 
removed and the cell layer washed twice more.
Trabecular bone explant-derived cell cultures only:
25 units collagenase IV/ ml DMEM supplemented with 2 mM CaCl2 were added 
following removal o f  the final PBS wash and the flask was incubated in culture 
conditions for approximately 40 minutes. At this stage, the cell layer was examined by 
phase-contrast microscopy (Wilovert) to ensure that necrosis had not occurred, that the 
cell layer was not peeling from the flask surface and that the extracellular matrix was 
being digested. The cell layer was again washed three times in PBS.
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All cell cultures:
5 ml trypsin-EDTA (Gibco BRL) was added per 75 cm2 flask following removal 
of the final PBS wash. The flask was incubated under culture conditions for 5-10  
minutes and examined by phase-contrast microscopy to ensure that the cell layer was 
being removed from the flask surface. A cell suspension was produced by gently 
pipetting up and down repeatedly with a sterile 2 ml pipette to break down large clumps 
of cells. The suspension was transferred to a fresh 50 ml Falcon tube containing 200- 
500 p.1 fetal calf serum (FCS, Globepharm) to stop the action o f the trypsin.
The cell suspension was centrifuged at 200g (Beckman centrifuge, model GPR) 
for 10 minutes at 4°C with the brake off so that the pellet would ndt be disturbed by 
rapid halting. The supernatant was removed and 2 ml fresh culture medium containing 
20 units/ ml DNase I were added to the pellet. Resuspension o f the pelfet was achieved 
by gently pipetting up. and down with a sterile 2 ml pipette. The suspension was 
removed to a fresh Falcon tube with a 70 pM filter (Becton Dickinson) attached, 
removing fine bone chips. The filter was washed through with 2 ml DMEM plus DNase 
I and the suspension was made up to 2 ml DMEM for every flask plus 2 ml.
Cells were counted using a haemocytometer (see section 2.1.2) and seeded in 
the range 5x 103 to 5x 104 cells per cm2 flask. Medium was replaced every 3-4 days 
until confluency at which stage the cells were treated.
2.1.5 Storage o f cell lines in liquid nitrogen
Following passaging o f cultures, a small quantity o f cells were stored to 
maintain the stocks. Sufficient cells to seed 2 T75 flasks were made up in 10% DMSO  
and 50% FCS and the tubes were then placed at -20°C for a few hours, then at -70°C 
overnight, then finally into liquid nitrogen.
2.1.6 Treatment of cells with exogenous growth factors and morphogenetic proteins 
Cells were fed at least 24 hours prior to treatment in an attempt to abolish the
effects o f early response genes. The serum content o f this replacement medium was 
dropped from 10% to 2%. Cells were treated with BMP-2, BMP-4, BMP-6, BMP-7, 
TGF-beta 1, FGF-2 and la,25-dihydroxy vitamin D 3 (calcitriol) and the following  
investigations were performed:
a) dose response, in which a range of doses of these factors has been applied to 
cultures to discover the most effective dose for induction/repression o f specific gene 
expression;
b) time course, in which the effective dose o f these factors has been applied to 
cultures over varying time intervals to determine when the most dramatic effects of  
these factors are; and,
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c) interaction studies, where various combinations o f these factors have been 
introduced to cultures to examine the effects of two or more factors simultaneously on 
the expression of specific genes.
The ranges used for each factor were: lO M O "  M for calcitriol; 5- 200 ng/ ml 
final concentration for BMP-2 and BMP-7; 5- 150 ng/ ml final concentration for BMP- 
4 and BMP-6; and, 0.05- 1.25 ng/ ml TGF-beta. FGF-2 was used at 2.5 ng/ ml final 
concentration as this was found previously to produce an effect. The time intervals used 
were from 30 minutes to 24 hours generally but in some cases longer exposures to the 
factors were appropriate. h
For the BMPs, FGF-2 and TGF-beta, a small sample o f the stocks was serially 
diluted in DMEM plus FCS, the appropriate quantity o f diluted factor being added
' v !
directly to medium in the flask and mixed by gentle swirling. For calcitridl, the same 
procedure was- carried out using a Hamilton syringe in minimal lighting Conditions as 
calcitriol is sensitive to light. The flasks were incubated for their accorded time and 
then prepared for extraction o f their nucleic acids.
2.2 FLUORESCENCE ACTIVATED CELL SORTING fFACS)
2.2.1 Principle and applications of flow cvtometrv
Flow  cytometry is a sophisticated technique which enables the swift 
measurement o f single particles as they pass individually in a fast-flowing stream 
through a detector. Flow cytometers have the capabilities to measure a wide range of 
cellular parameters based on light scatter and fluorescence and can separate cells into 
subpopulations depending on the parameters selected. This latter application is known 
as cell sorting (Carter and Meyer, 1990). The properties chosen for measurement can 
include enzyme activity, pH and nucleic acid content, and with the use o f monoclonal 
or polyclonal antibodies conjugated to fluorescent dyes, cell surface markers such as 
receptors can be tagged and their density and distribution gauged. Cell sorting involves 
the use o f  electrostatic deflection of droplets, whereby the stream o f  cells is vibrated 
and a voltage applied resulting in droplets, each containing a single cell, breaking off in 
a stream with a positive or negative electric charge. The voltage is applied as a pulse, 
which coincides with the formation o f the droplet containing the cell. The delay 
between the initial detection o f the cell and its containment within the droplet is set 
exactly and therefore only the desired cells will be charged and collected: they are 
separated from the stream when they pass through the electrostatic field formed 
between high voltage plates (see figure 2.1). Two subpopulations can be collected  
simultaneously with the rest of the cells going to waste collection.
Fluorescence is a result of electrons returning to a ground state by the emission 
o f a quantum o f light following excitation of the original molecule. The wavelength of 
the emitted light will be longer than that of the absorbed light as it will be o f lower
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energy. Therefore, they can be separated from each other with the use o f optical filters 
which results in the detection of a positive signal against a negative background.
Two important properties o f fluorescent compounds are the extinction  
coefficient, the quantity o f light absorbed at a given wavelength, and the quantum 
efficiency, the number of photons emitted for every photon absorbed. The absorption 
maximum should be at a wavelength close to one o f the spectral lines o f the laser used 
in the flow cytometer; the argon-ion laser used in these experiments produced light at 
488 nm wavelength. If the quantum efficiency is high, a strong fluorescent signal will 
be obtained (Ormerod, 1990). Fluorescein isothiocyanate (FITC) and k-phycoerythrin 
(R-PE) are two o f the most widely used fluorescent labels (fluorophores/fluorochromes) 
today because they can both be excited at 488 nm. When two fluoropho^is are used in a 
dual labelling system, overlap between the emission spectra must be avoided to increase 
the efficiency o f the sort - the emission maxima o f FITC and R-PE are 520 nm (green 
light) and 576 nm (orange light) respectively. Therefore, there may be some level o f  
crosstalk between the two dyes which must be compensated for in the FACS process.
2.2.2 Labelling o f samples
It is thought that trabecular and marrow-derived bone cells express Stro-1 and 
alkaline phosphatase (AP) proteins on their cell surfaces at progressive stages o f  
maturation (Stewart et al, 1996). In order to determine at which stage(s) o f maturation 
the genes of interest in this investigation were expressed, cells were sorted according to 
the presence or absence o f either or both Stro-1 or AP.
Cells were cultured to confluency and passaged as described in section 2.1.3 
until after the stage o f counting by haemocytometer. At this point, the cells from each 
treatment group were aliquoted into FACS tubes (Falcon) as follows: 105 - 2x 105 cells 
into each of three tubes designated negative control (no antibody labelling), Stro-1 
(control Stro-1 antibody labelling only) and AP (control AP antibody labelling only) - 
the cells in these tubes were necessary to set up the parameters for sorting. The rest o f  
the sample was placed in a separate tube for dual labelling. The tubes were centrifuged 
at 200g for 10 minutes with the brake off (Beckman centrifuge, model GPR) and the 
supernatant was removed carefully. Cells were resuspended in blocking buffer (see 
Appendix 1), 500 pi for controls and 5 ml for dual labelling, and incubated in ice for 15 
minutes. Cells were pelleted by centrifugation and the supernatant removed. The cell 
pellets were resuspended in primary antibody as follows - quantities for the controls are 
for 105 cells, and for dual labelling samples, quantities are for 107 cells: 
sample \ antibody OB/L Stro-1 IgGj AP
negative control 100 pi ------  10 pg/  ml —
Stro-1 
AP




10 pg/ ml 
10 pg/ ml
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The suspended cells were incubated in ice for 45 minutes, then HHF (HBSS, 
lOmM Hepes, 5% FCS - see Appendix 1) was added up to 4 ml. The cells were 
centrifuged for 10 minutes at 200g with the brake off and the supernatant was removed. 
Cells were then resuspended in secondary antibody (conjugates): 1/200 anti-IgG i R-PE 
and 1/25 anti-IgM FITC were made up in HHF and 50 p.1 was added to the controls and 
1 ml to the dual labelling cell pellets. The tubes were again incubated in ice for 45 
minutes before addition of HHF to 4 ml and subsequent centrifugation. Control cells 
were resuspended in 500 pi HHF and the dual labelling cells were resuspended in 2 ml 
HHF. They were then stored in ice for immediate FACS analysis. *
2.2.3 Cell sorting ‘f;
The flow  cytometer (FACStar plus, Becton Dickinson) was switched on a 
couple o f hours before, use to allow the machine to warm up adequately) The system  
was flushed through to ensure the removal o f clumps o f cells, debris or air bubbles, and 
the droplet delay was set. The cell sample was filtered again just before analysis to 
ensure removal o f clumps and so avoid blocking the machine. The samples were put 
through the flow cytometer in the same order as labelled (see section 2.2.2). The Stro-1 
sample fluorescence (FL-2) was shown in the vertical plane on the monitor. The 
fluorescence for the AP sample (FL-1) was shown in the horizontal plane. 
Compensation for the cross-talk fluorescence was adjusted where necessary to ensure 
efficient separation of the four subpopulations o f cells.
The dual labelled sample was taken into the flow cytometer. A count o f 104 cells 
was taken first as an idea of the distribution of cells between the subpopulations, then it 
was decided which populations to collect first. Sample tubes were labelled with the 
subpopulation to be collected: -/- for cells not labelled with Stro-1 or AP; +/- for cells 
labelled only with Stro-1; +/+ for those labelled with both antibodies; and -/+ for AP 
positives only. 500 |il HHF were added to each collection tube, two o f which were 
placed in the collection holders. Up to 3x 105 cells for each subpopulation, where 
possible, were obtained and the tubes were placed in ice until the FACS was completed. 
For those subpopulations for which sufficient cells were collected, a sample was 
reanalysed to assess purity of the sort. All data were stored onto a disk formatted in BD  
HP*2 to facilitate conversion and analysis.
2.2.4 Treatment o f cells
The cell suspension was removed into a fresh 1.5 ml tube and the cells were 
pelleted at 2000 rpm for 5 minutes in a benchtop centrifuge. The supernatant was 
removed carefully and the sealed tube placed briefly in liquid nitrogen to snap freeze 
the cell pellet. The tube was then stored at -70°C unless RNA was to be extracted 
immediately from the cells.
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2.2.5 Analysis o f data
The disk was labelled with the appropriate information and taken to a Quadra 
650 system (Macintosh) for conversion. The application Consort File Exchange (Becton 
Dickinson) allowed translation of the data to a format readable by the machine. They 
were converted by use o f the FACSConvert file where the data became readable by the 
CellQuest program, within which final analysis o f the FACS data occurred.
At this point, the data were plotted as a dot plot o f FL-1 readings (AP) against 
FL-2 readings (Stro-1). The sample was gated using the negative plot, so that less than 
5%  o f cells were present in any o f the positively labelled quadrants. This gate was 
pasted onto the singly and dual labelled plots to ensure consistency and so that 
background could be removed. This also facilitated comaprisons witll^pthpr treatment 
groups in the .same experiment. Sectors representing the four collected subpopulations 
were added onto the cfual labelled sample. These four rectangles were copied and 
automatically placed.into the corresponding areas on the other plots from the same 
treatment group so that distributions o f cells between the four subpopulations could be 
compared in the dual labelled sample. Statistical analysis o f the data was also 
performed in the same program, supplying percentages o f the total number o f cells 
present in each subpopulation region.
2.3 PR E PA R A T IO N  OF N U C LEIC  A C ID S FROM  B O N E  A N D  
OSTEOSARCOMA CELL CULTURES
2.3.1 Extraction o f RNA from cultured cells
RNAzol™  B (Biogenesis Ltd.) solution contains both guanidinium thiocyanate 
and phenol and can be used as a simple one-step extraction for RNA: cells can be lysed 
directly in RNAzol™  B, promoting the formation of RNA complexes with guanidinium 
thiocyanate and water, while simultaneously abolishing the hydrophilic interactions of 
DNA and proteins. Thus, DNA and proteins are effectively removed to the organic 
phase leaving only RNA present in the aqueous phase (after Chomczynski and Sacchi, 
1987).
Cells were passaged as detailed above until just following the centrifugation 
stage. Once the cells were spun down, the pellets were washed twice with PBS. The 
sample were lysed in 200 jil RNAzol™  B and sealed, then vortexed briefly before 
addition o f 20 pi chloroform. The samples were again sealed tightly and vortexed for 15 
seconds then chilled at 4°C for 10 minutes. The suspensions were centrifuged at 12000g 
for 15 minutes at 4°C (model GS-15R refrigerated centrifuge, Beckman).
At this point, the homogenate formed two layers: an upper colourless aqueous 
layer containing the RNA, and the lower blue organic phase. A white interphase was 
also usually present indicating an excessive amount o f protein present in the 
homogenate. The aqueous phase was transferred to a fresh tube and an equal volume of
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chilled isopropanol was added. The samples were then stored at 4°C for 15 minutes 
prior to a second centrifugation at 12000g for 15 minutes at 4°C.
The supernatant was removed carefully with a pipette and the samples inverted 
and allowed to air dry for 10 minutes before addition o f 50 jil water. The RNA pellets 
were allowed to resuspend at 4°C for 16 hours. If resuspension was unsuccessful, the 
RNA was heated to 60°C for 10 minutes before storage at -70°C, unless the RNA was to 
be used immediately in a reverse transcription reaction.
This approach was found to have limited applications as, while suitable for 
reverse transcription (see 2.3.2) and polymerase chain reaction am plication  (see 2.4), 
the RNA was generally not o f sufficient purity for Northern blot analysis (see 2.7.2).
This may have been due to co-purification o f proteoglycans. To obtain^extremely clean
V; '
RNA, it was necessary to use a more extensive method.
Human trabecular bone-derived cells were passaged as above, and at the pellet 
stage following trypsinisation, the cells were washed twice with PBS and re-pelleted. In 
the case of cultured cell lines, medium was removed and the monolayer was washed 
three times in PBS. For cells in a T75 flask, 8 ml o f the following lysis solution were
added; for cell pellets derived from FACS analysis, 500 jxl were used per tube:
4.22 M guanidine thiocyanate 
0.026 M sodium citrate
0.53% sodium lauroyl sarcosine
To 20 ml of lysis solution were added 144 |xl 2-mercaptoethanol just prior to 
use. Cells were suspended in this lysis solution by pipetting and the suspension was 
transferred to a 50 ml Falcon tube to which were added:
0.09 M sodium acetate, pH 44
8 ml water-saturated phenol
1.6 ml chloroform
The contents o f the tube were vortexed for 30 seconds and placedjpn ice for 15 
minutes. The mixture was transferred to a baked glass Corex tube and centrifuged for 
15 minutes at 10000 rpm in a SA600/SS34 rotor (Beckman). The aqueous supernatant 
was removed to a fresh 50 ml Falcon tube to which 7 ml ice-cold isopropanol were 
added. The RNA was allowed to precipitate overnight at -20°C.
The suspension was centrifuged for 15 minutes at 5000 rpm, then the 
supernatant was removed. The pellet was dissolved in 2 ml DEPC-treated water 
(Appendix 1) and 2 ml phenol/ chloroform (1:1) were added. The mixture was vortexed 
for 10 seconds then centrifuged for 5 minutes at 3000 rpm. The supernatant was 
removed to a fresh 15 ml Falcon tube. 0.68 M ammonium acetate and 90% ethanol
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were added and the RNA was allowed to precipitate overnight at -20°C. The following 
day the tube was centrifuged for 5 minutes at 5000 rpm, the supernatant was removed 
and the pellet was washed in 70% ethanol. All liquid was removed and the pellet was 
allowed to air dry for 10 minutes before dissolution in an appropriate volume o f DEPC- 
treated water. RNA was quantified by UV spectrophotometry (Ultrospec II, LKB 
Biochrom) and stored at -70°C until use in Northern blot analysis (see 2.7.2).
2.3.2 Preparation of cDNA from RNA
The effects of factors on gene expression can be examinedun several ways 
follow ing extraction o f the RNA. In this investigation, two methods have been 
introduced: reverse-transcription polymerase chain reaction (RT-PCI^) and Northern 
analysis (see section 2.7.2).
Before low levels o f RNA can be amplified, they must first be reverse 
transcribed to cDNA so that the DNA-dependent DNA polymerase used in the PCR 
will have a template. cDNA synthesis was carried out as follows:
5 p.1 5x first strand buffer (Gibco BRL)
0.2 U random hexamer primers [Pd(N)6] (Pharmacia Biotech)
8 mM DTT (Gibco BRL)
0.8 mM dNTP mix (supplied as 100 mM each nucleotide,
Pharmacia Biotech)
100 U reverse transcriptase (Superscript RT, 200 U/ pi,
Gibco BRL)
20 U RNasin (RNase inhibitor, 40 U/ pi, Promega)
This was made up to 20 pi with distilled water and 25 p,l mineral oil was overlaid. 5 pi 
RNA'was added through the oil layer and mixed by gently flicking the tube. Samples 
were checked for genomic contamination by setting up parallel reactions in the absence 
of reverse transcriptase.
Optional at this point was removal o f 5 pi to a fresh tube and the addition of 
0.5 p,l radiolabel to this to monitor the incorporation efficiency o f the reverse 
transcription reaction.
The samples were centrifuged briefly and incubated in a programmed heating 
block (Program temperature control system, PC-700, Astec) at 37°C for 90 minutes 
followed by denaturation at 100°C for 15 minutes and rapid cooling on ice. The cDNA  
was then stored at -20°C unless it was to be used immediately in the PCR.
2.4 A M PL IFIC A T IO N  OF cD N A  BY  R EV ER SE T R A N SC R IB E D  
POLYMERASE CHAIN REACTION (RT-PCR^
2.4.1 Generation o f primers for the RT-PCR
As low levels of mRNA expression may be evident and the efficiency o f reverse 
transcriptase may be very low, a technique which can increase the quantity o f cDNA
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target so that it may be analysed relatively easily is desirable. Such a technique is PCR. 
The principle o f PCR is that two short regions of known sequence (primers) are used to 
amplify a segment o f DNA which lies between them. These primers are usually 
oligonucleotides o f around 20-24 nucleotides in length and are typically complementary 
to sequences that lie on opposite strands o f the template DNA. The template DNA is 
denatured by heating in a large molar excess of both oligonucleotides with the four 
dNTPs and Taq DNA-dependent DNA polymerase (usually 94-95°C). The reaction 
mixture is then cooled to a temperature low enough that the primers will anneal to the 
template efficiently but high enough that they will not bind to non-specific sequences 
(range 50-65°C). The next stage o f the PCR is to heat the mixture to around 72°C to 
allow extension o f the annealed primers by Taq DNA polymeras$; TJiis cycle o f  
denaturationv annealing and extension is then repeated 25-40 times, each cycle  
effectively doubling the quantity o f desired cDNA product. The product may then be 
analysed by agarose gel electrophoresis and its identity confirmed by restriction enzyme 
digestion, Southern blotting or sequencing.
The sequences o f primers for M SX-2 and its pseudogene pM SX-2 were 
supplied by Professor Paul Sharpe, UMDS, London. Those for glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) and osteocalcin were supplied by Dr. Mark Birch, 
University o f Liverpool. Those for BMP-2 and BM P-4 were derived from the 
sequences of the BMP clones downloaded from the Daresbury database and using the 
Amplify package to check primer sequences. The primers were cross-referenced to 
check for non-specific amplification o f other members o f the BMP family.
The sequences o f the primers and the sizes of their PCR products are:
MSX-2: 5'-GGAGCGGCGTGGATGCAGGAACC-3' (sense)
5'-TGGTGCACGCAGGGTTAGCAGCG-3' (anti-sense)
When amplified from genomic DNA, these primers produce a fragment o f 3.5 kb in 
length (not visible on a gel as it is not readily amplifiatle). From cD N A, a 584 bp 
fragment is produced.
osteocalcin: 5'-ATGAGAGCCCTCACACTCCTCG-3' (sense)
5'-GATCTGGCCCGGCATCTTCGC-3' (anti-sense) -  
These primers produce a fragment o f 304 bp in length from cDNA.
GAPDH: 5'-GGTGAAGGTCGGAGTCAACGG-3' (sense)
5'-CCAGTACTCAGGAAGGTGCTA-3' (anti-sense)
These primers produce a fragment of 511 bp in length from cDNA.
BMP-2: 5,-CGTGACCAGACTTTTGGACACC-3’ (sense)
5'-TGTTCATCTTGGTGCAAAGACCT-3' (anti-sense)




The PCR product derived from cDNA here is 521 bp in length.
All of the above primers were supplied in concentrated stocks which were diluted to 
20-30 pmoles/ pi with water and stored in small aliquots at -20°C until use.
2.4.2 Amplification of cDNA for MSX-2/pMSX-2. osteocalcin. GAPDH. BMP-2 and 
BMP-4 h
PCR for each template target was set up individually so that problems with 
primer dimers and with competition for dNTPS and Taq would be minifpis^d. This also 
meant that visible product on a gel would not be confused with excessive quantities o f
m ‘ . '
template.
In setting up a PCR, it is important to minimise the risk o f aerosol 
contamination with previously amplified material. This is done by keeping a separate 
set o f pipettes which are dedicated for use in PCR and which do not come into contact 
with any DNA unless filter tips are used. A different pipette is used for loading gels and 
this procedure is carried out in a separate area from the location where the PCR is set up 
and where all stocks of reagents are aliquoted.
The reaction mix was made as a mastermix where all reagents except for the 
mineral oil overlay and the cDNA were placed in a single large tube and aliquoted:
2.5 jil lOx reaction buffer
2.5 mM MgCl2
10-15 pmoles 5' primer
10-15 pmoles 3 'primer
200 pM dNTP mix
0.5 units Taq polymerase
to 24 pi distilled water 
This was then overlaid with 25 pi mineral oil and 1 pi cDNA was added through the oil 
layer. The tubes were sealed and spun briefly at 12000g before being cycled in a PCR 
machine (either Program Temp Control System PC-700, Astec or DNA thermal cycler 
version 2.2, Perkin Elmer Cetus) under the following conditions:
Initial denaturation: 94°C for 4 minutes;
Cycling: 95°C for 1 minute;
62°C for 1 minute (BMP-2 and BMP-4) or 
65°C for 1 minute (GAPDH, M SX-2 and osteocalcin); 
and, 72°C for 1.5 minutes.
This cycling step was carried out for 30- 40 cycles as appropriate.
Final extension: 72°C for 7 minutes;
Cooling: 4°C until analysis by gel electrophoresis.
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To act as a positive control, templates for each set o f primers were amplified 
and analysed alongside each set of samples. A water control was also set up in parallel 
to control for aerosol contamination with previously amplified material.
2.5 MOLECULAR CLONING TECHNIQUES
2.5.1 Transformation o f E. coli.
To obtain plasmid in sufficient quantity for manipulation, restriction enzyme 
digestion or probe generation, the plasmid must be transferred into bacteria where it 
will increase in copy number with increase in bacteria population. Such transformation 
can only occur when the bacterial cells have been made competent, i.e. permeable to 
DNA. The bacteria (R  coli.. strain DH 5a) used in these transformation were supplied 
competent.
A 500 jil stock 6 f competent cells was thawed on ice. Aliquots o f 50 p.1 were 
placed in 0.5 ml Eppendorf tubes on ice. To each tube, 25 ng o f plasmid were added. 
An additional tube to which 15 jxl water were added was included as a control for 
ampicillin resistance of the bacteria. The tubes were incubated at 0°C for 30 minutes to 
facilitate plasmid uptake prior to a heat shock at 42 °C for 90 seconds to close the pores 
in the bacterial walls. Following this, 900 |il o f bacterial growth medium were added 
and mixed before a 45 minute incubation at 37°C. 100 |il o f the mix were then plated 
out onto agar containing ampicillin at a final concentration o f 100 jug/ ml and incubated 
at 37°C for no longer than 16 hours.
Next day, a selection of colonies from agar plates was inoculated into 20 ml 
Sterilin tubes containing 10 ml bacterial growth medium and ampicillin and incubated 
at 37°C for 5-16 hours. Before inoculation o f a larger volume (100- 1000 ml) of  
medium, it is necessary to confirm that the plasmid is present by firstly purifying a 
small quantity of DNA from the bacteria and then subjecting it to several restriction 
enzyme digestions.
2.5.2 Preparation of plasmid DNA from bacterial cultures
The bacteria were treated according to the Wizard Minipreps DNA purification 
system (Promega). 1.5 ml culture were spun down at top speed in-a benchtop 
microcentrifuge (MSE microcentaur microfuge) for 2 minutes and the supernatant 
removed. This step was carried out twice more so that almost half of the bacterial 
culture was used. 200 |il Cell Resuspension Solution (50 mM Tris-HCl, pH 7.5, 10 mM 
EDTA, 100 jig/ ml RNase A) were added to the cell pellet and the suspension was 
transferred to a fresh microfuge tube. 200 p.1 Cell Lysis Solution were added (0.2 M 
NaOH, 1% SDS) and mixed by inversion until the suspension cleared. 200 j l l I  
Neutralisation Solution were added (1.32 M potassium acetate, pH 4.8) and the mixture 
was inverted several times before being spun at top speed in a microfuge. The cleared 




The DNA Purification Resin was thoroughly mixed prior to each removal of an 
aliquot. 1 ml was added to the cleared supernatant and mixed by inversion. The 
suspension was purified by spin column centrifugation and eluted with water. The 
plasmid was then stored at -20°C until use.
2.5.3 Restriction enzvme digestion of DNA
Restriction enzymes are endonucleases which bind specifically to and cleave 
double-stranded DNA at or close to a conserved sequence o f usually four to six base 
pairs in length. This sequence is known as the recognition site and generally displays 
two-fold symmetry. The sequence may be cut by a restriction enzyme in two ways: 
either the enzyme cleaves both strands o f the DNA at the axis of symrffctry to generate 
fragments o f DNA which carry blunt ends: or, it cuts each strand at similar locations on 
opposite sides o f the axis bf symmetry, generating fragments o f DNA that carry 
overhanging ends.
This technique was used in this project to determine the identity o f plasmid 
DNA isolated from bacterial culture by comparing the digested products with a DNA  
marker ladder and to cleave out an insert in a plasmid so that, following purification 
from either the agarose gel or from solution, it could be used to generate a radioactive 
probe.
Generally, 5-10 pg o f plasmid were digested in 100 p i solution containing 
manufacturer's buffer, bovine serum albumin (BSA) and up to 50 units o f enzyme. The 
digestion was checked after 3 hours’ incubation at the required temperature by 
electrophoresing a 1 pi aliquot adjacent to uncut plasmid at 100 volts for 20 minutes. 
Completely digested product showed only bands o f the expected size(s) and no 
background bands, which indicate undigested material. The digested band was then 
ready for purification by precipitation or elution from the agarose gel.
2.6 GEL ELECTROPHORESIS
Size fractionation, identification and purification o f DNA, RNA and proteins 
can be carried out by electrophoresis through polyacrylamide or agarose gels. DNA or 
RNA was loaded into wells in a solution usually containing a Ficoll dye (Sx Ficoll dye 
stocks are 30% Ficoll-400, 100 mM EDTA pH 7.0 and either bromophenol blue or 
xylene cyanol, used for agarose gels at 0.1 % concentration). Appropriate size markers 
were run alongside DNA and RNA samples if  the gel was to be used for a size 
fractionation purpose.
2.6.1 Agarose gel electrophoresis
Agarose gel electrophoresis was used throughout this investigation for 
visualisation o f PCR products, integrity o f RNA and examination o f restriction 
endonuclease digestion o f plasmid DNA. Gels, unless used for Northern blot analysis
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(see 2.7.2), were made up in lx  TAE (see Appendix 1) and run in this same buffer at a 
maximum of 120 volts. The concentration o f agarose used depended on the length o f  
the nucleic acid being examined: the optimal resolution o f 0.7% agarose is 0.8-10 kb, 
where that o f 2% agarose is 100-2000 bp (Sambrook et al, 1989a).
Nucleic acid was visualised by ethidium bromide staining and UV fluorescence 
at 254 nm on a UV transilluminator (Chromato-Vue Transilluminator, model M-20, 
Ultra-Violet Products Ltd). Photographs were taken o f the gels using a hand-held 
camera (Polaroid Direct Screen Initant Camera, model DS34) with instant film  
(Polaroid Professional Coaterless Black and White Instant Pack Film 667).
2.6.2 Removal o f DNA fragments from agarose minigels f:
Wearing appropriate protection, the DNA band o f interest was excised from the 
agarose gel using a scalpel. The piece o f agarose was trimmed to remove excess gel 
material and placed in a preweighed Eppendorf tube. The tube plus gel segment was 
weighed again and the weight o f agarose segment calculated (1 gram agarose equals 
approximately 1 ml), as 3 volumes of sodium iodide (Nal) solution were required. The 
tube was incubated at 55°C for 5 minutes to dissolve the agarose. An aliquot o f  
GLASSMILK suspension was vortexed and 5 |il added for 5 jig or less o f DNA (1 ill 
was. added for every additional 500 ng DNA above 5 |ig): GLASSMILK suspension 
contains silica particles to which the DNA adsorbs under these conditions.
The suspension was allowed to stand for 5 minutes at room temperature with 
vortexing every minute to keep the silica particles in suspension. The tube was then 
pulse-spun for 5 seconds at top speed and the supernatant was transferred to another 
tube (this was kept to ensure that all the DNA had been eluted). The pellet was spun 
again for another 5 seconds and any remaining Nal solution was removed with a 
pipette. 10-50 volumes NEW WASH (NaCl, ethanol, water) were added and the pellet 
was resuspended by digging into it with a pipette tip while pipetting up and down. The 
suspension was spun for 5 seconds and the supernatant discarded. This washing step 
was repeated twice more. The pellet was resuspended in water and incubated at 55°C 
for 3 minutes then centrifuged for 30 seconds to obtain a firm pellet. The supernatant 
containing the eluted DNA was carefully removed to a fresh tube. This elution step was 
repeated once more. The purified DNA was stored at -20°C until use.
2.6.3 Preparation o f gels for electrophoresing RNA
RNA was analysed by agarose gel electrophoresis for two reasons: to check its 
integrity and for the purpose o f blotting it onto a membrane so that it may be probed 
with a fragment of radioactively labelled DNA complementary to an mRNA of interest. 
Throughout this type of electrophoresis, all reagents were dedicated to RNA use only 
and were autoclaved where possible. All plasticware and glassware was treated 
appropriately to ensure that equipment was RNase-free: plasticware was rinsed in
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DEPC-treated water or BDH water, and glassware was baked at 180°C for 16 hours 
following autoclaving. Gloves were worn throughout and changed frequently.
2.7 GEL BLOTTING TECHNIQUES
2.7.1 Southern blotting
This technique was used to fix DNA onto a nylon membrane so that a fragment 
o f radioactively labelled DNA complementary to a sequence of interest could bind to it.
Following electrophoresis and examination by UV analysis, the gel was placed 
back into buffer and the Southern blot apparatus was set up as follows^a glass plate was 
placed on an inverted support inside a tank. On this was placed a wick o f 3MM paper 
cut to the same width as the gel. Onto this was placed 1-2 sheets of 3MM paper cut to 
the same dimensions as the gel. Into the tank were poured approximately 500 ml 0.4 M
m ' . X
NaOH - sufficient so that thd ends o f the wick were well covered - allowing the wick 
and sheets o f  3MM to.be dampened. A fresh 10 ml pipette was rolled gently but firmly 
over the paper to remove any bubbles. Parafilm was used to seal the edges o f the sheets 
o f paper. The gel was removed from the buffer and placed, upside-down, onto the 
sheets of paper and rolled over with the pipette. A pre-cut piece o f nylon membrane 
(Hybond N+, Amersham Life Sciences), labelled in pencil with the date and experiment, 
was gently laid onto the gel and rolled over. 2-3 more sheets of 3MM paper were placed 
on top, and 6 sheets of blotting paper (Sigma) on top o f this. Another glass sheet was 
added and a small weight (500-750 grams) was placed on top. This was allowed to blot 
for 5-16 hours before disassembly, at which point the layers down to the last sheet o f  
3MM paper above the gel were removed. The top layer o f 3MM paper below the gel 
was picked up and the whole gel "sandwich" was inverted. The now top layer o f paper 
was removed and a pencil was used to mark the gel wells onto the membrane. Once this 
was done, the gel was disposed o f and the membrane was placed in 2x SSC (see 
Appendix 1) for 5 minutes to remove sodium hydroxide. The membrane was allowed to 
dry briefly before being sealed in a plastic hybridisation bag and stored at -20°C until 
probed.
2.7.2 Northern blotting
The agarose gels for Northern blotting were made according to a protocol 
involving formaldehyde and formamide. 0.9% agarose was boiled in lx  MOPS (see 
Appendix 1) and allowed to cool slightly before 0.17 volume o f formaldehyde was 
added in a fume hood. The gel was mixed thoroughly and poured. The gel tank was 
filled with lx  MOPS.
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The samples were pelleted and dried in a dessicator then dissolved in 20 p i 
DEPC-treated water at a concentration o f 1 pg/ jxl. To these were added:
20 pi formamide 
7 pi formaldehyde
2 pi bromophenol blue dye (see Appendix 1) 
final concentration of lx  MOPS 
These were denatured at 70°C for 10 minutes before being placed directly on ice 
for 5 minutes following which they were loaded onto the gel and electrophoresed at 
approximately 4 volts/ cm length. 1
The apparatus for Northern blotting was essentially similar to that for Southern 
blotting, except that the RNA was blotted in lOx SSC as compared to 0*4 M NaOH and 
the lower papers and membrane were all presoaked in lOx SSC. This was allowed to 
blot overnight then dismantled as above. In this case, the membrane was washed for 10 
minutes in 50 mM sodium phosphate, pH 7.2 (diluted in DEPC-treated water prior to 
use from 1M stock, see Appendix 1), then it was placed in a UV crosslinker (CL-1000 
UV crosslinker, UVP) for 2 minutes at 1200 p,W/ cm2. The blot was then baked at 80°C 
for 60 minutes to fix the RNA. To examine the integrity o f the RNA, the blot was 
stained for 2 minutes in a solution o f methylene blue (0.03% methylene blue, 0.3 M 
sodium acetate, pH 4.2). Excess dye was removed with repeated washes in DEPC- 
treated water until maximum contrast was obtained. Two strongly dyed bands 
representing 28S and 18S ribosomal RNA were observed indicating that RNA was 
intact and undegraded. The blot was then wrapped in Saranwrap and stored at -20C  
until use.
2.8 RADIOACTIVE PROBING OF BLOTTED MEMBRANES
2.8.1 Preparation of the probe j
Linearised purified plasmid or a fragment o f DNA was labelled for use as a 
probe using one o f two kits: the random primer labelling kit (Gibco BRL) or the Prime- 
a-gene labelling kit (Promega) respectively. 25-100 ng DNA were denatured by heating 
to 95°C for 5 minutes and then rapidly cooled by placing in ice. Using the random 




7.5 pi random primer buffer mixture
25 pCi a 32P-dCTP
10 p.1 water
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For the Prime-a-gene kit, the following were added to the denatured DNA:




2 pi acetylated bovine serum albumin (BS A)
50 pCi a 32P-dCTP
to 49 pi with water.
2x 0.5 pi were removed for spotting onto filter paper, then 5 units Klenow DNA  
polymerase were added. The tube was incubated at 25°C for 60 minutes then 2x 0.5 pi 
aliquots were removed for spotting. In the case of the random primer Mf, 2.5 fil STOP 
buffer were a^ded to the mixture to terminate the incorporation reaction; for the Prime- 
a-gene kit, the mixture was heated to 95°C for 2 minutes then chilled in an ice bath prior 
to addition o f EDTA to a final concentration o f 20 mM.
The incorporation of label into the DNA was calculated using the spotted filters 
thus: one o f each of the time-point papers was washed in 3x 0.2 M sodium phosphate, 
lx  water and lx  ethanol and allowed to air dry. The papers were then placed in 
scintillation tubes and 250 pi scintillation fluid were added. The counts were then read 
by a p-counter (liquid scintillation counter, Rackbeta model 1209, LKB Wallac). The 
counts were converted to percentages to make comparisons more understandable.
Taking the counts at time=0, the percentage counts after washing as compared 
to those before washing gave a background level as no incorporation o f label can take 
place without enzyme. The counts at time=60 were taken next: the percentage o f counts 
after washing compared to those before washing give a total incorporation level, 
including background. Therefore, to obtain an absolute level o f incorporation, the 
background percentage must be subtracted from the total percentage. This final figure 
should be at least 70% to indicate reasonable incorporation. The probe can be stored at 
-20°C for a couple o f days or used immediately in a hybridisation reaction.
2.8.2 Hybridisation
Church's buffer (see Appendix 1) was heated to hybridisation temperature, then 
sufficient buffer to keep the membrane wet was added to it in a hybridisation bottle and 
placed in a rotating waterbath at 60°C for at least 3 hours. Labelled probe was added 
following a change o f buffer. This was allowed to hybridise at 65-70°C for at least 16 
hours then the buffer was removed and the membrane was monitored with a hand-held 
p-counter (series 900 mini-monitor, Mini-Instruments Ltd) for non-specific  
hybridisation. This was removed with repeated treatments o f wash buffer (see Appendix 
1) at 5 degrees below the hybridisation temperature, with the membrane being checked 
between each wash for background levels. If there was still a high level of background
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present, the temperature at which the wash took place was increased to hybridisation 
temperature.
When a satisfactory level of background radioactivity was reached the blot was 
allowed to dry very briefly, removing only the excess o f solution before being wrapped 
in Saranwrap. It was placed in an autoradiography cassette (Cronex Quanta Fast Detail 
Cassette, DuPont) with film (DuPont) and laid down at -70°C for 1 hour initially. This 
film was developed and examined and the length o f time o f exposure o f the next film  
against the blot was adjusted accordingly.
■' •■■I
2.8.3 Stripping the blot
Following satisfactory exposure to film, the probe was removedfrom the blot by 
treatment with strip solution (see Appendix 1). The blot was treated at 80°C for 30-60  
minutes, depending on the intensity o f the radioactive signal. When no detectable 
radioactivity remained, the blot was wrapped and exposed to film for up to a week. The 
film was developed and examined for residual signal. In the event that signal remained 
the procedure was repeated until any signal remaining was suitably low.
2.9 ANALYSIS OF DATA
2.9.1 Image analysis
In order to gauge a change in the level o f expression o f mRNA, some form of  
quantitiation is required. In these experiments, GAPDH was used as a housekeeping 
gene, insofar as its expression does not appear to be affected by treatment o f the cells 
with any o f the reagents used. The intensity of signal obtained following blotting and 
probing o f GAPDH RT-PCR products should therefore reflect the quantity o f total 
RNA, which should be equal in all lanes if the same number o f cells were used or if  the 
same amount o f template was introduced. Any variation in the GAPDH band intensities
.4
must be removed to allow analysis of the band intensities Of the other genes o f interest, 
as variation here could simply be due to differences in the number o f cells, and 
therefore in the absolute quantity of RNA originally in the sample, and not because o f a 
true effect o f treatment with the factors.
Image analysis allows an image o f the autoradiograph or gel to be raptured into 
a computer where variations in background staining and band intensity are removed, 
and where measurements o f the intensities can be made for later comparison.
The gel was placed on a UV transilluminator and the image was photographed 
(TM-765 Kinetic Pulnix camera with cosmicar TV zoom lens). It was opened in the 
Imagedok program (Kinetic Imaging Ltd.) on a Hewlett Packard Vectra VL2 computer, 
where the contrast was adjusted to obtain the clearest image. In the case of analysing an 
autoradiograph, visible light was used and the same process continued. A hard copy o f  
the image was produced when required (UP-D860E digital graphic printer, Sony). The
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image was saved as a TIFF file onto a disk in the SyQuest drive (EZ 135MB drive, 
SyQuest) and opened in the Phoretix program (Kinetic Imaging Ltd.).
Here, the image was handled as follows: the first step was that a lane profile had 
to be created. The image contained one row of samples consisting o f DNA amplified 
using one set of primers (in this example, for BMP-4, see figure 2.2). The row was 
selected by clicking in one corner and dragging the rectangle over the entire row. This 
was now termed a “lane”. The process was repeated for another “lane” containing 
samples amplified with primers for GAPDH.
The next stage was to define the peaks and edges o f each1 sample, then to 
remove the background from the “lane” (see figure 2.2). This was achieved by opening 
the “analyse lanes” option, then the “remove background” option. Thdffollpwing stage 
was to measujre the intensity of the detected bands. This could be viewed as a table of 
absolute measurements. These data were saved onto the SyQuest drive and opened into 
the Microsoft Excel program (Microsoft Corporation Inc.) for further analysis.
To simplify, only the first two sample bands from figure 2.2 were analysed for 
the following example (figure 2.3). The intensity measurement o f each GAPDH band 
was divided by that o f a designated GAPDH control, usually that derived from an 
untreated sample (table i, figure 2.3). This analysis was also performed for BMP-4 
(table ii, figure 2.3). The final stage was to remove inter-sample variation in loading by 
expressing each BMP-4 value as a ratio of the related GAPDH value (table iii, figure 
2.3). In this example, it can be seen that the true ratio o f BMP-4 expression between 
untreated and treated samples is higher than it would be were the variation not removed, 
thus reflecting a more accurate effect o f treatment on gene expression.
2.9.2 Statistical analysis
In order to examine whether the effects o f agents on osteoblast-related gene 
expression were statistically significant, the data were subject to analysis. It could not 
be assumed that the data were normally distributed. Therefore the Kruskal-Wallis test 
was selected as the most suitable statistical analysis test for these investigations as it is a 
non-parametric test, and therefore does not assume a normal distribution o f data. It can 
be used to analyse more than three sample groups o f varying sizes and, as-it is based on 
a ranking system  and compares the median values o f the samples, the absolute 
magnitudes o f  the changes in gene expression seen in these experiments is not 
considered, merely whether or not a change was observed following treatment with one 
or more agents.
The H value is used to compare the median values between all the sample 
groups tested. A value determined experimentally shown to be equal to or greater than 
the critical H value indicates a statistically significant result (Neave, 1995). It is 
calculated by the formula:
62
k
H=[12/N(N+1)] I  (R2/n) - 3(N+1)
1
where N= total number o f values analysed, k= number o f samples, E= sum of, R= rank 
o f each value, n= size o f each sample (number o f repeats per treatment). This is 
illustrated in the example below (Neave, 1995) where samples o f the mileages per 
gallon for three different engine designs are compared:
design mileage per gallon ranks ranjcsums
a 19.8 20.5 20.8 19.7 4 6 7.5 2.5 20
b 21.7 20.8 21.2 10 7.5 9 26.5?
c 19.7 19.4 19.9 2.5 1 5 8.5V
H= [12/10(11)] x (20V4 + 26.52/3 + 8.52/3) - 3(11) = 6.073
The critical H value for three samples o f unequal sizes of 4, 3 and 3 is 5.791, 
therefore there is a significant difference in performance between the three designs of 
engine. This does not describe between which samples the significant difference lies.
The second stage o f the Kruskal-Wallis test is to compare every sample with 
each o f the other samples by use o f Q values. These determine the statistical 
significance o f the differences observed between individual sample medians and, as for 
H values, an experimentally determined value equal to or greater than the critical Q 
value is indicative o f statistical significance (Heath, 1995). The Q value is calculated 
by the formula below:
Q=  R l -R2____
square root [N(N+1)/12 x (l/n i+ l/n 2)]
where R= mean rank of sample, N= total numbers o f values analysed in Kruskal-Wallis 
test, n= size o f each sample (number o f repeats per treatment). In the above example, 
three tests are required: a compared to b, then compared to c, then b compared to c. 
Working through the first o f these:
Q = 26.5/3 - 20/4  = ' 8.833-5_________ = 3.833 = 1.658
square root [10(11)/12 x (1/4+1/3) square root(9.167x0.583) 2.312
The critical value for Q in this instance is 2.394, therefore there is no significant 






The other values showing comparison o f a and c or b and c are shown to be 
significant, therefore the engine design c gives significantly lower mileage than the 
other designs. The groups arranged on the vertical axis are compared to those on the 
horizontal axis, such that a value denoting a significant decrease f underlined) means 
that the expression level of the group on the vertical axis is significantly lower than that 
of the group on the horizontal axis to which it is being compared.
It is to be noted however that testing for the value o f Q was only performed 
where a statistically significant H value was obtained: in those instances where H was 




2.10.1 Extraction with phenolrchloroform
The method most frequently used to remove proteins from aqueous solution is to 
extract with phenol:chloroform, as two different organic solvents are more efficient 
than one, and then again with chloroform, to remove trace residues o f phenol. The 
phenol was supplied as equilibrated with Tris-HCl pH 8.0. An equal volume o f  
phenol:(chloroform:isoamyl alcohol= 24:1), that is, phenol:chloroform:isoamyl alcohol 
= 25:24:1, was added to a tube containing impure nucleic acid and the contents were 
mixed to form an emulsion. The tube was then centrifuged at 12000g for 5 minutes and 
the upper aqueous phase, containing the nucleic acids, was transferred to a fresh tube. 
An equal volume o f chloroform was added and mixed and centrifuged as above. The 
nucleic acids were recovered by precipitation with ethanol in the case o f DNA or 
isopropanol in the case of RNA.
2.10.2 Precipitation of nucleic acids
Precipitation using either ethanol or isopropanol is the most widely used method 
o f concentrating nucleic acids. For the recovery o f small amounts o f low molecular 
weight nucleic acids, the aqueous solution o f  nucleic acid was added to an equal 
volume o f chilled isopropanol and mixed by inversion. The nucleic acid precipitated out 
o f solution after being left at -70°Q overnight (RNA) or at -20°C for between 30 
minutes and 16 hours (fragments of digested DNA). Precipitation o f undigested plasmid 
DNA was in double volume of ethanol at -20°C overnight.
2.10.3 Quantitation of nucleic acids
Depending on the purity o f the sample, two methods were used to estimate the 
concentration o f nucleic acid in solution. If the sample was very pure, optical density 
measurements o f the amount o f ultra-violet light absorbed by the nucleotide bases was 
carried out. If there were significant amounts o f contaminants such as phenol, proteins,
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proteoglycans, agarose or other nucleic acids, estimation of the quantity o f nucleic acid 
was done by analysis on agarose minigels.
2.10.3. ISpectrophotometric measurement
Readings were taken at 260 nm and 280 nm: the reading at 260 nm allows 
calculation o f the amount of nucleic acid present, as optical density (OD) measurement 
of 1 corresponds to approximately 50 jig/ ml double-stranded DNA, 40 |LLg/ ml for 
single-stranded DNA and RNA, and 20 p,g/ ml for oligonucleotides. The ratio between 
O D 26o and O D 28o gives an estimate o f the purity o f the nucleic acid sample (pure 
preparations o f DNA and RNA give values o f 1.8 and 2.0 respectively) (Sambrook et 
al, 1989b). Contamination with phenol or protein reduces this value.
2.10.3.2Minigel method ,
If there is a possibility that the nucleic acid preparation contains contaminants, 
electrophoresis through agarose minigels is rapid and convenient. By comparing the 
intensity o f fluorescence o f ethidium bromide-stained bands of nucleic acid o f unknown 
concentration with that o f standards o f known concentration run side by side, the 
quantity o f nucleic acid in the test sample can be estimated.
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F ig u re  2 .1  F lu o re s c e n c e  a c t iv a te d  c e ll  s o r t in g  ( C a r te r  a n d  M e y e r ,  1 9 90 )
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Left Sort Right Sort 
To Waste
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P e a k s
I n t e n :•sity |T]
1 7 3 . 6 2
1 S 1 . 9 2  -
1 3 0 . 2 2  -
1 0 8 . 5 1  -
8 6 . 8 1  -
6 5 . 1 1  -
4 3 . 4 1  -
2 1 . 7 0  -
0 . 00
0  2 4  4 8  7 2  9 6  1 2 0  1 4 4  1 6 8  1 9 2  P o s n
F ig u re  2 .2  D e n s i to m e tr ic  a n a ly s is  o f  R T -P C R  g e ls  o r  S o u th e rn  b lo ts
In  th is  e x a m p le ,  a  la n e  w a s  c a p tu re d  f ro m  a  b lo t  o f  B M P -4  R T -P C R  p ro d u c t  a n d  
s u b je c te d  to  a n a ly s is  b y  d e n s i to m e try .  O n  th e  p lo t a b o v e ,  m a x im a l d e n s it ie s  (p e a k s )  are  
in d ic a te d  b y  a r ro w s  a n d  th e  e d g e s  o f  th e  sa m p le  b a n d s  b y  d o tte d  lin e s . B a c k g r o u n d  w a s  
re m o v e d  a lso  ( in d ic a te d  b y  lin e s  jo in in g  th e  h ig h e s t  p o in t  o f  th e  d o tte d  e d g e s ) .  T h e r e f o r e ,  
th e  v o lu m e s  m e a s u re d  in  th is  a n a ly s is  a re  r e p re s e n te d  b y  th e  re m a in in g  a re a s  u n d e r  th e  
c u rv e s .  C le a r ly ,  w h e n  c o m p a r e d  to  b a n d s  1 a n d  3 , th e  b a n d s  in  2  a n d  4  a re  m o re  d e n s e .
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Figure 2.3 Example of calculation to determine the ratio of mRNA expression
BMP-4 expression in untreated and treated cells
Sample GAPDH measurement 
control 36084
treated 9046.5
ratio cf control 
1
0.25
ii Sample BMP-4 measurement 
control 14212.5
treated 43873.5
ratio cf control 
1
3.09
in Sample ratio cf ratio c f adjusted ratio cf
GAPDH control BMP-4 control BMP-4 control 
control 1 1 1
treated 0.25 3.09 12
Figure 2.3 Calculation of ratio o f BMP-4 mRNA expression after treatment with 
calcitriol
The actual measurements of GAPDH are expressed as a ratio of the control sample 
(see i). The same is done for the BMP-4 measurements (see ii). Finally, the 
differences in GAPDH must be taken into account, therefore the ratios o f BMP-4 
mRNA transcripts are expressed relative to the ratio o f GAPDH in the same 
treatment group (see iii).
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Chapter 3
Altered pattern of gene expression in osteoblast-like cells following 
exposure to calcitriol and members of the TGF-beta superfamilv
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I n t r o d u c t io n
A sequence o f gene expression in osteoblasts has been elucidated: the 
expression levels o f genes characteristic o f proliferation and extracellular matrix 
biosynthesis, such as c-fos, c-myc, histone-4, type I collagen, fibronectin and TGF-beta, 
are transiently upregulated in the first ten days of culture o f primary rat osteoblasts. As 
proliferation decreases, expression o f these genes is attenuated and genes associated 
with the development, maturation and organisation o f the extracellular matrix are 
transcribed, including alkaline phosphatase and matrix gla protein. The expression o f  
these genes is downregulated coincident with the upregulation o f that k)f genes thought 
to influence extracellular matrix mineralisation, for example osteopontin and 
osteocalcin (Owen et al; Aronow et al, 1990). f ,  ,
Studies with osteoblast-like cell lines indicate a more de-regulated progression 
from proliferation to differentiation: proliferation o f the cells continues, albeit at a 
gradually reduced rate, as they become committed to a differentiated phenotype, 
resulting in the expression o f mineralisation genes in the absence o f an extracellular 
matrix (Stein et al, 1990). This suggests that the mechanisms which control the 
progression from proliferation to matrix maturation and then mineralisation are de­
regulated in these cells. Therefore, osteoblastic cell lines are potentially useful tools in 
the study o f  bone formation to elucidate the mechanisms whereby osteoblastic 
proliferation and differentiation are controlled. Several cell lines now exist which 
mimic osteoblast characteristics at different stages o f differentiation and maturation, as 
evidenced by their gene expression patterns.
MG-63 cells (CRL 1423, American Tissue Culture Collection) are derived from 
an osteosarcoma removed from a 14 year-old male and are distinguished by a high 
proliferation rate. Previous studies with the MG-63 line have indicated that they share 
characteristics with osteoblastic cells: they express basal and inducible alkaline 
phosphatase and osteocalcin and they respond to treatment with calcitriol (Mahonen et 
al, 1990; Szulc and Delmas, 1996). Unstimulated MG-63 cells thus mimic an immature 
stage o f osteoblast differentiation. The cells attach well to fibronectin and vitronectin 
and produce fibroblastic growth factors-1 and -2 (FGF-1 and FGF-2) but, unlike 
osteoblasts, MG-63 cells do not express platelet-derived growth factor (PDGF), nor do 
they produce a mineralised extracellular matrix (Hauschka et al, 1988).
Rodent cells have been studied extensively as putative models o f osteoblastic i 
function. MC3T3-E1 cells are derived from mouse calvariae and require an ascorbic 
acid-dependent extracellular matrix for expression o f the osteoblastic phenotype 
(Franceschi and Iyer, 1992). ROS 17/2.8 cells are derived from a rat osteosarcoma and 
represent a mature osteoblast phenotype (Williams et al, 1994): expression o f alkaline 
phosphatase mRNA peaks during active cell growth and large amounts o f osteocalcin 
are produced constitutively (Rodan et al, 1988).
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The pattern o f MSX-2, BMP-2, BMP-4 and osteocalcin gene expression was 
studied in osteoblast-like cells exposed to a variety o f growth factors and agents which 
might modulate the expression of these genes. RNA extracted from cells was analysed 
by RT-PCR and Southern blotting and/ or Northern blotting. For each, densitometric 
analysis o f the autoradiographs was used to determine treatment-induced changes in 
mRNA transcript expression. The “housekeeping gene” glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) was used to correct for treatment-induced variations in cell 
number and/ or differences in the quantity of mRNA/ cDNA template. All values were 
normalised using the level o f expression o f the housekeeping gbhe as an internal 
standard, and compared to the level o f gene expression in the untreated control.
$ '
3.1 Establishing optimum conditions for the polymerase chain reaction 
Magnesium chloride concentration
Magnesium chloride is an essential chelating agent in the polymerase chain 
reaction, insufficient or too great a quantity resulting in a reduction in the efficiency o f  
the polymerase enzyme (Guide to Optimising PCR, Promega). To gauge the optimal 
concentration o f magnesium chloride, a titration was performed using concentrations o f  
Mg2+ between 0.5 mM and 5 mM in increments o f 0.5 mM, using equivalent amounts 
of MSX-2 cDNA plasmid as a template (see figure 3.1a). The optimal concentration for 
the M SX-2 PCR was shown to be 2.5 mM magnesium chloride. All other parameters 
for the PCR were gauged at this magnesium chloride concentration.
Annealing temperature
According to the ratio of G/C to A/T residues in the primer sequences selected 
in the PCR, the annealing temperature of the primer to the target sequence of the cDNA  
will vary: the greater the ratio of G/C to A/T, the higher the annealing temperature 
(Sambrook et al, 1989). Using equivalent amounts o f cDNA template and 2.5 mM 
magnesium chloride, reaction mixtures with primers specific for MSX-2, osteocalcin, 
BM P-2, BMP-4 and GAPDH were cycled for 35 cycles at annealing temperatures 
ranging from 55 °C to 68 °C. Based on the results o f this series o f PCRs (see figure 
3.1b), the annealing temperature for BMP-2 and BMP-4 was selected to be 62 °C (lane 
3); that for MSX-2, osteocalcin and GAPDH was 65 °C (lane 4).
Sensitivity o f the PCR
False negative signals can arise due to a concentration o f target template which 
falls below the threshold of sensitivity o f the PCR. Therefore the sensitivity o f this 
reaction was gauged using MSX-2 template diluted serially 1 in 10 in the range 1 (ig to 
1 fg using conditions as previously described for 35 cycles (figure 3.1c). The threshold 
of sensitivity was shown to lie between 10 pg and 1 pg.
Cvcle number
Using an excessive number of cycles can result in saturation o f the signal and an 
inability to detect a change in the level o f template expression. Therefore it was
C o n c e n tra t io n  o f  M g C l2 (m M )
1.5 2 .0  2 .5  3 .0  3 .5  4 .0  4 .5  5 .0  m a rk e r  1 m a rk e r  2
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M S X -2  
P C R  p r o d u c t
F ig u re  3 . l a  O p tim is a t io n  o f  th e  m a g n e s iu m  c h lo r id e  c o n c e n tra t io n  in th e  p o ly m e r a s e  c h a in  re a c t io n  (P C R )
M a g n e s iu m  c h lo r id e  w a s  a d d e d  to  re a c t io n  tu b e s  p r io r  to  th e  a d d i t io n  o f  T a q  p o ly m e r a s e  a n d  M S X - 2  c D N A - c o n ta in in g  p la s m id  te m p la te  
to  g iv e  f in a l  c o n c e n t r a t io n s  r a n g in g  f ro m  1 .5 - 5 m M . T h e  r e a c tio n  m ix e s  w e re  a m p lif ie d  fo r  35  c y c le s .  P r o d u c ts  w e re  a n a ly s e d  in  a  1 .5%  
a g a r o s e  g e l in  T A E  b u f fe r  ru n  a t 8 0  V  fo r  9 0  m in u te s .
1 2 3 4 5  1 2 3 4 5  1 2 3 4 5  1 2 3 4 5  1 2 3 4 5  m a rk e r
B M P - 2  B M P - 4  M S X -2  o s te o c a lc in  G A P D H
F ig u re  3 . l b  O p tim is a t io n  o f  th e  a n n e a l in g  te m p e r a tu re s  fo r  e a c h  p r im e r  s e t  in  th e  P C R  
U s in g  th e  o p t im u m  c o n c e n t r a t io n  o f  m a g n e s iu m  c h lo r id e  a s  p re v io u s ly  d e te rm in e d ,  e q u iv a le n t  a m o u n ts  o f  c D N A  te m p la te  w e re  a m p lif ie d  
f o r  35  c y c le s  a t  a n n e a l in g  t e m p e r a tu r e s  o f  5 5 , 6 0 , 6 2 , 6 5  a n d  6 8  ° C  ( la n e s  1 to  5 r e s p e c t iv e ly ) * ;P o l lo w f n g  a n a ly s i s  b y  a g a r o s e  g e l 
e l e c t ro p h o r e s is ,  th e  te m p e ra tu re  a t w h ic h  th e  b r ig h te s t  b a n d  w a s  p r o d u c e d  w a s  s e le c te d  a s  o p tim a l a n d  u s e d  in  f u tu re  a n a ly s e s .
M S X -2  
P C R  p ro d u c t
F ig u re  3 .1 c  T itr a t io n  o f  D N A  te m p la te  to  a s s e s s  th e  s e n s i t iv i ty  o f  th e  P C R
M S X - 2  c D N A  w a s  s e r ia l ly  d i lu t e d  in  in c r e m e n ts  o f  10 a n d  a p p l ie d  to  th e  r e a c t io n  m ix e s .  P C R  w a s  p e r f o rm e d  fo r  35  c y c le s  a n d  th e  
p ro d u c ts  a n a ly s e d  b y  a g a r o s e  g e l  e le c t ro p h o re s is .  A t h ig h e r  c o n c e n t r a t io n s  o f  th e  te m p la te  (1 jag a n d  1 0 0  n g , la n e s  1 a n d  2 ) , a  b a n d  o f  a  la rg e r  
s iz e  th a n  th e  e x p e c te d  5 8 4  b p  w a s  s e e n .  T h e  la c k  o f  in te r f e re n c e  a n d  th e  a p p e a r a n c e  o f  a  b a n d  o f  th e  e x p e c te d  s iz e  a t lo w e r  c o n c e n t r a t io n s  o f  
te m p la te  (1 0  n g  a n d  lo w e r )  s u g g e s ts  th a t  th e  h ig h e r  b a n d  m a y  h a v e  b e e n  c a u s e d  b y  m is p r im in g  a s  a  r e s u l t  o f  a  h ig h  c o n c e n t r a t io n  o f  s a lt  o r  
a n o th e r  c o n ta m in a n t  in  th e  p la s m id  s to c k . T h e  s ig n a l  b a n d  w a s  s e e n  to  d is a p p e a r  a t  c o n c e n t r a t io n s  o f  p la s m id  e q u iv a le n t  to  1 p ic o g ra m  (p g )  
o r  lo w e r .
o s te o c a lc in nm c
c y c le s  o f  a m p l i f ic a t io n 25 3 0 35  4 0  2 5 3 0 35  4 0
G A P D H QnmQrr,
c y c le s  o f  a m p lif ic a t io n 2 5 3 0 3 5  4 0  25 3 0 35  4 0
c a lc i t r io l - t r e a te d  u n tre a te d
F ig u re  3. I d  O p tim is in g  th e  n u m b e rs  o f  c y c le s  r e q u ir e d  fo r  a m p lif ic a t io n  o f  te m p la te s  fo r  G A P D H  a n d  o s te o c a lc in  P C R s  
M G -6 3  c e l ls  w e re  c u l tu r e d  in  D M E M  c o n ta in in g  10%  fe ta l  c a l f  s e ru m  u n ti l  c o n f lu e n c y ,  a t  w h ic h  p o ^ n t D M E M  c o n ta in in g  2 %  fe ta l  c a l f  
s e ru m  w a s  a d d e d  to  th e  c e lls .  A f te r  2 4  h o u r s ,  th e  c e l ls  w e re  e x p o s e d  to  1 n M  c a lc i t r io l  fo r  2 4  h o u r s ,  th e  R N A  w a s  h a r v e s te d  a n d  R T -P C R  a n d  
a g a r o s e  g e l e l e c t ro p h o r e s is  p e r f o rm e d .  T h e  f ig u re  a b o v e  i l lu s tr a te s  th e  d if f e r e n c e s  in  b a n d  in te n s i ty  f o l lo w in g  in c re a s in g  n u m b e rs  o f  c y c le s  
d u r in g  th e  P C R  fo r  o s te o c a lc in  a n d  G A P D H . A t h ig h e r  n u m b e rs  o f  c y c le s ,  th e  d if fe r e n c e  in  in te n s i ty  b e tw e e n  b a n d s  is  r e d u c e d  a s  th e  re a c tio n  
b e c o m e s  s a tu ra te d :  a n y  a p p a r e n t  v a r ia t io n  in  g e n e  e x p re s s io n  is  a b o l is h e d . T h e  c o n t r a s t  b e tw e e n  o s te o c a lc in  m R N A  e x p r e s s io n  in  c o n t ro l  an d  
c a lc i t r io l - t r e a te d  c u l tu r e s  is  g r e a te s t  a t  lo w  c y c le  n u m b e rs .  T h e r e f o r e ,  a m p lif ic a t io n  o f  3 0 -3 5  c y c le s  w a s  u s e d  a s  s ta n d a r d  in  fu tu re  a n a ly s is ,  
a n d  a d ju s te d  a c c o rd in g ly  th e r e a f te r  f o r  m o re  a c c u r a te  c o m p a r is o n .  7 1
q u a n t i ty  o f  te m p la te
1 p g  1 0 0  n g  10 n g  1 n g  100  p g  10 p g  1 p g  100  fg  10 fg  1 fg  +  - m a rk e r
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necessary perform a cycle titration (figure 3 .Id). PCRs for osteocalcin and GAPDH 
using cycle numbers in the range 25 to 40 cycles were performed: at 25 cycles, the 
difference in osteocalcin expression between untreated and calcitriol-treated cells is 
clear; at 30 cycles or greater, this difference in osteocalcin expression becomes difficult 
to discern. Therefore in each following experiment, depending on the quantity o f RNA 
extracted, 30- 35 cycles was used as an initial cycle run and if no signal or a saturated 
signal was the result, a second run was performed with an appropriately adjusted 
number o f cycles.
■ ;i
3.2 Effects o f calcitriol treatment on osteocalcin mRNA transcript expression
Osteocalcin expression is directly affected by calcitriol due to $ie presence o f a
v  '
vitamin D response element (VDRE) in the promoter region o f the gene (Breen et al, 
1994, b; reviewed by Ilian and Stein, 1992). Expression o f this gene was examined 
following treatment o f MG-63 cells for 24 hours with various doses of calcitriol (see 
figure 3.2). RNA was extracted and subjected to RT-PCR followed by Southern blotting 
for osteocalcin and GAPDH. Steady state levels o f osteocalcin were unaffected by 
treatment with 1 0 11 M calcitriol, but at doses greater than this (10'7M to 10'°M ) a 
substantial increase in osteocalcin mRNA was observed when compared with untreated 
control. Interestingly, a similar profile for the expression o f osteocalcin protein was 
seen following treatment with calcitriol (Beresford et al, 1984).
3.3 Effects o f members o f the TGF-beta superfamily, alone or in combination with 
calcitriol, on the expression of osteoblast-related genes in MG-63 cells
TG F-beta-1 and BMPs are distantly related members o f the TGF-beta 
superfamily and signal intracellularly via cell surface serine/threonine kinase receptors. 
This experiment was designed to compare the effects o f these agents on the 
transcription o f the same genes in MG-63 cells, and to examine the modulatory effects 
of calcitriol on these factors (see figure 3.3). Confluent MG-63 cells maintained in 
DMEM supplemented with 10% fetal calf serum were cultured for 24 hours in DMEM 
containing 2% fetal calf serum prior to the addition o f the following concentrations of 
growth factors: 1- 100 nM calcitriol, 1- 250 ng/ ml BMP-2/ BMP-7, 1- 25_ng/ ml BMP- 
4, 1 -50  ng/ ml BMP-6 and 0.05- 1.25 ng/ ml TGF-beta. Also examined were the effects 
of addition o f 10 nM calcitriol to these doses o f factors. After exposure to the agents for 
24 hours, RNA was extracted and analysed for mRNA expression o f M SX-2, 
osteocalcin , BM P-2, BM P-4 and GAPDH by RT-PCR and Southern blotting. 
Densitometric analysis of the blots was performed: all values are relative to untreated 
control and to the levels o f GAPDH and therefore to loading. The results from three 
independent experiments o f dose responses for calcitriol are shown in table 3.1a. A 
dose response for members of the TGF-beta superfamily, alone and in combination with 
10 nM calcitriol, is summarised in table 3.1b. The results from three independent
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Concentration of calcitriol (M)
0 10-7M 10 8M 10-9 M lO-io M lO-i'M
o s te o c a lc in
G A P D H
Concentration of calcitriol (M)
0 10-7M 10'8M 10-9 M lO-io M 10-H M
F ig . 3 .2  D o s e - d e p e n d e n t  in c re a s e  in  o s te o c a lc in  m R N A  e x p re s s io n  in  
M G -6 3  c e lls  f o llo w in g  t r e a tm e n t  w ith  c a lc i t r io l  
M G -6 3  c e l ls  w e re  c u l tu r e d  in  D M E M  c o n ta in in g  10%  fe ta l  c a l f  s e ru m  u n til  2 4  
h o u r s  p r io r  to  t r e a tm e n t  w ith  c a lc i t r io l ,  w h e n  th e  s e ru m  c o n c e n t r a t io n  in  th e  
r e p la c e m e n t  m e d iu m  w a s  d r o p p e d  to  2 % . A f te r  2 4  h o u r s ,  R N A  w a s  h a r v e s te d  
a n d  R T - P C R  w ith  p r im e rs  s p e c if ic  f o r  G A P D H  a n d  o s te o c a lc in  w a s  p e r f o rm e d ,  
f o l lo w e d  b y  S o u th e rn  b lo t t in g  w ith  p r o b e s  fo r  th e s e  g e n e s .  P C R  w a s  p e r f o rm e d  
f o r  3 0  c y c le s .  T h is  e x p e r im e n t  w a s  c a r r ie d  o u t  tw ic e  (n = 2 ) .
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experiments where selected doses of TGF-beta superfamily members and o f calcitriol 
were added alone or in combination are shown in table 3.1c.
Effects of calcitriol alone
Taking differences in GAPDH levels and therefore loading into account, 
expression of BMP-4, MSX-2 and osteocalcin is increased by calcitriol, wifh maximal 
levels occurring at a dose o f calcitriol o f 10 nM, when compared with control (table 
3.1a). A biphasic effect o f the agent on the expression o f MSX-2 and BMP-4 transcripts 
was shown: MSX-2 and BMP-4 mRNA expression at 100 nM calcitriol being less than 
at 10 nM, although still greater than control. Overall, there was a modest increase in 
BMP-2 mRNA expression following treatment with calcitriol.
Effects of BMP-2 alone f-
V* '
At all doses tested, BMP-2 increased the expression of its own mRNA, with 
maximal effects occurring at 1 ng/ ml BMP-2 (table 3.1b). At the lowest dose tested (1 
ng/ ml), BMP-2 also had a stimulatory effect on the mRNA expression o f  osteocalcin 
and BMP-4. At higher doses however, the effect became less emphatic (expression o f  
osteocalcin transcripts) or even inhibitory (BMP-4 mRNA expression). M SX-2 mRNA  
expression was increased at higher doses o f the agent to levels twice that o f untreated 
control.
Effects of BMP-2 and calcitriol in combination
When compared with calcitriol treatment alone, BMP-2 antagonised the 
stimulatory effect o f calcitriol on the level o f expression o f the mRNAs studied (table 
3.1c). When compared with the equivalent dose o f BMP-2 alone, the effects o f  
combining the agent with calcitriol were more complex: in two out o f three repeats, 
MSX-2, osteocalcin and BMP-4 mRNA expression levels were increased, and BMP-2 
mRNA levels were decreased (table 3.1b).
BMP-4 alone
When compared with control, the doses of BMP-4 tested had no effect on the 
expression o f the mRNAs for osteocalcin or BMP-4 (table 3.1b). There was, however, a 
modest increase in the level of expression o f M SX-2 and BMP-2 transcripts, with 
maximal increases observed at 10 ng/ ml and 25 ng/ ml BMP-4 respectively.
BMP-4 and calcitriol in combination _
Similar to the effects of BMP-2 in combination with calcitriol when compared 
to treatment with calcitriol alone, all doses tested of BMP-4 antagonised the stimulatory 
effects of 10 nM calcitriol on the expression o f the four genes studied (table 3.1b). 
Treatment with BM P-4 and calcitriol in combination stimulated BM P-4 mRNA  
expression only at the maximal dose when compared to treatment with BMP-4 alone. 
BMP-2 mRNA levels were decreased when compared to the effects o f BMP-4 alone, 
and MSX-2 expression was stimulated. Osteocalcin expression was maximally induced 
at the lowest BMP-4 dose (1 ng/ ml BMP-4 plus 10 nM calcitriol) and is dose-
75
dependently decreased thereafter (10 ng/ ml and 25 ng/ ml BM P-4 plus 10 nM 
calcitriol) to levels still greater than treatment with BMP-4 alone.
Effects o f BMP-6 alone
When compared with control, at all doses the addition o f BMP-6 increased the 
expression of all o f the genes studied by 2- to 7-fold (table 3.1b).
Effects o f BMP-6 and calcitriol in combination
Compared to treatment with either agent alone, the effects o f  BM P-6 and 
calcitriol in combination were to decrease BMP-2 expression (table 3.1b). In contrast, 
the expression levels o f MSX-2, osteocalcin and BMP-4 transcriptsiwere essentially 
unchanged or increased following treatment with both factors in combination when 
compared with treatment with either factor alone. f.
BMP-7 alone
Treatment with BMP-7 had a substantial positive effect on the expression o f all 
of the genes studied (tables 3.1b and 3.1c). For MSX-2, the maximal increase was 
observed at 50 ng/ ml BMP-7, whereas for osteocalcin, BMP-2 and BM P-4, this 
occurred at the 10 ng/ ml dose (table 3.1b).
BMP-7 and calcitriol in combination
When added in combination, calcitriol and BMP-7 interacted positively to 
regulate the expression o f transcripts for MSX-2, osteocalcin and BMP-4 (50, 10 and 
50, and 1- 250 ng/ ml respectively, tables 3.1b and 3.1c). In contrast, treatment with 
both factors in combination stimulated BMP-2 transcript expression to a lesser extent 
than treatment with calcitriol alone (table 3.1b).
Effects o f TGF-beta-1
TGF-beta-1 stimulated expression o f all genes tested when compared to 
untreated control (table 3.1b). Maximal increase was seen with the low est dose 
(0.05 ng/ ml) for BMP-4 and MSX-2, and with a dose o f 0.25 ng/ ml for BMP-2. With 
increased dose o f TGF-beta-1, this stimulation o f expression was lessened but not 
reduced below 2-fold the level of the untreated control. Osteocalcin expression levels 
were stimulated to 4-fold those of steady state, an effect which was maintained 
regardless of dose.
Effects o f TGF-beta-1 in combination with calcitriol
TGF-beta or calcitriol alone stimulate the levels o f mRNA transcript o f all o f the 
genes studied (tables 3.1a and 3.1b). However, the changes in transcript expression 
following treatment o f MG-63 cells with TGF-beta and calcitriol in combination were 
extremely variable from one experiment to another and therefore are difficult to 
interpret (tables 3.1b and 3.1c). It is possible that the conflicting signals o f proliferation 
(TGF-beta) and differentiation (calcitriol) may be resulting in unpredictable 
consequences for gene expression. It would be appropriate therefore to investigate the 
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0 1 10 100
mRNA
MSX-2 1 1 6 4
1 0 6 ndi
1 2 2 nd
osteocalcin 1 3 14 6
1 1 2 nd
1 3 3 nd
BMP-2 1 2 28 3
1 1 1 nd
1 2 1 nd
BMP-4 1 1 6 4
1 1 3 nd
1 2 4 nd
Table 3.1a The effects of calcitriol on the expression of osteoblast-related 
genes in MG-63 cells 
Confluent MG-63 cells maintained in DMEM supplemented with 10% fetal 
calf serum were cultured in DMEM containing 2% fetal calf serum 24 hours 
before the addition of calcitriol in the range 1- 100 nM. Following exposure 
to the factor for 24 hours, RNA was extracted and analysed by RT-PCR and 
Southern blotting for MSX-2, osteocalcin, BMP-2 BMP-4 and GAPDH  
transcript expression. The table above is a summary of the densitometric 









None BMP-2 BMP-4 BMP-6 BMP-7 TGF-beta
1 50 250 1 10 25 1 10 50 1 10 50 250 0.05 0.25 1.25
10 nM calcitriol
1 1.5 2.5 2.3 1.2 2.2 1.6 5.3 7.4 7.4 10.8 4.3 14.2 10.2 8 7 3
+ 6 2.4 2.7 4.6 2 1.3 3.2 6.7 11.4 5.6 10 8.6 18.6 9 5.3 3.5 3.8
- 1 2.6 1.3 1.3 1 1 1.4 3.7 2.3 3 4.8 24 13 6.3 4.6 4 4.1
+ 14 2.4 2.2 12 4.4 3.6 2.2 8.4 6 26 11 31 ' 21. 9 9 3 4
- 1 6 4 2 2.3 1.7 2.7 3.3 4.1 3.8 6.4 15.2 3.9 4.5 5.6 7.6 2.3
+ 28 1.9 1.3 2.5 1 1.5 1 1.9 2.1 1.8 9.4 8.2 5.4 2.7 3 1.6 2
- 1 3.6 0.3 0.2 0.9 1 0.9 3.6 3.3 4.4 9 24 8.6 4.4 6.5 6 4.8
+ ■ 6 1 2.9 1.9 0.6 1 2.6 12.5 6.8 25 22 25 13 12 2.4 5.2 8.2
Table 3.1b The effects of members of the TGF-beta superfamily, alone or in combination with 10 nM calcitriol, on the expression of 
osteoblast-related genes in MG-63 cells 
Confluent MG-63 cells maintained in DMEM supplemented with 10% fetal calf serum were cultured in DMEM containing 2% fetal calf 
serum 24 hours prior to exposure for 24 hours to the agents above. RNA was extracted and analysed by RT-PCR and Southern blotting for 
MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH mRNA expression. The table above is a summary of the densitometric values obtained 
from one experiment.
I
Factor 50 ng/ ml 
BMP-2
50 ng/ ml 
BMP-7









Table 3.1c The effects o f selected doses of calcitriol and members of the TGF-beta superfamily, alone or in combination, on the
expression of osteoblast-related genes in MG-63 cells
!
Confluent MG-63 cells maintained in DMEM supplemented with 10% fetal calf serum were cultured in DMEM containing 2% fetal 
calf serum 24 hours prior to the addition of the above factors. After 24 hours’ exposure, RNA was extracted and analysed by RT-PCR 
and Southern blotting for MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH transcript expression. The table above is a summary of the 
densitometric values obtained from three independent experiments, nd, not done. go
- 3 2 36 14 3 3 8 3 67 6 6 2
+ 3 3 160 19 7 327 5 5 •119 nd nd nd
- 1 1 2 13 3 2 5 2 1 14 2 3
+ 2 3 4 21 4 7 9 2 5 nd nd nd
- 4 2 2 4 2 2 6 1 0 28 1 1
+ 1 0.5 2 5 4 10 3 . 1 4 nd nd nd
- 0 0 0 9 1 0 7 1 1 6 3 4
+ 3 r 1 13 3 11 2 2 4 nd nd nd
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Data from this experiment were pooled (tables 3.1a-3.1c) for the purposes of 
statistical analysis, which can be seen in Appendix 3, null hypotheses 1-7.
3.4 The effects o f interactions between calcitriol and members o f the TGF-beta 
superfamily on the expression of osteoblast-related genes in MG-63 cells
Following on from the last experiment in which the interactions between 
calcitriol and members of the TGF-beta superfamily had marked effects on the 
expression o f osteoblast-related gene transcripts in MG-63 cells, the interactions of  
these agents were examined further in three experiments (one example shown in figure 
3.4). Where possible, doses o f the factors were selected so that the effects o f  
combinations o f agents could be observed without those of one agent obscuring those of 
another: these were 1 nM calcitriol, 50 ng/ ml BMP-2 or BMP-7 and 0.05 ng/ ml TGF- 
beta- 1. The results of tfte densitometric analysis for three independent experiments are 
shown in table 3.2a, and were subjected to statistical analysis (see Appendix 3). In the 
following section, emphasis has been placed on those combinations o f factors that 
yielded similar trends, in terms of direction, but not necessarily o f magnitude, in all 
three experiments.
As shown previously (table 3.1a), treatment with 1 nM calcitriol alone increased 
the level o f expression of transcripts for osteocalcin and BMP-2, but did not have a 
consistent effect on that of MSX-2 or BMP-4. Treatment with BMP-2 increased the 
level of expression of its own mRNA and, in two of three experiments, that of MSX-2 
(table 3.2a). That this trend is representative o f the true action o f this factor on the 
expression o f M SX-2 in this cell line is supported by the results o f previous 
experiments (table 3.1b). Treatment with BMP-2 also consistently decreased the level 
of B&1P-4 mRNA expression. When added in combination, calcitriol antagonised the 
stimulatory effect of BMP-2 on the expression o f MSX-2, but for osteocalcin and BMP- 
2 transcript expression, the results obtained were similar to those seen following  
treatment with calcitriol alone (table 3.2a). BMP-4 mRNA expression was at a similar 
level following treatment with calcitriol and BMP-2 in combination to that seen after 
treatment with BMP-2 alone.
When added alone, 50 ng/ ml BMP-7 increased the level o f transcript expression 
for MSX-2, osteocalcin and BMP-2, but had no consistent effect on the expression of 
BM P-4 mRNA (table 3.2a). When added in combination, calcitriol had a slight 
antagonistic effect on the stimulation o f expression o f transcripts for M SX-2, 
osteocalcin and BMP-4 compared to those seen following treatment with BMP-7 alone, 
and had an essentially additive effect on the expression of BMP-2 mRNA.
Treatment with TGF-beta markedly increased the level o f expression of MSX-2 
transcripts (3- 67-fold) and also increased the level o f expression o f osteocalcin  
transcripts. In contrast, TGF-beta had no consistent effect upon the expression of 
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Figure 3.4 The effects of interactions between calcitriol and members of the TGF-beta 
superfamily on the expression of osteoblast-related genes in MG-63 cells
MG-63 cells were cultured in DMEM containing 10% fetal calf serum until 24 hours prior to 
treatment when this was replaced with DMEM containing 2% fetal calf serum. The cells were 
then exposed for 24 hours to 1 nM calcitriol (D), 50 ng/ml BMP-2 (B2), 50 ng/ml BMP-7 (B7) 
and 50 pg/ml TGF-beta (Tb), alone or in combination. Suboptimal doses of agents were selected 
where possible to examine the interactive effects on gene expression. RT-PCR was performed for 
MSX-2 (35 cycles), osteocalcin (30 cycles), BMP-2 (35 cycles), BMP-4 (35 cycles) and GAPDH 
(30 cycles).
Apparent differences were observed between the quantity of RT-PCR product visualised by 
ethidium bromide staining in the gels and that seen following Southern blot analysis, for example, 
MSX-2 expression after treatment with BMP-7 alone. As these PCRs were carried out at a 
suboptimal annealing temperature of 55 © C, mispriming with non-target sequences may have 
occurred. However, specific probes were used under stringent hybridisation conditions (65 0 C) in 
the Southern blotting process, therefore changes in mRNA expression observed in the Southern 
blotting technique were analysed by densitometry. These gels and blots are representative of three 
independent experiments. Values below blots are average densitometric values, with underlines 
showing statistical significance for H values in the Kruskal-Wallis test.
Factor None 1 nM calcitriol 
mRNA
MSX-2 1 0.8 (0.1-1.6)
osteocalcin 1 2.2(1.4-2.8)
BMP-2 1 1.5 (1.2-1.9)
BMP-4 1 1.1 (0.5-1.6)
Table 3.2 a The effects of suboptimal doses of calcitriol, alone or in combination with members of the TGF-beta superfamily, on the 
expression of osteoblast-related genes in MG-63 cells 
MG-63 cells maintained in DMEM supplemented with 10% fetal calf serum were cultured for 24 hours in DMEM containing 2% 
fetal calf serum. They wer,e then exposed to the following concentrations of agents for 24 hours: 1 nM calcitriol, 50 ng/ ml BMP-2 or 
BMP-7 and 50 pg/ ml TGF-beta. RNA was extracted and analysed for the transcript expression o f MSX-2, osteocalcin, BMP-2, 
BMP-4 and GAPDH by RT-PCR and Southern blotting. Densitometric analysis was performed on the blots. Values are the average 
from three independent experiments with the range of values shown in parentheses.
1 nM calcitriol BMP-2 BMP-7 TGF-bet^
- 4.8(0.5-11.3) 5.7 (2.8-14.<2) 26 (3.3-66.5)
+ 1.3 (0.8-1.8) 4.6 (0.8-7.5) 1.6 (0.1-2.8)
- 1.3 (0.9-1.8) 5.6(1.8-12.6) 2.5(1.2-4.8)
+ 2.1 (1.5-2.8) 3.6(1.8-5.9) 2.6 (1.4-3.8)
- 2.3(1.5-3.6) 2.4(1.5-3.9) 2.2 (0.1-5.6)
+ 1.3 (0.8-1.9) 3.7 ( 0.6-7.2) 2.1 (0.1-3.7)
- 0.1 (0-0.2) 3.5 (0.9-8.6) 2.9 (1.0-6.5)
+ 0.1 (0-0.4) 3 (0.4-6.8) 0.4 (0-0.7)
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Factor None BMP-2 BMP-7 TGF-beta BMP-2 BMP-2 BMP-7 BMP-2
+ BMP-7 + TGF-beta + TGF-beta + BMP-7
__________________________________________________________________________________ _______ + TGF-beta
mRNA
MSX-2 1 4.8 (0.5-11.3)5.7 (2.8-14.2) 26 (3.3-66.5) 5.4 16.2 .27.6 12
osteocalcin 1 1.3 (0.9-1.8) 5.6(1.8-12.6) 2.5(1.2-4.8) 2.8 2.3 4.1 ' 5.2
BMP-2 1 2.3 (1.5-3.6) 2.4(1.5-3.9) 2.2 (0.1-5.6) 1.5 0.6 1 0.3
BMP-4 1 0.1 (0-0.2) 3.5 (0.9-8.6) 2.9(1.0-6.5) 7.2 3.0 9.8 0.4
Table 3.2b The effects o f suboptimal doses of members of the TGF-beta superfamily, alone or in combination, on the 
expression o f osteoblast-related genes in MG-63 cells 
MG-63 cells maintained in DMEM supplemented with 10% fetal calf serum were cultured for 24 hours in DMEM  
containing 2% fetal calf serum. They were then exposed to the following concentrations o f agents for 24 hours: 1 nM 
calcitriol, 50 ng/ ml BMP-2 or BMP-7 and 0.05 ng/ ml TGF-beta. RNA was analysed by RT-PCR and Southern blotting for 
expression of transcripts of MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH. Densitometric analysis%as performed on the
i
blots. Values are the average from three independent experiments (single treatments) with the range shown in parentheses or 
from one experiment (combinations).
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the stimulatory effect o f TGF-beta on MSX-2 mRNA expression (table 3.2a). When 
compared with TGF-beta alone, treatment with calcitriol in combination did not alter 
the expression of transcripts for osteocalcin or BMP-2, but did consistently decrease the 
level o f those for BMP-4.
In a single experiment, the effects o f adding members o f the TGF-beta 
superfamily in combination were investigated. The most striking observation was that 
when added in combination with BMP-7, the effects of any other family members on 
the level of expression of BMP-4, MSX-2 and osteocalcin transcripts were greater than 
those seen with these other members alone, with the most potent combination in the 
experiment being BMP-7 and TGF-beta (table 3.2b). BMP-2 mRNA expression was 
decreased to levels lower than those seen with single agents when anyfcombination of  
TGF-beta superfamily members was applied to the cells (table 3.2b). When all three 
family members were added in combination, the level o f BMP-4 and BMP-2 mRNA 
expression was reduced when compared with that; seen in untreated cultures.
Statistical analysis for this experiment can be seen in Appendix 3, null 
hypotheses 8 -11 .
3.5 The effects o f calcitriol on osteoblast-related gene expression in osteoblast-like 
cells
MG-63 cells, MC3T3-E1 cells and ROS 17/ 2.8 cells were treated with 10 nM 
calcitriol for 24 hours prior to harvesting o f their RNA. These cell lines were selected as 
models o f different stages of osteoblast-like maturation, with MC3T3-E1 cells being 
thought to be representative of preosteoblasts (Franceschi and Iyer, 1992), MG-63 cells 
representing a more differentiated osteoblastic phenotype (reviewed by Aubin et al, 
1993) and ROS 17/ 2.8 cells having many o f the properties o f mature osteoblasts 
(Rodan et al, 1988). Therefore, it may be possible to discern different patterns of gene 
expression in these different cell types. RNA was examined by Northern blot analysis 
for the expression of MSX-2 or Msx-2, alkaline phosphatase and osteocalcin. The levels 
of expression were normalised for loading by comparison with the methylene blue 
stained membranes (see table 3.3). Figure 3.5 illustrates one example o f this 
experiment.
When analysed by Northern blot, M SX-2 expression in MG-63 cells was 
inhibited by calcitriol treatment when compared with control whereas osteocalcin  
mRNA levels were modestly increased. Calcitriol had little effect on the steady state 
levels o f Msx-2 in MC3T3-E1 cells, whereas in ROS 17/ 2.8 cells, Msx-2 expression 
was doubled, alkaline phosphatase levels were modestly increased and osteocalcin  
mRNA expression was markedly increased when compared with control. Only MSX-2/ 
Msx-2 expression levels were subjected to statistical analysis as insufficient repeats for 
the other genes were performed (see Appendix 3, null hypothesis 12).
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Figure 3.5 Effects of calcitriol on gene expression in osteoblast-like cells
Cells were cultured to confluency in DMEM containing 10% fetal calf serum at which 
point medium was replaced with DMEM containing 2% fetal calf serum. MC3T3-E1 cells 
were cultured in the constant presence of 50 |iM ascorbate-2-phosphate. 24 hours after 
replacement of the medium, cells were exposed to the agents as above for 24 hours. RNA 
was extracted and analysed by Northern blot. The Figures shown are representative and the 
number of independent repeats is indicated by the value of “n”. Densitometric values are 
shown beneath each blot.
Cell type MG-63 cells MC3T3-E1 cells ROS 17/ 2.8 cells
mRNA 10 nM calcitriol
1 1 1
MSX-2/Msx-2
+ 0.2 (0.1-0.4) 1.0 (0.8-1.3) 1.3 (1.0-2.1)
1 nd 1
osteocalcin
+ 1.2 nd 5.1
nd nd . 1
alkaline phosphatase
+ nd nd 1.2 (1.2-1.3)
Table 3.3 The effects of calcitriol on osteoblast-related gene expression in osteoblast-like cell lines as assessed by Northern blot analysis
Cells were maintained in DMEM supplemented with 10% fetal calf serum until confluent, at which point medium was replaced with
DMEM containing 2% fetal calf serum. MC3T3-E1 cells were constantly cultured in the presence of 50 |iM  ascorbate-2-phosphate. After
24 hours, cells were exposed to 10 nM calcitriol for a further 24 hours prior to extraction of RNA and analysis by. Northern blot.
This table is a summary of up to four independent experiments: blotting for Msx-2 from ROS 17/ 2.8^ :c^lls was performed four times; that
for MSX-2/Msx-2 from MG-63 and MC3T3-E1 cells, and for alkaline phosphatase for ROS 17/ 2.8 cells was performed twice; all other
blotting was carried out once. Values are averaged with the range shown in parentheses and represent the relative levels of osteoblast-
related gene expression in MG-63 cells, MC3T3-E1 cells and ROS 17/ 2.8 cells following treatment with 10 nM calcitriol for 24 hours, nd,
not done. 87
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3.6 Northern blot analysis o f RNA extracted from MG-63 cells treated with 
calcitriol, cycloheximide and actinomycin D, alone or in combination
In order to gain some insight into the mechanisms o f the regulation o f  
expression o f MSX-2, cycloheximide, a protein synthesis inhibitor, and actinomycin D, 
an RNA synthesis inhibitor, alone or in combination with 10 nM calcitriol, were 
introduced to MG-63 cells for 24 hours (figure 3.6). MG-63 cells maintained in DMEM 
supplemented with 10% fetal calf serum were cultured for 24 hours in DMEM  
containing 2% fetal calf serum. The cells were then exposed to 2.5 jug/ ml 
cycloheximide or 250 ng/ ml actinomycin D, alone or in combifiation with 10 nM 
calcitriol, for 24 hours prior to the harvesting o f RNA and analysis for the expression of 
MSX-2 by Northern blot analysis. Densitometric analysis on the b lo f was performed
V : '
and normalised using the average intensity o f the two ribosomal bands (28S and 18S) 
following methylene blue staining (see table 3.4).
In a single experiment, a decrease in M SX-2 expression was seen following  
treatment with calcitriol when analysed by Northern blot as previously observed (table 
3.3). When compared to untreated control, actinomycin D treatment resulted in an 
abrogation o f MSX-2 mRNA transcript levels. Cycloheximide treatment alone resulted 
in increased MSX-2 expression when compared to untreated control.
Adding the agents in combination resulted in an increase in MSX-2 expression 
following treatment with cycloheximide and calcitriol when compared with control: 
MSX-2 transcript levels were stimulated when compared to treatment with calcitriol 
and decreased when compared to cycloheximide alone. Actinomycin D and calcitriol 
together inhibited MSX-2 mRNA expression when compared with control: when 
compared to the actions of either agent alone, a small increase in MSX-2 mRNA levels 
was seen.
3.7 Examination o f the effects of over-expression o f MSX-2 on calcitriol-induced 
MSX-2 expression in ROS 17/2.8 cells
ROS 17/ 2.8 cells were transfected with a human M SX-2 construct by Jane 
Hodgkinson, UMDS, London, using a lipofectamine protocol. Transfectants (denoted 
R2/8 and R2/11) were cultured continuously in G418 to prevent reversion and treated 
with 10 nM calcitriol for 24 hours prior to harvest o f their RNA and assessment by 
Northern blot analysis (figure 3.7). As for the previous experiment, blots were 
normalised for loading using the methylene blue stained membranes. The RNAs were 
blotted twice and the mean of the densitometric values was used in comparison with 
levels in untransfected ROS 17/ 2.8, MG-63 and MC3T3-E1 cells (see table 3.5).
Following treatment of these transfectants with calcitriol, R2/11 levels were 
approximately halved whereas R2/8 levels of MSX-2 were doubled. Statistical analysis 
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Figure 3.6 Northern blot analysis of RNA extracted from MG-63 cells treated with 
calcitriol, cycloheximide and actinomycin D, alone or in combination 
MG-63 cells were cultured to confluency in DMEM containing 10% fetal calf serum which 
was replaced with DMEM containing 2% fetal calf serum 24 hours before treatment with the 
agents above. To gain some insight into the mechanism(s) whereby MSX-2 expression is 
regulated in osteoblast-like cells, confluent MG-63 cells were treated with the protein 
synthesis inhibitor, cycloheximide, and the RNA synthesis inhibitor, actinomycin D, alone or 
in combination with lOnM calcitriol (D). RNA was harvested after exposure to these agents 
for 24 hours and assessed by Northern blot analysis for MSX-2 mRNA transcript expression. 
Densitometric values are shown beneath the blot. This experiment was performed once.
untreated 2.5 |ig/ml 250ng/ml 10 nM calcitriol 10 nM calcitriol 10 nM calcitriol
cycloheximide actinomycin D + 2 .5 |ig /m l + 250ng/ml
cycloheximide actinomycin D
MSX-2 1 1.5 0.1 0.3 1.2 0.4
Table 3.4 Northern blot analysis of RNA extracted from MG-63 cells treated with calcitriol, cycloheximide and actinomycin D, alone 
or in combination
MG-63 cells were maintained in DMEM supplemented with 10% fetal calf serum until confluence at which point medium was replaced 
with DMEM containing 2% fetal calf serum. After 24 hours, the cells were exposed for 24 hours to the following doses of agents, alone or 
in combination: 10 nM calcitriol, 2.5 p.g/ml cycloheximide and 250 ng/ml actinomycin D. RNA was extracted and subjected to analysis by 
Northern blot. Autoradiographs were quantitated by densitometric analysis: the table above represents the relative expression levels of MSX-2 
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Figure 3.7 Northern blot analysis of RNA extracted from ROS 17/2.8 cells 
stably overexpressing MSX-2 and treated with calcitriol 
Samples of total RNA derived from ROS 17/2.8 cells transfected with a construct 
containing the coding sequence of the human MSX-2 gene were supplied byJane 
Hodgkinson, UMDS, London. Two transfectants, denoted R2/8 and R2/11, had been 
cultured constantly in DMEM containing G418 and treated for 24 hours with 10 nM 
calcitriol prior to the harvest of the RNA. This was analysed by Northern blot for the 
expression of MSX-2 mRNA transcripts. RNA was blotted twice. Densitometric 
values are shown beneath the blot.
Cell type 'M G -63 MC3T3-E1 ROS 17/2.8 R2/8 R2/11
_________ ;__________________________________ (n=2) (n=2)_________ (n=4)__________ (r=2) (r=2)
10 nM calcitriol
MSX-2/msx-2
+ 0.2 (0.1-0.4) 1.0 (0.8-1.3) 1.3(1.0-2.1) • 2.3 (2.1-2.5) 0.6 (0.4-0.7)
Table 3.5 The effects of over-expression of MSX-2 on calcitriol-induced expression of MSX-2 in osteoblast-like cells 
Cells were maintained in PMEM supplemented with 10% fetal calf serum until confluent at which point medium was replaced 
with DMEM containing 2% fetal calf serum. MC3T3-E1 cells were cultured constantly in the presence of 50 |xM ascorbate-2- 
phosphate. After 24 hours, cells were exposed to 10 nM calcitriol for 24 hours, then RNA was extracted and analysed by Northern 
blot.
The table above summarises the results .of a number of independent experiments, as indicated by “n”, and of repeat blotting, as 
denoted by “r”, and represents the relative levels of MSX-2 mRNA transcripts in different cell lines, some overexpressing MSX-2, 




The RT-PCR technique, used extensively in the course of this research, is useful 
in the detection of absolute changes in gene expression, for example the absence or 
presence of an mRNA transcript. In order to observe more quantitative changes in gene 
expression, such as increases or decreases in the expression levels of mRNA transcripts 
elicited by treatment with an agent, an internal quantitative control would be required. 
Another method, such as dot-blot hybridisation/ Northern blotting, where variations in 
messenger mRNA levels for different genes within the same sample and between different 
samples run simultaneously can be quantitatively evaluated, would in hindsight be 
preferable. However, even with the limitations of the RT-PCR technique, consistent 
trends were seen in the course of the research in this project. In this discussion, and those 
which follow, the focus is on the changes in direction, and not in magnitude, in the 
expression of transcripts of osteoblast-related genes.
The investigation of gene expression in established osteoblast-like cell lines and 
how it differs from that of normal osteoblastic cells (herein defined as cells cultured from 
normal adult human bone and studied in primary culture or at first passage) may lead to 
some understanding of the genetic pathways that regulate osteogenic differentiation. 
Examination of the cascade of gene expression in osteoblast-like cells may reveal 
similarities with that in bone-derived cells and may support the use of these cell lines as 
models for osteoblast differentiation.
The importance of BMP-2 and BMP-4 in bone formation has already been 
discussed (see section 1.8). In this investigation, the regulation of their expression in 
MG-63 cells by other members of the TGF-beta superfamily and by calcitriol was shown 
to differ. BMP-2 mRNA levels were stimulated by calcitriol, BMP-6, BMP-7 and TGF- 
beta, the latter in contrast to the study in subcultures of fetal rat calvarial osteoblasts where 
BMP-2 expression was suppressed by TGF-beta treatment, where a higher dose (2 
ng/ml) was used (Harris et al, 1994). Interestingly, BMP-2 transcript expression was 
upregulated by BMP-4 treatment also. The finding that BMP-2 upregulates its own 
expression in MG-63 cells supports the discovery that BMP-2 stimulates production of its 
own mRNA in rodent cells (Ghosh-Choudhury et al, 1996). This effect was maximal at 
the lowest dose and its magnitude decreased with increased levels of agent, therefore it 
would appear that in the absence of another agent, BMP-2 regulates its own expression, 
maintaining steady levels. High levels of BMP-2 serve to inhibit the expression of BMP- 
4, which was stimulated only by the lowest dose of BMP-2. The induction of BMP-2 
expression by BMP-4 acts as a negative regulator of BMP-4 expression due to the 
inhibitory effects of higher doses of BMP-2 on BMP-4 expression.
Taken together this suggests that increased levels of expression of BMP-2 
augments BMP-2 expression and downregulates that of BMP-4. BMP-2 mRNA 
expression is stimulated by the presence of BMP-2, therefore BMP-2 expression is
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maintained. Only when levels of BMP-2 decrease does expression of BMP-4 transcripts 
increase. This complementarity of BMP-2 and BMP-4 in vitro is reflected in development 
of the embryo where BMP-2 and BMP-4 respectively exhibit dorsalising and ventralising 
functions in insects and mammals (Rusch and Levine, 1994; Staehling-Hampton et al, 
1994; Steinbeisser et al, 1995).
BM P-2 BM P-4
A possible model for the expression o f  BM P-2 and BM P-4 in human osteosarcoma cells
Also noted were the effects of BMP-4 on the expression of osteoblast-related 
genes where it was shown that of all the agents tested in MG-63 cells, BMP-4 was the 
least potent stimulator of transcript expression for any of the genes examined. For the 
other family members, the rank order of potency for increasing transcript expression (low  
to high) was BMP-2, BMP-6, TGF-beta and BMP-7. BMP-4 mRNA expression was 
stimulated only by the higher doses of calcitriol and was suppressed at lower 
concentrations of the agent. BMP-4 had no effect on its own transcription and was 
stimulated by BMP-6: maximal expression of BMP-4 occurred with high doses o f BMP- 
6, suggesting that expression of BMP-6 must be upregulated in order for BMP-4 to be 
expressed. The trend of the effects of BMP-7 and TGF-beta on BMP-4 transcript 
expression indicate that these agents have little effect on the expression of this gene when 
compared to that in untreated cells, but stimulate the expression of BMP-2. A longer 
exposure to these agents would be necessary to determine their effects on BMP-4 
expression as modulated by increased BMP-2 expression. Taken together, these results 
indicate that the actions of BMP-7 and TGF-beta occur earliest in the sequence of 
expression, as induction of all genes of interest followed treatment with these agents, and 
that a possible model of the cascade of BMP gene expression can be suggested.
►  BMP-4' ►  TGF-beta BMP-2
A possible model for the cascade o f BMP gene expression in human osteosarcoma cells
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In the progression of MG-63 cells towards osteoblastic differentiation, BMP-4 
and BMP-2 are expressed prior to MSX-2 and osteocalcin. High levels of BMP-2 block 
any increase in BMP-4 and osteocalcin mRNA levels, the effects on the latter perhaps 
being mediated by the induction of MSX-2 expression. BMP-4 also induces MSX-2 
expression. Low levels of BMP-2 have no real effect on MSX-2 expression, but increase 
that of BMP-4 and galvanise differentiation by stimulating osteocalcin expression. 
Therefore, in the absence of a strong differentiation stimulus, BMP-2 blocks osteogenic 
differentiation. Moreover, it would appear that in order for osteoblastic differentiation to 
proceed in MG-63 cells, expression of BMP-2 must be downregulated. Thus a possible 
model for the cascade of osteoblast-related gene expression and of osteogenic 
differentiation in MG-63 osteosarcoma cells can be suggested:
The role of calcitriol in the promotion of osteogenic differentiation has been 
established in several studies (Beresford et al, 1986; Harter et al, 1995; reviewed by 
White et al, 1994). While non-genomic actions have been studied (see Introduction 
section 1.8), many of the genomic effects of calcitriol are mediated by the vitamin D 
receptor (VDR) and its interaction with the promoter region of target genes known as the 
vitamin D response element (VDRE), leading to direct transcriptional regulation by 
calcitriol, such as that observed for osteocalcin expression. The effects of this hormone in 
MG-63 osteoblast-like cells have been examined (Mahonen et al, 1990) and, as in 
osteoblastic cells, an induction of mRNA expression of osteocalcin and vitamin D 
receptor was seen following treatment of the cells with calcitriol.
In the studies described in this chapter, osteocalcin expression was used as an 
indicator of differentiation to the osteoblastic phenotype. It was also employed as a model 
in the study of vitamin D regulation of gene expression. As expected, calcitriol promoted 
osteocalcin expression. The increase in the expression of BMP-4, BMP-2, MSX-2 and 
osteocalcin following treatment of the cells with calcitriol is indicative of an overwhelming 
drive towards differentiation: even increased levels of BMP-2 and MSX-2 are insufficient
BM P-2 - ►  BM P-4 ^  ^  M SX -2 osteocalcin
A possible model for the cascade o f  osteoblast-related gene expression in human osteosarcoma cells
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to prevent the expression of osteocalcin. Stimulation of osteocalcin mRNA expression 
was also seen following treatment with BMP-6, BMP-7 and TGF-beta. BMP-2 had a 
biphasic effect on osteocalcin expression. BMP-4 had no real effect on osteocalcin 
transcript levels and stimulated those of MSX-2. This strengthens the hypothesis that 
decreased BMP-2 levels allow differentiation to proceed by blocking an increase in MSX- 
2 levels and stimulating osteocalcin transcript expression, with higher levels of BMP-2 
and BMP-4 preventing differentiation through the induction of the expression of MSX-2.
Expression of MSX-2 as an intermediate in the cascade of expression in the 
osteoblastic differentiation pathway was more extensively examined. As for BMP-4, 
induction of MSX-2 transcript expression by calcitriol was biphasic. Its stimulation by 
BMP-2 occurred with increasing dose. BMP-4 enhanced MSX-2 expression. This may 
have occurred indirectly, through the subsequent induction of BMP-2 by increased BMP- 
4 levels. The negative regulation of differentiation by MSX-2 (see Introduction section 
1.6) is supported by the data in this chapter: induction of MSX-2 by BMP-2 or BMP-4 is 
coincident with a lack of stimulation in osteocalcin gene expression. However this 
inhibitory effect is not of sufficient magnitude to withstand the strong and direct 
stimulatory effect of calcitriol on osteocalcin mRNA expression. The finding that in adult 
human bone-derived cells, MSX-2 expression is consistently induced by both BMP-2 and 
BMP-4, concurs with observations in orofacial development, where BMP-2 and BMP-4 
expression in the presumptive dental epithelium induces Msx-1 and Msx-2 expression in 
the mesenchyme (Thesleff et al, 1996), and in BMP-induced ectopic bone formation in 
Wistar rats where Msx-2 expression was noted 6 days after implantation of BMP into the 
subcutaneous muscle layer (Iimura et al, 1994, b). BMP-6, BMP-7 and TGF-beta all 
enhanced MSX-2 expression maximally at lower doses in the ranges tested.
As previously outlined, studies into the effects of interactions between members 
of the TGF-beta superfamily have led to the idea that in vitro mixtures of BMPs have 
more potent effects upon the transcription of genes than single BMPs (Wang et al, 1990; 
Aono et al, 1995; Hazama et al, 1995; Lyons et al, 1995). Interactions between TGF-beta 
and BMP-7 blocked chondrogenesis in subconfluent primary rat calvarial cells (Asahina et 
al, 1993). BMP-2 was shown to affect the quantity and type of TGF-beta receptor 
expressed on the osteoblast cell surface, thus modulating the effects of TGF-beta 
(Centrella et al, 1995), and induced expression of TGF-beta in osteoblast-like cells 
(Zheng et al, 1994). Also, depending upon which was added first, calcitriol and TGF- 
beta abrogate the effects of the other agent in MG-63 cells (Iimura et al, 1994, a; Ingram 
et al, 1994). Therefore, it seemed appropriate to examine the effects of these agents in 
combination, compared to their individual effects, in MG-63 cells.
Investigations of the interactions between agents were performed using low doses 
of BMP-2, BMP-7, TGF-beta and calcitriol (tables 3.2a and 3.2b). The stimulation of
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BMP-2 transcript expression by BMP-2 and its concurrent inhibition of the expression of 
BMP-4 transcripts confirms the observations made in previous experiments (table 3.1b) 
and supports the conclusion that an initial increase in BMP-2 mRNA expression further 
enhances levels of BMP-2 transcript, leading to a suppression of BMP-4 expression. In 
the presence of calcitriol, the stimulation of BMP-2 mRNA expression levels by BMP-2 
is similar to those seen following treatment with calcitriol alone. This, and the observation 
that this combination stimulates osteocalcin mRNA expression to levels similar to those 
seen with calcitriol alone, again supports the conclusion that the expression of BMP-2 
transcripts must be downregulated as differentiation proceeds.
BMP-7 and TGF-beta separately stimulated the levels of MSX-2 and osteocalcin 
transcript expression. It would seem appropriate in future work to extend these studies to 
include the effects of the agents studied on the expression of BMP-7 and TGF-beta, to 
clarify their position in the cascade.
Taken together, calcitriol in combination with members of the TGF-beta 
superfamily drives the cell towards a more differentiated phenotype, with increased 
mRNA levels of BMP-2, MSX-2 and osteocalcin. Interactions between members of the 
TGF-beta superfamily alone also promote differentiation, with expression of MSX-2 and 
osteocalcin transcripts ameliorated following treatment with any of the combinations 
tested. Effects on the transcription of the BMP-2 and -4 genes are more complex, and 
seem to indicate a more sedate progression through osteoblast-like differentiation.
To ascertain whether the effects of calcitriol on gene expression are osteoblast 
maturation-dependent, an investigation into the effects of calcitriol on gene expression in 
several osteoblast-like cell lines was performed. MC3T3-E1 cells are thought to model 
preosteoblasts, with MG-63 cells and ROS 17/2.8 cells modelling progressively more 
mature phenotypes.
When treated with calcitriol, MC3T3-E1 cells exhibited no change in Msx-2 
levels, suggesting a constitutive expression of this gene in these cells - this concurs with 
the proposal as outlined above that MSX-2 expression is seen in cells with a high 
proliferative potential and prior to the induction of osteoblastic differentiation. The 
reduction in MSX-2 mRNA levels seen in MG-63 cells treated with calcitriol, as 
consistently shown with Northern blot analysis, and the modest increase in osteocalcin 
expression indicates a progression towards a more mature phenotype. The modest 
increase in alkaline phosphatase levels, and the more pronounced increase in osteocalcin 
mRNA levels in ROS 17/2.8 cells treated with calcitriol are indicative of a more fully and 
terminally differentiated phenotype. The observation that Msx-2 expression is increased 
by calcitriol treatment in ROS 17/2.8 cells confirms that seen by Hoffmann et al, 1994.
Following treatment with 10 nM calcitriol in MG-63 cells, Northern blot analysis 
consistently showed a decrease in MSX-2 mRNA levels, whereas in contrast, RT-PCR/ 
Southern blotting consistently showed an increase in MSX-2 mRNA expression levels.
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RNA from the same cells treated with and without calcitriol was analysed by Northern 
blot analysis and by RT-PCR, and decrease and increase with treatment was seen 
respectively. Reverse transcription reactions in the absence of reverse transcriptase were 
carried out in parallel to control for genomic contamination and any experiments showing 
contamination were excluded. Therefore, differences between Northern blot analysis and 
RT-PCR could not be attributed to genomic contamination. It is most likely that the RT- 
PCR is exquisitely sensitive: through the selection of the primer sets, this procedure could 
be detecting incomplete message in the process of being degraded or synthesized. The 
method of choice would be Northern blot analysis, as full length RNA only is detected 
using this procedure, or RNase protection assay, which requires smaller quantities of 
RNA.
Msx-2 is expressed in differentiating murine mesenchymal cells in vitro upon 
attainment of confluence (Nove et al, 1995): its expression is downregulated as 
development progresses. This, together with the observation that expression is observed 
in highly proliferative cells (Takahashi et al, 1996), suggests that M SX-2 is a gateway in 
osteoblast-like differentiation and, by its downregulation, may provide a switch from 
proliferation to committed osteoblastic differentiation. Therefore, understanding the 
mechanisms of its expression were examined.
Cycloheximide blocks de novo translation of mRNA into an amino acid sequence, 
thus abolishing the generation of fresh proteins in the cell. Actinomycin D abrogates the 
transcription of mRNA, thus subducting novel genetic expression. When introduced to 
MG-63 cells for 24 hours, the expected ablation of mRNA is seen following treatment 
with actinomycin D alone.
Treatment with calcitriol and actinomycin D  together resulted in an abrogation of 
MSX-2 expression. This could suggest that one action of calcitriol on M SX-2 expression 
is independent of the generation of new transcripts. Treatment with cycloheximide alone 
stimulated MSX-2 expression, suggesting that the agent quashed the expression of a 
labile intermediate inhibitory protein. The modest increase in MSX-2 levels seen after 
introduction of cycloheximide and calcitriol in combination is suggestive of interference 
between the two agents, and perhaps indicates that the actions of both agents are within 
the same pathway whereby calcitriol could stimulate expression of the putative inhibitor to 
abrogate MSX-2 expression, and cycloheximide might override this to abolish expression 
of the inhibitor, thus releasing MSX-2 expression from calcitriol-induced 
downregulation.
The effects of inappropriate MSX-2 expression and of calcitriol treatment were 
examined in ROS 17/2.8 cells which were stably transfected by Jane Hodgkinson, 
UMDS, London, with a construct containing the MSX-2 coding sequence. As indicated, 
Msx-2 expression is modestly induced following calcitriol treatment of ROS 17/2.8 cells.
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In these transformants, overexpression of MSX-2 was reduced in R2/11 cells, and 
doubled in R2/8 cells with calcitriol treatment. This observation is of great interest as the 
R2/8 cells appear to behave as the ROS 17/2.8 cells upon treatment with calcitriol, 
suggesting that incorporation of the MSX-2 sequence into the R2/8 genome did not occur 
in this transformant. This was confirmed by Jane Hodgkinson with a Southern of the 
R2/8 DNA (results not shown). She probed a Northern blot of R2/11 (untreated and 
calcitriol-treated) with an osteocalcin probe and found that osteocalcin levels were only 
modestly induced by calcitriol treatment when compared to untreated control 
(untreated=l, calcitriol treatment=1.4, results not shown). The R2/11 transformants, in 
downregulating their expression of MSX-2 and modestly increasing osteocalcin 
expression upon treatment with calcitriol treatment, appear to exhibit a pattern of gene 
expression similar to that of the MG-63 osteosarcoma cell line following treatment with 
calcitriol. Although further examination of a more detailed pattern of gene expression is 
required, including type I collagen, alkaline phosphatase, osteopontin, osteonectin and 
bone sialoprotein, this result raises the intriguing possibility that by overexpressing MSX- 
2, this transformant may have reverted to an earlier stage in the pathway of osteoblast-like 
differentiation.
The conclusions of these experiments investigating the effects of calcitriol and 
members of the TGF-beta superfamily are that there is a definite sequence of gene 
expression in the progression of the osteoblast-like cell through the differentiation 
pathway. Within the limitations of the techniques used, MSX-2 expression was seen to be 
regulated by BMP-2 and BMP-4 in adult human bone-derived cells, and may mediate the 
suppression of osteocalcin expression by these BMPs. Expression of MSX-2 appears to 
be a key switch in this differentiation cascade where, in the absence of a strong 
differentiation signal, expression of the gene must be downregulated in order for 
differentiation to proceed. This downregulation may be as a result of stimulation of the 
expression of an intermediate inhibitory protein. Calcitriol and members of the TGF-beta 
superfamily consistently stimulate the expression of osteoblast-related genes, the most 
potent combination for MG-63 cells being calcitriol plus BMP-7. This suggests that 
regulation of the expression of these genes is most likely to involve a series of interactions 
between the signalling molecules found in bone.
Chapter 4
Altered pattern of gene expression in adult human trabecular bone-derived 




As indicated in the introduction to the previous chapter, there are differences 
between osteoblast-like cell lines and normal osteoblastic cells: the sequence of gene 
expression in osteoblast-like cells lacks clearly defined stages in the progression from 
proliferation to terminal differentiation (Stein et al, 1990), whereas in osteoblasts, an 
inverse correlation between proliferation and differentiation is seen and there is stage- 
specific expression o f osteoblast-related genes (reviewed by Aubin et al, 1993; Stein 
and Lian, 1993). The requirement for a structured extracellular matrix for development 
of the differentiated phenotype varies between osteoblast-like cell types, as does the 
regulation o f gene expression by exogenous growth factors (Hauschka et al, 1988; 
Franceschi and Iyer, 1992). f . ,
In ordgr to compare gene expression in these osteoblast-like cells with that in 
differentiating osteoblasts, cells were cultured from explants of adult human trabecular 
bone under conditions.previously described (see Materials and Methods, Beresford et al, 
1986). In the following series o f investigations, primary cultures were subcultured at a 
density o f 5x 103- 104 cells/ cm2.
4.1 Morphology of explant-derived cells in primary culture and at first passage
Figure 4.1 shows the outgrowth o f osteoblastic cells from a trabecular bone chip
in primary culture (photograph 4A). The cells migrate from the explant and proliferate 
to form a confluent cell layer. At this point, the cells are passaged to remove the bone 
chips as prolonged culture in the presence o f the bone chips can result in the initiation 
of adipocyte differentiation (photograph 4B). The passaged cells are replated at a 
density o f 104 cells/ cm2 in a fresh flask and are treated at confluence with the agent(s) 
of choice prior to harvest of the cells and extraction of RNA. Photograph 4C shows 
cells approaching 50% confluence and photograph 4D shows cells at 100% confluence 
just before harvest o f the cells.
4.2 Time course for the effects of calcitriol on the expression o f osteoblast-related 
genes in cultures o f human bone-derived cells
Confluent first passage trabecular bone-derived cells maintained in DMEM  
supplemented with 10% fetal calf serum in the presence o f 100 |iM  ascorbate-2- 
phosphate, a stable analogue of ascorbic acid, were treated with 10 nM calcitriol as 
medium was replaced. RNA was extracted from cells at various timepoints thereafter up 
to 24 hours following treatment and analysed by RT-PCR for expression o f MSX-2, 
osteocalcin, BMP-2, BMP-4 and GAPDH mRNA transcripts (figure 4.2, top). The 
identities o f the RT-PCR products were confirmed by Southern blotting using probes 
specific for the genes o f interest (figure 4.2, bottom). In this experiment, volumetric 
analysis o f the gels was carried out using densitometry to assess any changes in the
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P h o to g ra p h  4 A : O u tg ro w th  o f  c e lls  f ro m  a n  a d u lt  tra b e c u la r  b o n e -d e r iv e d  e x p la n t .  T h e se
c e lls  w e r e  m a in ta in e d  in  D M E M  s u p p le m e n te d  w ith  10%  fe ta l c a lf  s e ru m  a n d  100 p M
a s c o r b a te -2 - p h o s p h a te  u n til c o n f lu e n t ( a f te r  4  w e e k s )  a t w h ic h  p o in t th e  c e lls  w ere  
p a s s a g e d  a n d  r e p la te d  in  th e  a b s e n c e  o f  th e  e x p la n ts  (o rig in a l m a g n if ic a tio n  x lO O ).
P h o to g r a p h  4 B : O u tg ro w th  o f  a d ip o c y tic  c e lls  f ro m  an  a d u lt tr a b e c u la r  b o n e - d e r iv e d  
e x p la n t .  T h e s e  c e lls  w e re  m a in ta in e d  in  D M E M  s u p p le m e n te d  w ith  10%  fe ta l c a l f  s e ru m
a n d  100  p M  a s c o rb a te -2 -p h o s p h a te  a n d  w e re  c u l tu re d  in  th e  p re s e n c e  o f  th e  e x p la n t  f o r  8
w e e k s  (o r ig in a l  m a g n if ic a tio n  xlO O ).
F ig u r e  4 .1  a  M o rp h o lo g y  o f  e x p la n t-d e r iv e d  c e lls  in  p r im a ry  c u l tu re
P h o to g ra p h  4 C : T h e s e  c e lls  w e re  p a s s a g e d  a n d  m a in ta in e d  in  D M E M  s u p p le m e n te d  w ith  
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a n d  a s c o r b a te  fo r  2 4  h o u rs  p r io r  to  tre a tm e n t a n d  h a rv e s t  o f  R N A  (o r ig in a l m a g n if ic a tio n  
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exposure to lOnM calcitriol (hours)
C C0.5T0.5 Cl TI C2 T2 C4 T4 C6 T6 C12 T12 C24T24 + - + - M
1 1.6 1 0.6 1 0.7 1 0.8 1 0.3 1 0.5 1 2.4
- + - M
1 1.8 1 1.1 1 0.6 1 1.6 1 0.5 1 0.2 1 0.9 _ +  M
1 2.1 1 1 1 1.5 1 1 1 1.5 1 0.1 I 0.8
exposure to lOnM calcitriol (hours)
C C0.5T0.5 Cl Tl C2 T2 C4 T4 C6 T6 C12 T12 C24T24
Figure 4.2 Time course for the effects of calcitriol on the expression of
osteoblast-related genes in cultures of human bone-derived cells 
Confluent first passage trabecular bone-derived cells maintained in DMEM containing 10% 
fetal calf serum in the presence of 100 p.M ascorbate-2-phosphate were cultured in DMEM 
containing 2% fetal calf serum and 100 |iM ascorbate-2-phosphate supplemented with 10 nM 
calcitriol (T). RNA from these and from paired untreated control cells (C) was harvested at 
time intervals in the range 0-24 hours and subjected to RT-PCR for MSX-2 (35 cycles), 
osteocalcin (30 cycles), BMP-2 (35 cycles), BMP-4 (40 cycles) and GAPDH (30 cycles) 
followed by Southern blotting. The gels were selected for analysis by densitometry as the 
blots for BMP-2 and GAPDH were inadequate for analysis. Densitometric values are seen in 
the above figure under the gels. This experiment was performed once.
exposure to 10 nM calcitriol (hours)
_______________________0 5 ________ 1__________ 2__________4__________ 6 , 12_________24
mRNA
MSX-2 1.6 0.6 0.7 0.8 0.3 0.5 2.4
osteocalcin 1.2 1.0 0.7 1.3 0.5 “ 1.4 1.2
BMP-2 1.8 1.1 0.6 1.6 0.5 0.2 0.9
BMP-4 2.1 1.0 1.5 1.0 1.5 0.1 0.8
Table 4.1 Time course for the effects of calcitriol on the expression of osteoblast-related genes in cultures of human bone-derived cells 
Confluent first passage trabecular bone-derived cells maintained in DMEM supplemented with 10% fetal calf serum and 100 pM 
ascorbate-2-phosphate were cultured in DMEM containing 2% fetal calf serum and 100 pM ascorbate for 24 hours prior to treatment with 
10 nM calcitriol. At a range of timepoints from 0.5- 24 hours, RNA was extracted and analysed by RT-PCR and Southern blotting for 
MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH. Densitometric analysis was normalised for GAPDH and the table above summarises 




level o f mRNA transcripts as the blot for GAPDH was of inadequate quality (see table 
4.1).
Following addition o f fresh medium, irrespective o f the presence or absence o f  
calcitriol, there was a rapid increase in the mRNA transcript levels o f all genes 
examined: 30 minutes after replacement o f the medium, treatment with calcitriol 
modestly stimulated expression of MSX-2 and osteocalcin and more strongly that o f  
BMP-2 and BMP-4 mRNA transcripts when compared to that seen in untreated cells at 
the same timepoint. After 24 hours, calcitriol had increased expression o f M SX-2 
mRNA transcripts when compared to untreated control at the same timepoint.
Calcitriol is known to have pro-differentiation effects (Beresford et al, 1986). 
The downregulation of BMP-2 expression by addition of calcitriol th^efore indicates 
that abrogation o f the expression o f this gene may be a necessary step in the calcitriol- 
induced differentiation o f osteoblastic cells. Likewise, the enhancement o f M SX-2 
expression by calcitriol in this instance may be required in the initiation of osteoblastic 
differentiation.
As already reviewed in the Introduction (section 1.7), a vitamin D response 
element (VDRE) is present in the osteocalcin gene promoter. Transcription o f the 
osteocalcin gene is therefore subject to direct regulation by calcitriol. However, after 
24 hours’ exposure to calcitriol, there was no noticeable effect on the production o f  
osteocalcin mRNA transcripts when compared to that seen in untreated cells at the same 
timepoint. One possible explanation for this is that, amongst other growth factors and 
hormones, serum may contain calcitriol (Mahonen and Maenpaa, 1994), therefore 
mRNA expression of osteocalcin may already be maximally induced and addition o f  
exogenous calcitriol may not further induce expression. This explanation may also hold 
true for BMP-4 mRNA expression. Therefore in all subsequent experiments, fresh 
medium was added at least 24 hours prior to the addition o f exogenous calcitriol to 
allow for the subsidence o f gene expression induced by the addition of serum. An 
additional step to minimise the effects o f serum was to reduce the concentration o f  
serum present in the replacement medium from 10% to 2% (Mahonen and Maenpaa, 
1994).
4.3 The effect of culture in the absence and presence of ascorbate on the response of 
human bone-derived cells to calcitriol
Ascorbate-2-phosphate (asp) is a stable analogue o f ascorbic acid, which has 
been shown to be essential for the post-translational modification o f collagen and 
therefore the production of a structured extracellular matrix (Franceschi and Iyer, 1992). 
In this experiment (figure 4.3), confluent first passage human trabecular bone-derived 
cells maintained in DMEM supplemented with 10% fetal calf serum and in the absence 
or presence o f 100 |iM  ascorbate-2-phosphate were cultured for 24 hours in DMEM  
containing 2% fetal calf serum and 100 fiM ascorbate as appropriate. The cells were
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Figure 4.3 The effect of culture in the absence and presence of ascorbate on the response 
of human bone-derived cells to calcitriol 
Confluent first passage trabecular bone-derived cells cultured continuously in the absence or 
presence of 100 |iM ascorbate-2-phosphate (-asp and +asp respectively) were fed with DMEM 
containing 2% fetal calf serum and 100 |iM ascorbate-2-phosphate 24 hours prior to treatment 
with increasing doses of calcitriol. After 24 hours’ exposure to the agent, RNA was harvested and 
subjected to RT-PCR and Southern blotting to detect MSX-2 (35 cycles), osteocalcin (30 cycles), 
BMP-2 (35 cycles), BMP-4 (35 cycles) and GAPDH (30 cycles) mRNA expression. 
Densitometry was then performed on the gels as the blots for MSX-2 and GAPDH were 
overexposed (values under each gel are derived from densitometric analysis and represent 
expression relative to cells treated without asp - for levels relative to untreated +/- asp, see tables 
4.2a and b). The effects of ascorbate on calcitriol-induced osteocalcin expression were seen to be 
significant (underlined). This figure is representative of two independent experiments.
Table A
0
Final concentration of calcitriol (nM)
10-7 io-8 io-9 1 0 l° 1 0 11
MSX-2 1.2 1.2 1.8 1.7 1.0 0.2
osteocalcin 3.6 0.8 1.1 0.7 1.1 0.3
BMP-2 2.5 1.2 1.2 1.0 0.6 0.4
BMP-4 9.4 3.8 5.9 15 1.2 0.5
Table B
■ -i
Final concentration of calcitriol (nM)
0 io-7 10*8 io-9 p o 10-n
MSX-2 1.0 1.3 0.9 0.7 0.8 0.7
osteocalcin TO 4.6 3 3.1 1.9 2.9
BMP-2 1.0 1.9 1.5 1.3 1*1 1.2
BMP-4 1.0 2.6 1.5 0.4 4.2 1.2
Table C Final concentration of calcitriol (nM)
0 io-7 io-8 io-9 IO 10 10-n
MSX-2 1.0 1.2 1.1 1.2 0.8 0.1
osteocalcin 1.0 1.1 0.9 0.6 0.6 0.2
BMP-2 1.0 0.9 0.7 0.5 0.3 0.2
BMP-4 1.0 1.1 0.9 0.6 0.5 0.1
Table 4.2 The effect of culture in the absence and presence o f ascorbate on 
the response of human bone-derived cells to calcitriol 
Confluent first passage trabecular bone-derived cells maintained in DMEM  
supplemented with 10% fetal calf serum and cultured in the absence or 
presence o f 100 j l i M  ascorbate-2-phosphate were treated with DMEM  
containing 2% fetal calf serum and ascorbate-2-phosphate as appropriate for 24 
hours. The cells were then exposed to a range of doses of calcitriol for 24 
hours. RNA was extracted and analysed by RT-PCR and Southern blotting for 
M SX-2, osteocalcin, BM P-2, BM P-4 and GAPDH mRNA expression. 
Densitometric analysis was performed on the gels and table A above 
summarises the relative mRNA expression levels of the genes o f interest 
following culture in ascorbate-2-phosphate as compared to culture in its 
absence. For completeness, tables B and C record the relative expression levels 
of genes as compared to untreated control for cells cultured in the absence and 
presence of ascorbate-2-phosphate respectively.
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then exposed to doses o f calcitriol in the range lO ^M to 10 n M for 24 hours. RNA was 
extracted and analysed by RT-PCR and Southern blotting for the expression o f MSX-2, 
osteocalcin, BMP-2, BMP-4 and GAPDH. Densitometric analysis was performed on the 
gels and the results are shown in tables 4.2A- C.
In the presence o f ascorbate-2-phosphate, and therefore o f a functional 
extracellular matrix, the basal mRNA transcript levels o f BM P-2, BM P-4 and 
osteocalcin are increased when compared to those seen in cells cultured in the absence 
o f  ascorbate (table 4.2A). MSX-2 transcripts are essentially unaffected in the ascorbate- 
Ireated cultures. This suggests that the extracellular matrix is necessary for terminal 
osteoblastic differentiation under untreated conditions.
Culture o f cells in the presence of ascorbate causes the effects o^calcitriol on the
V ' ’■
expression o f mRNA transcripts to be biphasic: at higher doses, increase (M SX-2 and 
BM P-4) or no change (BMP-2 and osteocalcin) in mRNA transcript levels'is seen when 
compared to cells cultured in the absence o f ascorbate, and at the lower doses, 
downregulation o f mRNA expression is seen for all genes tested.
For com pleteness, tables 4.2B and 4.2C show the effects o f calcitriol on 
osteoblast-related gene expression in cells cultured in the absence or presence o f  
ascorbate respectively when compared to cells not exposed to calcitriol. Following  
treatment with calcitriol, the increase in BMP-2, BMP-4 and osteocalcin mRNA  
transcript levels in the absence of ascorbate (table 4.2B) is in contrast to the inhibition 
o f  calcitriol-induced BM P-2, BMP-4 and osteocalcin mRNA expression seen in 
ascorbate-treated cultures (table 4.2C). The effects o f calcitriol on the expression o f  
these genes may be therefore dependent on the maturation stage of the cell.
Statistical analysis o f these results can be seen in Appendix 3, null hypotheses 
13 and 22.
4.4 The effect o f ascorbate on BMP-7-induced ostedcalcin expression in human 
bone-derived cells
The previous experiment showed the necessity o f an extracellular matrix for the 
regulation o f gene expression by calcitriol and indicated a maturation-stage specific 
effect o f calcitriol on the expression o f BMP-2, BMP-4 and osteocalcin mRNA. In this 
investigation, the importance of the extracellular matrix was examined with regard to 
expression o f osteocalcin following exposure to BMP-7 for 24 hours (figure 4.4). 
Confluent first passage human trabecular bone-derived cells, maintained in DMEM  
supplemented with 10% fetal calf serum and in the presence or absence o f 100 jiM 
ascorbate-2-phosphate, were cultured for 24 hours in DMEM containing 2% fetal calf 
serum, and ascorbate if  appropriate. The cells were then exposed to a range of doses of 
BMP-7 (5- 200 ng/ ml) for 24 hours prior to the extraction o f RNA. This was analysed 
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F ig u re  4 .4  T h e  e ffe c t o f  a sc o rb a te  on  B M P -7 -in d u c e d  o s te o c a lc in  e x p re ss io n  in  
h u m a n  b o n e -d e riv e d  ce lls  
C o n f lu e n t f irs t p a s sa g e  tra b e c u la r  b o n e -d e riv e d  ce lls  c u ltu re d  c o n s ta n tly  in  D M E M  
c o n ta in in g  10%  fe ta l c a lf  se ru m  an d  in th e  p re se n c e  o r  a b s e n c e  o f  100 p M  asc o rb a te -  
2 -p h o s p h a te  (+ a sp  an d  -a sp  re sp e c tiv e ly )  w e re  fed  w ith  D M E M  c o n ta in in g  2%  fe ta l 
c a l f  se ru m  an d  100 p M  a s c o rb a te -2 -p h o sp h a te  2 4  h o u rs  p r io r  to  tre a tm e n t. T h ey  w ere  
th e n  tre a te d  fo r  24  h o u rs  w ith  a ra n g e  o f  d o se s  o f  B M P -7  (5 -2 0 0  n g /m l)  b e fo re  R N A  
w as  h a rv e s te d  an d  R T -P C R  an d  S o u th e rn  b lo tt in g  fo r  o s te o c a lc in  an d  G A P D H  w as  
p e r fo rm e d . T h is  f ig u re  is re p re se n ta tiv e  o f  tw o  in d e p e n d e n t e x p e r im e n ts .
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Basal levels o f osteocalcin mRNA transcripts are increased in ascorbate-treated 
cultures as compared to those seen in untreated cultures. When differences in loading 
are taken into account, the ability of BMP-7 to induce osteocalcin mRNA expression 
appears to be absolutely dependent on the presence of ascorbate, and by inference, on 
the presence o f a functional extracellular matrix. This indicates that induction of 
osteocalcin mRNA expression by BMP-7 is completely dependent on the maturation 
stage o f the cell.
4.5 The effect o f cell density on the response of human bone*derived cells to 
treatment with calcitriol
As established in the previous experiments, the interaction b^tw^en cell and 
matrix can be critical in determining the response o f the cell to exogenous growth 
factors. It therefore seemed appropriate to investigate the importance o f cell-cell contact 
in the expression o f osteoblast-related genes in, response to treatment with calcitriol. 
Equivalent numbers o f passaged trabecular bone-derived cells maintained in DMEM  
supplemented with 10% fetal calf serum and 100 pM ascorbate-2-phosphate were 
plated at different densities and allowed to settle for 24 hours in DMEM containing 2% 
fetal calf serum and 100 |iM  ascorbate before treatment for a further 24 hours with 
10 nM calcitriol (see figure 4.5). RNA was analysed for the mRNA expression o f  
M SX-2, osteocalcin, BMP-2, BMP-4 and GAPDH by RT-PCR and Southern blotting. 
The blots were analysed by densitometry: the values for M SX-2 reflect differences in 
loading as bands were undetectable.
Osteocalcin steady state mRNA levels were increased at the higher cell density 
(table 4.3B), as was the magnitude of the increase observed in response to treatment 
with calcitriol. In contrast, basal expression of BMP-2 and BMP-4 mRNA was greater 
at the lower cell density: BMP-2 mRNA expression was decreased by calcitriol 
treatment whereas that o f BMP-4 was increased. Following treatment o f cells at the 
higher density with calcitriol however, BMP-2 and BMP-4 transcript expression was 
relatively increased when compared to levels in untreated cells plated at the same 
denstiy, or with calcitriol-treated cells at the lower density (see table 4.3A).
Therefore, the response to calcitriol was seen to be cell density-dependent: 
mRNA transcript levels of BMP-2, BMP-4 and osteocalcin were stimulated following  
treatment with calcitriol at the higher cell density (see table 4.3A).
4.6 The effects o f  bone morphogenetic proteins on osteoblast-related gene 
expression in human bone-derived cells
As seen in table 4.4, several experiments show that, in the presence o f ascorbate, 
and therefore o f a collagen-dependent extracellular matrix, calcitriol modestly increases 
the transcript expression o f BMP-2 (average 1.7, range 0.5-3.5, table 4.4) and BMP-4 
(average 1.8, range 0.8-3.1) and more strongly stimulates that o f MSX-2 (average 2.2,
c e l l  d e n s i t y  ( c e l l s / c m 2 )
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F ig u r e  4 .5  T h e  e f f e c t  o f  c e ll  d e n s i ty  o n  th e  r e s p o n s e  o f  h u m a n  b o n e - d e r iv e d  c e l ls  to  
tr e a tm e n t  w ith  c a lc itr io l  
T o  in v e s t i g a t e  th e  in f lu e n c e  o f  c e l l - c e l l  c o m m u n ic a t i o n  in  th e  r e g u la t io n  o f  g e n e  
e x p r e s s io n ,  e q u i v a l e n t  n u m b e r s  o f  f i r s t  p a s s a g e  t r a b e c u la r  b o n e - d e r iv e d  c e l l s  c u l tu r e d  
c o n s ta n t ly  in  D M E M  w ith  10%  fe ta l  c a l f  s e ru m  a n d  100  p M  a s c o r b a te -2 - p h o s p h a te  w e re  
p la te d  a t  th e  a b o v e  d e n s i t ie s  a n d  f e d  w ith  D M E M  c o n ta in in g  2 %  f e ta l  c a l f  s e r u m  a n d  
1 0 0  p M  a s c o r b a te - 2 - p h o s p h a te .  T h e y  w e re  a l lo w e d  to  s e t t le  f o r  2 4  h o u r s  a n d  th e n  w e re  
e x p o s e d  to  10 n M  c a lc i t r io l  (D )  fo r  2 4  h o u rs .  R N A  w a s  h a r v e s te d  a n d  w a s  a n a ly s e d  b y  R T - 
P C R  a n d  S o u th e r n  b lo t t in g  f o r  M S X - 2  (4 0  c y c le s ) ,  o s te o c a lc in  ( 3 0  c y c le s ) ,  B M P - 2  (3 5  
c y c le s ) ,  B M P - 4  ( 4 0  c y c le s )  a n d  G A P D H ( 3 0  c y c le s ) .  T h is  f ig u re  is r e p r e s e n ta t iv e  o f  tw o  
in d e p e n d e n t  e x p e r im e n ts .  D e n s i to m e r ic  v a lu e s  r e la t iv e  to  u n tr e a te d  c e l ls  a t e a c h  d e n s i ty  a re
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Table 4.3 The effect of cell density on the response of human bone-derived 
cells to treatment with calcitriol 
First passage trabecular bone-derived cells maintained in DMEM supplemented 
with 10% fetal calf serum and 100 pM ascorbate-2-phosphate were plated at the 
above densities and allowed to settle for 24 hours before medium was replaced 
with DMEM containing 2% fetal calf serum and ascorbate. Cells were then 
treated with 10 nM calcitriol for a further 24 hours. RNA was extracted and 
analysed by RT-PCR and Southern blotting for expression o f M SX-2, 
osteocalcin, BMP-2, BMP-4 and GAPDH.
Table A summarises the relative calcitriol-induced expression levels o f the 
genes o f interest at the different cell densities as compared to untreated cells 
plated at the same density. For completeness, table B shows the relative 
expression levels of the genes o f interest at the different cell densities and 
following treatment with or without calcitriol as compared to untreated cells 
plated at the lower density.
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range 1-3.7, table 4.4) and osteocalcin (average 9.2, range 1-19). It seemed appropriate 
to examine the effects o f bone morphogenetic proteins on the expression o f these 
osteoblast-related genes to determine a sequence or cascade o f gene expression in these 
cells. Confluent first passage human trabecular bone-derived cells, maintained in 
DMEM supplemented with 10% fetal calf serum and 100 |lM  ascorbate-2-phosphate, 
were plated at 104 cells/ cm2 and cultured in DMEM containing 2% fetal calf serum and 
100 |iM  ascorbate for 24 hours prior to the addition of growth factors. The cells were 
then exposed to increasing doses o f BMP-2 (5- 200 ng/ ml), BMP-4 (5- 150 ng/ ml), 
BMP-6 (10- 150 ng/ ml) and BMP-7 (10- 100 ng/ ml) for 24 hours. RNA was extracted 
and analysed for the expression of MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH 
mRNA transcripts by RT-PCR (see figure 4.6a) and Southern blotting ( fe e  figure 4.6b). 
Densitometric analysis was performed upon the Southern blots. Where two values were 
obtained at the same dose, for example, untreated control and 20 ng/ ml BMP-2 (see 
figures 4.6a and 4.6b); an average of the two values is shown (table 4.5).
The effect o f the bone morphogenetic proteins on MSX-2 transcript levels was 
clearly potent, with the greatest magnitude o f increase in mRNA expression elicited by 
BM P-2, then BM P-4, BMP-6 and BMP-7. Osteocalcin mRNA levels were also 
increased following treatment with any o f the BMPs tested, with BMP-2 treatment 
producing the greatest increase, followed by BMP-7, BMP-6 and BMP-4.
Clear, potent auto-regulation o f BMP-2 transcript expression was observed. 
Expression o f BMP-2 was increased following treatment with any o f the BMPs tested, 
although to a lesser extent following treatment with BMP-6 and BMP-7.
Autoregulation was also observed for BMP-4, with greatest response at the 
lowest dose (5 ng/ ml) and a reduction of the magnitude of stimulation with increased 
dose (20- 150 ng/ ml) to steady state levels. BMP-2 treatment produced a very strong 
increase in levels o f BMP-4 mRNA transcripts.
Statistical analysis o f the results of these experiments can be seen in Appendix 
3, null hypotheses 14 and 15.
4.7 The effects o f calcitriol and meipbers o f the TGF-beta superfamily, alone and 
when added in combination, on the expression o f osteoblast-related genes in human 
trabecular bone-derived cells
The coincident expression o f several BMPs in mouse and chick development 
suggests the possibility o f  interactive effects or o f heterodimer formation between 
BMPs (Lyons et al, 1995; Barlow and Francis-West, 1997). Such combinations o f 
BMPs or heterodimers may have more pronounced effects than their homodimers. 
Therefore, following on from the previous experiment where cells were exposed to 
individual BM Ps, these experiments examine the effects on the expression o f  
osteoblast-related genes o f exposure to combinations o f BMPs, the related agent 
transforming growth factor-beta-1 (TGF-beta) and calcitriol.
114
Factor______________ None______ 10 -8 M calcitriol
mRNA
MSX-2 1 2.2 (1-3.7)
osteocalcin 1 9.2(1-19)
BMP-2 1 1.7 (0.5-3.5)
BMP-4 1 1.8 (0.8-3.1)
Table 4.4 The effects of calcitriol on osteoblast-related gene expression in human 
bone-derived cells
First passage trabecular bone-derived cells maintained in DMEM supplemented 
with 10% fetal calf serum and 100 pM ascorbate-2-phosphate were cultured in 
DMEM containing 2% fetal calf serum and 100 pM ascorbate for 24 hours prior to 
the addition of 10 nM calcitriol. After 24 hours, RNA was extracted and analysed by 
RT-PCR and Southern blot for MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH 
mRNA expression. Densitometric analysis was performed on the gels or blots as 
appropriate. The table above summarises the results o f five independent 
experiments and shows median values (range shown in parentheses).
Gels ng/ml BMP-2 ng/ml BMP-4 ng/ml BMP-6 ng/ml BMP-7 
0 0. 5 10 20 20 50 200 5 20 50 10015Q 10 20 50 75 150 10 20 50 100 + M
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F ig u re  4 .6 a  T h e  e f f e c ts  o f  b o n e  m o r p h o g e n e t ic  p r o te in s  o n  o s te o b la s t- r e la te d  g e n e  e x p r e s s io n  in  h u m a n  b o n e - d e r iv e d  c e lls  
C o n f lu e n t  f i r s t  p a s s a g e  t r a b e c u la r  b o n e - d e r iv e d  c e l ls  c u l tu r e d  in  D M E M  s u p p le m e n te d  w ith  1 0 %  fe ta l  c a l f  s e ru m  a n d  1 0 0  j iM  a s c o rb a te -  
2 -p h o s p h a te  w e re  fe d  w ith  D M E M  c o n ta in in g  2 %  fe ta l c a l f  s e ru m  a n d  100  (i.M a s c o r b a te - 2 - p h o s p h a te  2 4  h o u r s  p r io r  to  t r e a tm e n t  w ith  th e  
a g e n ts .  F o l lo w in g  2 4  h o u r s ’ e x p o s u re  to  th e  a g e n ts ,  R N A  w a s  h a r v e s te d  a n d  a n a ly s e d  b y  R T - P C R  f o r  M S X - 2  (3 5  c y c le s ) ,  o s te o c a lc in  (3 0  
c y c le s ) ,  B M P - 2  (3 5  c y c le s ) ,  B M P - 4  (3 5  c y c le s )  a n d  G A P D H  (3 0  c y c le s ) ,  a n d  S o u th e r n  b lo t t in g .  T h e  f ig u re  a b o v e  i l lu s tr a te s  th e  e th id iu m  
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F ig u re  4 .6 b  T h e  e f f e c ts  o f  b o n e  m o r p h o g e n e t ic  p r o te in s  o n  o s te o b la s t- r e la te d  g e n e  e x p r e s s io n  in  h u m a n  b o n e - d e r iv e d  c e lls  
T h is  f ig u re  i l lu s t r a te s  th e  S o u th e rn  b lo ts  o f  th e  g e ls  s e e n  in  f ig u re  4 .6 a . A v e ra g e  d e n s i to m e tr ic  v a lu e s  f ro m  tw o  in d e p e n d e n t  e x p e r im e n ts  a re  u n d e r  e a c h  b lo t. 
E ffe c ts  o f  B M P - 2  o n  o s te o c a lc in ,  B M P - 2  a n d  B M P - 4  t r a n s c r ip t  e x p re s s io n ,  a n d  o f  B M P -7  o n  th a t  o f  o s te o c a lc in  a n d  B M P -2  w e re  s e e n  to  b e  s ig n i f ic a n t .
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Dose (ng/ml)
0 5 in ?n sn 75 inn 15n ?nn
mRNA Factor
BM P-2 1 6.4 23 43 12 nd 1.5 (0 .8 -2 .2 )- nd 2.5
M SX-2 BM P-4 1 9.8 nd 22 28 nd 22 7 nd
BM P-6 1 nd 4.1 3.4 3.8 18 nd 27 nd
BM P-7 1 nd 0.8 8.7 16 nd 2.4 (0.5-5.3)* nd nd
BM P-2 1 3.4 7.4 5.1 4.3 nd 1 4 (1 2 .8 -1 5 )- nd 1.8
osteocalcin BM P-4 1 1.9 nd 3.2 4 nd 1.1 4.1 nd
BM P-6 1 nd 0.3 4.9 4.7 3.5 nd 2.2 nd
BM P-7 1 nd 3 4.8 1.3 nd 14(4 .1-21)* nd nd
BM P-2 1 6 14 15 12 nd 4.0 (3.5-4.6)~ nd 11
BM P-2 BM P-4 1 6.8 nd 8.9 8.3 nd 11 8.9 nd
BM P-6 1 nd 7 4.8 4.9 7.4 nd 13 nd
BM P-7 ,1 nd 1.6 7.1 11 nd 2 .7 (1 .6 -4 .1 )* nd nd
BM P-2 1 12 14 20 11 nd 7 (6 .9 -8 )- nd 0.1
BM P-4 BM P-4 1 6.2 nd 2.6 1.7 nd 2.5 1.2 nd
BM P-6 1 nd 1.2 1.6 1.5 1.7 nd 1.6 nd
BM P-7 1 nd 1 1.9 4.8 nd 1 (0.4-2)* nd nd
Table 4.5 The effects of bone morphogenetic proteins on the expression of osteoblast-related genes in human bone-derived cells 
Confluent first passage trabecular bone-derived cells maintained in DMEM supplemented with 10% fetal calf serum and 100 |iM asscorbate-2- 
phosphate were cultured for 24 hours in DMEM containing 2% fetal calf serum and ascorbate prior to the jE^ xposur£ for 24 hours to bone 
morphogenetic proteins. RNA was analysed by RT-PCR and Southern blotting for MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH transcripts. 
Densitometric analysis was performed to gauge changes in the levels of mRNA transcripts following normalisation using GAPDH levels. 
-Average of two values obtained from independent experiments with the range of values shown in parentheses. *Average of three values 
obtained from independent experiments with the range of values shown in parentheses, nd, not done. 11,
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Confluent first passage trabecular bone-derived cells, maintained in DMEM  
supplemented with 10% fetal calf serum and 100 p.M ascorbate-2-phosphate, were 
cultured in DMEM containing 2% fetal calf serum and ascorbate for 24 hours prior to 
the addition o f growth factors and agents. The cells were exposed to the agents, alone 
and in combination, for 24 hours. The doses selected were: 10 nM calcitriol, 100 ng/ml 
BM P-2/BM P-7 and 50pg/ml TGF-beta. RNA was then extracted and analysed for 
expression o f mRNA transcripts o f MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH 
by RT-PCR and Southern blotting (figure 4.7). Densitometric analysis o f the blots for 
M SX-2, BMP-2 and BMP-4 was performed, but gels were used for Osteocalcin as the 
blots were over-exposed (see tables 4.6a and 4.6b).
When compared to untreated control, calcitriol alone stim ulate expression o f  
M SX-2 and osteocalcin transcripts, but did not affect the mRNA expression levels o f  
the other genes. BMP-2 upregulated its own expression and that o f BMP-4. BMP-7 
stimulated BMP-2, MSX-2 and osteocalcin levels and had no effect on the mRNA  
expression o f BMP-4. Treatment with TGF-beta alone elevated expression o f all four 
genes.
Treatment with TGF-beta superfamily members in combination with calcitriol 
produced markedly different results (table 4.6a). Effects o f BMP-2 in combination with 
calcitriol on the expression o f BMP-2 and BMP-4 mRNA were similar to those seen 
following treatment with BMP-2 alone, whereas in contrast, BMP-2 in combination 
with calcitriol elicited an increase in M SX-2 mRNA expression and had a supra- 
additive effect on osteocalcin transcript levels when compared to the effects o f either 
agent alone. BMP-7 in combination with calcitriol decreased levels o f  M SX-2 and 
BMP-4 transcripts, increased those of BMP-2 and had a supra-additive effect upon 
those o f osteocalcin when compared with the action o f either agent alone. Combining 
TGF-beta and calcitriol had no effect on BMP-2 transcript levels, and decreased those 
of BMP-4, when compared with TGF-beta alone. This combination produced a modest 
increase in M SX-2 and a supra-additive increase in osteocalcin mRNA expression 
levels when compared with the action of either agent alone.
The effects o f members o f the TGF-beta superfamily in combination were also 
examined (table 4.6b). BMP-2 and BMP-7 in combination decreased mRNA expression 
of BMP-2 and MSX-2 to levels below those seen following treatment with either agent 
alone. BMP-7 had an antagonistic effect on the stimulation by BMP-2 o f BMP-4 
transcript expression. In contrast, BMP-2 and BMP-7 stimulated osteocalcin transcript 
expression to levels similar to those seen following treatment with BMP-7 alone. 
BMP-2 and TGF-beta in combination reduced the expression o f BMP-2 and BMP-4 to 
levels lower than those seen following treatment with either agent alone. Addition o f  
TGF-beta and BMP-2 had no effect on the stimulation by TGF-beta alone on 
osteocalcin  transcript expression. This combination stimulated M SX-2 mRNA  
expression to levels greater than those seen following treatment with either agent alone.
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+ 3.7 (3.1-4.3)- 1.4 (0.9-1.8)- 3.3 (3-3.6)~
- 0.6 (0.5-0.8)- 4.1 (1-16.5)* 5.7 (0.5-11)-
+ 17 (0.7-34)- 13 (0.4-26)- 14 (0.7-29)-
- 4.1 (3.5-4.6)~ 2.7 (1.6-4.1)* 3.1 (2.4-3.8)~
+ 4.5 (4.1-4.9)- 3.2 (2.8-3.6)- 3.2 (2.7-3.7)-
- 7.5 (6.9-8)- 1 (0.7-2)* 4.9 (4.5-5.3)~










Table 4.6a The effects of calcitriol, alone or in combination with members o f the TGF-beta superfamily, on the expression of 
osteoblast-related genes in adult human bone-derived cells 
Confluent first passage trabecular bone derived cells maintained in DMEM supplemented with 10% fetal calf serum and 100 pM  
ascorbate-2-phosphate were cultured for 24 hours in DMEM containing 2% fetal calf serum and ascorbate. The cells were then exposed 
for 24 hours to the following concentrations o f agents: 10 nM calcitriol, 100 ng/ ml BMP-2 or B M P-7;lnd 50 pg/ ml TGF-beta. RNA 
was analysed by RT-PCR and Southern blotting for MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH transcripts. The table above 
summarises the densitometric analyses: -average of two values obtained from independent experiments with the range of values shown 
in parentheses; *median of three values obtained from independent experiments with the range o f values shown in parentheses. § 
indicates that the level of expression was below the limit of detection of the assay.
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MSX-2 1 1.5 (0.8-2.2)- 2.4 (0.5-5.3)* 2.8 (2.5-3.1)~ 1.2(1 .1-1 .2)- 3.4 (1.4-5.3)— 7.7 (5.9-9.5)-
osteocalcin o§ 0.6 (0.5-0.8)- 4.1 (1-16.5)* 5.7 (0.5-11)- 8.2 (0.5-16)- 6.3 (0.6-12)- 12 (2 -21)~
BMP-2 1 4.1 (3.5-4.6)~ 2.7(1.6-4.1)* 3.1 (2.4-3.8)- 1.8 (1.6-2)- 2.8 (2.7-3)- 4.4 (4.1-4.7)-
BMP-4 1 7.5 (6.9-8)~ 1 (0.7-2)* 4.9 (4.5-5.3)~ 6.5 (5.9-7.1)- 4.5 (4.1-4.9)- 1 (0.5-1.6)-
Table 4.6b The effects of members of the TGF-beta superfamily, alone or in combination, on the expression of osteoblast-related genes 
in adult human bone-derived celis 
Confluent first passage trabecular bone derived cells maintained in DMEM supplemented with 10% fetal calf serum and 100 pM  
ascorbate-2-phosphate were cultured for 24 hours in DMEM containing 2% fetal calf serum and ascorbate. The cells were then exposed 
for 24 hours to the following concentrations of agents: 100 ng/ ml BMP-2 or BMP-7 and 50 pg/ ml TGF-betarRNA was analysed by 
RT-PCR and Southern blottirig for MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH transcripts. The table above summarises the 
densitometric analyses: -average of two values obtained from independent experiments with the range of values shown in parentheses; * 
average of three values obtained from independent experiments with the range of values shown in parentheses; § indicates that the level 
of expression was below the detection limit of the assay.
1 2 2
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BMP-7 and TGF-beta in combination stimulated mRNA expression o f BMP-2 and 
osteocalcin when compared with the action of either agent alone. This combination had 
a supra-additive effect on the expression levels of MSX-2. In contrast, BMP-4 transcript 
expression was unaffected by this combination: BMP-7 antagonised the stimulatory 
effects of TGF-beta on the mRNA expression o f this gene.
Statistical analysis o f these results can be seen in Appendix 3, null hypotheses 
16-18, and 20.1-20.3.
4.8 The effects o f combinations o f calcitriol, fibroblastic gro\Vth factor-2 and 
members o f the TGF-beta superfamily on the expression of osteoblast-related genes in 
human bone-derived cells ,
The importance o f members o f the fibroblastic growth factor family in bone 
formation has been emphasised by the wide range o f osseous malformations, some o f 
which are lethal (see section 1.3), and which result from mutations in their receptors. 
Normally, FGF-2 is found in chondrocytes in the proliferating and upper hypertrophic 
regions o f the growth plate, with resting zone cells showing little or no staining for this 
factor, and in the zone o f Ranvier, which regulates latitudinal bone growth (Jingushi et 
al, 1995). Stimulation o f bone growth on the periosteal surfaces was seen after injection 
of basic FGF (FGF-2) into the subcutaneous tissues overlying the calvariae of normal 
mice (Dunstan et al, 1993).
In culture, the continuous presence o f FGF-2 is known to stimulate proliferation 
and inhibit the expression o f the differentiated osteoblastic phenotype (Canalis et al, 
1988; Locklin et al, 1995), although the pro-proliferative effects of FGF-2 were shown 
to be reversible (Oliver et al, 1990). Also, FGF-2 has been shown to interact positively 
with TGF-beta in chondrocyte culture, suggesting that these factors act through 
different pathways (O’Keefe et al, 1994). Therefore it seemed appropriate to examine 
the interactions of FGF-2 with calcitriol and members o f the TGF-beta superfamily on 
osteoblast-related gene expression in trabecular bone-derived cells.
Confluent first passage human trabecular bone-derived cells, maintained in 
DMEM supplemented with 10% fetal calf serum and 100 |iM  ascorbate-2-phosphate, 
were cultured for 24 hours in DMEM containing 2% fetal calf serum and ascorbate. The 
cells were then exposed to the following doses o f agents, alone or in combination, for 
24 hours: 2.5 ng/ ml FGF-2, 10 nM calcitriol, 100 ng/ ml BMP-2/BMP-7 and 50 pg/ ml 
TGF-beta. RNA was extracted and analysed for the expression of the mRNA transcripts 
of M SX-2, osteocalcin, BMP-2, BMP-4 and GAPDH by RT-PCR and Southern blotting 
(figure 4.8). For the effects o f BMP-2, BMP-7 and TGF-beta alone, see figure 4.7. 
Densitometric analysis o f the gels was performed (table 4.7).
When compared to untreated control, calcitriol enhanced mRNA transcript 
levels o f  M SX-2 only. Treatment with FGF-2 alone stimulated expression o f BMP-2 
and M SX-2 mRNA and modestly increased that o f BMP-4. FGF-2 and calcitriol in
Gels
C D F  B2 B7 Tb D D+ D+ D+
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F ig u re  4 .8 a  T h e  e f f e c ts  o f  c o m b in a t io n s  o f  c a lc i t r io l ,  f ib ro b la s t ic  g ro w th  f a c to r -2  a n d  m e m b e r s  o f  th e  T G F - b e ta  s u p e r fa m ily  
o n  th e  e x p r e s s io n  o f  o s te o b la s t - r e la te d  g e n e s  in  h u m a n  b o n e -d e r iv e d  c e lls  
C o n f lu e n t  f i r s t  p a s s a g e  t r a b e c u la r  b o n e - d e r iv e d  c e l ls  m a in ta in e d  in  D M E M  s u p p le m e n te d  w ith  1 0 %  fe ta l  c a l f  s e ru m  a n d  
100  j iM  a s c o r b a te -2 - p h o s p h a te  w e re  in c u b a te d  fo r  2 4  h o u r s  in  D M E M  c o n ta in in g  2 %  fe ta l c a l f  s e ru m  a n d  100  p M  a s c o r b a te -2 -  
p h o s p h a te .  C e l ls  w e re  th e n  e x p o s e d  f o r  2 4  h o u r s  to  a g e n ts ,  a lo n e  o r  in  c o m b in a t io n ,  a t th e  f o l lo w in g  f in a l c o n c e n tra t io n s :  10 n M  
c a lc i t r io l  (D ) , 2 .5  n g /m l f ib ro b la s t ic  g r o w th  f a c to r -2  (F ) , 100  n g /m l B M P -2  (B 2 )  o r  B M P -7  (B 7 ) ,  a n d  5 0  p g /m l T G F - b e ta  (T b ) . 
R N A  w a s  e x t r a c te d ,  a n d  R T - P C R  f o r  M S X - 2  (3 5  c y c le s ) ,  o s te o c a lc in  (3 5  c y c le s ) ,  B M P - 2  (3 5  c y c le s ) ,  B M P - 4  (3 5  c y c le s )  a n d  
G A P D H  (3 0  c y c le s ) ,  a n d  S o u th e r n  b lo t t in g  w a s  p e r f o r m e d .  D e n s i to m e t r y  w a s  p e r f o r m e d  o n  th e ^ e e l s  ( v a lu e s  b e lo w  g e ls ) .  
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F ig u re  4 .8 b  T h e  e f f e c ts  o f  c o m b in a t io n s  o f  c a lc i t r io l ,  f ib ro b la s t ic  g ro w th  f a c to r -2  a n d  m e m b e r s  o f  th e  T G F - b e ta  s u p e r f a m ily  
o n  th e  e x p r e s s io n  o f  o s te o b la s t - r e la te d  g e n e s  in  h u m a n  b o n e - d e r iv e d  c e l ls  
T h is  f ig u re  r e p r e s e n ts  th e  S o u th e rn  b lo ts  o f  th e  g e ls  s h o w n  in  f ig u re  4 .8 a .  T h is  e x p e r im e n t  w a s  c a r r ie d  o u t  o n c e .
Factor None calcitriol FGF-2 calcitriol+FGF-2 BMP-2 BMP-7 TGF-beta
mRNA calcitriol FGF-2
MSX-2 1 1.8 (1.8-1.9)- 2.8
osteocalcin 0§ 1.1 (1-1.2)— 0.9
BMP-2 1 1.1 (0.9-1.2)~ 3




- 1.5 ( 0 .8 - 2 .2 ) - 2 .4  (0 .5 -5 .3 )* 2 .8  ( 2 .5 - 3 .1)~
+ 2 .3 5 .4 2 .6
- 3 .7  ( 3 .1 - 4 .3 ) - . I v4 ( 0 .9 - 1 .8 ) - 3 .3  ( 3 - 3 .6 ) -
+ 2 .3 1.9 6 9
- 0 .6  ( 0 .5 - 0 .8 ) - 4 .1  (1 -1 6 .5 )* 5 .7  (0 .5 - 1 1 ) -
+ 0 1 0 .5
- 17 ( 0 .7 - 3 4 ) - 13 ( 0 .4 - 2 6 ) - 14 ( 0 .7 - 2 9 ) -
+ 1 0 .5 1
- 4 .1  (3 .5 -4 .6 )~ 2 .7 (1 .6 - 4 .1 ) * 3.1 (2 .4 -3 .8 )~
+ 2 .5 4 .4 2 .6
- 4 .5  ( 4 .1 - 4 .9 ) - 3 .2  (2 .8 -3 .6 )~ 3 .2  (2 .7 -3 .7 )~
+ 2 .6  . 2 .6 2 .6
- 7 .5  (6 .9 -8 )— 1 (0 .7 -2 )* 4 .9  (4 .5 -5 .3 )~
+ 0 .6 3 .4 4 .9
- 6 .9  (6 .5 -7 .3 )~ 0 .4  ( 0 .1 - 0 .7 ) - 1.7 ( 1 .5 - 1 .9 ) -
+ 1.2 0 2 .2
Table 4.7 The effects of FGF-2, alone or in combination with calcitriol and/ or members of the TGF-beta superfamily, on the expression of osteoblast-related 
genes in human bone-derived cells
Confluent first passage trabeculaf bone derived cells maintained in DMEM supplemented with 10% fetal calf seriim and 100 pM ascorbate-2-phosphate were 
cultured for 24 hours in DMEM containing 2% fetal calf serum and ascorbate. The cells were then exposed for 24 hours to the following concentrations of agents:
2.5 ng/ ml FGF-2, 10 nM calcitriol, 100 ng/ ml BMP-2 or BMP-7 and 50 pg/ ml TGF-beta. RNA was analysed by RT-PCR and Southern blotting for MSX-2, 
osteocalcin, BMP-2, BMP-4 and GAPDH transcripts. The table above summarises the densitometric analysis. -Average of two values obtained from independent 
experiments with the range of values in parentheses, *Average of three values obtained from independent experiments with the range of values shown in parentheses.
§ Band undetectable with this technique. 126
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combination decreased osteocalcin mRNA expression to levels below the detection 
limit o f  this assay. Calcitriol antagonised the stimulatory effects o f FGF-2 on the 
expression o f BMP-2 and BMP-4 transcripts. In contrast, this combination produced an 
additive increase in the levels of MSX-2 mRNA expression.
FGF-2 and BMP-2 in combination strongly decreased the expression o f  
osteocalcin and BMP-4 transcripts, and more modestly decreased levels o f BMP-2 
mRNA expression, when compared with the action o f either agent alone. BMP-2 
antagonised the stimulatory effects o f FGF-2 on MSX-2 mRNA expression. Addition o f  
calcitriol to this combination had no effect on the expression o f M SX-2 and BMP-2 
transcripts, stimulated the expression o f BMP-4 transcripts to levels similar to those 
seen with calcitriol alone, and resulted in osteocalcin transcript level^fsimjlar to those 
seen following treatment with FGF-2 or calcitriol alone.
BM P-7 and FGF-2 in combination produced an additive increase in the 
expression o f M SX-2 transcripts, and also increased BMP-2 and BM P-4 mRNA  
expression to levels greater than those seen following treatment with either agent alone, 
but resulted in levels o f osteocalcin transcript similar to those seen following treatment 
with FGF-2 alone. Addition o f calcitriol to the combination ablated expression o f BMP- 
4 transcripts and reduced those o f MSX-2 to levels similar to those seen following  
treatment with calcitriol alone. Calcitriol antagonised the stimulatory effect o f FGF-2 
and BMP-7 in combination on the expression o f BMP-2 transcripts and reduced still 
further the levels o f osteocalcin transcript expression.
FGF-2 and TGF-beta in combination had no effect on M SX-2, BMP-2 and 
BM P-4 transcript levels when compared to the action o f TGF-beta alone. This 
combination produced a reduction in osteocalcin mRNA levels when compared to the 
effect o f either agent alone. Addition of calcitriol to the combination had a potent effect 
on the expression of MSX-2 mRNAs, with a dramatic increase in the levels of  
transcripts. Addition of calcitriol, FGF-2 and TGF-beta had no effect on the level of  
BM P-2 transcripts when compared to the action o f FGF-2 and TGF-beta in 
combination, whereas BMP-4 mRNA levels were decreased. Following combined 
treatment, osteocalcin transcript levels were similar to those seen after treatment with 
calcitriol alone.
Statistical analysis of these results can be seen in Appendix 3, null hypotheses 
19 and 21.
4.9 Effects o f cycloheximide and actinomycin D treatment on calcitriol-regulated 
osteoblast-related gene expression in human bone-derived cells
As stated earlier, and in the Introduction (section 1.7), the osteocalcin promoter 
contains a vitamin D response element (VDRE). This has been studied extensively and 
is considered as a model of vitamin D-regulated gene expression (reviewed by Pike et 
al, 1993). It was therefore considered to be appropriate to gain some understanding of
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F ig u re  4 .9  E f fe c ts  o f  c y c lo h e x im id e  a n d  a c t in o m y c in  D  tr e a tm e n t  o n  c a lc i t r io l - r e g u la te d  
o s te o b la s t - r e la te d  g e n e  e x p r e s s io n  in  h u m a n  b o n e - d e r iv e d  c e lls  
C o n f lu e n t  f i r s t  p a s s a g e  t r a b e c u la r  b o n e - d e r iv e d  c e l l s  m a in ta in e d  in D M E M  s u p p le m e n te d  
w ith  1 0 %  fe ta l  c a l f  s e r u m  a n d  1 0 0  p M  a s c o r b a te - 2 - p h o s p h a te  w e re  c u l tu r e d  in  D M E M  
c o n ta in in g  2 %  fe ta l c a l f  s e ru m  a n d  100  p M  a s c o r b a te  fo r  2 4  h o u r s  p r io r  to  th e  a d d i t io n  o f  th e  
a g e n ts  in  th e  f o l lo w in g  c o n c e n t r a t io n s :  u n t r e a te d  ( C ) ,  10 n M  c a lc i t r io l  (D ) ,  2 .5  p g /  m l 
c y c lo h e x im id e  (C y )  a n d  2 5 0  n g / m l a c t in o m y c in  D  (A ) . F o l lo w in g  e x p o s u re  to  th e  a g e n ts  fo r  
2 4  h o u r s ,  R N A  w a s  h a r v e s te d  a n d  R T - P C R  fo r  M S X - 2  (3 5  c y c le s ) ,  o s te o c a lc in  (3 0  c y c le s ) ,  
B M P -2  (3 5  c y c le s ) ,  B M P - 4  (3 5  c y c le s )  a n d  G A P D H  (3 0  c y c le s ) ,  a n d  S o u th e r n  b lo t t in g  w a s  
p e r f o r m e d .  D e n s i to m e t r y  w a s  p e r f o r m e d  o n  th e  b lo ts  ( v a lu e s  b e lo w  e a c h  b lo t ) .  T h is  
e x p e r im e n t  w a s  c a r r ie d  o u t o n c e .
C  C y  A  D  C y + D  A + D  +  - M
C  C y  A  D  C y + D  A + D
1 3.9 1.3 3.6 2.1 0.9
2.6 1.8 3.4 2.8 0.8
Factor none 2.5 mg/ ml 250 ng/ ml 10 nM calcitriol 2.5 mg/ ml cycloheximide 250 ng/ ml actinomycin D
cycloheximide actinomycin D + 1 0  nM calcitriol + 1 0  nM calcitriol
mRNA
MSX-2 1 3.9 1.3 3.6 2.1 0.9
osteocalcin 1 0.9 0.8 1.8 1.4 0.8
BMP-2 1 2.6- 1.8 3.4 2.8 0.8
BMP-4 1 2.8 0.1 5.1 8.7 0.2
Table 4.8 The effects of calcitriol, cycloheximide and actinomycin D on the expression o f osteoblast-related genes in human bone-derived 
cells
Confluent first passage trabecular bone-derived cells maintained in DMEM supplemented with 10% fetal calf serum and 100 jiM ascorbate-2- 
phosphate were cultured for 24 hpurs in DMEM containing 2% fetal calf serum and 100 |xM ascorbate. The cells were then exposed to the 
agents for 24 hours. RNA was extracted and analysed by RT-PCR and Southern blotting for mRNA transcripts o f MSX-2, osteocalcin, BMP-2, 
BMP-4 and GAPDH. The table above represents the values obtained following densitometric analysis of the gels or blots from one experiment.
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the regulation by calcitriol of the other genes of interest. Cycloheximide, an inhibitor of 
protein synthesis, and actinomycin D, an inhibitor o f transcription and thereby o f  
mRNA synthesis, were selected as agents for use in the examination of the direct or 
indirect regulation of expression o f the genes of interest by calcitriol.
Confluent first passage trabecular bone-derived cells, maintained in DMEM  
supplemented with 10% fetal calf serum and 100 fiM ascorbate-2-phosphate, were 
cultured for 24 hours in DMEM containing 2% fetal calf serum and ascorbate. The cells 
were then exposed to the following concentrations of agents for 24 hours: 2.5 pg/ ml 
cycloheximide, 250 ng/ ml actinomycin D and 10 nM calcitriol. RNA. was harvested 
and analysed for the mRNA expression o f MSX-2, osteocalcin, BMP-2, BMP-4 and 
GAPDH by RT-PCR and Southern blotting (see figure 4.9). DensitomStriG analysis of 
the blots was performed (table 4.8).
Cycloheximide treatment enhanced expression o f BMP-2, BMP-4 and MSX-2 
transcripts and had no effect on levels o f osteocalcin mRNA compared to untreated 
control. This suggests that in untreated cells, an inhibitory protein prevents the mRNA  
expression o f BMP-2, BMP-4 and MSX-2, but that no such inhibitor affects osteocalcin 
expression. Actinomycin D treatment abrogated expression o f BMP-4 and more 
modestly inhibited that of osteocalcin, suggesting that the half-lives of these transcripts 
is relatively short. When compared to untreated control, actinomycin D treatment 
fostered an increase in the transcript levels of BMP-2 and MSX-2, suggesting that the 
transcription o f an inhibitor or of a degrading molecule was blocked with this treatment. 
Calcitriol stimulated mRNA expression levels o f all four genes.
When compared to the effects o f calcitriol alone, the combination o f
cyclohexim ide and calcitriol resulted in a smaller magnitude o f increase in the
.>
expression o f BMP-2 and MSX-2, suggesting some level o f interference between the 
two agents. One possible explanation could be that the formation o f the vitamin D 
receptor complex, or its interaction with the basal transcription apparatus, is affected by 
the introduction o f cycloheximide, resulting in fewer transcripts than would be present 
following treatment with calcitriol alone. The production o f other accessory molecules 
could also be affected. The effect o f this combination on BMP-4 mRNA transcript 
levels was greater than that observed following treatment with cyclohexim ide or 
calcitriol alone, indicating that calcitriol induction of BMP-4 mRNA expression may be 
independent o f the regulation by an intermediate labile protein, and that the BMP-4 
promoter may contain a vitamin D response element (no evidence in literature). 
Cycloheximide and calcitriol together had a similar effect on osteocalcin mRNA levels 
to that seen following treatment with calcitriol alone, confirming that calcitriol-induced 
expression o f osteocalcin mRNA is direct.
Treatment with actinomycin D and calcitriol in combination resulted in a 
pronounced decrease in the levels o f mRNA transcripts for MSX-2 and BMP-2 when 
compared to the effects of either agent alone, suggesting that one function of calcitriol
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may be to increase the turnover o f these transcripts. Increased production and 
degradation o f transcripts in this instance would be observed only as increased 
degradation due to the absence of de novo transcription, as blocked by actinomycin D. 
Osteocalcin and BMP-4 mRNA levels are unchanged following treatment with 
actinomycin D and calcitriol when compared to treatment with actinomycin D alone, 




As stated previously, the limitations of the RT-PCR technique as employed in 
the course of this research are such that absolute quantitation is impossible. The 
emphasis of this discussion is therefore on the consistent changes in direction in the 
expression of transcripts of osteoblast-related genes observed using this technique, 
and not on changes in magnitude.
The sequence of gene expression in differentiating osteoblasts is more complex 
than that shown previously for osteoblast-like cells: factors such as cell density and 
interaction with the extracellular matrix appear to have a critical role in the regulation of 
osteoblastic gene expression.
As shown in this results chapter, cell density has a crucial part in the 
differentiation of trabecular bone-derived cells: compared with cells plated at the lower 
density, those plated at the higher density displayed a more differentiated phenotype, 
where BMP-2 expression was downregulated and osteocalcin expression was 
increased. Upon addition of calcitriol to the lower density cells, a similar pattern was 
observed. Treatment with calcitriol of cells at the higher density resulted in increased 
expression of these genes when compared to untreated control at the same density, to 
untreated control at the lower density or to treated cells at the lower density. This 
pattern is similar to that seen in MG-63 cells treated with high doses of calcitriol when 
compared to untreated cells and is suggestive of a strong drive towards differentiation. 
One possible explanation for this regulation is that cells will proliferate or differentiate 
according to intercellular communication. This may occur through an increase in the 
quantity o f signalling molecules accumulating in the medium with increasing cell 
number, or more directly through gap junctional communication between neighbouring 
cells as the population grows more dense. Indeed, in cultured differentiating murine 
mesenchymal cells, the expression of Msx-2 was seen to be dependent on the cell 
density as expression was induced only upon the cells reaching confluence (Nove et 
al, 1995). Therefore, as the trabecular bone-derived cells were harvested 48 hours 
after plating at 5x 103 cells/ cm2 and 104 cells/ cm2 and MSX-2 expression was 
essentially undetectable, it is possible that the expression of MSX-2 in these cells, and 
its induction by calcitriol, is dependent upon cell-cell communication.
Ascorbate-2-phosphate, a stable analogue of ascorbic acid, is required for the 
formation of a fully functional extracellular matrix by bone-derived cells cultured in 
vitro as it promotes post-translational modification of collagen (Franceschi and Iyer, 
1992). Culturing cells in the absence of ascorbate-2-phosphate would result in little or 
no functional extracellular matrix, possibly affecting the differentiation ability of the
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cells. Therefore, this would allow for the examination of the importance of cellimatiix 
interaction.
In these studies, it was shown that the responsiveness of cells to calcitriol was 
generally increased in the presence of an extracellular matrix. Basal and calcitriol- 
induced expression of MSX-2 was generally enhanced in the presence of an 
extracellular matrix: without ascorbate-2-phosphate, only a high dose of calcitriol 
could induce expression of this gene above steady state levels. Induction of osteocalcin 
expression by calcitriol is essentially unaffected by the absence or presence of 
extracellular matrix.
The induction of BMP-2 by calcitriol is dose-dependent in the absence of an 
extracellular matrix whereas with ascorbate-2-phosphate, BMP-2 expression is 
suppressed with calcitriol. This suggests that expression of this gene occurs in 
proliferating cells and that it is decreased in cells with a more differentiated phenotype. 
This suggests that induction of BMP-2, then its downregulation, may be a first stage 
in the progression from proliferation to commitment.
When comparing the effects of increasing doses of calcitriol in cells cultured in 
the absence or presence of an extracellular matrix, interesting patterns emerge. The 
biphasic effects of calcitriol on osteoblast-related gene expression in the presence of an 
extracellular matrix suggests that the extracellular matrix potentiates the induction by 
calcitriol o f expression of genes which are thought to act earlier in the differentiation 
pathway, that is, BMP-2, BMP-4 and MSX-2, while having little effect on the 
induction of osteocalcin expression. This indicates that the extracellular matrix allows 
induction by calcitriol of some progress towards differentiation but has little effect on 
the terminal differentiation of these cells. In contrast, BMP-7-induced expression of 
osteocalcin is clearly enhanced in the presence of an extracellular matrix as compared 
to that seen in cells treated with the same doses of the agent in the absence of 
ascorbate-2-phosphate. Taken together, these results suggest that celkmatrix 
communication is agent-dependent and therefore will affect the pattern of gene 
expression and the progression through differentiation accordingly.
The temporal pattern of gene expression was investigated in cells cultured in 
the presence of ascorbate-2-phosphate and treated with 10 nM calcitriol over a period 
of 24 hours. The gene expression pattern in untreated cells at time= 30 minutes was 
used as control as the time= zero timepoint was lost. The results are difficult to 
interpret due to the replacement of medium which was coincident with treatment of the 
cells with calcitriol. Endogenous calcitriol may be present in the serum contained in the 
fresh medium and could have affected the outcome of the experiment. As noted in the 
results chapter, calcitriol treatment after 24 hours was seen to have little effect on the 
steady state levels of BMP-2, BMP-4 and osteocalcin and to stimulate MSX-2 levels. 
MSX-2 expression was marginally stimulated with calcitriol treatment initially and this
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modest increase was steadily maintained throughout the course of the experiment to 
result in an overall rise in MSX-2 expression when compared with untreated cells at 
the start or at the endpoint of the experiment. The fresh serum may have maximally 
increased osteocalcin mRNA expression such that addition of exogenous calcitirol 
would have no further effect upon its expression. For this reason, all other 
experiments reviewed in this chapter were performed following replacement of 
medium, supplemented with 2%  fetal calf serum, 24 hours prior to treatment with 
exogenous factors.
The effects of members of the TGF-beta superfamily on gene expression in 
trabecular bone-derived cells cultured in ascorbate-2-phosphate were examined. The 
inducibility of BMP-2 mRNA expression by TGF-beta and by all four of the BMPs 
tested suggests that it is expressed last. The inhibitory effects of BMP-2 on BMP-4 
expression observed in MG-63 cells were also apparent here, but at a dose four times 
greater than in MG-63 cells: in trabecular bone-derived cells, only the maximal dose of 
BMP-2 ablated BMP-4 expression. BMP-4 simulates BMP-2 expression, and 
enhances its own. Therefore, at doses of 100 ng/ ml or less there is positive regulation 
of BMP-4 mRNA expression by BMP-2. It would appear that different doses of 
BMPs are required to exact the same effects on their gene expression in osteoblastic 
cells as in MG-63 cells.
MSX-2 expression was enhanced by any dose of BMP-2, BMP-4 or BMP-6. 
BMP-7 treatment had a dose-dependent trend in increasing MSX-2 expression but 
several doses resulted in diminished MSX-2 mRNA levels. With BMP-6 treatment, 
levels of MSX-2 mRNA were increased dose-dependently. The inductive properties of 
BMP-6 are in keeping with the finding that BMP-6 affects earlier stage osteoprogenitor 
cells than either BMP-4 or BMP-2 (Hughes et al, 1995).
Treatment with BMP-4 or BMP-7 results in similar patterns of osteocalcin gene 
expression: essentially a dose-dependent increase is seen following treatment with 
either agent, with several doses exhibiting a less stimulatory effect. At doses of 5-100 
ng/ml, BMP-7 has similar effects on BMP-4 expression as the same doses of BMP-4 
have on osteocalcin expression. Taken together, this could indicate that BMP-7 action 
on BMP-4 expression may have a knock-on effect on osteocalcin expression. BMP-2 
treatment induces osteocalcin expression at all doses. Treatment with BMP-6 
stimulates osteocalcin maximally at low doses but the magnitude of this increase is 
reduced with increasing dose. This supports an implied role for BMP-6 in 
chondrogenic differentiation, where a transient increase and subsequent 
downregulation induces terminal differentiation in the absence of an osteogenic 
stimulus (Carey and Liu, 1995). At the dose tested, TGF-beta exerted the same 
stimulation in the expression of all four genes tested in osteoblastic cells as in MG-63 
cells.
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These data indicate a complex pattern of regulation of gene expression in 
trabecular bone-derived cells. While there are many similarities in the ability of agents 
to modulate the levels of osteoblast-related transcript expression, the relative potency 
of these factors differs from that seen in MG-63 osteosarcoma cells. In this cell line, it 
was seen that of the TGF-beta superfamily members, BMP-7 was the most potent of 
the factors tested, maximally increasing the expression of MSX-2, osteocalcin, BMP-2 
and BMP-4 transcripts, whereas in trabecular bone-derived cells the most potent agent, 
also upregulating the mRNA expression levels of all four of the genes examined, was 
BMP-2.
MSX-2 osteocalcinBMP-6 BMP-2 BMP-4
A possible model for the cascade of osteoblast-related gene expression in human trabecular bone-derived cells
Overall, in MG-63 cells the increasing order of potency of factors in 
stimulating mRNA expression levels was BMP-2, TGF-beta and BMP-7. This order 
differs in trabecular bone-derived cells: in increasing order of potency, TGF-beta, 
BMP-7 and BMP-2 increase transcription of osteoblast-related genes. This may be due 
to the heterogeneity of the population of trabecular bone-derived cells: in each culture 
flask, cells which represent different stages in the differentiation pathway may be 
present, and the expression of transcripts within these cells may be modulated in a 
stage-specific, maturation-dependent manner, for example, in bone-derived cell 
populations, osteocalcin is expressed by the mature osteoblast phenotype only. It is 
therefore reasonable to suggest that the effects of bone-related factors may also be 
specific to the stage of differentiation of the cell. In relation to the cascade of 
osteoblast-related gene expression in the relatively undifferentiated MG-63 cell line, it 
can be inferred that the majority of cells in the trabecular bone-derived cultures are 
already partially differentiated and are at a stage when introduction of BMP-2 has the 
strongest effect. Another possibility is that the presence of the extracellular matrix, 
upon which factors may be sequestered, may have increased the local concentration of 
agents and elicited a different genetic response from that seen in the MG-63 cells, 
which secrete no matrix.
The concept of interactions between agents affecting the expression patterns of 
osteoblastic genes was examined in MG-63 cells in the first results chapter. This was 
investigated in trabecular bone-derived cells cultured in the presence of ascorbate-2-
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phosphate, and the effects of fibroblastic growth factor-2 (FGF-2) alone or in 
combination were also observed. BMP-2 and MSX-2 expression was increased 
following treatment of the cells with any agent, alone or in combination. When 
compared to control, osteocalcin expression was shown to be augmented following 
treatment with members of the TGF-beta family in combination with each other or with 
calcitriol; in contrast, FGF-2, alone or in any combination with the other agents tested, 
either did not affect steady state levels of osteocalcin transcript expression, or 
decreased them. This strongly suggests that FGF-2 prevents the terminal 
differentiation of osteogenic cells. BMP-4 expression was most interestingly 
moderated by agents when added alone: calcitriol, BMP-2 and TGF-beta stimulated 
expression, and mRNA levels were unaffected following treatment with BMP-7 or 
FGF-2. FGF-2 or BMP-7 therefore maintain the basal expression of BMP-4 mRNA 
and perhaps mainly promote proliferation in cells at this early progenitor stage, 
whereas the other agents promote osteogenic differentiation. Of the combinations, 
BMP-7 plus TGF-beta had no effect, as perhaps the block on upregulation by BMP-7 
prevented the stimulatory effects of TGF-beta. BMP-7 plus calcitriol plus or minus 
FGF-2, attenuated BMP-4 mRNA levels but strongly augmented those of osteocalcin 
which suggests that these combinations are markedly osteogenic.
The effects o f these interactions are obviously complex, and of these only 
BMP-2 and FGF-2 or of FGF-2, calcitriol and BMP-7 in combination attenuates 
expression o f BMP-4 and osteocalcin at the same time. This suggests that these 
particular combinations suppress the differentiation of the cells and may in fact 
encourage proliferation. However, the proliferation of these cells treated or untreated 
was not tested.
The interaction of calcitriol and FGF-2 stimulated expression of BMP-2, BMP- 
4 and M SX-2 and blocked terminal differentiation. This observation is of interest as 
the action of either agent alone had no effect on osteocalcin expression, and no effect 
on M SX-2 or BMP-4 mRNA expression respectively. A possible explanation is that 
this combination may have impeded the progress of differentiation and, with a longer 
treatment and an examination of the kinetics of the temporal pattern of expression 
following this combined treatment, this may have become apparent.
To investigate the mechanisms of regulation of gene expression in trabecular 
bone-derived cells, secondary passaged cells cultured in the presence of ascorbate-2- 
phosphate were treated with cycloheximide, actinomycin D and calcitriol, alone or in 
combination. The stimulation of the mRNA expression of all four genes of interest by 
calcitriol was noted. The enhancement of the expression levels of BMP-2, BMP-4 and 
M SX-2 following treatment with cycloheximide and calcitriol indicates that the 
regulation of their expression involves (an) intermediate labile protein(s). Osteocalcin
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expression is essentially unaffected by cycloheximide treatment, supporting the direct 
regulation of the expression of this gene by calcitriol.
The recent finding that BMP-4 transcript expression is regulated by E-box 
proteins (Ebara et al, 1997) suggests a mechanism of regulation of BMP-4, BMP-2 
and MSX-2 transcript expression. Inhibitor of DNA binding/differentiation (Id) 
proteins are helix-loop-helix transcription factors (HLH TFs) lacking the basic DNA 
binding domain. The HLH protein-protein binding domain is retained, allowing 
heterodimerisation with basic HLH TFs which prevents their binding to DNA, thus 
negatively regulating transcription (Simonson et al, 1993). Targets of Id binding 
include E-box proteins (Kreider et al, 1992), homeodomain-containing transcription 
factors which bind to the E-box motif CANNTG and activate transcription (Jen et al, 
1992). In the 1 kb fragment immediately 5’ to the coding sequence of the Msx-2 gene 
(see figure 4.10), five such motifs exist. Also noted is the absence of a vitamin D  
response element. Calcitropic agents have been shown to modulate Id expression: 
calcitriol dose-dependently suppressed its expression (Kawaguchi et al, 1992). To be 
noted was that cycloheximide had no effect on the vitamin D inhibition of Id 
transcription, indicating that the effect of vitamin D on Id expression is a direct one 
(Ogata et al, 1993). Therefore it is possible that MSX-2 and BMP-4 mRNA 
expression is regulated by E-box proteins and, by conjecture, subject to modulation by 
Id proteins.
Treatment with actinomycin D downregulated transcript levels of BMP-4, had 
little effect on those of MSX-2 and osteocalcin, but increased those of BMP-2. This 
suggests that transcripts for BMP-4 have a high turnover rate and are therefore more 
unstable than those for the other genes examined. Also, as outlined previously, 
reduced levels of BMP-4 stimulate BMP-2 mRNA expression, possibly accounting for 
the increase in BMP-2 levels. It is possible that a longer exposure to a higher dose of 
actinomycin D would have resulted in a downregulation of the mRNA levels of the 
other genes of interest, however interpretation is complex in the absence of 
measurement of the half-lives of these mRNAs.
The conclusions of this chapter are that the regulation of osteoblast-related gene 
expression in osteoblastic cells is complex and has a pattern of expression closely 
resembling that seen in MG-63 osteosarcoma cells. In the case of trabecular bone- 
derived cells, BMP-2 is the most potent regulator of osteoblast-related gene 
expression. However, within the limitations of the examination of the effects of these 
agents on the expression of the genes tested, MG-63 cells were an adequate model of 
adult human osteoblastic differentiation. Cell-cell and cell-matrix communication were 
seen to be critical factors in determining the genetic response of osteoblastic cells to the 
agents. Regulation of the expression of these osteoblast-related genes is intricate and 
may involve interactions between osteoinductive agents sequestered in or immobilised
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on bone. The calcitriol-induced upregulation of expression of the osteogenic commitment/ 
differentiation genes BMP-4, BMP-2 and MSX-2 may require an additional, as yet 
unidentified, labile intermediate protein.
This results chapter shows that there are differences in the pattern of gene expression 
in osteoblasts, which exhibited some variation from one experiment to another. These 
differences and variations could be explained by the differences between donors, such as 
age, gender and site of extraction (see Appendix 2), or by the heterogeneity of cell 
populations within flasks, such that in any flask, there may be cells at different stages of 
maturation with different patterns of gene expression. Therefore, it would be of considerable 
interest to define these subsets of cells in such a way that gene expression patterns could be 
examined within each subpopulation separately.
-1233 gga tcctgatagg tatgctgctt aaaatttcaa agtCAGGTGa gatgagcttt ccccaaagat attcaggctt 
-1160 tgggtttgca aagtcgaacc ctgttatttg cagagagaat aaaggcacta aatgtcacaa atacccttct 
-1090 cccctgccca tcacctccca agaCAGATGc tatgctgaCA CCTGaactcc aatgacaaac 
-1030 acaaactcaa aacaaacaaa caaacaaaca aaaaacctca tgagcacact tttgcacggg cctagagagg
- 960 agactcaagg ggtgagaaat atcccgattg acagtttcta aaacttgtcc tgtttggaca gtgtatgaaa
- 890 tggagatCAT TTGagtaaat tagctgccag aaccaatggg ggctgggtct gctggtgcac acctacagtc
- 820 tgaacaccag ggacgaagcc agtggggtag caagttcagg accatcttgg gtaatatagt gagcgacttc
- 750 taagctagcc agagctggag agcaagagtc tgttttaaag gaaaaaaaaa aagggagaaa gggtagagtt
- 680 agttgaatat cccttggcca cctctcagcc tttctcatct ttgtcccttt tcttaaggaa tgagttacag ctaatgtctt
- 600 ggaacactct ccaaagataa gacaactaag gaccatgcct aaactatttc tattagtaaa gatgctgcta
- 530 ctgttttcca ttatagtaca aagatacact agtttgagct catagtggga gctttataaa tgttccatgc
- 460 cctccgcaga tttccaacat tctcaggcgg gagcgtgtgg gatcggcacc agaaacactt taaagagggg
- 390 ttaaaagaca agaaatgaga ctcaacaagc ttcctcttta aacaatcggc tttaattacg ccttagactt
- 320 ttg/cagtttgg gcgattataa cccttgaggg atcgcctaat aacaactctg ctgactgctc ctgtaattaa
- 250 ctcctaattt atttcaaacg gggcggggga agggccccaa gcctctccag ggagagccaa tcggtggcga
- 180 gcgtccgtgg cgtcaggagc agggccgtcg cCAGTTGgtt gagccgagtc tcccacttcc
- 120 cctcggagga gaggctgggc tcccagcgcg cccctgccgg ctcccccccc aaaagttgga gtcttcgctt
- 50 gagagttgcc agcggagtcg cgcgccgaca gctacgcggc gcagaaagtc
Figure 4.10 The 5’ flanking sequence of the mouse msx-2 gene
The sequence above is the 1.2kb fragment immediately upstream of the coding 
sequence for the murine msx-2 gene. Indicated in bold type are the putative binding sites for 
E-box binding proteins.
Chapter 5
Effects of calcitriol and dexamethasone on the expression of osteoblast- 




Glucocorticoid treatment is associated with decreased bone mass and a change in 
cell activity. Continued exposure to glucocorticoids can result in osteoporosis through 
stimulation of bone resorption and reduction o f bone formation (Cosman et al, 1994). 
Effects o f glucocorticoids on osteoblasts include suppressed replication o f preosteoblasts 
and attenuation o f type I collagen, osteocalcin expression and tissue inhibitor o f  
metalloproteinases (TIMPs) (Doherty et al, 1995), although as osteoblastic differentiation 
is galvanised (reviewed by Delany et al, 1994) and mineralisation and bone nodule 
formation is stimulated by treatment of osteoblastic cell cultures withMexamethasone (Iba 
et al, 1995; Ishida et al, 1995), these effects must depend on the stage o f maturation o f the 
cell. Interaction o f osteoblasts with their extracellular matrix is limiteCby, glucocorticoid 
treatment: decreased ppintegrin levels as a consequence o f glucocorticoid treatment 
caused inhibition of attachment of osteoblasts to their extracellular matrix as this integrin is 
necessary for the binding o f fibronectin and collagen (Gronowicz and McCarthy, 1995): 
fibronectin synthesis and secretion is also abrogated in cells treated with dexamethasone 
(Gronowicz et al, 1991). The premature detachment of osteoblasts from their extracellular 
matrix has clearly important implications for the development o f osteoporosis.
As described previously, clonogenic progenitor cells (colony forming unit- 
fibroblastic cells (CFU-F)), which are associated with the marrow stroma, give rise to 
osteoblasts when treated with a differentiation stimulus (see Introduction, section 1.4). In 
the culture of adult human bone marrow cells, a high proportion o f CFU-F can be induced 
to become osteoblastic following continuous treatment in the presence o f a physiological 
dose o f glucocorticoid, for example 10 nM dexamethasone (dex) (Cheng et al, 1994). 
Therefore, these cells, cultured in the presence or absence o f dex and other factors, can be 
used in an attempt to investigate more fully the differentiation stage-specific expression of 
osteoblast-related genes.
Variations in the induction o f gene expression by growth factors observed in 
trabecular bone-derived cells seen in the previous chapter may be due to differences in 
donor age, sites o f extraction or due to the presence o f cells at different stages of 
differentiation within the cultured cell pppulations. There is good evidence (Stewart et al, 
1996) to suggest that expression o f the Stro-1 and alkaline phosphatase cell surface 
antigens may reflect the maturity of the osteoblast. The expression o f Stro-1 occurs earlier 
than, but later overlaps with, that o f alkaline phosphatase, with expression o f both markers 
being downregulated in sequence. This results in a progression from the double negative 
state (Stro-1 negative, alkaline phosphatase negative) to Stro-1 positivity (multipotent 
precursor), to double positivity (committed osteoprogenitor), to alkaline phosphatase 
positivity alone (mature osteoblast), to a double negative state again. The double negative 
subpopulation is the least well defined in that it may contain Stro-1 negative, alkaline 
phosphatase negative precursors, which can acquire positivity for both these antigens, as 
well as late stage cells o f the osteoblast lineage, such as osteocytes and lining cells, which
139
have downregulated expression of these antigens. Nevertheless, when used in conjunction, 
the Stro-1 and alkaline phosphatase cell surface antigens can be used to “stage” the early 
differentiation o f adult human cells o f the osteoblast lineage. It therefore seemed 
reasonable to examine the expression o f osteoblastic genes within these separate 
subpopulations of trabecular bone- and bone marrow-derived cells and to investigate the 
effects o f calcitriol on gene expression within these fractions.
In the following chapter, the subpopulations are denoted thus:
■ a
R2: Stro-1 antibody negative (Stro-1 -ve), alkaline phosphatase antibody negative (AP-ve); 
R3: Stro-1 antibody positive (Stro-1 +ve), alkaline phosphatase antibod^negative (AP-ve); 
R4: Stro-1 antibody positive (Stro-1 +ve), alkaline phosphatase antibody positive (AP+ve); 
R5: Stro-1 antibody negative (Stro-1 -ve), alkaline phosphatase antibody positive (AP+ve).
As well as further investigating the results of calcitriol treatment, the effects o f the 
glucocorticoid, dexamethasone (dex), on osteoblast-related gene expression and on the 
distribution of cells between the four subpopulations was investigated.
Either the R3 or R4 subpopulation was used to establish a ratio in the course of 
these experiments as occasionally not all subpopulations were represented. Asp was 
present constantly in all cultures. All PCRs and Southern blots were repeated twice, with 
each experiment repeated up to four times.
5.1 The effects o f constant culture in dex on the morphology o f adult human bone 
marrow-derived cells
Figure 5.1 illustrates the effects o f dex on cell morphology (photograph 5B) as 
compared to cells cultured in the absence o f dex (photograph 5A): untreated cells tend to 
have an elongated appearance whereas those treated with dex are more polygonal in shape.
5.2 Sorting subpopulations of human bone marrow-derived cells according to their 
expression of the Stro-1 and alkaline phosphatase cell surface antigens
First passage bone marrow-derived cells were maintained in DMEM containing 
10% fetal calf serum and 100 |iM asp and in the absence or presence of 10 nM dex until 
confluent at which point they were cultured for 24 hours in DMEM supplemented with 2% 
fetal calf serum and 100 |iM asp, and in the absence or presence o f dex as appropriate. 
Cells were then exposed to 10 nM calcitriol for 24 hours. Following labelling for the cell 
surface expression o f Stro-1 and alkaline phosphatase, cells were separated by FACS and 
the fractions retrieved for analysis. If sufficient cells were collected, the purity of 
subpopulations was estimated by performing FACS analysis again: only those 
subpopulations o f at least 85% purity were analysed for mRNA transcript levels o f  MSX- 
2, osteocalcin, BMP-2, BMP-4 and GAPDH by RT-PCR and Southern blotting.
P h o to g ra p h  5 A  F irs t  p a s s a g e  h u m a n  b o n e  m a rro w -d e r iv e d  c e ll  c u l tu re d  in  th e  a b s e n c e  
o f  d e x a m e th a s o n e .  T h is  w a s  p h o to g ra p h e d  a t x 3 2 0  m a g n if ic a tio n .
. * I *
P h o to g ra p h  5B  F ir s t  p a s s a g e  h u m a n  b o n e  m a r ro w -d e r iv e d  ce ll c u l tu re d  in  the 
p r e s e n c e  o f  10 n M  d e x a m e th a s o n e .  T h is  w a s  p h o to g r a p h e d  a t x 3 2 0  m a g n if ic a tio n .
F ig u r e  5 .1  T h e  e f fe c ts  o f  c o n s ta n t  c u l tu re  in  d e x a m e th a s o n e  o n  th e  m o r p h o lo g y  o f  ad u lt 
h u m a n  b o n e  m a r ro w -d e r iv e d  c e lls
F ir s t  p a s s a g e  b o n e  m a rro w -d e r iv e d  c e lls  w e re  p la te d  a t a  d e n s i ty  o f  5 x  1 0 3 c e lls /  c m 2
a n d  w e re  m a in ta in e d  in  D M E M  su p p le m e n te d  w ith  10 %  fe ta l c a l f  s e ru m  a n d  100  |iM
a s c o rb a te -2 -p h o s p h a te  in  th e  a b s e n c e  (5 A ) o r  p re s e n c e  o f  10  n M  d e x a m e th a s o n e  (5 B ) .  
U n tre a te d  c e lls  d is p la y  a ty p ic a l e lo n g a te d  f ib ro b la s t ic  a p p e a ra n c e  w h e re a s  th o s e  m a in ta in e d  
in  th e  p re s e n c e  o f  d e x a m e th a s o n e  e x h ib it  a  m o re  tru n c a te d ,  p o ly g o n a l a p p e a ra n c e .
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The results of one experiment o f treatment with dex and calcitriol on the 
distribution o f cells within the four subpopulations separated according to their expression 
o f Stro-1 and AP are detailed in figures 5.2a- d. For each figure, there are five dot plots: 
one showing secondary labelling, labelling with Stro-1 or AP only, and labelling for both 
Stro-1 and AP, and finally a plot showing the gating for subpopulations, with R 2 in the 
lower left quadrant and moving clockwise to R5 (lower right quadrant). Table 5.1 shows 
the distribution o f cells treated with calcitriol and/  or dex between the four fractions o f four 
FACS-analysed experiments as compared with the distribution o f control cells.
Under the culture conditions used in these experiments, ta lcitrio l m odestly  
decreased the proportion o f cells present in the R2 and R3 regions and increased that in the 
R4 and R5 subpopulations. Continuous culture in the presence o f t|ex .more strongly 
reduced the proportion o f cells present in the R2 and R3 fractions and increased the 
proportion o f  cells present in the R4 and R5 fractions. The effects o f treatment o f  bone 
marrow-derived cells with calcitriol and dex in combination were essentially similar to 
those seen in cultures treated with dex alone
As well as examining the number o f cells expressing Stro-1 and/ or AP in the 
population o f cultured cells, it is possible to determine the level of expression o f these cell 
surface antigens by measuring their mean fluorescence intensity (MFI) in the FI-1 (AP) 
and FL-2 (Stro-1) channels (X geo mean and Y geo mean respectively). Data for the MFIs 
obtained from four independent experiments were pooled and summarised in table 5.2. 
When compared with control, the level o f expression o f the Stro-1 antigen was not affected 
following treatment with calcitriol. However, following treatment with dex alone or when 
added in combination with calcitriol, there was a tendency towards a reduction in Stro-1 
antigen expression in the Stro-1 positive subpopulations (R3 and R4 fractions). Treatment 
with calcitriol alone increased the level o f AP antigen in both the AP positive 
subpopulations (R4 and R5 fractions). The effects o f dex were similar, but o f greater 
magnitude. When added in combination with dex, calcitriol antagonised the stimulatory 
effects o f dex on the levels o f expression o f this enzyme.
5.3 The effects o f calcitriol and dex, alone or in combination, on the expression o f  
osteoblast-related genes in subpopulations o f bone marrow-derived cells -
First passage bone marrow-derived cells were maintained in DMEM supplemented 
with 10% fetal calf serum and 100 |iM  asp and in the absence or presence o f 10 nM dex 
until conftuency when the cells were cultured for 24 hours in DMEM containing 2% fetal 
calf serum and 100 pM asp and 10 nM dex as appropriate. The cells were then exposed to 
10 nM calcitriol for 24 hours. RNA was harvested and analysed for the mRNA expression 
of M SX-2, osteocalcin, BMP-2, BMP-4 and GAPDH by RT-PCR and Southern blotting 
(figures 5.3a and 5.3b). The PCRs and blots were carried out twice and average values 
following densitometric analysis were taken. This experiment was performed three times 
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Region Events % Gated X geo mean Y geo mean
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R2 2075 98.11 2.71 4.11
R3 2 0.09 53.52 22.47
R4 11 0.52 118.83 193.77
R5 27 1.28 15.60 94.53
Stro-1 only .
Gated Events: 6315
Region Events % Gated X geo mean Y geo mean
R2 5258 83.26 7.50 5 .1 Of
R3 909 14.39 124.35 9.28 ;
R4 85 1.35 156.66 121.70
R5 63 1.00 21.64 77.86
AP only
Gated Events: 5019
Region Events % Gated X geo mean Y geo mean
R2 4832 96.27 2.49 6.08
R3 1 0.02 59.89 3.65
R4 16 0.32 81.22 137.00
R5 170 3.39 3.91 107.57
Stro-1 and AP (dual labelling)
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 6710 67.10 9.23 7.41
R3 2464 24.64 139.16 11.21
R4 409 4.09 164.01 102.55
R5 417 4.17 18.79 91.80
Figure 5.2a Sorting subpopulations of human bone marrow-derived cells according to their 
expression of the Stro-1 and alkaline phosphatase cell surface antigens
Confluent first passage human bone marrow-derived cells maintained in DMEM supplemented with 
10% fetal calf serum and 100 pM ascorbate-2-phosphate were cultured for 48 hours in DMEM 
containing 2% fetal calf serum and ascorbate. Cells were labelled with mouse anti-human antibodies 
raised against Stro-1 (IgM) and alkaline phosphatase (IgGO, then with goat anti-mouse secondary 
antibodies conjugated to the fluorochromes, FITC and R-PE. Cells were then separated according to the 
expression of Stro-1 and alkaline phosphatase by the use of fluorescence activated cell sorting (FACS).
The results are presented as dot plots: in the example above, in each graph any dot above or to the 
right of the central plot axis corresponds to positive labelling for Stro-1 and alkaline phosphatase (AP) 
respectively. Therefore the regions R2-R5 correspond to double negative, Stro-1 positive alone, positive 
for both antibodies and positive for AP only. Percentages of cells within each subpopulation, and the 
mean fluorescence intensity of the labelling of cells within each subpopulation, are recorded in tables to 
the right of each graph.
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s e c o n d a ry  a n t ib o d ie s  
Gated Events: 5025
geo mean Y
R2 4969 98.89 5.41 6.99
R3 11 0.22 86.95 41.15
R4 21 0.42 506.11 702.93
R5 24 0.48 30.65 113.59
S tro -1  o n ly
•i
Gated Events: 6512
Region Events % Gated X eecpiean Y geo mean
R2 5640 86.81 9.74 5.98
R3 788 12.10 160.41 11.35
R4 35 0.54 245.38 293.59





A P  o n ly
Gated Events: 6763
Region Events % Gated X geo mean Y geo mean
R2 5715 84.50 3.01 5.16
R3 124 1.83 21.48 22.55
R4 278 4.11 36.83 60.75
R5 646 9.55 6.33 46.39
JB0404.008 S tro -1  a n d  A P  (d u a l  la b e l l in g )
Gated Events: 7115
Region Events % Gated X geo mean Y geo mean
R2 6621 97.90 3.59 6.78
R3 5 0.07 95.77 22.39
R4 34 0.50 221.08 316.14
R5 103 1.52 8.48 135.86
JB 0404.008
FL1-H
F ig u r e  5 .2 b  T h e  e f f e c t s  o f  c a lc i t r io l  o n  th e  e x p r e s s io n  o f  th e  S tro -1  a n d  a lk a l in e  
p h o s p h a ta s e  c e l l  s u r fa c e  a n t ig e n s  o n  h u m a n  b o n e  m a r r o w -d e r iv e d  c e lls
C o n f lu e n t  f i r s t  p a s s a g e  h u m a n  b o n e  m a r r o w - d e r i v e d  c e l l s  m a in ta in e d  in  D M E M  
s u p p le m e n te d  w ith  10%  fe ta l c a l f  s e ru m  a n d  100  p M  a s c o r b a te - 2 - p h o s p h a te  w e re  c u l tu r e d  
f o r  2 4  h o u r s  in  D M E M  c o n ta in in g  2 %  fe ta l  c a l f  s e r u m  a n d  a s c o r b a te .  C e l ls  w e re  th e n  
e x p o s e d  to  10 n M  c a lc i t r io l  fo r  2 4  h o u r s  b e fo re  b e in g  la b e l le d  fo r  th e  e x p r e s s io n  o f  S tro -1  
a n d  A P  c e ll  s u r f a c e  a n t ig e n s  a s  p r e v io u s ly  d e s c r ib e d .
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F L 1 - H
J B 0 4 0 4 . 0 1 0
■T^ ' •
• *
s e c o n d a ry  a n t ib o d ie s  
Gated Events: 5102
Region Evgnts % Gated X ggQ mean,.Y geo mean
Tv10" 10' 10 10" 10 
F L 1 - H
R2 5044 98.86 2.64 3.18
R3 4 0.08 57.90 6.87
R4 30 0.59 100.75 142.44
R5 24 0.47 9.52 70.49
S tro -1  o n ly
t
Gated Events: 1980
Region Events % Gated X geofnean Y geo mean
R2 1533 77.42 5.76 2.45
R3 416 21.01 128.82 4.29
R4 26 1.31 140.80 129.00
R5 5 0.25 28.54 75.26
J B 0 4 0 4 . 0 1  1
F L 1 - H
A P  o n ly
Gated Events: 5025
Region Events % Gated X geo mean Y geo_mean
R2 2942 58.55 1.99 9.92
R3 6 0.12 67.12 8.98
R4 28 0.56 85.46 438.13
R5 2049 40.78 4.85 123.58
J B 0 4 0 4 . 0 1 2
J B 0 4 0 4 . 0 1 2
F L 1 - H
S tro -1  a n d  A P  (d u a l la b e ll in g )
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 4416 44.16 10.10 12.01
R3 967 9.67 112.04 19.88
R4 2011 20.11 121.22 142.54
R5 2606 26.06 18.58 111.72
F ig u re  5 .2 c  T h e  e f f e c ts  o f  d e x a m e th a s o n e  o n  th e  e x p r e s s io n  o f  th e  S tro -1  a n d  a lk a l in e  
p h o s p h a ta s e  c e ll  s u r f a c e  a n t ig e n s  o n  h u m a n  b o n e  m a r r o w -d e r iv e d  c e lls
C o n f lu e n t  f i r s t  p a s s a g e  h u m a n  b o n e  m a r r o w - d e r iv e d  c e l l s  m a in ta in e d  in  D M E M  
s u p p le m e n te d  w ith  1 0 %  f e ta l  c a l f  s e ru m , 1 0 0  f iM  a s c o r b a te - 2 - p h o s p h a te  a n d  10 n M  
d e x a m e th a s o n e  w e re  c u l tu r e d  fo r  4 8  h o u r s  in  D M E M  c o n ta in in g  2 %  fe ta l  c a l f  s e ru m  a n d  
a s c o r b a te  a n d  d e x a m e th a s o n e .  C e l ls  w e re  la b e l le d  f o r  th e  e x p r e s s io n  o f  S tro -1  a n d  A P  c e ll  
s u r f a c e  a n t ig e n s  as p r e v io u s ly  d e s c r ib e d .
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JB 0 4 0 4 .0 1 4
FL 1-H
JB 0 4 0 4 .0 1 6
JB 0 4 0 4 .0 1 6
1 0 1 10  
FL1-H
JB 0 4 0 4  015
FL1-H
FL1-H
s e c o n d a ry  a n t ib o d ie s  
Gated Events: 10000
mean Y
R2 9951 99.51 2.79 3.38
R3 8 0.08 50.77 56.55
R4 22 0.22 134.88 192.66
R5 19 0.19 10.94 122.63
S tro -1  o n ly
• -i
Gated Events: 10000
Region Events % Gated X geo mfl&n Y geo mean
R2 7145 71.45 14.44 2.94
R3 2820 28.20 128.46 5.08
R4 24 0.24 110.48 146.07
R5 11 0.11 20.45 93.74
A P  o n ly
Gated Events: 10000
Region Events % Gated X  geo mean Y geo mean
R2 5152 51.52 2.28 18.15
R3 0 0 0 0
R4 28 0.28 77.59 308.20
R5 48.20 48 .20 5.53 160.28
S tro -1  a n d  A P  (d u a l la b e ll in g )
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 4535 45.35 9.05 17.47
R3 671 6.71 106.16 28.53
R4 1557 15.57 113.41 191.95
R5 3237 32.37 18.18 143.91
F ig u r e  5 .2 d  T h e  e f f e c ts  o f  c a lc i t r io l  a n d  d e x a m e th a s o n e  in  c o m b in a t io n  o n  S tro -1  a n d  
a lk a l in e  p h o s p h a ta s e  c e ll  s u r fa c e  a n t ig e n  e x p re s s io n  o n  h u m a n  b o n e  m a r r o w -d e r iv e d  c e l ls  
C o n f l u e n t  f i r s t  p a s s a g e  h u m a n  b o n e  m a r r o w - d e r i v e d  c e l l s  m a in ta in e d  in  D M E M  
s u p p le m e n te d  w ith  10%  fe ta l c a l f  s e ru m  a n d  100  p M  a s c o r b a te -2 - p h o s p h a te  w e re  c u l tu r e d  fo r  
2 4  h o u r s  in  D M E M  c o n ta in in g  2 %  fe ta l c a l f  s e ru m  a n d  a s c o rb a te .  C e l ls  w e re  th e n  e x p o s e d  to  
10 n M  c a lc i t r io l  f o r  2 4  h o u r s  p r io r  to  la b e l l in g  f o r  th e  e x p r e s s io n  o f  S tro -1  a n d  A P  c e ll  
s u r f a c e  a n t ig e n s  a s  p r e v io u s ly  d e s c r ib e d .
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Subpopulation R2 (-/-) R3 (+/-) R4 (+/+) R5 (-/+)
Factor 
untreated * 55 (42-67)* 9.1 (6.3-25)* 3.7 (0-9.2)* 2(5 (3.2-42)*




16(0.5-44)* 1.8 (0-9.6)* 26(20-51)* 48(26-56)*
13(5.5-45)- 1.6 (1.4-6.7)- 2 5 (15 -37 )- 5 4 (3 2 -5 6 )-
Table 5.1 The effects of calcitriol and dexamethasone, alone and in combination, 
on the number of cells expressing the Stro-1 and/ or AP cell surface 
antigens in cultures of human bone marrow-derived cells
First passage bone marrow-derived cells maintained under standard culture conditions 
in the absence or presence of 10 nM dexamethasone were cultured for 24 hours in 
DMEM containing 2%  fetal calf serum and ascorbate, and dexamethasone as 
appropriate. Cells were then exposed to 10 nM calcitriol for 24 hours. The cells were 
then labelled for expression o f Stro-1 and AP cell surface antigens as previously 
described and were accordingly separated using FACS analysis. The table above 
summarises the proportions of cells distributed between the four subpopulations 
following treatment with calcitriol and/  or dexamethasone as compared to untreated 
cells. -Value is the median from three independent experiments with the range shown 
in parentheses. *Value is the median from four independent experiments with the range 
shown in parentheses.
Mean fluorescence intensity of Stro-1 
Subpopulation_______________________R3 (+/-) R4 (+/+)
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Factor
untreated 139 (70-175)* 102 (73-164)*




+ calcitriol 80(74-106)§ 83 (67-113)§
Mean fluorescence intensity of AP
Subpopulation_______________________ R4 f+/+)______________ R5 (-/+)
Factor
untreated 100(68-193)* 96(68-208)*
calcitriol 158 (54-250)§ 135 (48-185)*
dexamethasone 258(100-532)* 179(85-275)*
dexamethasone
+ calcitriol 192 (183-565)§ 146 (144-235)§
Table 5.2 The effects of calcitriol and dexamethasone, alone and in combination, 
on the level of expression of Stro-1 and AP cell surface antigens on subpopulations 
of adult human bone marrow-derived cells
First passage bone marrow-derived cells maintained under standard culture 
conditions in the absence or presence of 10 nM dexamethasone were cultured for 
24 hours in DMEM containing 2% fetal calf serum and ascorbate, and 
dexamethasone as appropriate. Cells were exposed to 10 nM calcitriol for 24 
hours. The cells were then labelled for expression o f Stro-1 and AP cell surface 
antigens as previously described and were accordingly separated using FACS 
analysis. The top table summarises the proportions o f the mean fluorescence 
intensity of labelling for Stro-1, and the bottom table represents those for AP 
between the four subpopulations following treatment with calcitriol and/ or 
dexamethasone as compared to untreated cells. § Value is the median from three 
independent experiments. * Value is the median from four independent 
experiments, with the range shown in parentheses.
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analysis by Joanne Screen, B.I.R.D. The median values, with the range of values shown in 
parentheses, were then entered into a table to facilitate comparisons between groups (table 
5.3).
In the untreated cells, MSX-2 transcripts are expressed at essentially similar levels 
between subpopulations. Treatment with calcitriol or dexamethasone strongly increased 
the levels o f mRNA for MSX-2 in the R2 and R3 subpopulations, whereas combined 
treatment resulted in an increase in MSX-2 transcript expression that was additive and 
supra-additive in the R5 and R2 subpopulations respectively, but in R3, the combined 
effects o f these agents were no different from the effects of treatment with either agent 
alone.
Osteocalcin mRNA expression was lower in the R2 and R3fsubpopulations of 
untreated cells when compared to R4. Calcitriol treatment stimulated levels in R2 and 
dexamethasone alone increased them in the R2 and R3 subpopulations. Calcitriol 
antagonised the stimulatory effects o f dex on thte expression o f osteocalcin transcripts in 
cells from regions R2 and R3.
In untreated cells, BMP-2 transcript expression was minimal in the R2 and 
maximal in the R5 subpopulations when compared with R4. Treatment with calcitriol 
stimulated the levels o f this transcript in the R2 and R3 regions, but decreased those in the 
R5 subpopulation. Dex alone strongly increased BMP-2 mRNA levels in the R2 and R3 
regions. Addition o f calcitriol and dex stimulated BMP-2 mRNA expression in R2 to 
levels comparable with the effects of either agent alone, whereas in R3 and R5, calcitriol 
antagonised the stimulation o f BMP-2 transcript expression by dex to levels greater than 
those seen following treatment with calcitriol alone, when compared with R4.
BMP-4 transcripts were most strongly expressed in the R2 and R3 regions of 
untreated cells, when compared with R4. Treatment with calcitriol had essentially no effect 
on the levels o f expression of BMP-4 transcript when compared to untreated cells. Dex 
alone stimulated BMP-4 transcript levels in the R5 and $ 2  regions but had no effect on 
levels in R3, when compared with R4. Treatment with calcitriol and dex in combination 
stimulated BMP-4 mRNA expression in R2 to levels comparable with the effects o f dex 
alone and had a supra-additive effect in the R3 region, whereas in the R5 fraction, calcitriol 
antagonised the stimulation of BMP-4 transcript expression by dex to levels comparable 
with those in R4.
Statistical analysis was performed to compare gene expression patterns between the 
four subpopulations and can be seen in null hypothesis 23, Appendix 3.
5.4 The effects o f  constant culture in dex on the morphology of adult human trabecular 
bone-derived cells
Figure 5.4 shows the effects o f dex on cell morphology (photograph D) as 
compared to cells cultured in the absence o f dex (photograph C): as observed in the
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subpopulations of marrow-derived cells
untreated 
R2 R3 R4 R5
lOnMD 











F ig u re  5 .3 a  T h e  e f fe c ts  o f  c a lc itr io l a n d  d e x a m e th a so n e , a lo n e  o r  in  c o m b in a tio n , o n  th e  e x p re s s io n  o f  o s te o b la s t- re la te d  g e n e s  in  su b p o p u la tio n s  o f  
a d u lt h u m a n  b o n e  m a rro w -d e r iv e d  c e lls  
C o n f lu e n t  f ir s t  p a s s a g e  a d u lt  h u m a n  b o n e  m a rro w -d e r iv e d  c e lls  m a in ta in e d  in  D M E M  s u p p le m e n te d  w ith  10%  fe ta l c a l f  s e ru m  a n d  100  |iM  
a s c o rb a te -2 -p h o a p h a te , a n d  in  th e  a b s e n c e  o r  p re s e n c e  o f  10 n M  d e x a m e th a so n e , w e re  c u l tu re d  fo r  2 4  h o u rs  in  D M E M  c o n ta in in g  2 %  fe ta l c a lf  se ru m  
a n d  a s c o rb a te , a n d  d e x a m e th a s o n e  a s  a p p ro p r ia te .  T h e  c e lls  w ere  th e n  e x p o s e d  to  10 n M  c a lc itr io l fo r  2 4  h o u rs  p r io r  to  la b e ll in g  fo r  e x p re s s io n  o f  
S tro -1  a n d  A P  c e ll s u r fa c e  a n tig e n s . A c c o rd in g ly , c e lls  w e re  s e p a ra te d  in to  fo u r  s u b p o p u la tio n s . R N A  w a s  e x t ra c te d  a n d  a n a ly se d  fo r  the  e x p re ss io n  
o f  m R N A  tr a n s c r ip ts  fo r  M S X -2 , o s te o c a lc in ,  B M P -2 , B M P -4  (4 0  c y c le s )  a n d  G A P D H  (3 5  c y c le s )  b y  R T -P C R  a n d  S o u th e rn  b lo tt in g . P C R  an d  
S o u th e rn  b lo tt in g  w a s  p e r fo rm e d  tw ic e  fo r  e a c h  g e n e  an d  d e n s ito m e try  w as  c a r r ie d  o u t on  th e  b lo ts . V a lu e s  o b ta in e d  fo r  d ire c t  r e p e a ts  w ere  a v e ra g e d  
an d  m e d ia n  v a lu e s ,  w ith  th e ir  r a n g e  sh o w n  in  p a r e n th e s e s ,  w e re  re c o rd e d  in  ta b le  5 .3 . T h e  g e ls  a b o v e  a r ^  r e p r e s e n ta t iv e  o f  fo u r  in d e p e n d e n t 
e x p e r im e n ts . ,







F ig u re  5 .3 b  T h e  e f fe c ts  o f  c a lc itr io l a n d  d e x a m e th a s o n e , a lo n e  o r  in  c o m b in a tio n , o n  th e  e x p re s s io n  o f  o s te o b la s t- re la te d  g e n e s  in  su b p o p u la tio n s  
o f  h u m a n  b o n e  m a rro w -d e r iv e d  c e lls
T h is  f ig u re  s h o w s  S o u th e rn  b lo ts  fo r  th e  e x p e r im e n t in  fig u re  5 .3 a  an d  is re p re se n ta tiv e  o f  fo u r  in d e p e n d e n t e x p e r im e n ts .  D e n s ito m e tr ic  v a lu e s  a re  sh o w n  
b e n e a th  e a c h  b lo t - u n d e r lin e  in d ic a te s  s ta tis t ic a l s ig n if ic a n c e  w ith  H  v a lu es .
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subpopulations of marrow-derived cells
untreated j lOnM D
R2 R3 R4 R5 R2 R3 R4 R5
dex jdex+lOnM 
R2 R4 R5 R2 R4 R5






10 nM calcitriol 10 nM dexamethasone
0.9 (0.3-1.6)+ 1.4 (0.4-2.5)-
4.4(0.4-11)* 5.1(0.3-10)-
3.3 (2.9-1 l)t 10(1.9-50)* 
27 (20-33)- 10=
It 1.2 (0.6-1.7)*
It 1.5 (1.5-1.5) -





0.4 (0.2-0.7)~ 0.3 (0.3-0.4)- 1* 1 (0.9-1.1)-
18(6.3-30)- 10= 1* 1.8 (1.7-2) -
2.6 (0.7-4.5)- 1.2 (0.3-2.3)t It 1.2 (0.7-1.7)-
3.5 (1-6)- 1.1= 1* 2.1 (0.7-3.6)-
0.3 (0.2-41)t 0.8 (0.5-3.3)* It 1.9 (0.5-19)t
3.3(1.6-10)* 26(1.3-50)- It 2.4 (1.5-7)t
4.7 (0.4-9)- 2.2 (1.7-2.7)- It 0.7 (0.7-0.7)-

















Table 5.3 The effects of calcitriol and dexamethasone, alone or in combination, on the expression of 
osteoblast-related genes in subpopulations of adult human bone marrow-derived cells 
Confluent cells maintained under standard culture conditions and in the absence or presence of 
dexamethasone were cultured for 24 hours in DMEM containing 2% fetal calf serum and ascorbate, and 
dexamethasone as appropriate. The cells were treated with 10 nM calcitriol for 24 hours and then were 
harvested and labelled for the cell surface expression of Stro-1 and AP antigens. Cells were accordingly 
separated using FACS analysis. RNA was extracted from each subpopulation and examined for the mRNA 
expression of MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH by RT-PCR and Southern blotting. These 
latter two processes were performed twice for each independent experiment. Densitometry was performed 
and the values obtained for repeats of PCRs and Southern blots were averaged. The table above represents 
the median values obtained from four independent experiments. *=Value obtained from one experiment. 
-Average value from two experiments; * average value from three experiments; t average value from four 
experiments, with the range of values shown in parentheses.
P h o to g r a p h  5 C  F ir s t  p a s s a g e  h u m a n  tra b e c u la r  b o n e -d e r iv e d  c e ll  c u l tu re d  in  th e  
a b s e n c e  o f  d e x a m e th a s o n e .  T h is  w a s  p h o to g ra p h e d  a t x 3 2 0  m a g n if ic a tio n .
P h o to g ra p h  5 D  F ir s t  p a s s a g e  h u m a n  tra b e c u la r  b o n e -d e r iv e d  c e ll c u l tu r e d  in  th e  
p r e s e n c e  o f  10  n M  d e x a m e th a s o n e .  T h is  w a s  p h o to g ra p h e d  a t x 3 2 0  m a g n if ic a t io n .
F ig u r e  5 .4  T h e  e f f e c ts  o f  c o n s ta n t  c u l tu re  in  d e x a m e th a s o n e  o n  th e  m o r p h o lo g y  o f  a d u lt 
h u m a n  t r a b e c u la r  b o n e - d e r iv e d  c e lls
F i r s t  p a s s a g e  tr a b e c u la r  b o n e -d e r iv e d  c e lls  w e re  p la te d  a t a  d e n s ity  o f  5 x  1 0 3 c e lls /
c m 2 a n d  w e re  m a in ta in e d  in  D M E M  s u p p le m e n te d  w ith  1 0 %  fe ta l c a lf  s e ru m  a n d  1 0 0  p M
a s c o r b a te -2 - p h o s p h a te  in  th e  a b s e n c e  (5 C )  o r  p re s e n c e  o f  10  n M  d e x a m e th a s o n e  (5 D ) .  
U n tr e a te d  c e lls  d is p la y  a  ty p ic a l e lo n g a te d  f ib ro b la s tic  a p p e a ra n c e  w h e re a s  th o s e  m a in ta in e d  
in  th e  p r e s e n c e  o f  d e x a m e th a s o n e  e x h ib it  a  m o re  tru n c a te d ,  p o ly g o n a l  a p p e a ra n c e  a n d  se e m  
to  h a v e  m o re  a t ta c h m e n ts  to  th e  p la s tic  f la sk .
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marrow-derived cells (see figure 5.1), untreated cells tend to have an elongated appearance 
whereas those treated with dex are more polygonal in shape.
5.5 Sorting subpopulations of human trabecular bone-derived cells according to their 
expression of the Stro-1 and alkaline phosphatase cell surface antigens
First passage trabecular bone-derived cells were maintained in DMEM containing 
10% fetal calf serum and 100 fiM asp and in the absence or presence o f 10 nM dex until 
confluent at which point they were cultured for 24 hours in DMEM supplemented with 2% 
fetal calf serum and 100 pM asp, and in the absence or presence oftdex as appropriate. 
Cells were then exposed to 10 nM calcitriol for 24 hours. Following labelling for the cell 
surface expression o f Stro-1 and alkaline phosphatase, cells were sepa$ite4 by FACS and 
where possible, the fractions retrieved for analysis o f purity: those fractions showing 
greater than 85% purity were analysed for mRNA transcript levels of MSX-2, osteocalcin, 
BMP-2, BMP-4 and GAPDH by RT-PCR and Southern blotting.
The results of one experiment o f treatment with dex and calcitriol on the 
distribution of cells within the four subpopulations separated according to their expression 
of Stro-1 and AP are detailed in figures 5.5a- d. For each figure, there are five dot plots: 
one showing secondary labelling, labelling with Stro-1 or AP only, and labelling for both 
Stro-1 and AP, and finally a plot showing the gating for subpopulations, with R2 in the 
lower left quadrant and moving clockwise to R5 (lower right quadrant). Table 5.4 shows 
the distribution o f cells treated with calcitriol and/  or dex between the four fractions of two 
FACS-analysed experiments relative to the distribution o f control cells.
Under these culture conditions, calcitriol appears to have little effect on the 
expression o f the Stro-1 and AP cell surface antigens in the R2 and R3 sort regions when 
compared to control cells, but decreases the proportion o f cells present in the R4 region 
and modestly increases that in the R5 subpopulation. Continuous culture in the presence of 
dex strongly reduced the proportion o f cells present in the S.2 and R3 fractions and clearly 
increased the proportion o f cells in the R4 and R5 fractions. The effects o f treatment with 
calcitriol and dex in combination were similar to those seen following treatment with dex 
alone.
Table 5.5 shows the mean fluorescence intensity values for Stro-1 and AP labelling 
for the four fractions o f cells following treatment with calcitriol and dex, alone and in 
combination for two FACS-analysed experiments. When compared with control, treatment 
with calcitriol or dex alone decreased the levels o f Stro-1 antigen expression in the R4 
fraction. Calcitriol and dex in combination produced levels o f Stro-1 antigen expression in 
the R4 fraction comparable to those seen in cells treated with dex alone. Calcitriol 
markedly decreased alkaline phosphatase antigen expression in the R4 subpopulation when 
compared to control. Dex modestly decreased AP antigen expression in R4 and markedly 
stimulated it in the R5 region. Calcitriol modestly antagonised the effects o f dex on AP 
antigen expression in the R4 and R5 subpopulations.
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se c o n d a ry  a n tib o d ie s  
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
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R2 9722 97.22 3.45 3.29
R3 17 0.17 26.25 13.03
R4 142 1.42 48.74 73.44
R5 119 1.19 14.67 31.28
S tro -1  o n ly
Gated Events: 10000 t
Region Events % Gated X geo mean Y geo mean
R2 7639 76.39 8.02 3.34
R3 1998 19.98 62*09 4.71
R4 289 2.89 60:89 ' 57.62
R5 74 0.74 15.70 30.73
A P  o n ly
Gated Events: 10000
R e g io n  E v e n ts  %  G a te d  X  g e o  m e a n  .Y .g e o .m e a n
R2 9021 90.21 2.15 3.93
R3 4 0.04 40.86 4.04
R4 41 0.41 53.01 97.36
R5 934 9.34 4.15 53.76
S tr o - 1 an d  A P  (d u a l la b e llin g )
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 7928 79.28 5.37 4.03
R3 1192 11.92 70.91 4.23
R4 162 1.62 69.78 56.98
R5 718 7.18 7.45 58.94
F ig u re  5 .5 a  S o rtin g  su b p o p u la tio n s  o f  h u m a n  tra b e c u la r  b o n e -d e r iv e d  c e lls  a c c o rd in g  to  
th e ir  e x p re s s io n  o f  th e  S tro-1  an d  a lk a lin e  p h o sp h a ta se  ce ll su r fa c e  a n tig e n s
C o n f lu e n t  f i r s t  p a s s a g e  h u m a n  tr a b e c u la r  b o n e -d e r iv e d  c e lls  m a in ta in e d  in  D M E M  
su p p le m e n te d  w ith  10%  fe ta l c a lf  se ru m  a n d  100 p.M a sc o rb a te -2 -p h o sp h a te ^ w e re  c u ltu re d  
fo r  4 8  h o u rs  in D M E M  c o n ta in in g  2%  fe ta l c a lf  se ru m  a n d  a sc o rb a te . C e lls  w e re  la b e lle d  
w ith  m o u se  a n t i-h u m a n  a n tib o d ie s  ra is e d  a g a in s t S tro -1  ( Ig M ) a n d  a lk a lin e  p h o s p h a ta s e  
( Ig G i) ,  th e n  w ith  g o a t a n ti-m o u se  s e c o n d a ry  a n tib o d ie s  c o n ju g a te d  to  th e  f lu o ro c h ro m e s ,  
F IT C  a n d  R -P E . C e lls  w e re  th e n  s e p a ra te d  a c c o rd in g  to  th e  e x p re s s io n  o f  S tro -1  an d  
a lk a lin e  p h o sp h a ta se  by  th e  u se  o f  f lu o re sc e n c e  a c tiv a te d  ce ll so r tin g  (F A C S ).
T h e  re su lts  a re  p re se n te d  as d o t p lo ts : in th e  e x a m p le  a b o v e , in e a c h  g ra p h  a n y  d o t ab o v e  
o r  to  th e  r ig h t o f  th e  c e n tra l p lo t  a x is  c o r re s p o n d s  to  p o s i t iv e  la b e ll in g  fo r  S tro -1  an d  
a lk a lin e  p h o s p h a ta s e  (A P ) re sp e c tiv e ly . T h e re fo re  th e  re g io n s  R 2 -R 3  c o rre s p o n d  to  d o u b le  
n e g a tiv e ,  S tro -1  p o s i t iv e  a lo n e , p o s it iv e  fo r  b o th  a n t ib o d ie s  a n d  p o s i t iv e  f o r  A P  o n ly . 
P e rc e n ta g e s  o f  c e lls  w ith in  ea ch  su b p o p u la tio n , a n d  th e  m e a n  f lu o re s c e n c e  in te n s ity  o f  the  











s e c o n d a ry  a n t ib o d ie s  
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 9706 97.06 2.72 3.46
R3 8 0.08 24.42 7.24
R4 64 0.64 35.99 85.88





S t r o - 1 o n ly  i
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 8784 87.84 f4.78 3.55
R3 917 9.17 (>7.42 4.51
R4 115 1.15 46.93 56.49













A P  o n ly
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 8891 88.91 2.36 4.26
R3 2 0.02 57.00 7.67
R4 19 0.19 72.61 308.10






S tro -1  a n d  A P  (d u a l  la b e ll in g )
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 7730 77.30 4.80 4.06
R3 1167 11.67 81.77 3.75
R4 240 2.40 82.30 52.89
R5 863 8.63 6.95 60.32
F ig u re  5 .5 b  T h e  e f f e c ts  o f  c a lc i t r io l  o n  th e  e x p r e s s io n  o f  S tro -1  a n d  a lk a l in e  p h o s p h a ta s e  
c e ll  s u r f a c e  a n t ig e n s  o n  h u m a n  tr a b e c u la r  b o n e -d e r iv e d  c e lls
C o n f lu e n t  f i r s t  p a s s a g e  h u m a n  t r a b e c u la r  b o n e - d e r iv e d  c e l l s  m a in ta in e d  in  D M E M  
s u p p le m e n te d  w ith  10%  fe ta l c a l f  s e ru m  a n d  1 0 0  p M  a s c o r b a te - 2 - p h o s p h a te  w e re  c u l tu r e d  
f o r  2 4  h o u r s  in  D M E M  c o n ta in in g  2 %  fe ta l  c a l f  s e ru m  a n d  a s c o r b a te .  C e l l s  w e re  th e n  
e x p o s e d  to  10 n M  c a lc i t r io l  fo r  2 4  h o u r s  b e fo re  b e in g  la b e l le d  fo r  th e  e x p r e s s io n  o f  S tro -1  
a n d  a lk a l in e  p h o s p h a ta s e  c e ll  s u r fa c e  a n t ig e n s  a s  p r e v io u s ly  d e s c r ib e d  ( s e e  f ig u re  5 .5 a ) .
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JB0304.009
10v 10' 10 10 
FL1-H
s e c o n d a ry  a n t ib o d ie s  
Gated Events: 10000
Reeion Events % Gated X eeo mean Y eeo mean
R2 9320 93.20 2.90 3.97
R3 80 0.80 62.10 8.19
R4 148 1.48 48.25 232.39
R5 452 4.52 9.25 81.28
J B 0 3 0 4 .010 S tro -1  o n ly  
Gated Events: 10000
Reeion Events % Gated X eeolnean Y eeo mean
R2 6080 60.80 7.73 4.01
R3 3357 33.57 90.05 5.75
R4 310 3.10 78.70 112.51
R5 253 2.53 11.46 88.31
FL1-H
JB 0 3 0 4  01 1 A P  o n ly
Gated Events: 10000
Reeion Events % Gated X eeo mean Y eeo mean
R2 2251 22.51 2.12 12.86
R3 6 0.06 70.84 6.88
R4 43 0.43 47.94 1311.12
R5 7700 77.00 3.42 257.28
JB030<1.012
FL 1 -H
S tro -1  a n d  A P  (d u a l la b e ll in g )
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 1747 17.47 6.31 13.15
R3 606 6.06 95.80 15.44
R4 3107 31.07 112.00 299.84
R5 4540 45.40 8.38 222.44
JB 0 3 0 4 .0 1 2
FL1-H
F ig u r e  5 .5 c  T h e  e f f e c ts  o f  d e x a m e th a s o n e  o n  th e  e x p r e s s io n  o f  th e  S tro -1  a n d  a lk a l in e  
p h o s p h a ta s e  c e l l  s u r f a c e  a n t ig e n s  o n  h u m a n  tr a b e c u la r  b o n e - d e r iv e d  c e lls
C o n f lu e n t  f i r s t  p a s s a g e  h u m a n  t r a b e c u la r  b o n e - d e r iv e d  c e l l s  m a in ta in e d  in  D M E M  
s u p p le m e n te d  w i th  10%  fe ta l  c a l f  s e ru m , 100  | i M  a s c o r b a te - 2 - p h o s p h a te  a n d  10 n M  
d e x a m e th a s o n e  w e r e  c u l tu r e d  f o r  4 8  h o u r s  in  D M E M  c o n ta in in g  2 %  fe ta l  c a l f  s e ru m , 
a s c o r b a te  a n d  d e x . C e l ls  w e re  th e n  la b e lle d  fo r  th e  e x p re s s io n  o f  S tro -1  a n d  A P  c e ll  s u r fa c e  
a n t ig e n s  a s  p r e v io u s ly  d e s c r ib e d .
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a  geo mean 
2.32
i g<?p mean 
3.08
R3 62 0.62 20.43 8.08
R4 132 1.32 32.31 129.00
R5 354 3.54 4.37 45.78
S tro -1  o n ly
■ A
Gated Events: 10000 ff• > i 1
Region Events % Gated X geo mean Y geo mean
R2 7100 71.00 7.11 3.34
R3 2355 23.55 75.96 5.13
R4 284 2.84 73.40 105.71
R5 261 2.61 11.56 80.57
A P  o n ly
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 3538 35.38 1.81 10.75
R3 19 0.19 80.01 7.38
R4 29 0.29 60.86 466.85
R5 6414 64.14 2.84 182.75
S tro -1  a n d  A P  (d u a l la b e ll in g )
Gated Events: 10000
Region Events % Gated X geo mean Y geo mean
R2 2719 27.19 5.02 11.94
R3 599 5.99 86.64 14.85
R4 1471 14.71 94.17 241.14
R5 5211 52.11 7.14 185.33
F ig u r e  5 .5 d  T h e  e f f e c ts  o f  c a lc i t r io l  a n d  d e x a m e th a s o n e  in  c o m b in a t io n  o n  S tro -1  a n d  
a lk a l in e  p h o s p h a ta s e  c e l l  s u r f a c e  a n t ig e n  e x p r e s s io n  o n  h u m a n  t r a b e c u la r  b o n e - d e r iv e d  
c e l ls
C o n f lu e n t  f i r s t  p a s s a g e  h u m a n  t r a b e c u la r  b o n e - d e r iv e d  c e l l s  m a in ta in e d  in  D M E M  
s u p p le m e n te d  w ith  10%  fe ta l c a l f  s e ru m , 100  p M  a s c o r b a te - 2 - p h o s p h a te  a n d  10 n M  d e x  
w e re  c u l tu r e d  f o r  2 4  h o u r s  in  D M E M  c o n ta in in g  2 %  fe ta l  c a l f  s e ru m , a s c o r b a te  a n d  d e x . 
C e l l s  w e r e  th e n  e x p o s e d  to  10  n M  c a lc i t r io l  f o r  2 4  h o u r s  p r io r  to  la b e l l in g  f o r  th e  
e x p r e s s io n  o f  S t r o - 1 a n d  A P  c e ll  s u r fa c e  a n t ig e n s  a s  p re v io u s ly  d e s c r ib e d .
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Subpopulation R2 (-/-) R3 (+/-) R4 (+ M  R5 (-/+)
Factor
i
untreated 48(17-79) 6.7(1.6-12) 19(0.2-38) 22(6.4-38)
calcitriol 49(20-11)  7 .7(3.7-11.7) 9.7(1.5-18) 30(6.8-52)
dexamethasone 14(10-17) 3.2 (0.5-6) 23(17-30) 58(43-73)
dexamethasone
Table 5.4 The effects of calcitriol and dexamethasone, alone and in combination, 
on the number of cells expressing the Stro-1 and/ or AP cell surface 
antigens in cultures of human trabecular bone-derived cells
First passage trabecular bone-derived cells maintained under standard culture 
conditions in the absence or presence of 10 nM dexamethasone were cultured for 24 
hours in DMEM containing 2% fetal calf serum and ascorbate, and dexamethasone as 
appropriate. The cells were exposed to 10 nM calcitriol for 24 hours and were then 
labelled for expression of Stro-1 and AP cell surface antigens as previously described 
and were accordingly separated using FACS analysis. The table above summarises the 
proportions o f cells distributed between the four subpopulations following treatment 
with calcitriol and/ or dexamethasone as compared to untreated cells. Each value is the 
median from two independent experiments with the range shown in parentheses.
+ calcitriol 17(6.4-27) 3.1 (0.5-6) 20(13-26) 59(50-68)
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Mean fluorescence intensity of Stro-1
Subpopulation______________________ R3_(+/-)______________ R4 (+/+)
Factor
untreated 66 (61 -71) 324 (70-577)
calcitriol 67 (51-82) 60 (37-82)
dexamethasone 76(57-96) 96.(78-112)
dexamethasone
+ calcitriol 58(29-87) 66(38-94)
Mean fluorescence intensity of AP
Subpopulation______________________ R4_(+/+)______________ R5 (-/+)
Factor
untreated 483 (57-909) 84 (59-108)
calcitriol 95 (53-137) 99(60-139)
dexamethasone 382 (300-464) 263 (222-304)
dexamethasone
+ calcitriol 300 (241-360) 219 (185-253)
Table 5.5 The effects of calcitriol and dexamethasone, alone and in combination, 
on the level of expression of Stro-1 and AP cell surface antigens on subpopulations 
of adult human trabecular bone-derived cells
First passage trabecular bone-derived cells maintained under standard culture 
conditions in the absence or presence of 10 nM dexamethasone were cultured for 
24. hours in DMEM containing 2% fetal ca lf serum and ascorbate, and 
dexamethasone as appropriate. Cells were exposed to 10 nM calcitriol for 24 
hours. The cells were then labelled for expression o f Stro-1 and AP cell surface 
antigens as previously described and were accordingly separated using FACS 
analysis. The top table summarises the proportions of the mean fluorescence 
intensity of labelling for Stro-1, and the bottom table represents those for AP 
between the four subpopulations following treatment with calcitriol and/ or 
dexamethasone as compared to untreated cells. All values represent the median of 
two independent experiments with the range shown in parentheses.
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5.6 The effects o f calcitriol and dex, alone or in combination, on the expression of 
osteoblast-related genes in subpopulations o f trabecular bone-derived cells
First passage trabecular bone-derived cells, maintained in DMEM supplemented 
with 10% fetal calf serum and 100 p.M asp and in the absence or presence o f 10 nM dex 
until confluency, were cultured for 24 hours in DMEM containing 2% fetal calf serum and 
100 pM asp and 10 nM dex as appropriate. The cells were then exposed to 10 nM calcitriol 
for 24 hours. RNA was harvested and analysed for the mRNA expression o f MSX-2, 
osteocalcin, BMP-2, BMP-4 and GAPDH by RT-PCR (figure 5.6a) and Southern blotting 
(figure 5.6b). The PCRs and blots were carried out twice and average values following 
densitometric analysis were taken. This experiment was performed three times and in 
addition, the cDNA from another donor treated only with dex was sup^ied, for analysis by 
Joanne Screen, B.I.R.D. The median values, with the range o f values shown in parentheses 
were then entered into a table to facilitate comparisons between groups (table 5.6).
In the untreated cells, MSX-2 transcript expression was increased in the R5 and R2 
subpopulations, when compared with R4. Treatment with calcitriol alone stimulated 
expression o f M SX-2 mRNA in the R3 and R5 regions, whereas dex alone increased 
expression of this transcript in the R5 region only. Treatment with calcitriol and dex in 
combination resulted in an additive and supra-additive increase in the R5 and R2 
subpopulations respectively, with levels o f MSX-2 expression in R3 seen to be similar to 
those seen following treatment with calcitriol alone.
Osteocalcin mRNA expression was essentially similar between subpopulations of 
untreated cells. Treatment with calcitriol decreased levels in the R3 region, but stimulated 
those in the R5 subpopulation. Dex alone increased levels o f this transcript in the R3 
subpopulation. Treatment with calcitriol and dex in combination increased osteocalcin 
transcript levels in a supra-additive manner in the R5 and R2 subpopulations when 
compared with R4.
The expression of BMP-2 mRNA was seen to be increased in the R2 subpopulation 
and decreased in R3 when compared with R4. Calcitriol alone increased levels o f this 
transcript in the R5 region, whereas treatment with dex alone, increased those in the R2 
and R3 subpopulations. The combined treatment resulted in increased levels o f this 
transcript in a supra-additive manner in the R5 and R2 subpopulations "when compared 
with R4.
BMP-4 transcripts are least strongly expressed in the R2 subpopulation o f untreated 
cells. Levels of this transcript were strongly increased in the R5 region following treatment 
with calcitriol, whereas dex alone increased BMP-4 mRNA expression levels in the R2 and 
R3 regions, when compared with R4. Treatment with calcitriol and dex in combination 
stimulated the expression of BMP-4 mRNA in R3 and R5, with a supra-additive increase 
seen in R2, when compared with R4.
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subpopulations of trabecular bone-derived cells
dex+10nM Duntreated 










F ig u re  5 .6 a  T h e  e f f e c ts  o f  c a lc i t r io l  a n d  d e x a m e th a s o n e ,  a lo n e  o r  in  c o m b in a t io n ,  o n  th e  e x p r e s s io n  o f  o s te o b la s t - r e la te d  g e n e s  in  
s u b p o p u la t io n s  o f  h u m a n  tr a b e c u la r  b o n e -d e r iv e d  c e l ls  
C o n f lu e n t  f i r s t  p a s s a g e  a d u l t  h u m a n  t r a b e c u la r  b o n e - d e r iv e d  c e l l s  m a in ta in e d  in  D M E M  s u p p le m e n te d  w ith  10%  fe ta l  c a l f  s e ru m  a n d  
100  p M  a s c o r b a te - 2 - p h o s p h a te  in  th e  a b s e n c e  o r  p r e s e n c e  o f  10 n M  d e x a m e th a s o n e ,  w e re  c u l tu r e d  f o r  2 4  h o u r s  in  D M E M  c o n ta in in g  2 %  
fe ta l  c a l f  s e ru m  a n d  100  p M  a s c o r b a te ,  a n d  d e x a m e th a s o n e  a s  a p p ro p r ia te .  C e l ls  w e re  th e n  e x p o s e d  to  10 n M  c a lc i t r io l  fo r  2 4  h o u r s  p r io r  to  
la b e l l in g  f o r  e x p r e s s io n  o f  S tro -1  a n d  A P  c e l l  s u r f a c e  a n t ig e n s :  p r im a ry  a n t ib o d ie s  w e re  d e r iv e d  f ro m  h y b r id o m a  s u p e r n a ta n t  (B 4 -7 8  
h y b r id o m a  p r o d u c e d  th e  m o u s e  a n t i - h u m a n  a lk a l in e  p h o s p h a ta s e  Ig G , w h ic h  w a s  p u r i f i e d  b y  p r o te in  K  c o lu m n  p u r i f i c a t io n  b y  D r. C . 
J e f f e r is s ,  B I R D ) ;  th e  s e c o n d a ry  c o n ju g a te s  o f  g o a t  a n t i - m o u s e  a n t i- Ig M  a n d  a n t i- Ig G  w e re  l in k e d  to  F IT C  a n d  R -P E . F o l lo w in g  re tr ie v a l  o f  
th e  f r a c t io n s  c o n ta in in g  th e  f o u r  s u b p o p u la t io n s ,  R N A  w a s  e x t r a c te d  a n d  a n a ly s e d  b y  R T -P C R  a n d  S o u th e r n  b lo t t in g  fo r  M S X - 2 ,  o s te o c a lc in ,  
B M P - 2 ,  B M P - 4  (4 0  c y c le s )  a n d  G A P D H  (3 5  c y c le s )  m R N A  e x p r e s s io n .  P C R  a n d  S o u th e r n  b lo tt in g *  w a s  c a r r ie d  o u t  tw ic e  fo r  e a c h  
e x p e r im e n t .  V a lu e s  o b ta in e d  f o r  d i r e c t  r e p e a ts  w e re  a v e r a g e d  a n d  m e d ia n  v a lu e s ,  w ith  th e i r  r a n g e  s h o w n  in  p a r e n th e s e s ,  w e r e  r e c o rd e d  in  






F ig u re  5 .6 b  T h e  e f f e c ts  o f  c a lc i t r io l  a n d  d e x a m e th a s o n e ,  a lo n e  o r  in  c o m b in a t io n ,  o n  th e  e x p r e s s io n  o f  o s te o b la s t - r e la te d  g e n e s  in 
s u b p o p u la t io n s  o f  h u m a n  t r a b e c u la r  b o n e -d e r iv e d  c e lls  
T h is  f ig u r e  s h o w s  S o u th e r n  b lo ts  f o r  th e  e x p e r im e n t  in  f ig u r e  5 .6 a  a n d  is  r e p r e s e n ta t iv e  o f  f o u r  in d e p e n d e n t  e x p e r im e n t s .  
D e n s i to m e tr ic  a n a ly s is  w a s  p e r f o rm e d  o n  th e  b lo ts  (a v e ra g e  v a lu e s  s h o w n  b e n e a th  e a c h  b lo t) .  U n d e r l in e  in d ic a te s  s ta t is t ic a l ly  s ig n if ic a n t  
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Blots
subpopulations of trabecular bone-derived cells 
untreated lOnM D dex dex+lOnM D 
R2 R3 R4 R5 : R4 R5 R2 R4 R5 R2 j R4 R5 R2
Subpopulations
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- 2.7 (0.3-18)* 1.4 (1-3.3)* 1* 3.6 (0.6-4.7)*
+ 1.2(1.1-1.5)* 1.3 (1.34.6)* It 1 3.1 (2.4-3.7)-
- 1 (0.6-2.5)* 3.6 (1.5-5.8)— 1- 5.2 (3.5-7)-
+ 3.6 (2.3-4.9)~ 2.9= 1- 'v' £.6(2.4-15)-
- 1.2 (0.5-1.9)- 1 (1-3.3)* 1* ' 0.6 (0.4-0.7)-
+ 1.1 (1.1-2.8)*. 2.4 (1.3-3.5)— It 0.6 (0.2-2.4)*
- 1 (0.2-2)* 0.4 (0.2-0.6)- 1- 3.4 (1.6-5.3)-
+ 7.3 (5.8-8.9)- 1.6= 1- 7.3 (3.3-11)-
- 5.6 (0.2-11)- 0.4 (0.2-l)t 1* 1.5 (1.3-1.8)-
+ 4.9 (0.4-11.7)t 1.9 (0.2-40)* P 0.8 (0.2-3.6)t
- 1 (0.6-1.7)* 0.9 (0.6-1.3)- 1- 1.8(1.5-2.2)-
+ 9.7 (8.7-11)- 1.7= 1- 4.4 (2-6.7)—
- 0.5 (0.2-17)* 0.7 (0.3-2.5)t 1* 1 (0.5-46)*
+ 3 (1.5-18)+ 4(1.5-25)* It 0.9 (0.4-16)+
- 1.2 (1-1.4)- 1.4= 1- 6.4 (5.1-7.7)-
+ 10(9.3-11)- 6.4= 1- 6.6 (6.4-6.9)~
dexamethasone, alone or in combination, on the expression of
osteoblast-related genes in subpopulations of adult human trabecular bone-derived cells 
Confluent cells maintained under standard culture conditions and in the absence or presence of 
dexamethasone were cultured for 24 hours in DMEM containing 2% fetal calf serum and ascorbate, and 
dexamethasone as appropriate. The cells were treated with 10 nM calcitriol for 24 hours and then were 
harvested and labelled for the cell surface expression of Stro-1 and AP antigens. Cells were accordingly 
separated using FACS analysis. RNA was extracted from each subpopulation and examined for the mRNA 
expression of MSX-2, osteocalcin, BMP-2, BMP-4 and GAPDH by RT-PCR and Southern blotting. These 
latter two processes were performed twice for each independent experiment. Densitometry was performed 
and the values obtained for repeats of PCRs and Southern blots were averaged. The table above represents 
the median values obtained from up to four independent experiments. «Value obtained from one 
experiment. -Average value from two experiments; * average value from three experiments; t average 
value from four experiments, with the range of values shown in parentheses.
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Statistical analysis to compare gene expression patterns between the four 
subpopulations o f adult human trabecular bone-derived cells was performed and can be 




Long term culture of cells in the presence of dexamethasone had marked effects on 
cell morphology: both bone marrow- and trabecular bone-derived cells exhibited a 
smooth, elongated, fibroblast-like appearance when cultured under normal conditions, but 
in the presence of dexamethasone, morphology was truncated, and cells appeared more 
polygonal and therefore more osteoblastic in appearance. This is consistent with the 
observations by Cheng et al (1994) and with the finding that dexamethasone stimulates 
osteoblastic differentiation, although this effect is dependent upon the stage of cell 
maturation (reviewed by Delany et al, 1994). The change in morphology may be mediated 
by the reduction in the attachment of the cells to their extracellular matrix (Gronowicz and 
McCarthy, 1995).
Treatment of bone marrow-derived cells with dexamethasone resulted in a reduced 
proportion of AP negative cells (cells in the R2 and R3 fractions) and increased numbers 
in the AP positive regions (R4 and R5). Untreated trabecular bone-derived cells display a 
similar pattern. The effects of dexamethasone on both human trabecular bone- and bone 
marrow-derived cells suggest that culture in the presence of dexamethasone stimulates the 
progression of these cells from R2 to R5, and therefore drives the terminal differentiation 
of these cells at all stages of maturation. Within the R2 fraction also, there may be 
represented a proportion of cells driven through to terminal differentiation. This is 
supported by the finding that expression of bone sialoprotein, a molecule expressed only 
by mineralising cells (osteoblasts, odontoblasts and cementoblasts), is upregulated by 
dexamethasone (Sodek et al, 1995) as mediated by the presence of a glucocorticoid 
response element (GRE) in its promoter (Ogata et al, 1995). The reduced numbers of cells 
in the R2 fraction, however, imply that there are fewer osteogenic precursors. This 
supports the conclusion that treatment with glucocorticoids reduces the proliferation of 
osteogenic precursors (Doherty et al, 1995). By conjecture, fewer precursors would 
result in a reduced pool of osteogenic cells in the future, suggesting a mechanism 
whereby dexamethasone might cause a reduction in bone mineral density.
When compared with control, calcitriol modestly reduced the number of cells in 
the R3 fraction of bone marrow-derived cells, and increased that in the R4 and R5 
subpopulations: calcitriol modestly decreased the proportion of cells in the R4 
subpopulation and stimulated that in the R5 fraction of trabecular bone-derived cells. This 
suggests that calcitriol promotes the maturation of cells already progressing through 
differentiation, but effects only minor changes in the precursor populations. Treatment 
with calcitriol in combination with dex was seen to have no effect on the distribution of 
cells between the subpopulations when compared with dex alone, suggesting that acute 
treatment (less than 48 hours) with calcitriol is insufficient to neutralise the effects of dex 
on the number of cells expressing these surface antigens.
To investigate further the effects of these agents on the expression of Stro-1 and 
AP antigens, changes in the levels of antigen expression on the cells were examined by
166
the use of mean fluorescence intensity measurements. In bone marrow-derived cells, 
dexamethasone decreases the expression of Stro-1 in the R3 and R4 subpopulations but 
greatly increased that of AP in the R4 and R5 fractions. Therefore, taking these results 
together, dexamethasone stimulates the number of cells expressing AP in the R4 and R5 
subpopulations, and increases the expression level of AP on these cells. The reduction in 
the level of Stro-1 expression on the R3 and R4 fractions combined with increases in AP 
again suggests that the number of precursors is decreased (R2 and R3 fractions). This 
supports the observation earlier that dexamethasone enhances the differentiation of 
osteogenic cells while reducing the pool of precursors, and relates to the observations 
made in fig. 5.1, where dexamethasone treatment altered the morphology of the 
fibroblast-like cultured cells to a more osteoblastic one.
In bone marrow-derived cells, calcitriol alone has little effect on the expression 
levels of the Stro-1 antigen, but stimulates levels of AP expression, thereby promoting the 
specialisation of cells already progressing through differentiation. This suggests again that 
the primary actions of calcitriol are on maturing cells, and not on precursors. Calcitriol 
antagonises the stimulation of AP expression by dexamethasone to levels still greater than 
control: in the R4 and R5 subpopulations, cell numbers are unaffected whereas AP 
expression levels are decreased, when compared to the effects of dexamethasone alone. 
Expression levels of Stro-1 antigen are increased in the R4 subpopulation. Taking these 
results together, treatment with calcitriol modulates the differentiative effects of dex. 
Therefore, it would appear that in bone marrow-derived cells, co-treatment with calcitriol 
modulates the expression levels of the AP antigen but does not affect the number of cells 
expressing it when compared to the actions of dex alone. When compared to the effects of 
dex, co-treatment with calcitriol does not affect the level of expression of Stro-1 antigen in 
the R3 subpopulation but modulates the decrease elicited by dex in the R4 region, and 
does not greatly affect the number of cells expressing it in any of the fractions. This 
supports the idea that calcitriol has little effect on precursors.
In trabecular bone-derived cells, dex, alone or in combination with calcitriol, 
decreases expression levels of Stro-1 and AP in R4 relative to untreated cells, concomitant 
with an increase in AP expression in R5 region. This, the increase in numbers in the R5 
fraction, and the decrease in the number of cells in the R2 and R3 regions following 
treatment with dex, alone or in combination with calcitriol, suggests that dex promotes the 
terminal differentiation of maturing trabecular bone-derived cells, and strongly reduces the 
proliferation of their precursors. Levels of Stro-1 and AP antigen expression are reduced 
in the R4 subpopulation following treatment with calcitriol, but AP antigen expression 
levels are modestly increased in R5. This and the stimulation of cell numbers in the R5 
suggests that calcitriol also acts as a maturation-enhancing agent, primarily affecting cells 
already differentiating.
Therefore, in trabecular bone- and bone marrow-derived cells, treatment with dex, 
alone or in combination, stimulates the differentiation of the precursor cells and reduces
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their numbers, and increases the number of terminally differentiated osteoblastic cells 
(R5), when compared to untreated cells. By conjecture, in the short-term, the number of 
terminally differentiated cells is increased, so initially producing more bone, but with a 
reduced number of precursors, there would be an eventual decrease in the number of cells 
capable of producing bone. Acute treatment with calcitriol does not ameliorate the long­
term effects of dexamethasone on the numbers of differentiated cells in cultures of 
trabecular bone- and bone marrow-derived cells.
As differences were seen between trabecular bone- and bone marrow-derived cells 
and between the effects of dex and calcitriol on the numbers of cells expressing Stro-l/AP 
cell surface antigens and/  or the levels of antigen expressed on each cell, thus supporting 
the suggestion that the actions of these agents may be maturation-dependent, the 
separation of cells according to their cell surface expression of the Stro-1 and alkaline 
phosphatase antigens was shown to be appropriate.
RT-PCR was employed to examine the pattern of gene expression in the 
subpopulations of cells from bone marrow and trabecular bone. To reiterate, this 
technique is unsuitable for absolute quantitation of the magnitude of change in gene 
expression levels. However, within the limitations of RT-PCR, and emphasising any 
changes in direction only in the expression of osteoblast-related genes, consistent trends 
were observed. The expression of the genes of interest was seen to be restricted to certain 
subpopulations, but the patterns were different in bone marrow- and trabecular bone- 
derived cells. In bone marrow-derived cells, the pattern of expression in the untreated 
control cultures suggests that transcripts for BMP-4 and MSX-2 are maximally expressed 
earlier in the differentiation cascade (AP negative, R3) than BMP-2 (Stro-1 negative, R5) 
and osteocalcin (Stro-1 negative, R4/R5). Treatment with calcitriol stimulates expression 
of BMP-2, BMP-4 and osteocalcin earlier in the cascade (R2), thereby promoting the 
early differentiation of cells. Interestingly, the expression of MSX-2 was increased in R2 
but the maximal increase was in R3: the dramatic increase in MSX-2 in this region may 
downregulate the expression of osteocalcin in the R3 fraction.
The potent stimulation of MSX-2, osteocalcin and BMP-2 in the AP negative 
subpopulations (R2 and R3) by dexamethasone confirms the conclusion that 
dexamethasone enhances the early specialisation of these bone marrow-derived cells. One 
known effect of glucocorticoids is to suppress the replication of preosteoblasts (Doherty 
et al, 1995): this is confirmed by the FACS data where numbers of cells present in the R2 
and R3 fractions are reduced by long-term culture in dexamethasone. Therefore the 
galvanisation of differentiation in a reduced number of cells, accompanied by a reduction 
in the number of osteoblastic precursors, can be related to the effects of dexamethasone in 
vivo, where decreased bone formation (Cosman et al, 1994) occurs as a result of the 
production of fewer mature osteoblasts (Doherty et al, 1995). The increased expression of 
BMP-4 in the Stro-1 negative, AP positive subpopulation (R5) when compared with 
control, where BMP-4 transcript expression is downregulated coincident with
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downregulation in Stro-1 antigen expression, suggests that the continued expression of 
this gene may contribute to the increased number of cells in the R5 region or to the 
differentiation of this subpopulation following treatment with dexamethasone.
Treatment with calcitriol and dexamethasone in combination increases BMP-2 
mRNA expression in the AP negative fractions (R2 and R3) and suppresses expression in 
the R5 fraction, when compared to the effects of dexamethasone alone. There is some 
degree of antagonism between the two agents as the maximal increase following treatment 
with both agents is lower than that seen following treatment with dexamethasone alone. 
The magnitude of maximal BMP-4 transcript expression, also in the R3 fraction, indicates 
that the agents were acting independently of each other as an additive increase was seen. 
Expression of MSX-2 and osteocalcin mRNA is maximally stimulated in the R2 fraction: 
MSX-2 expression in the Stro-1 negative fractions (R5 and R2) was increased in a supra- 
additive manner; osteocalcin transcript levels in the R5 region were also greater than in 
those seen following treatment with either agent alone, but the maximal increase (in the 
R2 region) indicated some antagonism between the agents as levels were lower than 
following treatment with dexamethasone alone.
Taken together, these data suggest that calcitriol alone acts as a maturation- 
enhancing agent, promoting the specialisation of cells by further increasing the expression 
of osteoblast-related genes in early subpopulations. Dexamethasone acts at all levels and 
promotes differentiation and maturation, but reduces the number of osteogenic 
precursors. Dexamethasone has a more dominant effect on the expression of osteoblast- 
related genes in bone marrow-derived cells than calcitriol when the two agents are added 
in combination, as calcitriol can only partly antagonise the effects of dexamethasone on 
the expression of these genes. The interactions between these two agents produced 
additive or supra-additive effects on the maximal expression of BMP-4 and MSX-2 
transcripts respectively, which occurred in subpopulations where the cell numbers were 
decreased, suggesting that the expression of these genes is involved in the increased 
differentiation of bone marrow-derived cells.
Interestingly, when variation in the levels of transcript expression in the control 
subpopulations was taken into account, the expression pattern in bone marrow-derived 
cells in the R2 fraction following treatment with calcitriol was seen to closely resemble 
that seen in MG-63 cells after exposure to the agent. Expression of all four genes was 
increased, with maximal increase observed in BMP-2, then osteocalcin, MSX-2 and 
BMP-4. This supports the idea that MG-63 cells can be used as an adequate model of 
osteoblastic differentiation. A further step would be to label these osteosarcoma cells for 
the expression of Stro-1 and alkaline phosphatase and examine how these vary following 
treatment with calcitriol and/  or dexamethasone, and also how the expression of the genes 
of interest change within the subpopulations.
While calcitriol and dexamethasone, alone or in combination, increase the level of 
expression of osteoblast-related transcripts in both trabecular bone- and bone marrow-
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derived cells, the gene expression pattern in untreated trabecular bone-derived cells is 
different in detail from that seen in untreated bone marrow-derived cells. In the control, 
maximal levels of BMP-2 and osteocalcin are seen in the R2 region (respectively AP 
positive R5 and R4 fractions in bone marrow-derived cells), those of BMP-4 in the 
R4/R5 regions and those of MSX-2 in the Stro-1 negative R5/R2 fractions (both 
expressed maximally in the Stro-1 positive R3 region for bone marrow-derived cells). 
This pattern of gene expression (BMP-4-MSX-2-BMP-2-osteocalcin) is similar to the 
expression pattern outlined for human bone-derived cells previously (in order, BMP-2- 
BMP-4-MSX-2-osteocalcin, see results chapters 1 and 2). Treatment with calcitriol 
induces maximal levels of expression of transcripts for all four genes in the R5 fraction 
but the magnitude is decreased for BMP-2, when compared with control. Therefore in 
these cells, calcitriol maximally induces osteoblast-related gene expression in cells 
positive for alkaline phosphatase cell surface expression only, that is, in terminally 
differentiated cells.
Dexamethasone treatment induces a maximal increase in MSX-2 in R5 (R3 in 
bone marrow-derived cells), and BMP-4 and osteocalcin in the Stro-1 positive R3 region 
(Stro-1 negative R5 and R2 subpopulations in bone marrow-derived cells, respectively). 
Osteocalcin transcript expression is suppressed in the R5 subpopulation by treatment with 
dexamethasone, which is consistent with findings that dexamethasone inhibits the 
expression of osteocalcin in osteoblast cultures (reviewed by Delany et al, 1994). 
Maximal increase in BMP-2 expression was in the R2 region (Stro-1 positive R3 region 
in bone marrow-derived cells), and a decrease was seen in the R5 subpopulation: 
respectively, the proportion of cells was decreased and increased when compared with 
control (see table 5.4). Therefore, following treatment with dexamethasone, expression of 
BMP-2 mRNA is increased in reduced numbers of undifferentiated cells, and reduced in 
the increased numbers of terminally differentiated cells. This suggests that expression of 
BMP-2 transcripts is related to the proliferative capability of the cell.
Calcitriol and dexamethasone in combination produce additive effects on the 
magnitude of maximal expression of transcripts for MSX-2, BMP-2 and BMP-4: 
expression levels for osteocalcin transcripts are increased in a supra-additive manner. 
Levels of transcript expression of all four genes are increased in the Stro-1 negative (R5 
and R2) subpopulations (AP negative R2 and R3 fractions in bone marrow-derived cells) 
when compared to the action of dexamethasone alone, suggesting that the action of 
calcitriol and dexamethasone in concert promotes the terminal differentiation of these 
cells. That this stimulation of differentiation occurs in the R2 cell population, where cell 
numbers are decreased when compared to untreated cells or cells treated with calcitriol 
alone, supports the idea that this subpopulation can contain cells which are fully 
differentiated.
Of the four subpopulations of cells separated according to their expression of 
Stro-1 and alkaline phosphatase, the one which is most ambiguous is the double negative
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population (R2): neither Stro-1 nor alkaline phosphatase is expressed on the cell surface 
of these cells. As the methodology stands, it is impossible to discover if this fraction 
represents a population which is early and undifferentiated, fully differentiated or a 
mixture of both. Ideally, the development and application of an antibody which could 
distinguish between primitive precursors and terminally differentiated osteoblasts could at 
least partly answer this. However, in trabecular bone- or bone marrow-derived cells, the 
reduction in precursor proliferation by dexamethasone decreased the number of cells in 
this subpopulation, and the increase in osteocalcin transcript expression in the R2 region 
following treatment with calcitriol and dexamethasone in combination indicates that the R2 
subpopulation contains terminally differentiated cells. Therefore, it is likely that, 
following treatment with calcitriol and dexamethasone, the R2 subpopulation contains a 
mixture of both undifferentiated and terminally differentiated cells. Extrapolating these 
findings to an in vivo situation, a substantial decrease in the numbers of precursors would 
result in fewer mature osteoblasts when the precursors differentiate, which in turn would 
cause a net imbalance in bone remodelling. By conjecture and as previously discussed, 
acute treatment with calcitriol would not rescue the detrimental effects to bone formation 
of constant exposure to dexamethasone.
Taken together, these data support the conclusion that calcitriol and 
dexamethasone are both osteogenic differentiation agents, increasing the expression of 
osteoblast-related genes including MSX-2, but in contrast to the finding for bone marrow- 
derived cells, calcitriol has the more dominant effect in trabecular bone-derived cells. 
Also, while the agents have broadly similar effects on cell numbers and modulation of 
gene expression in trabecular bone- and bone marrow-derived cells, the cell 
subpopulations in which the effects of these agents occur differ. This implies that, while 
the effects of the agents are maximal in specific subpopulations and therefore in specific 
maturation stages, the maturation stages at which these effects take place are different 
between trabecular bone- and bone marrow-derived cells.
One explanation for differences in the patterns o f gene expression in cells derived 
from bone marrow and trabecular bone, untreated or following treatment with 
dexamethasone and/  or calcitriol, could be that the bone marrow-derived cells are 
progressing through differentiation for the first time and as a consequence, no inhibitions 
on the expression of genes later in the cascade have been placed. Trabecular bone 
contained cells at different maturation stages, therefore the culturing of trabecular bone- 
derived cells may have resulted in de-differentiation, where when first plated, cells 
already involved in the cascade of differentiation are returned to a less mature state by the 
presence of proliferative signals from the medium or, as cell density is known to have an 
effect on gene expression, intercellular communication may be involved.
While separation of cells using FACS was seen to provide some indication that the 
expression of osteoblast-related genes may be cell maturation-dependent, some variation 
in the response of cells to treatment with exogenous factors was still apparent. Therefore,
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the other factors indicated previously (age, gender, site of extraction of bone, etc.) must 
play a role in the regulation of expression of these genes. Indeed, it was shown recently 
that increased androgen serum levels and greater expression of the androgen receptor at 
specific skeletal sites in males contributes to gender-related differences in the morphology 
of the skeleton (Kasperk et al, 1997). Appendix 2 contains a donor list, including age, 
gender, extraction site and whether the patient contributed trabecular bone, marrow or 
both. Six patients donated marrow (four female, two male; all but one above the age of 50 
years; all but one contributed rib); twelve patients donated trabecular bone (five female, 
seven male; all but three above the age of 60 years; at least four sites of extraction). In the 
absence of sufficient tissue samples, these parameters could not be tested here, therefore 
an obvious next step in an attempt to discern the factors affecting osteoblast-related gene 
expression in osteoblastic cells would be to test the effects of the exogenous growth 
factors in age- and gender-matched donors following extraction of samples from the same 
region of bone.
This results chapter shows that there are differences in the effects of calcitriol and 
dexamethasone on trabecular bone- and bone marrow-derived cells. Overall, both agents 
are potent differentiative factors and regulate the expression of osteoblast-related genes, 
including MSX-2. The regulation by these agents of the expression of these genes, and 
therefore of differentiation, was seen to be maturation-specific and was related to the 
source of cells (bone marrow or trabecular bone). Dexamethasone reduced the number of 
precursors and stimulated the progressive differentiation of all cells at different stages of 
maturation. Co-treatment with calcitriol resulted in increased numbers of terminally 
differentiated cells but did not affect the anti-proliferative effects o f dexamethasone on 
early, immature cells. A net decrease in the number of mature osteoblasts, and therefore 
of bone formation, as a result of reduced proliferation of precursors following 
dexamethasone treatment would not be substantially altered following subsequent acute 
treatment with calcitriol, despite an initial increase in the number of terminally 
differentiated cells. Thus, by conjecture, dexamethasone-induced osteoporosis may not be 
reversed by acute treatment with calcitriol.
Chapter 6 
D ISC USSIO N  AND FU TU R E W O RK
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Classically, the study of homeobox-containing genes has centred on their role in 
the patterning and differentiaiton of cells in the development of the embryo (reviewed by 
Gehring, 1994). The importance of such genes in morphogenetic pathways, for example 
in the development and outgrowth of the limb, and at other sites of epithelial- 
mesenchymal interactions, such as craniofacial development and tooth morphogenesis, 
has been underlined in a comprehensive body of research in rodent and avian embryos. 
The discovery that the homeobox-containing gene MSX-2 is expressed at these sites has 
implicated its homeodomain-containing protein product in the regulation of these 
processes. Also shown is that MSX-2 expression is induced by the bone morphogenetic 
proteins in a paracrine fashion: signalling by epithelially-produced BMP-4 induces 
expression of BMP-2, BMP-4 and MSX-2 in underlying mesenchyme and is a key 
feature of morphogenesis.
In this project, it has been consistently shown that MSX-2 mRNA expression in 
adult human bone-derived cells is induced by BMPs -2 and -4. The finding that the same 
regulation of MSX-2 by BMPs in the differentiation of the mesenchymally-derived 
osteoblastic cell lineage occurs in adult tissue as in embryonic tissue development has 
important implications for the understanding of osteogenesis and the maintenance of bone 
as an organised tissue in the adult, and by inference, in the comprehension of the 
breakdown of such processes in the development of osteoporosis. It was suggested that 
the tightly restricted expression of MSX-2 is critical in the switch between proliferation 
and differentiation, and that it acts as a mediator of BMP-induced osteogenesis. Its 
function is not conclusively clear in these studies, but it has been shown to act as a 
negative regulator of chondrogenesis (Mina et al, 1996) and, as BMPs act as adipogenic 
antagonists (Gimble et al, 1995), it is possible that MSX-2 mediates this negative 
differentiation signal also. It is therefore possible that MSX-2 expression and subsequent 
downregulation acts primarily as a negative regulator of chondrogensis/ adipogenesis, 
leading to the formation of bone by default, or appropriate M SX-2 expression could 
actively stimulate osteogenesis. This has obvious implications for the development of age- 
related bone disease such as osteoporosis, where inappropriate expression of MSX-2 
could conceivably result in a strong drive away from osteogenesis and towards 
adipogenesis/ chondrogenesis. Examination of the function of MSX-2 in bone cells is 
clearly importnat, therefore disabling the functions of MSX-2 by development of an 
MSX-2 knock-out mouse or introduction of antisense oligonucleotides to cells in culture 
would be a vital step in the understanding of the role of this protein in bone cell biology.
Regulation by the pleiotropic steroid hormone metabolite calcitriol appears to be 
conserved between cells derived from osteosarcoma and from normal adult tissue. This 
regulation was shown to involve indirect mechanisms. Exploration of the precise 
mechanisms involved requires knowledge of the promoter sequence, therefore cloning of
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sequence further upstream from the 1.2 kb sequence already elucidated is necessary to 
confirm that the effects of calcitriol on the expression of MSX-2 are indirect. It is possible 
that some or all of the E box sequences in the 1.2 kb promoter region are functional and 
therefore may play a critical role in the regulation of the expression of this gene. In order 
to test this, firstly it would be of interest to ensure that binding occurs at these sites. 
Therefore use of oligonucleotide sequences identical to these motifs in an electromobility 
shift assay (EMSA) would determine if cell proteins bind to any of these sequences. A 
next step would be to fuse the promoter sequence to a reporter gene, such as beta- 
galactosidase, luciferase or chloramphenicol acetyl transferase, to determine if any of 
these sequences are functional. Disruption of these sequences by deletion analysis or in 
vitro mutagenesis could examine if a loss of function occurs.
Once it is clear that E box proteins bind to the MSX-2 promoter and are 
functional, activating transcription, investigations into the role of Id (inhibitor of 
differentiation) genes can take place. Competition using Id proteins in an EMSA to 
examine a proposed loss of binding at the E box protein binding sites would be a first 
step. Co-transfection of a construct containing coding sequence for Id protein fused to an 
inducible promoter (EG) and the construct containing the MSX-2 promoter linked to a 
reporter gene already described could show that transcription of the reporter gene is 
reduced or ablated when the Id construct is activated.
Use of the RT-PCR technique revealed consistent trends in the effects of the 
parameters tested upon the expression of osteoblast-related genes. However, as stated in 
the Discussion sections of each Results chapter, this technique is not appropriate for the 
absolute quantitation of changes in magnitude of gene expression. Therefore, it would be 
of interest to analyse the RNA from these experiments with another more quantitative 
method, such as dot-blot hybridisation.
Use of FACS analysis was shown to be appropriate: the results showed exactly 
what the experiments were designed to show, namely that the expression of osteoblast- 
related genes is dependent upon the stage of maturation of the cell, that the effects of 
agents on the expression of these genes is also stage-specific, even to the extent of being 
opposite at different stages, and that differences between donors may reflect the varying 
proportions of cells at different stages of maturation/ differentiation. The proposed model 
for the cascade of osteoblastic gene expression was partially upheld: in untreated bone 
marrow-derived cells, BMP-4 is expressed earliest, then MSX-2 and osteocalcin. Further 
work where cells are separated by FACS, then recultured and treated with calcitriol and 
dexamethasone may elucidate the position of BMP-2 in the cascade. It would be useful 
also to monitor the expression of Stro-1 and AP over time in these sorted and replated 
subpopulations. Of great interest also would be to understand where in the progression of
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cells from progenitor to mature osteoblast that BMPs have their greatest effects. This 
could be examined by treating these sorted and recultured cells with BMP-2 or BMP-4.
The discovery that the calcitropic agents calcitriol and dexamethasone have 
maturation-specific effects on the expression of osteoblast-related genes warrants further 
investigation. Separation of cells by FACS followed by treatment with these factors could 
elucidate their effects, as the fractions obtained in the course of this research were not 
100% pure. The repercussions of the effects of these agents in clinical terms suggests 
mechanisms whereby drug-induced osteopenia and osteoporosis might occur. The results 
shown suggest that dexamethasone strongly suppresses the replication of osteoblast 
precursors, thus reducing the pool of osteoprogenitors which can differentiate into mature 
bone-forming cells. It would therefore be of great interest to examine agents which could 
be shown to counteract the detrimental effects of dexamethasone on bone formation. 
Preliminary data following treatment of bone cell cultures with fibroblast growth factor-2 
(FGF-2) indicates that this agent is a potent stimulator of osteogenic proliferation. Indeed, 
use of FGFs in stimulating bone formation has already been shown (Dunstan et al, 1993). 
Studies on the interactions between these factors could be of clinical importance in the 
prevention or treatment of osteoporosis.
Cell: cell and cell: matrix communication was seen modulate the effects of the 
agents studied on the expression of osteoblast-related genes. This may be mediated by the 
levels of adhesion molecules and the prevalence of gap junctional communication between 
cells. It would be appropriate to examine the levels of the expression of these molecules at 
different cell densities, in the presence and absence of extracellular matrix, and to 
investigate how these levels might be modulated by the agents studied.
The interactions between osteogenic factors in this project indicate a complex 
regulation of osteoblast-related gene expression. This would seem sensible when 
considered in terms of the in vivo situation, where several factors are present at or near 
the bone-forming surface and osteoblasts at any given time. Local concentrations, and 
therefore effects, of these factors will vary according to rates of synthesis, sequestration 
to the matrix and degradation, and importantly upon the expression levels of their 
receptors (nuclear vitamin D receptor and cell surface serine/threonine kinase receptors). 
An obvious next step would be to examine the levels of expression of these receptor 
molecules as cells proliferate and differentiate, and how their ligands might modulate 
them.
The regulation of osteogenesis by the CBFA1 gene was comprehensively 
examined recntly (reviewed by Rodan and Harada, 1997). To recap, CBFA1 is expressed 
in all prospective endochondral bone sites and by intramembranous craniofacial bone, as
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derived from the branchial arches (Komori et al, 1997). In situ hybridisation studies 
indicate that that CBFA1 is expressed in osteoblastic and chondroblastic bipotential cells 
during mesenchymal condensation but continues to be expressed only in cells of the 
osteoblast lineage (Ducy et al, 1997). The expression patterns of CBFA1 and MSX-2 are 
therefore coincident. It would be of great interest to examine the expression of both genes 
simultaneously in adult human bone-derived cells, and to investigate the effects of the 
BMPs on the expression of CBFA1. Interestingly, in the 1.2 kb MSX-2 promoter region, 
there are no consensus binding sites for CBFA1 (see figure 1.5 and 4.10), therefore it 
would be o f great interest to observe if the expression of these two genes is inter-related.
The preceding chapters indicate that osteoblastic differentiation is influenced in a 
complex manner in adult human bone-derived cells by osteoinductive agents, including 
calcitriol, bone morphogenetic proteins and dexamethasone. A more extensive 
investigation into the expression of other genes in the osteoblast differentiation pathway, 
such as type I collagen, osteonectin, osteopontin and bone sialoprotein, and how they are 
affected by these osteogenic agents, would be of great interest to further characterise 
intermediate stages in the progression of precursors to osteoblast maturity, and thereby to 
increase understanding of how these cells lose function over time, and why with age, 
osteoblasts become relatively less abundant.
A PPEN D IX  1 
Stock  so lu tion s
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Tissue culture
DMEM (Dulbecco’s modified Eagle’s medium):
100 ml lOx DMEM (+NEAA, -glutamine, -pyruvate,
-bicarbonate)
20 mM Hepes buffer
0.09% sodium bicarbonate
1 mM sodium pyruvate
2 mM L-glutamine
2 5 IU-25 pg penicillin/streptomycin t
This was made up to 1 litre with Milli-Q water and adjusted to pH 7.2 with sodium 
hydroxide before filter sterilisation. It was then aliquoted into 500 ml arjtoclaved bottles 
and stored at 4°C. (All tissue culture stocks were supplied by Gibco BRL).
Phosphate buffered saline (PBS):
10 PBS tablets were dissolved in 1 litre o f Milli-Q water and autoclaved. It was allowed 
to cool to room temperature before use.
Collagenase IV:
This was made up in sterile water or serum-free medium and stored in 1 ml aliquots at 
-20°C. It was used at 25 U/ ml final concentration.
Deoxyribonuclease I (DNase I):
This was made up in 150 mM sodium chloride to 2000 units/ ml. It was used at 
2 0  units/ ml final concentration.
Transforming growth factor-beta-1 (TGF-beta-1):
This was constituted in 4 mM hydrochloric acid plus 1 mg/ ml bovine serum albumin 
and stored in 500 pi aliquots at -20°C.
Bone morphogenetic proteins 2 ,4  and 6  (BMP-2, BMP-4 and BMP-6 ):
These were made up in DMEM and stored in 500 pi aliquots (BMP-2 at 100 pg/ ml, 
BMP-4 and BMP- 6  at 25 |tg/ ml) at -20°C.
Bone morphogenetic protein 7 (BMP-7):
This was made up in DMEM and stored in sealed evacuated tubes in 40 pi aliquots of 
100 pg/ ml at -20°C.
la,25-dihydroxy vitamin D 3 (calcitriol):
This was made up in absolute ethanol and stored in sealed evacuated tubes under 
gaseous nitrogen in 250 pi aliquots o f 3.44x 10*M at -20°C.
Basic fibroblastic growth factor (FGF-2, NBS Biologicals):
This was made up in PBS and stored in 10 jlxI aliquots of 50 (ig/ ml at -20°C.
Ascorbate-2-phosphate (asp):
This was supplied as a desiccate and stored at -20°C in a box containing desiccant. It 
was made up in DMEM to a stock strength of 10 mM and filter-sterilised before being 
stored at -20°C as 5 ml aliquots. It was used at a final concentration of 100 pM.
Dexamethasone (dex): ■*.
This was made up in serum-free DMEM to a stock concentration o f 5x 10 5 M and 
filter-sterilised before being stored at -20°C as 1 ml aliquots. It wasf used at a final 
concentration of 10*8 M.
FACS
Hanks balanced salt solution (HBSS) xlO stock:
54 mM potassium chloride
4 mM potassium hydrogen phosphate (KH2PO4)
2 M sodium chloride
4 mM disodium hydrogen phosphate (Na2 HP0 4 .2 H2 0 )
This was made to 1 litre with distilled water and stored. Prior to use, it was diluted in 
distilled water and autoclaved at 15 lb/ in2 for 30 minutes.
Blocking buffer:
10% AB serum
5% fetal calf serum (FCS)
1% bovine serum albumin (BSA)
made up in HBSS
An appropriate quantity o f BSA was measured and dissolved in HBSS. To this were 
added the two types o f serum and the volume adjusted with HBSS. If the blocking 
buffer was required to be sterile, the BSA dissolved in HBSS was filter-sterilised prior 





made up in HBSS
This was made fresh at the start of each experiment and used to increase volumes o f cell 




Randon hexamer primers [Pd(N)6]:
iml o f sterile water was added to 50 U Pd(N )6 and gently pipetted up and down to 
suspend. This was stored at -20°C.
PCR primers:
These were produced by Pharmacia Biotech and required dilution to 20-30 pmoles/ pi 
before use in the PCR. Concentrated stocks and ready-to-use diluted primers were 
stored in aliquots at-20°C. i
Gel electrophoresis <
DEPC-treated water:
1 ml o f diethylpyrocarboriate (DEPC) was added to 1 litre of Milli-Q water in a fume 
cupboard. This was covered and left mixing on a magnetic stirrer overnight. The 
follow ing day, the treated water was autoclaved, then allowed to cool to room 
temperature before use.
lOx TAE gel running buffer:
400 mM Tris base
50 mM sodium acetate
10 mM EDTA
This was diluted in distilled water and brought to pH 8.1 with glacial acetic acid so that 
when diluted to working strength (lx ) the running pH was 7.9.




No pH adjustment was necessary 
distilled water.
50x MOPS, pH 7.0 (RNA gel running buffer):
1 M MOPS
250 mM sodium acetate
50 mM EDTA, pH 7.0
This was adjusted to pH 7.0 with sodium hydroxide and autoclaved. It turned a 








175.3 g sodium chloride
8 8 .2  g sodium citrate
800 ml distilled water was added then the solution was adjusted to pH 7.0 with
hydrochloric acid. It was made up to 1 litre and filter-sterilised or autoclaved.
1M sodium phosphate, pH 7.2:
89 g sodium phosphate, dibasic
This was adjusted to pH 7.2 by addition o f 3-4 ml concentrated orthophosphoric acid 
and autoclaved. f .
0.4 M sodium hydroxide:
8  g sodium hydroxide pellets were added to 500 ml distilled water and mixed on a 
magnetic stirrer until dissolved.
50x Denhardt’s solution:
5 g Ficoll
5 g polyvinylpyrrolidone (PVP)
5 g bovine serum albumin
This was made up to 500 ml with Milli-Q water and filter-sterilised before storage at 
-20°C.
Denatured salmon sperm DNA:
This was supplied desiccated and was reconstituted by addition of water. It was made 
up to 8-10 mg/ ml final stock concentration and sheared by sonication. Following 





This was made up in DEPC-treated water for RNA gel electrophoresis analysis.
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Church’s buffer:
0.5 M sodium phosphate, pH 7.2 (see above)
1%  sodium dodecyl sulphate (SDS)
1 mM EDTA, pH .0
This was made up to 1 litre with DEPC-treated water and stored at room temperature. 
To ensure even distribution o f SDS, all the buffer was heated to hybridisation 
temperature and mixed before an aliquot was removed for the hybridisation reaction.
Wash buffer: -;i
40 mM sodium phosphate, pH 7.2
1% SDS f .
This was made up in distilled water and stored at room temperature.
General solutions 
lOx TE, pH 8.0:
100 mM Tris base, pH 8.0
10 mM EDTA, pH 8.0
This was made up to 100 ml with distilled water and autoclaved.
Bacterial culture
Ampicillin:
This was made up as a 25 mg/ ml stock in Milli-Q water and sterilised by filtration 
before being stored at -20°C in 5 ml aliquots.
Bacterial growth medium:
10 g Bacto-tryptone (Unipath Ltd.)
5 g Bacto-yeast extract (Unipath Ltd.)
1 0  g sodium chloride












409 marrow and trabecular








524 marrow and trabecular
Age Gender Site o f
extraction
84 female femoral head
73 female rib
69 female femoral head
89 female femoral head
6 6  female 1 iliac crest
39 female rib
*
61 female V- rib
54 male rib
2 1  male fibula fracture
32 male fibula





The table above lists the characteristics o f the donors who contributed tissue to this 
research. Of the donations, 12 were o f trabecular bone and 6  were of bone marrow. To be 
noted is the age range (21 -89  years) and the variety of sites o f extraction, which include 
rib, femoral head, knee and fibula.
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The calculated H value is only significant if  it is equal to or greater than the critical H 
value. Therefore, only the effects of calcitriol on BMP-2 and osteocalcin expression are 
statistically significant and the null hypothesis o f calcitriol having no effect on the 
expression of these genes in MG-63 cells must be rejected. Calcitriol appears to have no 
effect on the expression o f the mRNA o f the other genes tested, therefore as the null 
hypothesis is upheld for these genes, the second part o f the Kruskal-Wallis test, for Q 
values, was not performed upon them.
Q values
For this set of experiments, where the number o f samples equals 4, the critical Q value is 
2.639. If the calculated value is greater than or equal to the critical value, a significant 
difference between the two samples is indicated. Throughout the Q value sections in 
Appendix 3, numbers in bold type indicate an increase at 5%  significance when the 




00o 0.289 2 .1 2 2
IQ' 9 1.061 0.707 1.500
10-9 1 0 -8 lO-7 0
These data indicate no significant differences in osteocalcin gene expression following 





lO 8 0.289 2.122
10-9 1.061 0.707 1.500
10-9 10-8 10-7 0
Therefore there is no significant increase in BMP-2 expression following treatment with 
any dose o f calcitriol.
Therefore, while calcitriol produces an overall significant stimulatory effect on the 
expression o f osteocalcin and BMP-2, this is not due to differences in effect between 
specific doses.
Null hypothesis 2: BMP-2 does not affect osteoblastic gene expression in MG-63 cells
BMP-2 (ng/ml) relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
0 1 1 1 1 1 1 1 1 1 1 1 1
1 1.5 2 .6 5.8 3.6
50 1.5 2.5 36 1.0 1.3 1.6 1.5 1.7 3.6 o o o
250 2.3 1.3 0 0 .2
critical H value
at 5%  significance 6.333 6.333 6.333 6.333
calculated
H values 5.500 4.333 5.833 5.889
BMP-2 has no statistically significant effect on the expression of any o f the genes tested, 
therefore the null hypothesis that BMP-2 has no effect on osteoblast-related gene 
expression in MG-63 cells must be upheld.
Null hypothesis 3 :
BMP-7 does not affect the transcript levels o f osteoblast-related genes in MG-63 cells
BMP-7 (ng/ml) relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
0 1 1 1 1 1 1 1 1 1 1 1 1
1 1 0 .8 4.8 6.4 9.0
1 0 4.3 24 15 24
50 2.8 3.4 14 1.8 2.9 13 1.5 1.7 3.9 0.9 1.0 8 .6
250 10 6.3 4.5 4.4
critical H value
at 5%  significance 7.111 7.111 7.111 7.111
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calculated
H values 5.867 6.578 7.467 4.911
BMP-7 treatment was seen to have a significant effect only on the expression of BMP-2 
transcripts. Therefore the null hypothesis that BMP-7 has no effect on BMP-2 mRNA 
expression in MG-63 cells must be rejected.
Q values




1 0 0.258 2.214
50 1.265 0.949 1.342
250 0.633 0.516 0.258 1.581
250 50 1 0 1 0
There were no significant differences in BMP-2 mRNA expression following treatment 
with BMP-7.
Therefore, treatment with BMP-7 has an overall significant stimulatory effect on BMP-2 
mRNA expression which cannot be related to specific doses.
Null hypothesis 4:
TGF-beta has no effect on the expression o f osteoblast-related genes in MG-63 cells
TGF-beta (ng/ml) relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
0 1 1 1 1 1 1 1 1 1 1 1 1
0.05 3 8  67 1 2 5 0  1 6 1 1 7
0.25 7 .4 8 6
1.25
critical H value
3 4 2 5
at 5%  significance 
calculated
6.333 6.333 6.333 6.333
H values 5.222 5.222 3.222 3.638
No significant effects on osteoblast-related gene expression were seen following treatment 
of MG-63 cells with TGF-beta. Therefore the null hypothesis is upheld.
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Statistical analyses of the effects o f BMP-4 and BMP- 6  on osteoblast-related gene 
expression in MG-63 cells were not done as insufficient independent repeats o f the 
experiments were performed.
The following section examines the expression o f osteoblast-related genes in 
MG-63 cells treated with a combination o f the above agents at the following doses: 
lOnM calcitriol (D), 50 ng/ml BMP-2 (B2) or BMP-7 (B7) and 0.05 ng/ml TGF-beta (Tb).
Null hypothesis 5 :
i
Interactions between calcitriol and increasing doses o f  BMP-2 have no effect on 




10 nM D 2 6  6
1 ng/m l BMP-2 + D 1.5 
50 ng/ ml BMP-2 + D 3 3 160 






















critical H values 6.333







No significant difference between the treatment groups was seen, therefore the null 
hypothesis is upheld.
Null hypothesis 6 :
Interactions between calcitriol and increasing doses o f  BMP-7 have no effect on 




10 nM D 2 6  6
1 ng/ ml BMP-7 + D 10
10 ng/ ml BMP-7 + D 9
50 ng/m l BMP-7 + D 7 19 327
250 ng/m l BMP-7 + D 9
critical H values 7.111




2 3 14 1 1 28 3 4 6
11 9 22
31 8  24





No significant difference between the treatment groups was seen, therefore the null 
hypothesis is upheld.
Null hypothesis 7 :
Interactions between calcitriol and increasing doses o f TGF-beta have no effect on 
osteoblast-related gene expression in MG-63 cells
Agent relative relative relative relative




10 nM D 2  6  6 2 3 14 1 1 28 < 3 4 6
0.05 ng/m lT G F + D 5 5 119 2 5 9 1 3 4 'V- 0 2 4
0.25 ng/ ml TGF + D 4. 3 2 . 5
1.25 ng/m l TGF + D 4 4 2 8
critical H values 6.333 6.333 6.333 6.333
calculated H values 2 .1 1 1 0 .2 2 2 0 .1 1 1 4.111
No significant difference between the treatment groups was seen, therefore the null 
hypothesis is upheld.
Null hypothesis 8 :
Calcitriol and BMP-2, alone or in combination, have no effect on osteoblast-related gene 
expression in MG-63 cells
Agent relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 1 1 1 1 1 1
calcitriol 0  1 2 1 3 3 1 2  2 0.5 1 2
BMP-2 0.5 3 11 1 1 2 2 2 4 0  0 .1  0 .2
calcitriol + BMP-2 1 1 2 2 2 3 1 1 2
oo01
critical H values 7.000 7.000 7.000 7.000
calculated H values 2.077 6.885 5.654 8.436
The only significant difference was in BMP-4 transcript expression between the treatment 
groups, therefore the null hypothesis that calcitriol and BMP-2, alone or in combination, 
do not affect BMP-4 mRNA expression must be rejected.
Q values





calcitriol + BMP-2 0 .1 1 2 2.150 1.810
BMP-2 calcitriol untreated
Calcitriol and BMP-2, alone or in combination, have no significant effect on BMP-4 gene 
expression in MG-63 cells.
i
Therefore, the result o f treatment with calcitriol and BMP-2, alone or in combination, have 
an overall inhibitory effect on BMP-4 expression which cannot be related to the effects of 
either agent alone or in combination.
Null hypothesis 9 :
Calcitriol and BMP-7, alone or in combination, have no effect on osteoblast-related gene 
expression in MG-63 cells
Agent relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 I 1 1 1 1 1 1 1 1 1
calcitriol 0  1 2 1 3 3 1 2  2 1 1 2
BMP-7 3 3 14 2 3 13 2 2 4 1 1 9
calcitriol + BMP-7 1 5 8 2 3 6 1 3 7 0.5 2 7
critical H values 7.000 7.000 7.000 7.000
calculated H values 12.462 7.192 4.089 0.423
The only significant differences were in M SX-2 and osteocalcin transcript expression 
between the treatment groups, therefore the null hypothesis that calcitriol and BMP-7, 
alone or in combination, do not affect MSX-2 and osteocalcin mRNA expression must be 
rejected.
Q values





calcitriol + BMP-7 0 2.154 1.586
BMP-7 calcitriol untreated
Calcitriol and BMP-7, alone or in combination, have no significant effect on MSX-2 gene 





calcitriol + BMP-7 0 0.849
BMP-7 calcitriol
Calcitriol and BMP-7, alone or in combination, have 
gene expression in MG-63. cells.
Therefore, the stimulatory effects of calcitriol and BMP-7, alone or in combination, on 
osteocalcin expression were shown to be significant overall but could not be related to 
specific interactions. Similarly, the inhibitory effects of calcitriol on MSX-2 expression 
relieved by treatment with BMP-7 were not shown to be specifically significant, despite 
the overall significance o f the effects of the agents on MSX-2 expression, as indicated by 
the calculated H value.
Null hypothesis 10:
Calcitriol and TGF-beta, alone or in combination, have no effect on osteoblast-related gene
expression in MG-63 cells
Agent relative relative relative relative
MSX-2 osteocalcin , BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 1 1 1 1 1 1
calcitriol 0  1 2 1 3 3 1 2  2 0.5 1 2
TGF-beta 3 7 67 1 2 5 0  1 6 1 1 7
calcitriol + TGF-beta 0 2 3 1 3 4 0 3 4 ”'0 0.4 1
critical H values 7.000 7.000 7.000 7.000
calculated H values 6.859 6.320 1.500 6.269
There was no significant difference in the transcript expression of any o f the genes tested 
following treatment with calcitriol and TGF-beta, alone or in combination, therefore the 






no significant effect on osteocalcin
Null hypothesis 11:
189
Members o f the TGF-beta superfamily, alone or in combination, have no effect on 
osteoblast-related gene expression in MG-63 cells
1) Compare against BMP-2 + BMP-7
Agent relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 1 1 1 1 1 1
BMP-2 0.5 3 11 1 1 2 2 2 4 0  0 .1  0 .2
BMP-7 3 3 14 2 3 13 2  2  4 . 1 1 9
TGF-beta 3 8  67 1 2 5 0  1 6 1 1 7
BMP-2+ BMP-7 6 3 2 . 7
BMP-2, BMP-7 
+ TGF-beta 1 2 . 5 0 0
critical H values 11.07 11.07 11.07 11.07
calculated H values 7.095 8.848 5.962 9.419
There was no significant difference in the transcript expression of any o f the genes tested 
following treatment with calcitriol and TGF-beta, alone or in combination, therefore the 
null hypothesis is upheld.
2) Compare against BMP-2 + TGF-beta
Agent relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 . 1 1 1 1 1 1
BMP-2 0.5 3 11 1 1 2 2 2 4 0  0 . 1  0 . 2
BMP-7 3 3 14 2 3 13 2 2 4 1 1 9
TGF-beta 3 8  67 1 2 5 0  1 6 1 1 7
BMP-2+ TGF-beta 16 2 1 3
BMP-2, BMP-7
+ TGF-beta 12 5 0 0
critical H values 11.07 11.07 11.07 11.07
calculated H values 8.009 8.847 7.800 9.190
There was no significant difference in the transcript expression of any o f the genes tested 
following treatment with calcitriol and TGF-beta, alone or in combination, therefore the 
null hypothesis is upheld.
3) Compare against BMP-7 + TGF-beta
Agent relative relative relative relative
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MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 1 1 1 1 1 1
BMP-2 0.5 3 11 1 1 2 2 2 4 0  0 . 1  0 . 2
BMP-7 3 3 14 2 3 13 2 2 4 1 1 9
TGF-beta 3 8  67 1 2 5 0  1 6 1 1 7
BMP-7+ TGF-beta 28 4 1 10
BMP-2, BMP-7 
+ TGF-beta 1 2 5 0
■ i 0
critical H values 11.07 11.07 11.07 ^ 11.07
calculated H values 8.009 8.809 8.562 10.962
There was no significant difference in the transcript expression o f any o f the genes tested 
following treatment with calcitriol and TGF-beta, alone or in combination, therefore the 
null hypothesis is upheld.
Null hypothesis 12:
Overexpression o f M SX-2 has no effect on the induction o f M SX-2 expression in 
osteoblast-like cells by calcitriol
Cells untreated MG-63 MC3T3-E1 ROS 17/2.8 R 2/8  R 2/11
MSX-2 expression 1 0.1 0.8 1 2.1 0.4
1 0.4 1.3 1 2.5 0.7
1 1.2
1 2.1
critical H value 11.07 
calculated H value 8.267
There was no significant difference in the transcript expression of any o f the genes tested 
following treatment with calcitriol and TGF-beta, alone or in combination, therefore the 
null hypothesis is upheld.
In the following section, the effects o f the osteogenic factors on the expression o f  
osteoblast-related genes in adult human trabecular bone-derived cells are examined.
Null hypothesis 13:
Calcitriol has no effect on the level of osteoblast-related gene expression in adult human 
trabecular bone-derived cells




expression expression expression expression
0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  1 1 1 1 1
1 0 7M 1. 2 1.3 0.9 1. 2
1 0 8M 1 1.1 1.9 3.1 3.7 1. 1 1.2 6.4 18.6 18.7 0.5 0.7 0.9 3.1 3.5 0.8 0.8 1.8 2.4 3.1
10-9M 1. 2 1 0.5 0 . 6
1 0 ,0M 0 . 8 0 . 8 0.3 0.9
1 0 n M 0 . 1 0.4 0 . 2 0.5
Critical
H values 11.07 11.07 11.07 11.07
Calculated 
H values 9.240 10.960
<
7.131 6.097
No significant effect of calcitriol on the expression of any o f the genes of interest was 
seen, therefore the null hypothesis is upheld.
Null hypothesis 14:
BMP-2 has no effect on the level o f osteoblast-related gene expression in adult human 
trabecular bone-derived cells
BMP-2 relative relative relative relative
(ng/ ml) MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
0 1 1 1 1 1 1 1 1 1 1 1 1
5 6.4 3.4 6 . 0 12.4
1 0 22.7 7.4 14.1 14.3
2 0 42.7 5.1 15.2 19.9
50 11.5 4.3 1 2 .2 11.4
1 0 0 0 .8  2 .2 12.8 15.0 3.5 4.6 6.9 8.0
Critical
H values 7.467 7.467 7.467 7.467
Calculated
H values 6.667 7.667 7.667 7.667
BMP-2 was seen to have significant effects on the expression of osteocalcin, BMP-2 and 
BMP-4 mRNA, therefore the null hypothesis that BMP-2 does not affect the expression of 
these genes must be rejected. BMP-2 was not shown to have a significant effect on the 
expression o f MSX-2 transcipts, therefore the null hypothesis is upheld for the expression 
of this gene following treatment with the agent.
Q values





1 0 0.775 1.581
2 0 0.258 0.516 1.265
50 0.258 0.516 0.258 0.949
1 0 0 1.044 0.745 0.447 1.342 2.600
50 2 0 10 5 0
The effect of BMP-2 on osteocalcin expression in adult human trabecular bone-derived 




1 0 0.516 1.898
2 0 0.258 0.775 2.214
50 0.516 0.258 0.258 1.581
1 0 0 0.745 1.342 1.044 0.447 1 .0 0 0
50 2 0 10 5 0





1 0 0.258 _1.898
2 0 0.258 0.516 2.214
50 0.775 0.516 0.258 1.265
1 0 0 0.447 1.342 1.044 0.745 1 .0 0 0
50 2 0 1 0 5 0
There is no significant effect o f BMP-2 on BMP-4 expression in adult human trabecular 
bone-derived cells.
Therefore, the overall significant stimulation in osteocalcin, BMP-2 and BMP-4 mRNA 
expression elicited by BMP-2 treatment was not shown to be statistically related to the 
dose o f the agent when individual treatment groups were compared.
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Null hypothesis 15:
BMP-7 has no effect on the level o f osteoblast-related gene expression in adult human 
trabecular bone-derived cells
BMP-7 relative relative relative relative
(ng/ ml) MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
0 1 1 1 1 1 1 1 1 1 1 1 1
1 0 0 .8 3.0 1 .6 i 1
2 0 8.7 4.8 7.1 1.9
50 16.0 1.3 * 4.8
1 0 0 0.5 1.4 5.3 4.1 16.5 20.9 1.6 2.5 4.1 V ' 0.4 0.7 2.0
Critical '
H values 7.111 7.111 7.111 7.111
Calculated
H values 4.978 7.111 7.244 3.511
BMP-7 was seen to have significant effects on the expression of osteocalcin and BMP-2 
mRNA, therefore the null hypothesis that BMP-7 does not affect the expression o f these 
genes must be rejected. The null hypothesis is upheld for the expression of MSX-2 and 
BMP-4 as following treatment with BMP-7 no statistically significant effect was seen.
Q values




2 0 0.516 1.581
50 0.775 0.258 0.633
1 0 0 1.094 0 .2 0 0 0.796 2.268
50 2 0 1 0 0






50 0.258 1.162 2.214
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100 0.945 0.647 0.397 1.532
50 20 10 0
There is no significant effect of BMP-7 on BMP-2 expression in adult human trabecular 
bone-derived cells.
Therefore, the overall significant stimulation in osteocalcin and BMP-2 expression elicited 
by treatment with BMP-7 was not seen to be specifically related to dose o f the agent when 
individual treatment groups were compared.
Null hypothesis 16:




1 1 1 1 1 1  
3.5 0.8 1.4 1.8 2.4 3.1 
6.9 8.0
6.5 7.3
expression in adult human trabecular bone-derived cells
Agent relative relative relative
MSX-2 osteocalcin BMP-2
expression expression expression
untreated 1 1 1 1 1 1 1  1 1  1 1 1 1 1
calcitriol 1 1.8 1.9 3.1 3.7 1 1.2 6.4 18.6 18.7 0.5 0.9 1.2 3.1
BMP-2 0.8 2.2 12.8 15.0 3.5 4.6
calcitriol
+ BMP-2 3 .14 .3  31.5 34.1 4.1 4.9
critical H values 6.777 6.777 6.777 6.777
calculated H values 7.004 9.326 7.867 9.343
There were significant differences in the transcript expression o f all o f the genes tested 
following treatment with calcitriol and BMP-2, alone or in. combination, therefore the null 
hypothesis is rejected with regard to the expression of all four genes.
Q values





calcitriol + BMP-2 1.733 1.014 2.357
BMP-2 calcitriol untreated
Calcitriol and BMP-2, alone or in combination, have no significant effect on MSX-2 gene 






calcitriol + BMP-2 0.956 1.486 2.857
BMP-2 calcitriol untreated
Calcitriol and BMP-2 in combination have a significant effect on osteocalcin gene
expression in adult human trabecular bone-derived cells when compared to untreated cells.




BMP-2 1.614 1.929 '
calcitriol + BMP-2 0.299 1.971 2.286
BMP-2 calcitriol untreated
Calcitriol and BMP-2, alone or in combination, have no significant effect on BMP-2 gene 





calcitriol + BMP-2 0.239 1.429 2.286
BMP-2 calcitriol untreated
Calcitriol and BMP-2, alone or in combination, have no significant effect on BMP-4 gene 
expression in adult human trabecular bone-derived cells.
Therefore, the overall significant stimulation seen in the. expression levels o f all genes 
tested was largely not seen when comparisons between individual treatment groups were 
made. The only specific significant stimulation was seen in osteocalcin expression 
folowing treatment with calcitriol and BMP-2 in combination when compared to untreated 
control cells.
Null hypothesis 17:
Calcitriol and BMP-7, alone or in combination, have no effect on osteoblast-related gene 
expression in adult human trabecular bone-derived cells
Agent relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 1  1 1  1 1 1 1 1 1 1 1 1 1 1
calcitriol 1 1.8 1.9 3.1 3.7 1 1.2 6.4 18.6 18.7 0.5 0.9 1.2 3.1 3.5 0.8 1.4 1.8 2.4 3.1
BMP-7 0.5 1.4 5.3 4.1 16.5 20.9 1.6 2.5 4.1 0.4 0.7 2.0
calcitriol
+ BMP-7 0.9 1.8 24.8 26.2 2.8 3.6
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0.1 0.7
critical H values 7.815 7.815 7.815 7.815
calculated H values 4.135 10.167 6.102 6.700
There were significant differences only in the transcript expression o f osteocalcin  
following treatment with calcitriol and BMP-7, alone or in combination, therefore with this 
exception, the null hypothesis is upheld.
Q values ^





calcitriol + BMP-7 1.022 1.603 2.940
BMP-7 calcitriol untreated
Calcitriol and BMP-7 in combination have a significant effect on osteocalcin gene 
expression in adult human trabecular bone-derived cells when compared to untreated cells. 
No other significant effect was seen.
Similar to the observations following treatment o f adult human trabecular bone-derived 
cells with calcitriol and BMP-2 in combination, the overall significant stimulation in 
expression levels of osteocalcin was largely not seen when individual treatment groups 
were compared, except for the augmentation in expression observed when the cells were 
treated with calcitriol and BMP-7 in combination as compared to untreated cells.
Null hypothesis 18:
Calcitriol and TGF-beta, alone or in combination, have no effect on osteoblast-related gene 
expression in adult human trabecular bone-derived cells
Agent relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 1  1 1  1 1 1 1 1 1 1 1 1 1 1
calcitriol 1 1.8 1.9 3.1 3.7 1 1.2 6.4 18.6 18.7 0.5 0.9 1.2 3.1 3.5 0.8 1.4 1.8 2.4 3.1
TGF-beta 2.5 3.1 10.5 12.9 2.4 3.8 4.5 5.3
calcitriol
+TGF-beta 3.0 3.6 25.8 29.2 2.7 3.7 1.5 1.9
critical H values 6.777 6.777 6.777 6.777
calculated H values 7.747 9.326 5.583
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7.943
There were significant differences in the transcript expression of MSX-2, osteocalcin and 
BMP-4 following treatment with calcitriol and TGF-beta, alone or in combination, 
therefore with the exception of BMP-2 expression, which was not enhanced following 










calcitriol + TGF-beta 0.299 0.771 2.286
TGF-beta calcitriol untreated
Calcitriol and TGF-beta, alone or in combination, have no significant effect on MSX-2 





calcitriol + TGF-beta 0.956 1.486 2.857
TGF-beta calcitriol untreated
Calcitriol and TGF-beta in combination have a significant effect on osteocalcin gene 
expression in adult human trabecular bone-derived cells when compared to untreated 





calcitriol + TGF-beta 1.076 0.286 1.429
TGF-beta calcitriol untreated
TGF-beta alone has a significant effect on BMP-4 gene expression in adult human 
trabecular bone-derived cells when compared to untreated cells. No other treatment, alone 
or in combination, was seen to be significant.
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Interestingly, this experiment yielded overall significant stimulation in the expression o f  
all the genes tested, with the exception o f BMP-2. Following comparison of the individual 
treatment groups, osteocalcin and BMP-4 expression was stimulated by treatment with 
calcitriol and TGF-beta in combination and TGF-beta alone when compared to untreated 
control, respectively.
Null hypothesis 19:
Calcitriol and FGF-2, alone or in combination, have no effect on osteoblast-related gene 













expression expression expression expression
1 1 1 1 1 1  1 1  1 1 1 1 1 1 1 1 1 1 1  
1.8 1.9 3.1 3.7 1 1.2 6.4 18.6 18.7 0.5 0.9 1.2 3.1 3.5 0.8 1.4 1.8 2.4 3.1 
14.2 3.0 1.1
4.6 0.5 2.3 1.2
critical H values 6.077 6.077 6.077 6.077
calculated H values 7.023 7.023 2.323 4.292
There were significant differences in the transcript expression o f MSX-2 and osteocalcin 
following treatment with calcitriol and FGF-2, alone or in combination, therefore for these 
two genes only, the null hypothesis must be rejected.
Q values














Calcitriol and FGF-2, alone or in combination, have no significant effect on MSX-2 gene 













Calcitriol and FGF-2, alone or in combination, have no significant effect on osteocalcin 
gene expression in adult human trabecular bone-derived cells.
Therefore, the overall significant stimulation in MSX-2 and osteocalcin transcript levels 
was not related to specific effects o f individual treatment groups.
Null hypothesis 20 :
Members o f the TGF-beta superfamily, alone or in combination, have no effect on 
osteoblast-related gene expression in MG-63 cells
1) Compare BMP-2 and BMP-7






untreated 1 1 1 1 1 1 1 1 1 1 1 1
BMP-2 0 . 8 2 . 2 1 2 .8 15.0 3.5 4.6 6.9 8 .0
BMP-7 0.5 1.4 5.3 4.1 16.5 20.9 1 .6 2.5 4.1 0.4 0.7 2 .0
BMP-2
+BMP-7 1 .1 1 .2 16.3 19.3 1 .6 2 .0 5.9 7.1
critical H values 6.527 6.527 6.527 6.527
calculated H values 1.181 6.472 7.277 6.818
There were significant differences in the transcript expression of BMP-2 and BMP-4 
following treatment with BMP-2 and BMP-7, alone or in combination, therefore for these 
two genes only, the null hypothesis must be rejected.
Q values





BMP-2 + BMP-7 0.572 1.238 1.176
BMP-7 BMP-2 untreated
BMP-2 and BMP-7, alone or in combination, have no significant effect on BMP-2 gene 














BMP-2 and BMP-7, alone or in combination, have no significant effect on BMP-4 gene 
expression in adult human trabecular bone-derived cells.
Therefore, the overall significant stimulation in BMP-2 and BMP-4 transcript levels was 
not seen following comparison of individual treatment groups.













untreated 1 1 1 1 1 1 1 1 1 1 1
BMP-2 0 .8 2 .2 12.8 15.0 3.5 4.6 6.9 8 .0
TGF-beta 2.5 3.1 10.5 12.9 2.4 3.8 4.5 5.3
BMP-2
+TGF-beta 1.4 5.3 12.4 14.8 2.7 3.0 4.1 4.9
critical H values 6.333 6.333 6.333 6.333
calculated H values 4.933 5.933 6.333 7.133
There were significant differences in the transcript expression o f BMP-2 and BMP-4 
following treatment with BMP-2 and TGF-beta, alone or in combination, therefore for 
these.two genes only, the null hypothesis must be rejected.
Q values









BMP-2 and TGF-beta, alone or in combination, have no significant effect on BMP-2 gene 










BMP-2 + TGF-beta 0.365 1.278 1.200
TGF-beta BMP-2 untreated 
BMP-2 and TGF-beta, alone or in combination, have no significant effect on BMP-4 gene 
expression in adult human trabecular bone-derived cells.
As for the previous experiment, the overall significant stimulation in BMP-2 and BMP-4 
mRNA expression levels was not seen following comparison of individual treatment
groups.
3) Compare BMP-7 and TGF-beta
Agent relative relative relative /elative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 1 1 1 1 1
BMP-7 0.5 1.4 5.3 4.1 16.5 20.9 1.6 2.5 4.1 0.4 0.7
TGF-beta 2.5 3.1 10.5 12.9 2.4 3.8 4.5 5.3
BMP-7
+TGF-beta 5.9 9.5 21.2 23.8 4.1 4.7 0.5 1.6
critical H values 6.527 6.527 6.527 6.527
calculated H values 5.981 7.727 7.727 4.527
There were significant differences in the transcript expression o f osteocalcin and BMP-2 
following treatment with BMP-7 and TGF-beta, alone or in combination, therefore for 
these two genes only, the null hypothesis is rejected.
Q values





BMP-7 + TGF-beta 1.321 1.147 2.713
TGF-beta BMP-7 untreated
BMP-7 and TGF-beta in combination have a significant stimulatory effect on osteocalcin 
gene expression in adult human trabecular bone-derived cells when compared to untreated 






BMP-7 + TGF-beta 1.073 1.114 2.623
TGF-beta BMP-7 untreated 
BMP-7 and TGF-beta, alone or in combination, have no significant effect on BMP-2 gene 
expression in adult human trabecular bone-derived cells.
The overall stimulation in BMP-2 transcript levels was not seen following comparisons 
between the individual treatment groups. However, following treatment with both agents 
in combination, osteocalcin mRNA levels were significantly increased when compared to 
those seen in the untreated control.
Null hypothesis 21:
Members o f the TGF-beta superfamily, alone or in combination with FGF-2, have no 
effect on osteoblast-related gene expression in MG-63 cells
1) Compare BMP-2 and FGF-2
Agent relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expressioi
untreated 1 1 1 1 1 1 1 1 1 1 1
BMP-2 0.8 2.2 12.8 15.0 3.5 .4.6 6.9 8.0
FGF-2 2.8 14.2 3.0 ' 1.1
BMP-2
+FGF-2 2.3 0.1 2.5 1.2
critical H values 5.833 5.833 5.833 " 5.833
calculated H values 4.083 5.833 6.083 6.083
There were significant differences in the transcript expression of osteocalcin, BMP-2 and 
BMP-4 following treatment with BMP-2 and FGF-2, alone or in combination, therefore 
with the exception of MSX-2 expression, which was seen to be unaffected by treatment, 
the null hypothesis is rejected.
Q values










BMP-2 and FGF-2, alone or in combination, have no significant effect on osteocalcin gene 









BMP-2 + FGF-2 0.833 0.289 0.913
FGF-2 BMP-2 untreated
BMP-2 and FGF-2, alone or in combination, have no significant effect on BMP-2 gene 





BMP-2 + FGF-2 0.500 0.289 1.278
FGF-2 BMP-2 untreated
BMP-2 and FGF-2, alone or in combination, have no significant effect on BMP-4 gene 
expression in adult human trabecular bone-derived cells.
Therefore, the overall stimulation in expression of osteocalcin, BMP-2 and BMP-4 mRNA 
transcripts was not seen when the individual treatment groups were compared.
2) Compare BMP-7 and FGF-2
Agent relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 1 1 1 1 1 1
BMP-7 0.5 1.4 5.3 4.1 16.5 20.9 1.6 2.5 4.1 0.4 0.7 2.0
FGF-2 2.8 14.2 3.0 1.1
BMP-7
+FGF-2 5.4 25.6 4.4 3.4
critical H values 6.333 








There were significant differences in the transcript expression of osteocalcin and BMP-2 
following treatment with BMP-7 and FGF-2, alone or in combination, therefore for these 
two genes only, the null hypothesis is rejected.
Q values





BMP-7 + FGF-2 0.737 0.775 2.213
FGF-2 BMP-7 untreated
BMP-7 and FGF-2, alone or in combination, have no significant effect on osteocalcin gene 





BMP-7 + FGF-2 0.844 0.516 2.123
FGF-2 BMP-7 untreated
BMP-7 and FGF-2, alone or in combination, have no significant effect on BMP-2 gene 
expression in adult human trabecular bone-derived cells.
Therefore, the overall significant stimulation in osteocalcin and BMP-2 mRNA expression 
was not seen when individual treatment groups were compared.
3) Compare TGF-beta and FGF-2
Agent relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
untreated 1 1 1 1 1 1 1 1 1 1 1 1
TGF-beta 2.5 3.1 10.5 12.9 2.4 3.8 4.5 5.3
FGF-2 2.8 14.2 3.0 1.1
TGF-beta
+FGF-2 2.6 19.4 2.6 4.9
critical H values 5.833 5.833 5.833 5.833
calculated H values 5.417 6.083 5.417 5.833
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There were significant differences in the transcript expression of osteocalcin and BMP-4 
following treatment with TGF-beta and FGF-2, alone or in combination, therefore for 
these two genes only, the null hypothesis is rejected.
Q values














BMP-7 and FGF-2, alone or in combination, have no significant effect on osteocalcin gene 









BMP-7 and FGF-2, alone or in combination, have no significant effect on BMP-4 gene 





Therefore, the overall significant stimulation in osteocalcin and BMP-4 transcript levels 
was not seen when the individual treatment groups were compared.
Null hypothesis 22:
The presence o f an extracellular matrix has no effect on the calcitriol-induced expression 
of osteoblast-related genes in human bond-derived cells
Cells
untreated 
10 nM calcitriol 
ascorbate-2-phosphate 
ascorbate-2-phosphate 
+ 10 nM calcitriol
relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
1 4 1 19 0.5 2 1 2
1 1 1 2  1 1 1 19 1 1 2 3 1 1 1 2
critical H value 6.386 6.386 6.386 6.386
206
calculated H values 2.636 6.659 1.977 1.045
The only significant effect o f calcitriol and/ or ascorbate-2-phosphate was seen on 
osteocalcin expression, therefore, with the exception o f this gene, the null hypothesis is 
upheld.
Q values









There was no significant effect on osteocalcin expression following treatment with 





Therefore, the overall stimulation in osteocalcin expression levels seen following culture 
in ascorbate-2-phosphate and/ or calcitriol was not related to individual treatment groups.
In the follow ing section, the expression patterns o f osteoblast-related genes in 
subpopulations o f adult human trabecular bone- and bone marrow-derived cells were 
examined. The subpopulations were obtained by physical separation using FACS 
following the labelling for the cell surface expression o f Stro-1 and alkaline phosphatase 
antigens.
Null hypothesis 23:
There is no difference in osteoblast-related gene expression between subpopulations of 
adult human bone marrow-derived cells




R2 0.3 0.6 1.2 1.6
R3 0 0 0.4 2.5
R4 1 1 1 1  




0 0.2 0.7 0.2 0.2 0.4 41.5 0.1
0 0.3 0.4 0 0.5 0.8 3.3 0
1 1 1  1 1 1 1 1  










H values 7.235 7.000 7.235 7.235
calculated
H values 1.163 5.154 1.483 2.796
There is no significant difference between the gene expression levels in the four 
subpopulations of untreated cells, therefore the null hypothesis is upheld.





1.9 10.0 50.0 















0 0.1 0.7 4.5
0.3 0.4 2.0 2.3 
1 1 1 1  






0 0 0.3 9.1
0 0.1 1.7 2.7
1 1 1 1  






0 0.1 0.9 3.9
0.1 1.8 2.0 5.0 
1 1 1 1  
0 0.1 0.8 1.5
7.235
3.722
There is no significant difference between the gene expression levels in the four 
subpopulations of calcitriol-treated cells, therefore the null hypothesis is upheld.




0.4 4.4 11.0 6.3 30.0
0.3 10.0 10.0
1 1 1 1  1 1





























O.'l 0.9 3.9 
0.8 2.5 
1 1 1 1  
0 3.2 7.3 12.4
6.874
4.368
The only significant difference between the gene expression levels in the four 
subpopulations of dexamethasone-treated cells is in BMP-2 expression, therefore for this 
gene only, the null hypothesis is rejected.
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Q values





R5 2.135 0.184 0.488
R4 R3 R2
There are no significant differences in BMP-2 expression between the fpur subpopulations 
of dexamethasone-treated adult human bone marrow-derived cells.
Therefore, the general significant effects on BMP-2 expression following culture in 
dexamethasone were not seen when individual fractions were compared.
3) cells treated with dexamethasone and calcitriol
Subpopulation relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
R2 20.5 33.0 0.9 6.0 0.4 8.9 2.0 6.8
R3 10.0 1.1 10.0 10.0
R4 1 1 1 1 1 1 1 1 1 1 1
R5 1.8 3.4 25.0 0 0.7 3.6 0.6 1.5 16.3 0.9 1.0
critical
H values 6.244 6.244 6.244 6.244
calculated
H values 6.311 1.511 2.044 2.800
1
48.3
The only significant difference between the gene expression levels in the four 
subpopulations of cells cultured in dexamethasone and treated with calcitriol is in MSX-2 
expression, therefore for this gene only, the null hypothesis is rejected.
Q values





R5 1.641 0.105 0.933
R4 R3 R2
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There are no significant differences in MSX-2 expression between the four subpopulations 
o f  adult human bone marrow-derived cells cultured in dexamethasone and treated with 
calcitriol.
Therefore, the overall stimulation in MSX-2 expression levels following culture in the 
presence of dexamethasone and calcitriol was not seen when cell fractions were compared 
against each other.
Null hypothesis 24:
There is no difference in osteoblast-related gene expression between^subpopuiations of 
adult human trabecular bone-derived cells














0 1.9 1.9 17.8 0 0.5 0.8 1.9
1 1 1 1 1 1 1 1  
0.3 0.7 7.3 0.3 1 7.1 0




0 0.3 1.1 11.0
1 1 1 1  
2. 0 3. 6 5. 0 










0 0.6 1.5 16.5





There is no significant difference between the gene expression levels in the four 
subpopulations o f untreated adult human trabecular bone-derived cells, therefore the null 
hypothesis is upheld.














































There was one significant difference, between the mRNA expression levels of MSX-2, in 
the four subpopulations o f calcitriol-treated adult human trabecular bone-derived cells, 
therefore for this gene only, the null hypothesis is rejected.
Q values
■ i





R5 2.008 0.730 2.200
R4 R3 R2
There are no significant differences in MSX-2 expression between the four subpopulations 
of calcitriol-treated adult human trabecular bone-derived cells.
Therefore, the significant effect o f calcitriol on MSX-2 expression was not specifically 
related to changes in expression between the four fractions o f cells.












0.1 1.1 1.2 1.5 1.1 1.1 2.8
1.3 1.3 4.6 












0.4 3.1 6.8 11.7 
0.2 1.9 4.0  
1 1 1 1  





1.5 2.0 4.0 17.8
1.5 4.0 25.0 
1 1 1 1  
0.4 0.6 1.1 16.2
7.279
*****_ greater than 6.957, less than 7.235
There was one significant difference, between the mRNA expression levels of BMP-4, in 
the four subpopulations of dexamethasone-treated adult human trabecular bone-derived 
cells, therefore for this gene only, the null hypothesis is rejected.
Q values






R5 0.395 1.733 1.660
R4 R3 R2
There are no significant differences in BMP-4 expression between the four subpopulations 
o f dexamethasone-treated adult human trabecular bone-derived cells.
Therefore, the overall significant effects o f dexamethasone on the expression o f BMP-4 
transcripts are not seen when the individual fractions are compared.
4) cells treated with calcitriol and dexamethasone
Subpopulation relative relative relative relative
MSX-2 osteocalcin BMP-2 BMP-4
expression expression expression expression
R2 2.3 4.9 5.8 8.9 8.7 10.7 9.3 10.9
R3 2.9 1.6 1.7 6.4
R4 1 1 1 1 1 1 1 1
R5 2.4 14.7 3.3 11.4 2.0 6.7 6.4 6.9
critical
H values 5.679 5.679 5.679 5.679
calculated
H values 3.964 4.821 5.679 5.439
There was one significant difference, between the mRNA expression levels o f BMP-2, in 
the four subpopulations o f adult human trabecular bone-derived cells treated with calcitriol 
and dexamethasone, therefore for this gene only, the null hypothesis is rejected.
Q values





R5 1.389 0.694 0.926
R4 R3 R2
There are no significant differences in BMP-2 expression between the four subpopulations 
of adult human trabecular bone-derived cells treated with calcitriol and dexamethasone.
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Therefore, the overall significant effects on BMP-2 transcript expression of treatment with 
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